data_2ju7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ju7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.698 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 68.6 p . . . . . 0 N--CA 1.441 -0.884 0 CA-C-O 120.637 0.256 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.97 -174.29 18.26 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.573 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.989 ' HE2' HG12 ' A' ' 127' ' ' ILE . 6.1 mtpt -97.64 120.71 38.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.642 0.734 . . . . 0.0 110.685 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 35.9 m-85 -123.79 124.95 43.82 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.402 ' CG ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.57 138.86 31.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -168.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.458 HG22 ' HD3' ' A' ' 122' ' ' ARG . 1.6 t -70.77 127.96 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.398 0.618 . . . . 0.0 109.918 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.784 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.2 mm100 -111.59 -47.24 3.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.518 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.548 ' HB2' HG11 ' A' ' 123' ' ' VAL . 24.3 m -161.61 152.82 18.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.987 -172.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.512 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -145.57 156.5 43.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.257 0.551 . . . . 0.0 111.362 174.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.81 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 51.3 mm-40 -97.51 142.81 28.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.954 174.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 16' ' ' GLU . 1.9 m-80 69.22 26.48 5.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 33' ' ' LYS . 4.7 p90 -63.26 -0.31 0.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.663 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 80.7 mt-10 -116.84 -51.2 0.04 OUTLIER Pre-proline 0 C--O 1.216 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.155 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 27.1 Cg_exo -55.43 -42.81 64.39 Favored 'Trans proline' 0 CA--C 1.511 -0.656 0 C-N-CA 121.853 1.702 . . . . 0.0 112.732 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -60.55 -49.6 76.87 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.833 -1.531 . . . . 0.0 109.601 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.043 ' HB2' HD12 ' A' ' 29' ' ' ILE . 25.2 mmt -63.02 -43.7 98.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.447 176.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 15.5 ptmt -64.71 -36.94 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.925 -171.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -73.37 -36.82 66.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.851 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -82.96 -28.18 29.98 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.6 -39.7 0.36 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.372 -1.394 . . . . 0.0 114.402 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.634 HD22 HG12 ' A' ' 29' ' ' ILE . 13.0 tp -80.65 129.09 69.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 117.689 0.745 . . . . 0.0 110.131 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.586 ' CG ' HD12 ' A' ' 28' ' ' LEU . 93.2 Cg_endo -73.5 146.87 40.09 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.296 1.998 . . . . 0.0 111.196 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.866 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 7.4 tt0 -48.81 -41.22 32.01 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.108 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.724 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 29.3 t70 -64.1 -37.44 87.45 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 119.197 0.908 . . . . 0.0 110.871 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.586 HD12 ' CG ' ' A' ' 25' ' ' PRO . 31.1 mt -69.78 -34.46 73.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 19' ' ' MET . 20.4 mt -64.11 -45.94 95.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.431 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.599 172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.043 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 35.1 mm-40 -51.32 -48.17 62.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.671 0.748 . . . . 0.0 112.078 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.724 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -63.53 -30.05 71.22 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.619 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.62 41.14 1.46 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.438 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 1.043 ' HE2' ' HA ' ' A' ' 30' ' ' GLN . 15.7 ptpt -79.96 -41.45 25.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -165.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 38.7 t70 -109.96 60.37 0.6 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.917 0.865 . . . . 0.0 110.562 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 mm -80.89 130.27 36.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.026 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.85 146.55 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.3 169.05 27.02 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 8' ' ' GLN . 15.2 t -127.85 141.55 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.339 0.569 . . . . 0.0 109.494 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.718 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.5 t -119.02 131.76 56.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -125.01 122.92 38.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.595 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.698 ' O ' ' HB2' ' A' ' 4' ' ' SER . 97.1 mt -117.47 138.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 49' ' ' LYS . 96.8 t -109.15 119.87 59.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.615 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.646 ' H ' ' HB3' ' A' ' 4' ' ' SER . 10.6 t-160 -97.77 114.72 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.352 0.596 . . . . 0.0 110.562 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -133.17 141.55 48.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -37.24 114.27 0.24 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 113.642 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 28.0 mtmt 75.47 -43.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.882 1.273 . . . . 0.0 112.539 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -96.28 109.79 22.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.897 0.856 . . . . 0.0 111.822 -171.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.7 128.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.261 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 78.0 mttt -107.94 125.44 51.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.297 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.656 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -120.04 123.64 43.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.6 m -106.84 124.15 49.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.656 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.2 mt -131.3 122.27 50.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.332 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.658 HG21 HG22 ' A' ' 58' ' ' VAL . 19.8 m -101.45 130.08 47.61 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.063 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.648 ' HD2' ' HE3' ' A' ' 74' ' ' MET . 30.4 t80 -116.64 106.21 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.35 -99.58 0.09 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.04 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t -99.09 -24.4 14.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.418 0.628 . . . . 0.0 110.483 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HE2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.96 123.01 47.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.239 -169.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.658 HG22 HG21 ' A' ' 53' ' ' THR . 24.3 t -98.26 124.8 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-O 121.873 0.844 . . . . 0.0 109.55 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -116.45 114.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.82 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 148.5 26.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.28 -1.782 . . . . 0.0 112.378 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -139.7 87.84 2.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.487 0.661 . . . . 0.0 110.482 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 33.4 mt-10 -107.21 127.16 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.643 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.506 ' HE1' ' HG2' ' A' ' 91' ' ' MET . 9.7 p90 -150.43 152.0 33.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.09 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.3 m -106.54 132.44 52.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.601 ' O ' HD11 ' A' ' 65' ' ' LEU . 3.8 pp -47.17 143.36 3.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 112.394 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 68.42 25.03 74.99 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.569 177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -135.24 145.45 47.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 23.6 tt0 -76.6 118.64 19.46 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.2 m -134.03 158.75 42.75 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.273 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 4.1 mt-10 -97.6 120.64 38.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.5 1.143 . . . . 0.0 111.906 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.766 HD13 ' HB1' ' A' ' 81' ' ' ALA . 32.5 mt -93.69 121.59 35.27 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.732 -2.031 . . . . 0.0 109.872 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.496 ' OE1' HG12 ' A' ' 59' ' ' ILE . 15.8 tt0 -95.22 120.54 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.46 ' O ' HD11 ' A' ' 59' ' ' ILE . 24.2 p -86.72 164.19 16.88 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.648 ' HE3' ' HD2' ' A' ' 54' ' ' TYR . 23.4 ttt -64.61 -14.65 58.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.198 0.523 . . . . 0.0 109.827 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -85.9 -40.7 15.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.798 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.42 -13.32 4.01 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.148 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.54 129.65 35.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.663 -0.316 . . . . 0.0 111.315 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -105.17 130.52 53.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 176.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -134.64 147.99 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.065 0.46 . . . . 0.0 112.048 -175.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 51.0 mttm -82.7 123.27 29.13 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.766 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -143.64 145.19 32.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.5 t -90.5 112.84 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.488 0.661 . . . . 0.0 109.803 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.714 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -109.14 134.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.363 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -113.67 153.1 29.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.602 ' HG2' ' HG3' ' A' ' 91' ' ' MET . 9.4 tmm? -129.41 124.88 35.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.257 1.027 . . . . 0.0 110.015 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 6.1 tp10 -56.67 -60.64 3.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.959 -1.928 . . . . 0.0 113.736 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 145.56 -54.38 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.552 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 23.0 t70 -80.67 27.24 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.008 0.909 . . . . 0.0 109.086 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.553 ' H ' ' C ' ' A' ' 87' ' ' GLY . 7.2 m-80 65.37 58.49 0.85 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.685 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.789 ' HE2' ' HG2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -108.14 121.37 44.71 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.602 ' HG3' ' HG2' ' A' ' 85' ' ' MET . 1.4 mpp? -118.27 114.61 23.26 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 84' ' ' LYS . 3.5 t -124.84 122.02 62.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.196 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.714 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.71 144.17 51.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.207 0.527 . . . . 0.0 110.61 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -122.31 126.43 48.09 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -138.58 114.6 10.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt 56.85 -102.45 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.268 0.355 . . . . 0.0 111.128 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.32 14.14 12.19 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.595 HD13 HD22 ' A' ' 115' ' ' LEU . 1.6 mm -94.37 113.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' MET . 18.2 ttpt -110.16 118.17 35.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.943 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -114.85 120.62 40.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.162 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.73 119.91 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.287 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.553 HG22 ' HE1' ' A' ' 104' ' ' PHE . 2.6 m -117.69 120.5 38.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.789 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 5.0 tm-20 -130.29 127.27 39.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.144 -0.347 . . . . 0.0 110.669 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 109' ' ' ILE . 7.1 m-30 -104.74 114.79 29.22 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 126.23 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.413 0.445 . . . . 0.0 110.771 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.56 31.79 71.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.811 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 64.06 19.34 11.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.99 0.516 . . . . 0.0 112.253 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.0 p -116.02 130.57 56.87 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.564 HD12 ' CE1' ' A' ' 104' ' ' PHE . 6.1 mt -110.21 128.59 66.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.834 -170.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -116.88 120.19 37.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.94 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.7 121.78 45.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.695 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 4.4 m -120.36 120.58 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.647 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.527 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 65.9 mtt -119.68 149.72 41.53 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.149 0.499 . . . . 0.0 110.36 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 49.8 m -118.86 119.82 35.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.595 HD22 HD13 ' A' ' 98' ' ' ILE . 3.4 tm? -123.79 113.49 18.63 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.623 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.56 10.78 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.952 0.882 . . . . 0.0 109.357 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -97.74 141.33 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.696 -173.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.86 114.95 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.621 0.724 . . . . 0.0 111.267 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.614 ' HD2' ' O ' ' A' ' 13' ' ' GLU . 1.3 t80 -117.01 125.58 51.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.68 -170.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.81 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -124.97 129.83 51.13 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.998 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.458 ' HD3' HG22 ' A' ' 9' ' ' VAL . 30.3 ttm180 -116.96 137.8 51.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.52 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.784 HG13 ' HB2' ' A' ' 10' ' ' GLN . 12.7 p -101.87 117.06 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.88 0.847 . . . . 0.0 109.771 173.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 16.2 m -121.36 127.9 51.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.079 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -121.3 137.54 54.65 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.299 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 24.5 ttt180 -68.1 147.77 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.989 HG12 ' HE2' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 C--O 1.247 0.948 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -170.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.64 ' HB3' ' C ' ' A' ' 41' ' ' ILE . 58.6 m . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 120.872 0.368 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.59 -164.04 28.47 Favored Glycine 0 CA--C 1.499 -0.933 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.888 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.856 ' HE3' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -90.03 117.8 29.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.732 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 59.2 m-85 -132.06 127.67 36.61 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.4 140.74 37.05 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.24 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 t -66.19 137.51 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.147 0.975 . . . . 0.0 111.566 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.521 ' HB3' HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -114.2 -59.94 1.95 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.942 -168.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.53 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 11.5 m -158.02 153.9 26.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.435 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.528 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -145.98 155.42 42.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.615 0.722 . . . . 0.0 112.015 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.747 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 16.6 mm-40 -94.2 142.11 27.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.342 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 9.0 m-20 72.61 -82.42 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.472 0 O-C-N 123.559 0.537 . . . . 0.0 111.876 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.61 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.8 p90 39.93 28.03 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.266 1.826 . . . . 0.0 113.236 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.665 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 74.5 mt-10 -147.26 -49.9 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.634 -172.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.777 ' HB2' HG23 ' A' ' 118' ' ' ILE . 59.6 Cg_endo -74.7 -23.98 13.95 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 108.411 -1.419 . . . . 0.0 108.411 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 118' ' ' ILE . 3.5 t80 -60.8 -52.79 63.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.983 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.004 ' HB2' HD12 ' A' ' 29' ' ' ILE . 24.6 mmt -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.526 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 7.5 ptmm? -66.05 -33.06 74.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.126 0.488 . . . . 0.0 110.069 -174.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.79 86.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.457 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.8 ptm -85.86 -22.16 27.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.88 -39.02 0.69 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.677 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 19' ' ' MET . 14.9 tp -75.54 130.01 80.5 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 117.308 0.554 . . . . 0.0 110.478 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' HD13 ' A' ' 28' ' ' LEU . 88.3 Cg_endo -78.1 153.83 28.72 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.799 1.666 . . . . 0.0 111.346 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.842 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.6 tt0 -50.09 -44.34 51.88 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.383 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.621 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 7.7 t70 -59.12 -37.26 76.8 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.308 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.835 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.8 mt -72.32 -37.5 68.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.912 0.387 . . . . 0.0 110.076 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 19' ' ' MET . 38.9 mt -59.22 -44.2 91.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.904 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.842 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.3 mm-40 -54.03 -34.01 58.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.621 1.169 . . . . 0.0 111.775 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 2.1 mptp? -68.44 -33.03 73.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.961 0.41 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.55 35.66 2.37 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.835 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 25.3 pttm -79.1 -32.24 44.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.297 0.57 . . . . 0.0 112.321 -169.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -99.16 24.55 7.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.062 -167.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.523 HD12 HG21 ' A' ' 35' ' ' ILE . 33.0 mt -81.13 115.93 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.372 0.606 . . . . 0.0 112.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -109.8 126.69 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.329 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -115.31 -169.02 15.71 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.963 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 11.1 t -121.57 141.1 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.8 t -117.01 139.22 50.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 1.1 mm-40 -135.23 124.59 24.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.965 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.862 HG12 ' HG ' ' A' ' 50' ' ' LEU . 5.1 mt -127.96 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.1 -171.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -111.16 120.47 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.627 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.567 ' H ' ' HB2' ' A' ' 4' ' ' SER . 11.5 t-160 -92.41 114.52 27.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.805 0.812 . . . . 0.0 110.45 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 142.21 46.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -33.58 111.17 0.06 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.643 0.589 . . . . 0.0 113.998 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.807 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 2.3 mtmt 66.62 -45.47 0.44 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.476 1.51 . . . . 0.0 113.342 -173.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -90.74 107.45 19.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.762 0.791 . . . . 0.0 111.282 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.618 HG21 ' SD ' ' A' ' 85' ' ' MET . 90.6 t -123.09 125.87 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.159 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -109.24 130.47 55.49 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.248 0.547 . . . . 0.0 109.678 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.862 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -116.42 133.33 56.14 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.88 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.822 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.1 m -114.34 124.88 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.644 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.9 mt -131.84 121.96 48.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.692 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 26.4 m -96.8 127.81 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.627 ' HD1' ' HE2' ' A' ' 74' ' ' MET . 50.0 t80 -120.88 107.34 12.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.91 -98.07 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.565 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -103.95 -24.14 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.854 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.633 ' HE2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.41 128.73 55.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.189 -172.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.649 HG22 HG21 ' A' ' 53' ' ' THR . 26.9 t -96.6 125.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.925 0.869 . . . . 0.0 109.522 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 73' ' ' THR . 1.3 mt -112.51 112.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.524 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.625 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -91.37 141.47 28.72 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.668 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.4 m120 -125.29 83.73 2.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.747 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 43.1 tt0 -102.24 126.75 49.32 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -147.62 153.08 38.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.955 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 13.5 m -114.05 128.68 56.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.807 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -58.59 143.32 46.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.155 0.502 . . . . 0.0 111.941 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.448 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 59.0 23.38 56.99 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.58 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 8.8 tt0 -145.32 133.13 21.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -80.48 119.42 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.285 0.564 . . . . 0.0 110.66 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.8 t -136.3 163.64 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.256 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -95.1 119.57 33.84 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.317 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 61.6 mt -100.72 122.39 43.27 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.728 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 59' ' ' ILE . 39.2 tt0 -89.24 128.1 35.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.654 ' O ' HD12 ' A' ' 59' ' ' ILE . 13.2 p -84.78 168.03 15.53 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.833 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.627 ' HE2' ' HD1' ' A' ' 54' ' ' TYR . 11.9 tpt -56.16 -28.22 57.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.437 0.637 . . . . 0.0 109.978 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 -27.73 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.995 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 123.12 -11.2 8.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.658 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.35 127.03 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.901 0.351 . . . . 0.0 110.466 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.84 127.65 48.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.65 147.07 27.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.362 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -82.01 123.77 29.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.479 0.657 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB1' ' CD1' ' A' ' 71' ' ' LEU . . . -139.07 147.44 42.02 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.49 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -95.26 111.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.649 0.738 . . . . 0.0 109.368 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.7 m -100.73 133.37 44.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.49 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.448 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 3.9 mmtt -106.08 151.37 24.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.734 ' HE1' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ttt -132.89 131.42 40.9 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.317 1.056 . . . . 0.0 112.785 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.104 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 5.4 tp10 -84.95 139.32 31.9 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 112.766 -2.015 . . . . 0.0 108.57 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -60.83 -25.39 63.77 Favored Glycine 0 C--O 1.23 -0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.953 -168.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.722 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 32.5 t70 -83.68 23.09 1.01 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 110.208 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.734 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 10.5 m-80 71.53 57.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.962 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 1.104 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -113.19 121.84 45.69 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 1.041 ' HG2' ' HB ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -116.78 115.8 26.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.118 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.733 HG11 HG23 ' A' ' 101' ' ' VAL . 5.3 t -125.73 117.7 49.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.568 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -129.86 144.29 51.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.408 0.623 . . . . 0.0 111.765 -177.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 59.3 m -127.26 131.74 50.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.774 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.45 130.04 27.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.825 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 64.05 -75.84 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.78 0.675 . . . . 0.0 110.948 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.63 29.9 0.25 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 98' ' ' ILE . 38.9 mm -116.55 131.92 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.58 -0.81 . . . . 0.0 108.851 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 113' ' ' MET . 11.6 ttmm -112.63 128.15 56.3 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.825 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 93' ' ' THR . 13.3 m -122.18 119.91 32.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.733 HG23 HG11 ' A' ' 92' ' ' VAL . 99.2 t -123.4 117.35 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 110.595 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 1.041 ' HB ' ' HG2' ' A' ' 91' ' ' MET . 32.3 m -118.31 121.38 40.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.885 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 8.2 tm-20 -129.55 128.38 42.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.881 0.372 . . . . 0.0 110.633 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 5.3 m-30 -96.88 115.37 27.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.074 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.96 102.87 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.754 175.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 108' ' ' THR . . . 54.24 75.03 0.25 Allowed Glycine 0 N--CA 1.455 -0.087 0 CA-C-O 119.758 -0.468 . . . . 0.0 113.701 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 6.6 t70 72.23 -26.44 0.18 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 106' ' ' GLY . 7.7 p -107.21 134.68 49.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.037 0.922 . . . . 0.0 112.315 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.551 HD12 ' CE1' ' A' ' 104' ' ' PHE . 4.4 mt -109.38 127.11 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.079 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -104.54 118.35 36.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 54.3 t30 -109.58 121.25 44.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.613 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.32 114.9 21.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.721 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.617 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 22.1 ttt -127.26 150.36 49.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -126.98 120.29 28.73 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.156 -0.34 . . . . 0.0 110.098 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.597 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -108.62 113.55 26.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.74 -91.84 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.31 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.17 1.64 7.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.934 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -91.32 141.53 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.815 -172.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.8 116.32 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.896 0.855 . . . . 0.0 110.585 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.617 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 60.8 t80 -103.52 117.98 35.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.88 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.747 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -124.22 124.63 42.86 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 33.9 ttt180 -127.24 132.67 50.34 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.973 -169.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 11.2 p -101.52 118.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.182 171.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 m -127.64 134.19 49.64 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.3 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.609 ' HZ1' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -136.19 150.55 49.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.336 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 ttt180 -69.06 149.35 48.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.849 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.856 HG13 ' HE3' ' A' ' 6' ' ' LYS . 3.0 pt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.104 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.674 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 30.0 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.75 179.73 16.0 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.343 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.706 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -106.99 122.48 46.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.726 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.9 m-85 -127.85 126.01 40.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -93.83 134.25 36.38 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -172.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -70.04 134.38 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.677 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.5 mm100 -115.71 -40.87 3.29 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.105 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.697 ' HB2' HG11 ' A' ' 123' ' ' VAL . 58.2 m -156.24 151.47 26.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.819 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.905 0.859 . . . . 0.0 111.109 174.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -103.28 130.09 50.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.902 176.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 3.2 m-20 67.96 21.27 8.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.506 ' O ' ' HG2' ' A' ' 19' ' ' MET . 47.5 p90 -67.35 17.07 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.89 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.4 mt-10 -132.6 -44.58 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 123.175 0.59 . . . . 0.0 111.18 -173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.914 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 38.1 Cg_endo -70.07 -28.77 23.35 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 C-N-CA 121.734 1.623 . . . . 0.0 109.637 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -65.57 -52.53 51.61 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.111 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.066 ' HB2' HD12 ' A' ' 29' ' ' ILE . 83.8 mmm -61.22 -37.86 84.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.685 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.914 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 8.4 pttt -69.73 -36.27 75.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.206 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -71.34 -25.99 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.59 172.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.588 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 29.6 tpp -82.61 -43.76 16.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.027 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.44 -42.75 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 HG12 ' A' ' 29' ' ' ILE . 12.8 tp -78.86 128.57 76.32 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.577 ' CG ' HD12 ' A' ' 28' ' ' LEU . 95.0 Cg_endo -73.32 149.95 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.228 1.952 . . . . 0.0 111.498 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.793 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 2.6 tt0 -50.09 -44.43 51.99 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.673 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 36.6 t70 -56.97 -42.96 81.11 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.803 0.729 . . . . 0.0 110.19 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.577 HD12 ' CG ' ' A' ' 25' ' ' PRO . 45.1 mt -68.47 -33.5 74.27 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.466 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 19' ' ' MET . 28.0 mt -62.87 -47.1 94.44 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.699 170.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.977 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 21.6 mm-40 -53.09 -38.46 62.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.229 1.012 . . . . 0.0 112.474 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.977 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.64 -30.2 68.85 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.739 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.77 28.98 5.07 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.86 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -78.25 -39.56 39.81 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -166.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -96.29 54.41 1.41 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.645 0.736 . . . . 0.0 110.812 -166.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 35' ' ' ILE . 31.4 mm -99.53 133.16 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.61 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 147.0 33.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.765 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.796 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -144.85 -172.57 15.43 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.981 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG23 ' HG3' ' A' ' 8' ' ' GLN . 60.8 t -123.71 143.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.241 0.521 . . . . 0.0 110.732 -173.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 51' ' ' THR . 14.9 m -122.96 120.99 35.03 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.809 0.338 . . . . 0.0 110.122 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HG2' ' CG ' ' A' ' 6' ' ' LYS . 25.5 mt-10 -116.32 124.52 50.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.166 0.508 . . . . 0.0 109.633 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 96.7 mt -123.66 134.58 66.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.915 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.88 114.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.674 ' H ' ' HB3' ' A' ' 4' ' ' SER . 3.3 t-160 -115.07 113.51 24.14 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.042 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 37.3 tt0 -111.07 143.1 42.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -35.17 108.4 0.05 OUTLIER Glycine 0 C--O 1.225 -0.425 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.59 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.757 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 16.2 mtmt 83.78 -40.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.603 1.561 . . . . 0.0 113.079 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.65 112.15 23.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.104 0.478 . . . . 0.0 110.606 -172.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.32 123.0 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.69 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 18.2 mtpp -113.47 130.87 56.23 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -127.61 130.59 49.25 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -118.04 122.69 43.8 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.67 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.8 mt -124.79 120.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 24.5 m -102.69 127.28 49.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -121.38 107.63 12.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.39 -95.44 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.627 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -107.86 -18.26 13.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 0.0 111.211 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HE3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -113.09 128.54 56.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.17 0.51 . . . . 0.0 111.254 -170.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 31.8 t -97.43 125.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 122.052 0.93 . . . . 0.0 109.592 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -114.52 114.16 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.909 -177.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 144.66 27.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.005 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m120 -129.02 138.85 52.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -145.08 124.73 13.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -151.39 152.29 32.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.03 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.654 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 4.7 m -108.0 132.0 53.98 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 pp -45.55 146.25 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 112.156 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.1 13.0 69.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.439 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.0 mm-40 -124.66 143.48 50.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.703 0.287 . . . . 0.0 110.293 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 80' ' ' LYS . 22.9 tt0 -84.54 116.91 23.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 63.3 m -134.03 158.83 42.55 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.285 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mt-10 -94.83 120.14 34.55 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 122.793 1.282 . . . . 0.0 111.681 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 28.9 mt -100.76 128.52 46.77 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.222 -2.263 . . . . 0.0 110.706 -170.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.744 ' HB3' HG23 ' A' ' 59' ' ' ILE . 16.1 tt0 -85.79 122.01 29.25 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.758 ' O ' HD11 ' A' ' 59' ' ' ILE . 12.6 p -85.85 164.53 17.46 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.255 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.57 -22.7 62.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.25 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.8 -41.27 53.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.761 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' A' ' 59' ' ' ILE . . . 140.27 -21.49 2.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.316 176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.66 139.44 39.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.618 0.709 . . . . 0.0 111.438 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.01 123.37 41.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.126 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 144.91 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 135.79 34.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.371 0.605 . . . . 0.0 111.966 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.682 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -147.5 152.46 38.08 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.051 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 HG22 ' HG3' ' A' ' 68' ' ' GLU . 70.1 t -95.78 112.43 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.844 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.765 ' CA ' ' HB ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -100.11 133.96 41.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.095 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.1 mmtt -103.28 151.44 22.68 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . 4.7 ttp -128.91 132.91 47.71 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.682 -1.207 . . . . 0.0 113.041 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.025 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.5 tp10 -100.45 141.13 33.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 112.367 -2.197 . . . . 0.0 108.303 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.87 -36.66 60.48 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.954 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' C ' HD21 ' A' ' 89' ' ' ASN . 19.4 t0 -87.92 53.64 2.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.805 0.812 . . . . 0.0 110.077 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.668 ' HB2' ' CD2' ' A' ' 104' ' ' PHE 0.251 0.0 OUTLIER 49.41 49.88 19.07 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.821 174.519 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 1.025 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 61.7 mttt -112.39 122.17 46.94 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.318 170.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.628 ' HE1' ' HZ ' ' A' ' 104' ' ' PHE . 5.7 mtm -129.17 117.05 20.15 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -122.16 118.64 56.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.345 -173.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.765 ' HB ' ' CA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -126.61 140.44 52.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.572 0.701 . . . . 0.0 111.451 -177.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -128.07 138.8 52.7 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.752 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.4 124.16 21.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 60.87 -101.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.024 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.32 15.46 6.41 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.485 HD13 ' HG ' ' A' ' 115' ' ' LEU . 37.5 mm -98.75 114.27 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 113' ' ' MET . 59.6 tttt -104.69 118.88 37.65 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.513 -171.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 m -115.67 118.95 34.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG23 HG13 ' A' ' 92' ' ' VAL . 98.1 t -113.41 120.41 63.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.716 HG22 ' HE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -117.34 119.84 36.35 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.268 174.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 90' ' ' LYS . 28.7 tt0 -129.67 119.92 24.32 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.85 ' CD1' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -113.97 119.2 36.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.697 176.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.03 138.09 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.463 170.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.71 96.63 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.648 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.597 ' HA ' ' HE2' ' A' ' 7' ' ' TYR . 25.8 m-20 70.07 4.98 5.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.72 0.408 . . . . 0.0 112.089 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -110.85 123.35 49.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 111.34 173.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.85 HG21 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mt -102.15 124.75 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.045 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' THR . 19.5 m -115.07 120.9 41.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.718 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.737 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 3.2 t-20 -116.06 121.27 41.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.892 0.377 . . . . 0.0 110.392 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.828 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -120.98 117.81 28.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.96 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 65.9 mtt -111.95 150.91 29.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.339 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 m -127.62 121.84 31.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -121.86 113.84 20.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.45 -93.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.883 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.62 17.06 3.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 110.112 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -85.53 137.44 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.19 114.62 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.675 0.75 . . . . 0.0 111.084 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 112' ' ' THR . 41.9 t80 -102.78 119.08 38.21 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.828 ' HG2' HG21 ' A' ' 112' ' ' THR . 0.8 OUTLIER -128.92 131.03 47.51 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 7.4 ptt180 -124.33 144.37 50.05 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.631 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 11' ' ' SER . 11.7 p -100.83 117.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.11 0.957 . . . . 0.0 109.488 173.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.506 ' HG ' HG22 ' A' ' 9' ' ' VAL . 73.9 m -123.66 121.52 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.568 -1.197 . . . . 0.0 108.646 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.467 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.11 149.33 52.13 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.58 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.726 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 15.9 ttp180 -70.17 146.62 50.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.673 -166.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.706 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.835 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 56.1 p . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.01 -172.43 21.59 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.641 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 2.8 mtpp -95.99 130.12 43.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.504 0.669 . . . . 0.0 109.811 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 17.5 m-85 -135.07 133.6 39.47 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -106.21 135.82 47.01 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 37' ' ' GLY . 1.2 p -68.84 141.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.592 0.711 . . . . 0.0 109.782 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.811 HE21 ' HA ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -113.69 -49.58 2.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.88 -171.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.486 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 14.7 m -159.69 159.63 33.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.871 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . 2.3 mt-30 -142.09 153.58 44.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.537 0.684 . . . . 0.0 111.93 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.478 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 1.2 mp0 -94.37 137.39 33.58 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.703 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.702 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 8.5 m-20 70.23 -83.35 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 O-C-N 123.892 0.745 . . . . 0.0 110.594 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.95 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.3 p90 37.66 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.75 1.62 . . . . 0.0 112.702 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.702 ' HG3' ' O ' ' A' ' 14' ' ' ASN . 46.7 mt-10 -145.01 -47.97 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.434 -172.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.677 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 44.1 Cg_endo -76.31 -25.25 10.06 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.963 -1.207 . . . . 0.0 108.963 170.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 118' ' ' ILE . 38.2 t80 -66.47 -52.59 44.58 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.063 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.035 ' HB2' HD12 ' A' ' 29' ' ' ILE . 17.5 mmt -64.04 -37.51 87.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.156 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.9 pttp -67.12 -39.12 86.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.542 ' HB3' ' HG ' ' A' ' 115' ' ' LEU . . . -72.06 -24.14 61.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.516 174.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.566 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 30.0 tpp -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.879 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.53 -38.16 0.3 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.315 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.7 HD22 HG12 ' A' ' 29' ' ' ILE . 15.0 tp -77.55 131.03 72.23 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.671 ' HD2' HD13 ' A' ' 28' ' ' LEU . 90.9 Cg_endo -79.1 151.74 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.502 1.468 . . . . 0.0 111.19 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.855 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 18.1 tt0 -50.59 -40.16 51.71 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.937 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 4.5 p-10 -60.84 -36.36 78.92 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 118.339 0.518 . . . . 0.0 111.511 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD13 ' HD2' ' A' ' 25' ' ' PRO . 21.7 mt -71.92 -36.88 70.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.301 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 19' ' ' MET . 30.8 mt -62.12 -43.74 98.16 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.369 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.855 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.2 mm-40 -50.23 -49.3 53.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.125 0.965 . . . . 0.0 111.846 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 2.2 mptp? -71.07 -30.32 66.43 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.829 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.99 32.74 3.9 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.931 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.95 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 13.9 ptmm? -78.81 -41.4 30.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.39 0.614 . . . . 0.0 112.589 -168.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.35 52.92 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.66 0.743 . . . . 0.0 110.785 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 35' ' ' ILE . 42.3 mm -92.91 131.18 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.643 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.717 ' HZ1' ' HB2' ' A' ' 36' ' ' LYS . 10.4 mtmp? -98.82 98.25 9.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.166 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -91.4 177.43 40.86 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.588 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.1 t -122.37 150.38 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 51' ' ' THR . 9.4 m -132.49 130.01 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 111.538 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.544 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 5.0 mp0 -122.87 140.02 53.4 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 4' ' ' SER . 61.2 mt -129.96 141.96 45.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.281 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 99.5 t -108.61 117.98 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 166.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.579 ' N ' ' HB3' ' A' ' 4' ' ' SER . 17.2 t-160 -95.16 115.21 27.13 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.442 0.639 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -137.61 143.11 41.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.535 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.73 107.95 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 O-C-N 123.835 0.709 . . . . 0.0 112.861 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.685 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mtmt 71.64 -38.65 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.843 1.257 . . . . 0.0 113.077 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.33 106.62 18.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.707 0.289 . . . . 0.0 110.878 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.26 122.9 66.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.23 0.538 . . . . 0.0 110.666 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.642 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 6.8 mptt -104.85 132.68 50.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.131 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.5 tt -120.14 132.49 55.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 39' ' ' SER . 17.2 m -117.92 124.04 47.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -128.43 121.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 62.1 m -104.01 129.41 51.61 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -118.07 107.26 13.78 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.99 -96.62 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.661 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 t -104.48 -24.1 13.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 0.0 110.645 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.74 128.48 49.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.84 0.829 . . . . 0.0 112.422 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.4 t -104.55 124.9 59.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.33 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.32 114.31 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.987 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -101.93 134.72 44.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.307 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.601 HD22 HG13 ' A' ' 59' ' ' ILE . 4.8 m120 -126.14 93.4 3.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -102.39 125.82 49.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.593 0.711 . . . . 0.0 109.915 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -149.57 152.89 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.27 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.573 HG23 ' OE2' ' A' ' 67' ' ' GLU . 3.6 m -109.15 132.4 54.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.345 174.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -52.09 140.11 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.798 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 65.31 24.11 70.44 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.522 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.573 ' OE2' HG23 ' A' ' 64' ' ' THR . 33.1 mt-10 -138.05 141.26 40.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -76.74 119.07 20.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.631 0.729 . . . . 0.0 109.734 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 m -132.9 152.6 51.85 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.899 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.6 pt-20 -95.57 145.37 25.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.282 1.039 . . . . 0.0 109.192 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.749 HD13 ' HB1' ' A' ' 81' ' ' ALA . 20.2 mt -110.51 133.73 53.02 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -168.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.678 ' OE2' ' HA ' ' A' ' 59' ' ' ILE . 8.1 tt0 -90.72 130.61 36.7 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.7 p -89.45 174.4 7.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.772 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.0 tpp -61.46 -25.93 67.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.6 . . . . 0.0 109.634 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.9 m -80.68 -39.06 27.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.093 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.67 1.13 7.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.523 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.68 138.89 37.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.846 0.323 . . . . 0.0 111.017 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 10.0 mmmm -97.72 131.75 43.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -136.58 133.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 34.0 mttm -83.05 123.46 29.5 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.507 0.67 . . . . 0.0 111.701 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.749 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -140.94 153.75 45.78 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.474 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -95.53 111.52 26.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.385 0.612 . . . . 0.0 109.944 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.752 ' CA ' ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -102.4 133.89 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.311 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 88.9 mttt -117.45 152.77 34.33 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.594 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.605 ' H ' ' HB2' ' A' ' 65' ' ' LEU . 5.1 ttm -118.45 119.83 35.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.29 1.043 . . . . 0.0 110.486 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.672 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 11.4 tp10 -63.37 -31.88 73.15 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.734 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.511 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 92.11 -32.23 5.54 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.622 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 37.2 t70 -94.69 62.2 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.582 0.705 . . . . 0.0 109.768 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 26.7 m-80 70.56 0.94 3.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.253 -1.34 . . . . 0.0 113.549 174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 33.0 mttp -109.4 122.91 48.4 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.788 -172.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.472 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 2.8 mpp? -117.7 115.46 25.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.808 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.38 124.2 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.689 -172.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.752 ' HB ' ' CA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -121.49 140.18 52.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.32 0.581 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.2 m -128.17 126.37 40.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.988 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -134.82 113.95 12.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.053 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 60.3 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.891 0.476 . . . . 0.0 111.354 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.85 10.42 3.38 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.545 HD13 HD11 ' A' ' 115' ' ' LEU . 2.0 mm -90.17 113.56 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -115.78 118.37 32.82 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.201 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.9 m -117.81 119.16 34.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.062 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.84 119.01 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.326 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 24.9 m -117.92 122.09 42.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.908 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.666 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 35.9 tt0 -128.74 129.15 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.724 0.297 . . . . 0.0 110.738 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 22.0 m-30 -95.07 120.51 35.4 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.003 177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 113.07 16.93 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.932 -0.48 . . . . 0.0 110.68 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.05 -102.3 0.83 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.779 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.97 17.23 6.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.138 0.494 . . . . 0.0 109.9 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.638 0.732 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.422 HD12 ' CE1' ' A' ' 104' ' ' PHE . 22.1 mt -111.4 128.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.789 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.7 m -104.67 119.34 38.77 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -118.31 122.72 43.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.226 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.671 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.2 117.5 26.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.444 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.583 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 5.1 ttm -118.63 146.07 44.94 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 m -128.75 121.79 29.19 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.543 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.545 HD11 HD13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -102.73 114.2 28.25 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 169.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -48.21 81.06 0.01 OUTLIER Glycine 0 N--CA 1.468 0.814 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -160.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.2 t70 157.18 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.627 1.571 . . . . 0.0 106.966 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -115.98 140.72 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.209 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.29 115.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.458 0.647 . . . . 0.0 111.155 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.449 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 3.6 t80 -100.06 118.74 37.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.671 ' HG2' HG21 ' A' ' 112' ' ' THR . 0.7 OUTLIER -123.86 131.83 53.65 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.508 HH12 HD11 ' A' ' 52' ' ' ILE . 45.1 ttt180 -124.39 131.69 53.51 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.061 -169.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 8.4 p -100.91 117.55 46.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.943 0.878 . . . . 0.0 109.431 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -131.67 136.9 48.05 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.928 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.445 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -135.08 150.88 50.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 0.0 111.399 -175.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 76.9 ttt180 -68.73 148.31 50.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.24 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.641 ' CG1' ' HB2' ' A' ' 6' ' ' LYS . 1.1 pp . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.034 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 80.6 p . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.93 -174.72 15.53 Favored Glycine 0 CA--C 1.507 -0.437 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.664 ' HE3' HG12 ' A' ' 127' ' ' ILE . 3.6 mtpp -93.39 118.49 31.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 9.9 m-85 -125.02 124.67 42.47 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -93.0 134.39 35.18 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.536 HG11 ' N ' ' A' ' 10' ' ' GLN . 25.3 t -68.08 137.38 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.925 0.869 . . . . 0.0 111.782 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.536 ' N ' HG11 ' A' ' 9' ' ' VAL . 1.2 mm100 -112.9 -69.12 0.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.699 -168.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.503 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 20.3 m -151.26 143.28 23.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.274 -170.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.795 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 5.5 mm-40 -121.3 157.61 29.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.499 0.666 . . . . 0.0 111.449 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.506 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 66.8 mt-10 -105.9 137.39 43.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.797 168.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.656 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 7.7 m-20 69.76 -80.52 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.87 0 O-C-N 123.524 0.515 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.795 ' CD1' ' HB2' ' A' ' 12' ' ' GLN . 34.0 p90 35.41 35.41 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.691 1.596 . . . . 0.0 113.374 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.664 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.6 mt-10 -152.9 -48.03 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.04 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.664 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 37.4 Cg_endo -75.73 -25.17 11.02 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 N-CA-C 108.657 -1.324 . . . . 0.0 108.657 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.762 ' HD2' HD11 ' A' ' 118' ' ' ILE . 52.6 t80 -65.94 -53.29 41.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.122 173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.104 ' HB2' HD12 ' A' ' 29' ' ' ILE . 16.9 mmt -61.93 -37.15 83.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.478 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 10.7 pttt -66.43 -41.71 88.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.075 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -72.07 -20.98 61.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.421 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.609 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 25.5 tpp -83.1 -46.21 13.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.871 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.49 -23.92 0.36 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.121 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.741 HD22 HG12 ' A' ' 29' ' ' ILE . 14.4 tp -91.95 132.91 31.51 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.616 ' CG ' HD12 ' A' ' 28' ' ' LEU . 85.0 Cg_endo -76.14 147.94 30.43 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.29 1.993 . . . . 0.0 111.7 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.825 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 4.2 tt0 -49.47 -44.64 46.02 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.56 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 5.1 t70 -61.35 -35.19 76.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.873 0.76 . . . . 0.0 111.445 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.616 HD12 ' CG ' ' A' ' 25' ' ' PRO . 41.1 mt -71.42 -35.71 71.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.874 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.104 HD12 ' HB2' ' A' ' 19' ' ' MET . 23.5 mt -63.73 -46.87 93.37 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.114 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.825 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 26.8 mm-40 -53.13 -38.62 62.84 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 111.376 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 3.8 mptp? -69.71 -46.54 65.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.313 0.578 . . . . 0.0 110.887 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.87 39.87 2.36 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.183 -170.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.492 ' HD2' ' OE2' ' A' ' 16' ' ' GLU . 18.2 pttp -79.77 -43.12 23.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.2 51.27 0.75 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.535 . . . . 0.0 112.0 -171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.667 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 9.3 mm -79.28 118.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.538 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -100.21 118.96 37.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.046 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -116.89 -160.75 12.01 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.462 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 39.6 t -125.53 137.45 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.728 0.264 . . . . 0.0 110.748 -174.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.5 t -110.22 134.6 52.07 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 30.6 mt-10 -136.89 121.17 18.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.85 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.6 mt -124.22 141.35 44.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 122.319 -0.238 . . . . 0.0 111.583 -169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 44' ' ' GLU . 86.1 t -110.56 114.83 48.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 165.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.414 ' H ' ' CB ' ' A' ' 4' ' ' SER . 20.3 t-160 -95.15 112.13 23.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.795 0.807 . . . . 0.0 109.576 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 42' ' ' VAL . 37.9 mt-10 -120.82 144.24 48.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.445 174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -35.85 105.72 0.03 OUTLIER Glycine 0 CA--C 1.52 0.388 0 O-C-N 123.793 0.683 . . . . 0.0 113.183 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 1.076 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 mtmt 72.85 -40.94 0.49 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.604 1.562 . . . . 0.0 113.631 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HZ1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -92.87 107.33 19.13 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.652 0.739 . . . . 0.0 111.544 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.94 124.76 73.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.228 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 44.1 mttp -110.83 123.04 49.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.28 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.85 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.6 tt -112.82 128.22 56.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.636 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 39' ' ' SER . 5.6 m -111.33 124.74 52.86 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.682 HG13 ' CD2' ' A' ' 50' ' ' LEU . 2.2 mt -131.12 120.86 47.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.715 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 43.4 m -98.75 127.09 44.57 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.667 ' CE1' ' HB ' ' A' ' 35' ' ' ILE . 48.5 t80 -121.5 108.11 13.24 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.0 -93.77 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.114 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -105.38 -23.46 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.063 0.459 . . . . 0.0 111.15 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.84 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.415 -170.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 71.3 t -98.08 125.33 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.769 0.795 . . . . 0.0 110.438 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.881 HG13 HD22 ' A' ' 61' ' ' ASN . 0.1 OUTLIER -99.85 115.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.245 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -102.49 126.65 49.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.36 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.881 HD22 HG13 ' A' ' 59' ' ' ILE . 3.6 m120 -127.8 97.38 4.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.522 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.13 125.7 50.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.712 ' CZ ' ' HB3' ' A' ' 61' ' ' ASN . 9.9 m-85 -129.06 152.8 48.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.177 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.5 m -112.59 122.7 48.46 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.076 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -46.51 125.67 7.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.181 0.515 . . . . 0.0 111.972 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' HD3' ' A' ' 84' ' ' LYS . . . 82.49 16.39 71.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.589 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.5 mm-40 -125.9 154.3 42.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.525 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 21.5 tt0 -79.87 119.31 22.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.6 m -132.79 156.58 46.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.496 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.541 ' HG3' ' HE2' ' A' ' 78' ' ' LYS . 3.3 pt-20 -96.18 143.93 26.85 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 12.5 mt -106.21 127.26 53.1 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.298 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.437 ' O ' HD12 ' A' ' 59' ' ' ILE . 46.6 tt0 -88.03 129.0 35.4 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 p -88.52 174.9 7.82 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.763 -172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.435 ' HB3' ' HE1' ' A' ' 19' ' ' MET . 20.2 ttt -70.14 -13.18 62.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.287 0.565 . . . . 0.0 109.761 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -90.9 -38.64 12.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.188 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.49 -13.86 4.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.493 -0.86 . . . . 0.0 114.157 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -80.4 147.04 31.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.584 0.692 . . . . 0.0 111.505 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 8.0 mmmm -96.24 136.47 36.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.551 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -138.0 143.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.875 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HD2' ' OE1' ' A' ' 68' ' ' GLU . 37.1 mtmt -84.9 126.6 33.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 111.758 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.544 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -146.52 146.85 30.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.05 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.7 113.06 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.003 0.43 . . . . 0.0 109.937 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.734 ' CA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.31 133.24 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.572 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.3 mmtt -104.97 151.87 23.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.08 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.724 ' HB3' HD23 ' A' ' 65' ' ' LEU . 11.7 tpp -128.68 134.79 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.371 1.081 . . . . 0.0 111.622 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.431 ' HB3' ' HG3' ' A' ' 90' ' ' LYS . 13.5 tp10 -82.12 -35.55 28.41 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.326 -176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 121.74 -36.5 3.22 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.178 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -78.82 26.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.858 1.313 . . . . 0.0 108.912 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.874 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 29.8 m-80 72.06 40.58 0.71 Allowed 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.582 168.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.877 ' HE2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -117.73 118.94 33.45 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 113.496 -1.684 . . . . 0.0 107.913 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.624 ' HA ' ' O ' ' A' ' 84' ' ' LYS . 42.4 mtm -116.65 123.03 46.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.848 0.832 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.85 118.7 54.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.663 -175.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.734 ' HB ' ' CA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.58 143.75 47.47 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.445 0.64 . . . . 0.0 111.356 -177.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 m -116.9 126.61 53.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.962 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.782 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 35.2 t80 -139.44 161.24 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.28 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 98' ' ' ILE . 22.8 ttmm -27.61 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.691 1.196 . . . . 0.0 114.008 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.34 8.49 19.02 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.58 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.782 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 26.3 mm -110.07 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -114.88 116.65 28.9 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.672 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.4 m -118.08 119.79 35.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 92' ' ' VAL . 84.6 t -115.71 117.52 55.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 m -118.89 120.95 38.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.877 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 24.2 tt0 -129.37 123.14 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.947 -0.471 . . . . 0.0 110.128 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.874 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 2.3 m-30 -89.71 114.0 25.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 172.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -125.45 112.13 15.91 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.72 -95.73 0.48 Allowed Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.215 -173.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -145.71 17.08 1.45 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 125' ' ' LYS . 5.2 m -128.07 135.3 49.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.884 0.85 . . . . 0.0 110.402 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.533 HG13 ' CD2' ' A' ' 7' ' ' TYR . 10.6 mt -102.62 131.45 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.593 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.6 m -115.36 119.22 35.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.133 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 19.4 t-20 -108.0 122.81 47.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.759 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.815 HG21 ' HG3' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -119.85 115.81 24.6 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mtt -114.1 150.12 34.55 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 110.262 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 32.1 m -126.61 122.5 35.21 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -116.73 111.16 19.39 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.14 -90.81 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.68 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -125.34 0.19 7.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.514 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -87.11 140.32 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 -177.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.76 116.36 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.471 0.653 . . . . 0.0 111.51 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.55 118.82 37.61 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.815 ' HG3' HG21 ' A' ' 112' ' ' THR . 20.8 ttpt -125.9 129.3 49.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.178 0.513 . . . . 0.0 109.65 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 34.8 ttm180 -120.22 127.17 52.19 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.261 -172.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 10' ' ' GLN . 14.7 p -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.1 m -135.34 130.09 34.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.913 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.582 ' HB3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -128.98 144.78 51.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.336 0.971 . . . . 0.0 112.552 -171.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.7 ttt180 -69.26 149.94 47.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.849 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.712 HD12 ' OXT' ' A' ' 127' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.822 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.531 ' HB3' ' N ' ' A' ' 43' ' ' HIS . 94.3 p . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.301 0.572 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.39 -178.48 17.06 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.14 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.563 ' HB2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -94.27 117.27 29.87 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 7.3 m-85 -122.39 132.41 54.36 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.773 ' HG3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.88 130.74 53.78 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.502 -174.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.72 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.47 139.05 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.854 176.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.785 ' HB2' HG13 ' A' ' 123' ' ' VAL . 4.8 mm-40 -111.05 -49.24 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.584 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB2' HG11 ' A' ' 123' ' ' VAL . 61.1 m -155.52 154.89 32.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.814 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -136.93 157.32 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.5 0.667 . . . . 0.0 111.375 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 4.3 mm-40 -114.03 130.59 56.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.994 176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.734 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.9 m-80 63.4 31.16 15.26 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.643 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 23.3 p90 -68.92 16.11 0.05 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.04 0.448 . . . . 0.0 110.87 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.818 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 40.7 mt-10 -129.12 -48.42 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.814 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.818 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.2 Cg_endo -69.91 -28.5 24.45 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.719 1.613 . . . . 0.0 110.297 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.515 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.1 OUTLIER -63.16 -52.55 61.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.369 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.935 ' HB2' HD12 ' A' ' 29' ' ' ILE . 85.9 mmm -61.78 -37.59 84.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.741 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 18.6 pttt -67.05 -37.31 83.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.229 0.538 . . . . 0.0 109.731 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -67.4 -25.36 65.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 18' ' ' PHE . 58.0 mtp -79.34 -53.4 6.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.26 -16.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.305 -0.862 . . . . 0.0 113.501 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD22 HG12 ' A' ' 29' ' ' ILE . 13.2 tp -81.68 130.7 60.23 Favored Pre-proline 0 N--CA 1.441 -0.891 0 CA-C-N 117.358 0.579 . . . . 0.0 109.924 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.58 ' CG ' HD12 ' A' ' 28' ' ' LEU . 91.6 Cg_endo -76.29 146.68 28.47 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.647 2.232 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.752 ' HA ' HD13 ' A' ' 29' ' ' ILE . 32.4 tt0 -50.72 -37.46 41.74 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.131 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.4 t70 -57.74 -47.19 83.17 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.165 0.893 . . . . 0.0 109.977 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.58 HD12 ' CG ' ' A' ' 25' ' ' PRO . 43.8 mt -68.75 -32.97 73.12 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.935 HD12 ' HB2' ' A' ' 19' ' ' MET . 36.0 mt -61.6 -44.82 99.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.027 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 18.5 mm-40 -52.24 -41.89 63.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.535 0.734 . . . . 0.0 111.789 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 1.027 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.81 -30.54 69.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.134 -176.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.36 32.14 3.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.964 -174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 20.5 pttm -79.63 -43.13 23.42 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -165.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.48 47.01 1.19 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.344 0.592 . . . . 0.0 111.922 -167.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.425 HG21 HD12 ' A' ' 35' ' ' ILE . 41.8 mm -81.6 118.36 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.15 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -84.85 145.86 27.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.082 0.468 . . . . 0.0 110.587 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.72 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -145.45 177.81 23.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.773 HG23 ' HG3' ' A' ' 8' ' ' GLN . 3.7 t -122.43 145.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.779 ' HA ' ' O ' ' A' ' 51' ' ' THR . 7.5 p -129.72 120.12 24.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.7 mp0 -110.12 124.07 50.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.876 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.787 HG12 ' HG ' ' A' ' 50' ' ' LEU . 76.3 mt -123.37 140.41 47.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -168.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.09 114.38 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.531 ' N ' ' HB3' ' A' ' 4' ' ' SER . 28.5 t-80 -105.06 114.11 28.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.323 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.29 143.81 49.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 169.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.35 107.85 0.05 OUTLIER Glycine 0 CA--C 1.522 0.491 0 O-C-N 123.517 0.511 . . . . 0.0 112.624 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.872 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.9 mtmm 76.86 -35.58 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.992 1.317 . . . . 0.0 113.069 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -90.53 109.57 20.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.15 0.5 . . . . 0.0 111.182 -172.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.1 t -123.0 128.8 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.343 0.592 . . . . 0.0 111.77 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 41.2 mtpt -109.42 126.83 53.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.787 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -118.87 122.59 42.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.779 ' O ' ' HA ' ' A' ' 39' ' ' SER . 3.2 m -108.5 125.15 51.48 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.669 HG13 ' CD2' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -130.75 122.63 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.545 0.688 . . . . 0.0 110.097 -170.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.4 m -103.85 129.78 51.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.196 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.434 ' C ' ' H ' ' A' ' 56' ' ' SER . 46.9 t80 -116.55 105.89 12.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.1 -17.44 0.11 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 54' ' ' TYR . 20.2 t 172.41 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.07 0.938 . . . . 0.0 109.608 -169.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -97.95 133.04 42.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.041 -169.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.6 t -99.63 124.69 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.579 0.704 . . . . 0.0 110.745 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -126.7 114.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.317 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.656 ' C ' HD21 ' A' ' 61' ' ' ASN . 0.3 OUTLIER -116.53 149.27 39.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -173.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.677 ' N ' HD21 ' A' ' 61' ' ' ASN . 0.5 OUTLIER -124.41 121.38 34.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.058 -171.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -103.69 126.26 50.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.175 0.512 . . . . 0.0 110.237 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -151.26 152.29 33.03 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.304 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 2.0 m -105.83 131.81 52.71 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 2.5 pp -72.72 168.54 18.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.762 0.791 . . . . 0.0 111.427 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 11.24 41.04 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.397 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 64' ' ' THR . 47.0 mt-10 -135.4 143.58 46.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -174.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.749 ' HB2' HG22 ' A' ' 82' ' ' VAL . 8.0 tt0 -83.26 117.11 22.74 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 67.6 m -132.97 157.39 45.28 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.878 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -94.98 119.57 33.72 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 122.876 1.322 . . . . 0.0 111.217 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.642 HD13 ' HB1' ' A' ' 81' ' ' ALA . 23.0 mt -102.69 145.89 29.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.704 -171.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 21.0 tt0 -109.25 123.86 49.95 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 p -91.43 167.93 11.91 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.253 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.556 ' HE3' HD11 ' A' ' 52' ' ' ILE . 2.0 mpt? -59.73 -29.0 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 110.62 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 p -81.18 -30.66 34.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.297 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.98 -5.99 9.55 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.45 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.28 140.74 38.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.346 0.573 . . . . 0.0 110.736 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HZ2' ' HB2' ' A' ' 72' ' ' GLU . 23.7 mmmt -95.67 128.16 42.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.17 137.5 48.34 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.654 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 69' ' ' CYS . 41.8 pttt -101.96 125.31 48.61 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.564 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.642 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -128.93 146.03 51.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.46 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 68' ' ' GLU . 91.8 t -92.79 111.89 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.811 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.05 131.07 53.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.342 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -104.09 152.48 22.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.776 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.72 ' HG3' ' SD ' ' A' ' 91' ' ' MET . 6.7 ttt -127.73 135.32 50.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.18 0.991 . . . . 0.0 111.488 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.078 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 9.2 tp10 -90.98 0.03 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.03 -1.895 . . . . 0.0 109.923 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.676 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 88.56 -65.73 3.29 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.858 173.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.482 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 19.1 m-20 -79.12 57.15 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 0.0 110.947 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.642 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 8.9 m-80 70.59 40.24 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.404 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 1.078 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -119.65 122.74 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.777 169.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.72 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -119.27 115.3 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 171.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 101' ' ' VAL . 2.1 t -125.26 118.86 53.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.811 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -130.04 143.8 50.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.786 0.803 . . . . 0.0 112.283 -178.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 t -126.96 136.99 53.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.806 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -139.86 131.7 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt 55.67 28.56 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.64 2.89 88.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.215 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -90.09 137.63 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 113' ' ' MET . 37.4 tttt -112.1 120.73 42.81 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.652 -172.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -121.52 120.78 35.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.999 0.428 . . . . 0.0 110.142 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 92' ' ' VAL . 95.4 t -116.4 121.07 66.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.798 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.535 HG21 ' HB2' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -117.19 121.28 40.78 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 177.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -121.36 115.91 23.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.722 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -118.0 119.49 34.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.48 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.15 114.75 17.41 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.514 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.59 46.6 4.85 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.43 11.4 5.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.098 0.475 . . . . 0.0 111.452 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 p -120.92 129.11 53.34 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.978 -0.451 . . . . 0.0 110.403 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.0 mt -109.75 130.24 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.726 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -116.92 119.36 35.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.535 ' HB2' HG21 ' A' ' 102' ' ' THR . 2.9 t-20 -115.38 123.33 48.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.854 0.359 . . . . 0.0 110.504 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 3.3 m -120.02 125.34 48.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.485 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.669 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 30.8 ttm -120.6 149.97 41.63 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.0 m -122.0 121.47 37.11 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -122.86 111.62 16.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 53.31 -101.64 0.09 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.59 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -100.9 -11.94 19.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 0.0 110.733 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -87.59 135.57 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.854 -170.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.404 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.6 p -112.62 115.2 49.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 121.292 0.568 . . . . 0.0 111.231 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.752 ' OH ' ' HD3' ' A' ' 122' ' ' ARG . 15.3 t80 -109.83 119.98 41.04 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 121.536 -0.728 . . . . 0.0 111.125 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.614 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 2.7 ttmt -123.92 124.52 42.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.749 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.752 ' HD3' ' OH ' ' A' ' 120' ' ' TYR . 22.2 ptt85 -119.38 144.14 47.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.371 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.2 p -100.99 118.86 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.483 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.449 ' HG ' HG22 ' A' ' 9' ' ' VAL . 65.4 m -123.55 130.41 52.64 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.421 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -134.01 139.01 45.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.038 0.447 . . . . 0.0 110.858 -174.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 2.9 ttt180 -71.85 149.28 45.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 112.055 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.577 ' N ' ' HG2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.71 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.626 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.32 177.18 15.25 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.691 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.974 ' HB2' HD11 ' A' ' 127' ' ' ILE . 44.6 mtpt -96.88 118.22 32.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 31.7 m-85 -120.81 125.08 46.63 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 15.4 tm0? -93.19 134.28 35.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.24 136.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.072 0.939 . . . . 0.0 109.666 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 123' ' ' VAL . 5.6 mm100 -111.52 -56.89 2.32 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.499 -167.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.63 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 57.3 m -152.97 150.75 29.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.666 HE21 HG23 ' A' ' 9' ' ' VAL . 17.8 mp0 -133.11 147.86 52.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.749 0.785 . . . . 0.0 110.998 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.932 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 9.7 mm-40 -92.55 127.76 38.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.092 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.545 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 45.3 m-20 70.06 -102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.094 0.871 . . . . 0.0 110.123 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CE1' ' HE2' ' A' ' 74' ' ' MET . 5.2 t80 72.82 13.19 5.13 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.249 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.715 ' HB2' ' HD3' ' A' ' 17' ' ' PRO . 33.3 mt-10 -141.2 -45.78 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.652 -171.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 16' ' ' GLU . 31.6 Cg_exo -60.97 -37.53 76.01 Favored 'Trans proline' 0 CA--C 1.494 -1.52 0 C-N-CA 122.439 2.093 . . . . 0.0 108.574 162.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -57.76 -53.92 52.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.113 -2.767 . . . . 0.0 109.628 175.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.069 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.13 -36.34 83.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.329 176.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.702 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 16.1 pttt -66.82 -40.15 87.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.08 28.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.1 -44.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -165.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.15 -51.26 0.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.591 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 28' ' ' LEU . 15.8 tp -85.08 135.8 39.04 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 116.945 0.372 . . . . 0.0 110.754 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.561 ' CG ' HD12 ' A' ' 28' ' ' LEU . 97.4 Cg_endo -77.69 151.43 28.43 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.968 2.445 . . . . 0.0 111.675 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.731 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -49.86 -45.39 50.46 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.891 -178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 2.4 p-10 -56.61 -42.26 78.46 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 118.664 0.666 . . . . 0.0 110.208 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.561 HD12 ' CG ' ' A' ' 25' ' ' PRO . 40.9 mt -70.55 -33.71 71.43 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.095 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 19' ' ' MET . 25.6 mt -64.75 -44.39 96.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 172.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.905 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 22.9 mm-40 -52.55 -40.72 62.83 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.079 0.952 . . . . 0.0 111.327 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.905 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -69.56 -31.29 69.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.713 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.63 33.41 2.87 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.902 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' ILE . 20.4 ptmt -78.61 -37.17 42.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.743 0.782 . . . . 0.0 112.784 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.41 51.11 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.96 -165.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 35' ' ' ILE . 27.3 mm -81.1 117.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -102.45 112.6 25.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.685 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -117.09 -163.15 12.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.142 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 23.7 t -129.32 150.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.2 p -127.96 118.47 23.63 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.972 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.715 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 1.7 mp0 -114.54 123.61 49.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.672 HG12 ' HG ' ' A' ' 50' ' ' LEU . 80.4 mt -122.6 137.83 54.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.078 0.466 . . . . 0.0 111.951 -170.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -109.46 118.58 57.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.626 ' H ' ' HB3' ' A' ' 4' ' ' SER . 15.2 t-160 -96.72 113.16 24.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.926 0.869 . . . . 0.0 110.499 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 8.3 tp10 -116.83 143.35 45.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.42 101.1 0.02 OUTLIER Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.824 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmt 79.1 -31.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.295 1.438 . . . . 0.0 112.353 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -90.44 108.85 20.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 0.0 110.601 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.59 124.13 67.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.359 0.599 . . . . 0.0 110.804 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 73.6 mttt -107.16 122.67 46.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.941 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.672 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -117.45 127.63 54.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.1 m -110.73 123.87 50.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.648 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -126.97 120.49 55.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.676 HG21 HG22 ' A' ' 58' ' ' VAL . 53.7 m -101.32 128.41 47.49 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.955 -171.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.5 t80 -110.35 157.8 19.13 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -43.06 101.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.608 0.567 . . . . 0.0 113.193 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 t 84.42 -21.59 0.25 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.369 1.068 . . . . 0.0 112.707 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 54' ' ' TYR . 4.2 tmmm? -131.49 122.97 27.1 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.783 -0.573 . . . . 0.0 111.733 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.676 HG22 HG21 ' A' ' 53' ' ' THR . 21.4 t -97.99 132.45 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 122.192 0.996 . . . . 0.0 111.407 -177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.668 HD13 ' HA2' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -117.84 114.77 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.506 -176.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.681 ' C ' HD21 ' A' ' 61' ' ' ASN . 10.0 p80 -91.36 146.36 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.118 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.681 HD21 ' C ' ' A' ' 60' ' ' HIS . 0.8 OUTLIER -131.57 105.32 7.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.774 0.429 . . . . 0.0 110.04 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -104.61 127.01 52.24 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.881 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -150.89 151.55 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 1.7 m -110.39 133.59 53.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.526 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.782 HD22 ' HE3' ' A' ' 85' ' ' MET . 4.0 pp -52.66 142.77 17.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.281 0.563 . . . . 0.0 111.129 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 25.08 76.4 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 64' ' ' THR . 70.3 mm-40 -132.75 138.22 47.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.478 0.18 . . . . 0.0 111.069 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.662 ' HB2' HG22 ' A' ' 82' ' ' VAL . 8.3 tt0 -78.53 118.08 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.606 0.717 . . . . 0.0 109.096 168.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.2 m -134.65 162.72 31.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.094 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.757 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 2.2 mt-10 -94.6 119.21 32.9 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.331 1.062 . . . . 0.0 110.585 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD13 ' HB1' ' A' ' 81' ' ' ALA . 25.5 mt -92.88 120.48 33.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.628 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.456 ' OE1' HG12 ' A' ' 59' ' ' ILE . 25.2 tt0 -92.79 121.9 34.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.477 ' O ' HD11 ' A' ' 59' ' ' ILE . 19.1 p -87.58 167.42 13.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.159 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.497 ' HE2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -56.01 -27.51 53.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 0.0 110.963 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -91.65 -12.6 33.69 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.668 ' HA2' HD13 ' A' ' 59' ' ' ILE . . . 122.23 -22.7 7.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.973 172.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.62 147.28 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.788 0.794 . . . . 0.0 111.147 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.22 132.03 56.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.791 -176.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.29 142.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.613 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.757 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 76.8 mttt -82.71 123.79 29.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.523 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.758 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -143.95 147.71 34.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.476 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 68' ' ' GLU . 44.3 t -91.34 113.44 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 109.694 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.744 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -95.62 133.11 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -103.02 140.04 37.8 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.782 ' HE3' HD22 ' A' ' 65' ' ' LEU . 8.0 tmm? -129.2 132.02 47.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.1 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.864 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 4.2 tp10 -80.28 -48.13 13.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.449 -2.16 . . . . 0.0 111.957 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 115.49 -45.21 1.33 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.225 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.08 44.22 0.75 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 122.51 1.148 . . . . 0.0 109.69 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 34.5 m-80 69.68 43.43 0.98 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.01 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.864 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 24.5 mttp -131.45 119.97 22.35 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.654 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 ttp -121.92 121.13 36.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.692 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.88 116.69 41.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.744 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -121.37 134.53 55.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.401 0.619 . . . . 0.0 110.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.8 m -128.33 127.36 42.55 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.557 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -122.69 111.46 16.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 46.51 -99.88 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.527 -173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.07 17.94 34.39 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.1 mm -100.88 113.13 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 113' ' ' MET . 42.1 tttp -113.86 118.99 35.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.571 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 93' ' ' THR . 32.1 t -120.64 119.81 33.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.763 0.316 . . . . 0.0 110.332 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 112' ' ' THR . 1.8 m -112.42 121.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 6.4 m -119.69 120.58 37.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.24 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 42.5 tt0 -130.55 129.19 42.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.101 -0.239 . . . . 0.0 111.029 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.645 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -109.79 118.69 37.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -129.24 102.97 6.69 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.122 171.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.85 62.46 2.81 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.312 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD2' ' HD3' ' A' ' 126' ' ' ARG . 7.3 m-20 67.88 -3.84 1.11 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.2 p -117.24 142.02 47.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.752 -0.592 . . . . 0.0 111.834 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.499 HD11 ' CG ' ' A' ' 7' ' ' TYR . 8.9 mt -116.91 135.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.521 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -112.22 119.81 39.63 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 169.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.8 t-20 -114.65 121.49 43.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 110.226 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 101' ' ' VAL . 6.6 m -122.35 117.86 27.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.638 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 33.9 ttm -124.67 149.34 47.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.3 m -123.88 121.85 36.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 118' ' ' ILE . 1.3 tp -117.56 114.58 23.64 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.566 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -82.89 0.19 Allowed Glycine 0 C--N 1.319 -0.366 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.603 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.07 5.64 2.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.862 0.839 . . . . 0.0 109.338 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -91.86 139.07 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.361 -173.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.404 ' H ' HG11 ' A' ' 119' ' ' VAL . 3.4 p -104.67 117.11 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.61 0.719 . . . . 0.0 110.757 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 27.2 t80 -107.16 120.41 42.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.735 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.932 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 3.6 mtmt -123.73 128.31 49.41 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.304 0.573 . . . . 0.0 109.673 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 14.7 ttt180 -119.75 132.34 55.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.067 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.63 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 7.7 p -100.5 117.42 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.537 ' HG ' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m -124.85 133.72 52.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.805 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.47 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.13 149.22 52.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 0.0 111.339 -176.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 ttp180 -69.6 150.47 47.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.053 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.8 pt . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.161 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 17.8 p . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.94 -176.53 16.11 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.819 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.734 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.79 116.93 30.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 50.9 m-85 -121.01 124.51 45.02 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.865 ' HG3' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.5 137.03 33.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.857 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -68.93 135.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.641 ' HB2' HG13 ' A' ' 123' ' ' VAL . 12.6 mm100 -110.76 -48.4 3.14 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.441 -168.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.576 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 31.3 m -158.12 156.75 31.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.542 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.22 158.18 45.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -119.7 125.79 49.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.663 -177.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.628 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 8.9 m-80 64.58 29.06 13.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 123.219 0.325 . . . . 0.0 111.704 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 1.019 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 29.6 p90 -67.58 6.12 0.69 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.078 0.466 . . . . 0.0 110.92 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.809 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 27.8 mt-10 -120.76 -46.23 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.142 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.873 ' HB2' HG23 ' A' ' 118' ' ' ILE . 32.9 Cg_endo -67.48 -29.71 37.0 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.4 1.4 . . . . 0.0 109.978 173.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.666 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 1.1 t80 -65.31 -52.18 55.72 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.48 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.972 ' HB2' HD12 ' A' ' 29' ' ' ILE . 87.1 mmm -61.04 -41.39 96.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.439 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.555 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 14.3 ptmt -68.78 -33.95 74.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.273 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -71.31 -22.71 61.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.15 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 18' ' ' PHE . 86.7 mmm -85.74 -72.15 0.5 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.38 0.609 . . . . 0.0 110.749 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.42 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.641 -172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.754 HD22 HG12 ' A' ' 29' ' ' ILE . 12.0 tp -86.23 125.03 69.26 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 117.952 0.876 . . . . 0.0 109.718 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.589 ' CG ' HD12 ' A' ' 28' ' ' LEU . 88.4 Cg_endo -72.21 148.18 49.33 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.496 2.131 . . . . 0.0 111.261 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.869 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 8.4 tt0 -48.84 -41.8 34.19 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.663 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.645 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 16.9 t70 -61.85 -37.86 86.08 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 118.944 0.793 . . . . 0.0 111.168 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.589 HD12 ' CG ' ' A' ' 25' ' ' PRO . 35.1 mt -70.37 -35.01 73.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.491 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 19' ' ' MET . 21.5 mt -63.92 -44.61 98.03 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.822 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.869 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.0 mm-40 -50.52 -47.73 57.36 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.974 0.892 . . . . 0.0 112.067 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.645 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -68.62 -30.84 69.65 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.641 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.04 31.65 4.43 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.088 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 1.019 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 14.0 ptmm? -79.23 -39.65 32.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -165.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.07 46.68 0.93 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.536 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 35' ' ' ILE . 7.8 mt -86.41 129.52 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 176.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 147.61 23.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 0.0 109.816 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.857 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -142.69 171.34 24.83 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.865 HG23 ' HG3' ' A' ' 8' ' ' GLN . 11.5 t -121.93 132.93 69.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 117.538 0.669 . . . . 0.0 110.588 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.707 ' HB3' HD23 ' A' ' 50' ' ' LEU . 5.7 m -113.42 120.64 41.75 Favored 'General case' 0 C--O 1.21 -0.997 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.17 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.734 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 46.9 mt-10 -119.66 123.0 42.75 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.117 0.484 . . . . 0.0 110.034 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 4' ' ' SER . 96.4 mt -119.31 138.28 50.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -168.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.83 115.07 48.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.229 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.552 ' N ' ' HB3' ' A' ' 4' ' ' SER . 27.3 t-80 -96.37 122.17 38.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 111.707 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.83 143.09 50.63 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -42.35 136.09 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.733 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.843 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 66.42 -50.97 0.43 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.198 0.999 . . . . 0.0 112.586 -174.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -99.13 109.26 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.457 0.646 . . . . 0.0 112.37 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG21 ' HE1' ' A' ' 91' ' ' MET . 80.7 t -122.72 129.14 75.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.96 -174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 39.0 mttp -109.77 135.21 51.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 39' ' ' SER . 1.6 tt -125.11 125.84 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.4 m -110.9 121.14 44.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.4 mt -123.96 121.1 61.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.436 0.636 . . . . 0.0 109.394 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.6 m -101.21 128.9 47.12 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.17 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t -121.31 -35.45 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.239 . . . . 0.0 111.559 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HZ2' HD13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -98.8 138.49 35.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.298 0.57 . . . . 0.0 112.127 -170.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.5 t -99.74 126.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.804 0.811 . . . . 0.0 110.769 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.759 HD13 ' HA2' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -118.94 114.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.002 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.584 ' C ' HD21 ' A' ' 61' ' ' ASN . 0.5 OUTLIER -87.15 146.5 26.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.342 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -127.78 106.91 9.45 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -108.01 126.18 52.41 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.695 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.21 152.28 34.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.309 0.576 . . . . 0.0 111.83 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 7.5 m -121.34 133.31 55.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.9 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 85' ' ' MET . 3.5 pp -46.39 141.95 3.28 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.449 0.642 . . . . 0.0 112.465 176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 66.06 21.9 70.18 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.91 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.5 mm-40 -132.44 140.94 48.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.712 0.256 . . . . 0.0 110.8 -174.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.672 ' HB2' HG22 ' A' ' 82' ' ' VAL . 9.5 tt0 -79.74 117.59 20.77 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.895 0.855 . . . . 0.0 109.311 171.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 m -128.4 159.27 35.88 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.522 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.662 ' HG2' ' HG2' ' A' ' 80' ' ' LYS . 38.9 mt-10 -94.57 119.18 32.84 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.89 1.329 . . . . 0.0 110.588 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.711 HD13 ' HB1' ' A' ' 81' ' ' ALA . 36.3 mt -94.72 121.5 36.37 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.772 -2.467 . . . . 0.0 109.602 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB3' HG23 ' A' ' 59' ' ' ILE . 26.8 tt0 -94.59 124.3 38.54 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.57 ' O ' HD11 ' A' ' 59' ' ' ILE . 19.1 p -86.1 164.78 17.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.894 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -62.27 -19.36 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.3 0.571 . . . . 0.0 109.564 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 m -73.78 -48.0 34.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.507 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.759 ' HA2' HD13 ' A' ' 59' ' ' ILE . . . 143.11 -31.18 1.98 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.019 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -77.0 138.71 39.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.929 0.365 . . . . 0.0 110.923 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.94 136.83 41.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.47 143.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 111.114 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 56.2 mttp -81.69 123.32 28.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.607 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -145.71 148.54 33.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.858 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 68' ' ' GLU . 38.8 t -91.74 114.27 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.956 0.408 . . . . 0.0 110.059 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -106.71 134.95 46.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.291 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.5 mmtt -105.11 155.51 18.94 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.85 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 2.1 tmt? -129.16 136.36 50.08 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.105 0.955 . . . . 0.0 112.077 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 8.9 tp10 -110.26 148.53 31.71 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.273 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -58.16 -25.54 57.24 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -168.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.646 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 4.9 m-20 -80.21 28.82 0.29 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.085 0.945 . . . . 0.0 109.738 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.612 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 61.52 47.24 6.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.177 -1.828 . . . . 0.0 109.385 172.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.716 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 7.0 mtpt -107.61 123.9 49.16 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.55 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.572 ' HE1' HG21 ' A' ' 48' ' ' VAL . 16.2 mmt -113.88 112.64 23.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.433 HG12 ' HE3' ' A' ' 99' ' ' LYS . 2.4 t -123.39 116.34 48.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.251 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -132.13 145.17 51.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.447 0.641 . . . . 0.0 110.667 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.5 m -125.49 124.91 42.39 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.497 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.66 ' CZ ' ' HE3' ' A' ' 96' ' ' LYS . 62.1 t80 -139.74 112.45 7.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.66 ' HE3' ' CZ ' ' A' ' 95' ' ' PHE . 8.6 mtmp? 42.52 57.87 3.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.21 -9.42 60.98 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.152 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 98' ' ' ILE . 2.0 mm -90.31 113.3 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -104.35 130.66 52.19 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.086 0.47 . . . . 0.0 110.577 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 93' ' ' THR . 19.0 t -125.34 124.92 42.61 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.893 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.32 118.59 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.441 . . . . 0.0 109.877 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 2.8 m -118.62 122.58 42.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.716 ' HG3' ' HE3' ' A' ' 90' ' ' LYS . 12.2 tt0 -129.28 124.95 35.7 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.005 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 109' ' ' ILE . 1.3 m-30 -101.42 115.47 30.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.51 117.46 21.35 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.515 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.06 -95.02 0.39 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.088 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.0 12.93 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.36 . . . . 0.0 110.439 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p -131.38 146.4 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.581 0.705 . . . . 0.0 111.784 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.745 ' HB ' ' OG ' ' A' ' 124' ' ' SER . 21.1 mt -129.09 135.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.341 -173.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 m -115.89 120.52 39.47 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.676 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 14.1 t-20 -107.88 124.79 50.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.004 0.431 . . . . 0.0 110.16 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -119.48 122.45 41.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.806 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.6 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.7 mtt -122.09 150.71 41.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 98' ' ' ILE . 7.0 m -122.43 120.14 33.06 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.595 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 3.4 tm? -124.63 115.1 20.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.06 -107.0 1.59 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.919 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -115.41 6.69 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.071 0.462 . . . . 0.0 109.959 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.873 HG23 ' HB2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -93.03 139.61 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.317 -173.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 p -108.65 114.99 48.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-O 121.413 0.625 . . . . 0.0 110.841 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.6 ' HD2' ' HB2' ' A' ' 113' ' ' MET . 7.2 t80 -112.03 121.34 44.72 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.367 0.604 . . . . 0.0 111.941 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 6.4 mtmm -121.28 139.42 53.42 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.391 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.676 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 11.4 ptt180 -123.43 142.39 51.04 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -99.86 118.56 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.745 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 93.5 p -129.57 133.23 47.08 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.358 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -129.32 147.28 51.14 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.718 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 10.6 ttp180 -70.85 148.83 47.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.0 110.172 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.63 HG13 ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.674 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 88.0 p . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 -173.37 17.72 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.321 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.917 ' HB2' HD11 ' A' ' 127' ' ' ILE . 42.9 mtpt -94.33 118.12 31.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.133 0.492 . . . . 0.0 110.086 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 30.7 m-85 -120.13 123.53 43.56 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -97.08 130.52 44.36 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -173.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 0.5 OUTLIER -69.94 140.75 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.581 0.705 . . . . 0.0 110.794 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.532 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.3 mm100 -109.06 -39.58 5.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.75 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.508 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 13.3 m -159.15 159.99 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.134 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -139.43 157.5 45.75 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.499 0.666 . . . . 0.0 111.376 177.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.683 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 6.2 tp10 -114.49 126.88 55.45 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.964 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.744 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 89.8 m-20 57.04 35.38 26.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.238 0.542 . . . . 0.0 111.867 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.838 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 32.7 p90 -69.16 21.73 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.402 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.806 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.1 mt-10 -135.36 -48.26 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -172.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.806 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 42.3 Cg_endo -71.0 -26.4 21.81 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.212 1.275 . . . . 0.0 109.432 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.802 ' HD1' HD11 ' A' ' 118' ' ' ILE . 44.6 t80 -65.11 -52.18 56.91 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.031 175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.919 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 23.3 mmt -61.51 -41.86 97.93 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.297 174.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.772 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 9.0 pttt -68.4 -33.92 75.1 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.553 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.23 66.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.639 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.0 ttm -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.86 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.8 -34.24 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.952 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -74.56 126.99 88.14 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.952 ' HD2' HD13 ' A' ' 24' ' ' LEU . 98.9 Cg_endo -79.27 141.68 16.32 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.896 1.73 . . . . 0.0 111.227 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.773 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 2.1 tt0 -49.67 -42.22 44.9 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.7 t70 -55.76 -44.14 77.36 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 118.544 0.611 . . . . 0.0 109.854 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.636 HD12 ' CG ' ' A' ' 25' ' ' PRO . 19.6 mt -68.4 -33.41 74.2 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.777 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.912 HD12 ' HB2' ' A' ' 19' ' ' MET . 27.3 mt -64.66 -44.14 96.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.5 169.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 1.045 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 23.0 mm-40 -53.04 -41.0 64.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 1.045 ' HE2' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -71.23 -31.55 67.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.358 178.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.6 44.66 1.18 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.865 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.838 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -79.67 -39.79 30.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -167.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.434 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 7.6 t70 -98.88 61.0 1.27 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.032 0.92 . . . . 0.0 110.236 -167.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 35' ' ' ILE . 3.9 mm -90.3 115.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.814 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -98.31 100.88 12.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.001 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.08 -175.57 34.77 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.2 t -122.05 155.51 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 51' ' ' THR . 16.0 m -133.95 119.68 19.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.145 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 3.1 mp0 -116.75 123.85 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 4' ' ' SER . 38.7 mt -116.84 143.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 92.6 t -109.02 114.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 167.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.5 ' N ' ' HB3' ' A' ' 4' ' ' SER . 15.9 t-160 -96.37 112.79 24.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 110.387 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -127.88 145.54 50.91 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -36.67 114.48 0.22 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.433 174.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 1.046 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 58.68 -25.31 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -172.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 21.8 mmtp -91.26 107.09 18.97 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.283 0.492 . . . . 0.0 111.036 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 46.3 t -124.53 124.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.0 110.491 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 1.2 tttm -115.22 139.06 50.26 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.3 tt -121.93 124.95 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.158 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.725 ' O ' ' HA ' ' A' ' 39' ' ' SER . 58.2 m -110.2 124.38 51.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.652 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -129.33 121.06 52.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.2 m -99.53 130.63 45.79 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.658 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -109.18 108.15 18.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.93 -89.68 0.13 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.919 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.8 t -124.82 -3.65 7.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.749 0.309 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -121.91 136.2 54.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.749 0.309 . . . . 0.0 110.181 -170.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 93.8 t -98.33 134.19 37.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.012 0.91 . . . . 0.0 112.223 -172.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -118.64 114.75 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.603 176.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.592 ' C ' HD21 ' A' ' 61' ' ' ASN . 0.0 OUTLIER -87.35 145.43 26.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.962 -172.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -135.07 98.6 4.04 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 49' ' ' LYS . 3.5 mp0 -102.55 132.08 48.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.992 -0.443 . . . . 0.0 110.618 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -150.02 151.81 33.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.663 0.744 . . . . 0.0 112.091 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 22.9 m -107.78 134.03 51.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.112 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.046 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.7 mt -48.08 131.13 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.869 0.366 . . . . 0.0 111.05 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.77 60.8 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.013 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 64' ' ' THR . 50.4 mm-40 -132.98 139.03 47.07 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.468 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 28.3 tt0 -80.56 116.98 20.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.9 t -135.75 160.74 37.6 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.272 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.5 pt-20 -95.95 145.15 25.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.221 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 19.4 mt -105.88 128.42 53.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.509 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.453 ' HB3' HG23 ' A' ' 59' ' ' ILE . 14.5 tt0 -91.63 120.29 32.27 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.609 ' O ' HD12 ' A' ' 59' ' ' ILE . 11.2 p -90.51 166.42 13.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.997 -173.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.27 -20.24 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.858 0.361 . . . . 0.0 110.64 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 p -82.61 -38.67 23.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.449 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 133.04 -14.89 4.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.56 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -77.38 138.39 39.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.824 0.312 . . . . 0.0 111.534 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 9.9 mmmm -96.85 135.83 38.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.804 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -137.13 131.45 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.346 177.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 41.0 pttt -83.68 124.24 30.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.478 0.656 . . . . 0.0 111.031 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -140.99 149.38 41.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.428 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 93' ' ' THR . 71.2 t -93.95 113.08 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.763 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -104.76 132.33 51.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -117.66 156.17 28.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.492 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.794 ' HB3' HD13 ' A' ' 65' ' ' LEU . 8.7 tpp -126.32 122.23 34.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.098 0.951 . . . . 0.0 110.147 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.621 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 12.2 tp10 -46.43 -43.9 16.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.752 -2.022 . . . . 0.0 110.527 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.568 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . 137.94 -59.65 0.61 Allowed Glycine 0 CA--C 1.5 -0.901 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.857 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.816 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -63.4 -72.0 0.15 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.16 0.505 . . . . 0.0 110.954 176.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.816 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 1.5 p30 -150.43 13.16 0.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.621 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -109.81 119.87 40.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.004 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.485 ' HG2' ' HB2' ' A' ' 85' ' ' MET . 50.9 mtm -121.98 115.96 23.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.783 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.504 HG13 HG23 ' A' ' 101' ' ' VAL . 1.4 t -124.06 122.15 63.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.905 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.763 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -113.07 143.53 44.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.8 m -125.62 129.78 50.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 58.5 t80 -138.59 157.56 45.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.649 175.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 98' ' ' ILE . 48.1 mtmt -41.71 104.58 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.932 0.493 . . . . 0.0 112.007 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.51 -30.7 1.01 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.229 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.693 HD13 HD11 ' A' ' 115' ' ' LEU . 2.1 mm -90.04 111.72 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 113' ' ' MET . 46.3 tttt -113.29 125.46 54.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.025 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -114.2 119.11 35.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 HG13 ' A' ' 92' ' ' VAL . 74.9 t -118.74 119.22 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -117.42 120.46 38.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.626 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.86 120.48 24.99 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.969 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.29 112.48 25.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.031 171.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -127.34 107.57 10.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.454 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.44 45.47 37.42 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.237 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 6.5 m-20 68.48 4.83 4.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.955 0.502 . . . . 0.0 111.84 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 p -117.95 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 104' ' ' PHE . 4.9 mt -109.91 132.57 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -107.33 119.76 40.28 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.822 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.763 ' HB2' ' HG2' ' A' ' 122' ' ' ARG . 18.8 m120 -106.61 121.65 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -121.75 118.78 29.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.103 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 77.1 mtm -124.8 149.83 46.98 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 98' ' ' ILE . 56.7 m -127.85 122.59 33.0 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 122.126 -0.359 . . . . 0.0 110.722 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.693 HD11 HD13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -111.84 112.41 24.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.18 -98.74 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.703 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -104.97 -12.87 15.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.502 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.802 HD11 ' HD1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.4 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.397 -172.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.59 115.05 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.487 0.66 . . . . 0.0 110.822 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 t80 -100.37 119.06 37.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.683 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 4.4 tmmm? -128.11 124.58 37.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.469 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.763 ' HG2' ' HB2' ' A' ' 111' ' ' ASN . 14.5 ptt180 -120.02 148.65 43.3 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.549 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 10' ' ' GLN . 6.7 p -101.61 118.26 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.596 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.734 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 84.3 p -125.42 132.54 52.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.8 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -132.0 146.65 52.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.63 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -70.08 149.6 47.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.933 -176.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.6 pt . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.471 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 82.1 p . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -170.7 13.45 Favored Glycine 0 CA--C 1.5 -0.888 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.915 ' HB2' HD11 ' A' ' 127' ' ' ILE . 17.0 mtpp -96.82 118.24 32.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.681 0.753 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.707 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 6.0 m-85 -120.7 134.91 55.25 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.0 140.13 36.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.563 HG11 ' N ' ' A' ' 10' ' ' GLN . 27.9 t -64.64 139.07 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 122.004 0.907 . . . . 0.0 110.984 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.815 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.5 mm-40 -114.12 -58.17 2.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.954 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.697 ' HB2' HG11 ' A' ' 123' ' ' VAL . 29.0 m -157.18 152.36 26.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.681 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HG2' ' HE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.67 151.35 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.54 0.686 . . . . 0.0 110.792 174.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.699 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 13.7 mm-40 -94.45 130.22 40.9 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.525 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.769 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 16.9 m-20 70.52 -82.31 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 O-C-N 123.715 0.634 . . . . 0.0 110.927 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.514 ' HA ' ' HD2' ' A' ' 18' ' ' PHE . 51.0 p90 39.57 36.46 0.24 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.651 1.58 . . . . 0.0 112.304 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.875 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.9 mt-10 -144.47 -46.5 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.157 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.875 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 61.1 Cg_endo -68.22 -34.72 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.968 1.779 . . . . 0.0 109.718 169.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.615 ' HD1' HD21 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -62.3 -50.03 73.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.947 -1.933 . . . . 0.0 111.198 174.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 1.058 ' HB2' HD12 ' A' ' 29' ' ' ILE . 61.0 mmm -62.96 -41.07 99.42 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.881 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 16.1 ptmt -69.03 -32.73 72.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.25 0.547 . . . . 0.0 110.319 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.55 71.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.954 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.0 mtt -83.42 -59.46 2.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.25 -44.3 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.678 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.6 tp -75.56 126.44 87.44 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 117.564 0.682 . . . . 0.0 110.037 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.557 ' CG ' HD12 ' A' ' 28' ' ' LEU . 86.3 Cg_endo -73.85 153.39 47.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.709 2.273 . . . . 0.0 111.424 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.777 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 1.3 tt0 -50.56 -43.71 56.39 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.243 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.703 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 p-10 -57.18 -41.72 79.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 118.4 0.545 . . . . 0.0 110.704 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD12 ' CG ' ' A' ' 25' ' ' PRO . 46.8 mt -71.08 -34.32 71.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.883 -0.51 . . . . 0.0 109.714 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 1.058 HD12 ' HB2' ' A' ' 19' ' ' MET . 45.4 mt -61.73 -46.9 95.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.692 170.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.777 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.6 mm-40 -52.36 -44.36 65.19 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.547 1.139 . . . . 0.0 112.05 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.703 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -69.71 -31.35 69.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.415 0.626 . . . . 0.0 110.343 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -122.09 29.16 5.63 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.585 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 29' ' ' ILE . 23.5 pttm -79.41 -28.34 41.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 111.523 -171.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.73 44.99 1.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.23 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 35' ' ' ILE . 27.7 mm -93.9 123.96 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -108.54 99.45 8.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.438 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.62 -179.96 44.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.936 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.5 t -123.26 148.24 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.768 ' HA ' ' O ' ' A' ' 51' ' ' THR . 19.2 m -128.77 123.53 33.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.974 0.416 . . . . 0.0 112.086 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 15.5 mp0 -117.0 123.46 46.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.775 HG12 ' HG ' ' A' ' 50' ' ' LEU . 25.0 mt -120.72 141.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.933 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG12 ' HG2' ' A' ' 44' ' ' GLU . 96.1 t -109.13 119.52 58.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.787 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.436 ' N ' ' HB3' ' A' ' 4' ' ' SER . 23.3 t-80 -93.07 112.55 24.55 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.854 0.835 . . . . 0.0 109.814 173.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 43.4 mm-40 -123.33 144.01 49.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' LYS . . . -41.6 107.09 0.09 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.363 176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.836 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmm 71.79 -24.01 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.121 1.369 . . . . 0.0 112.869 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 70.0 mmtt -96.0 109.77 22.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' A' ' 91' ' ' MET . 55.9 t -121.72 123.56 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 111.5 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.0 mttm -112.37 123.06 49.45 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.715 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.775 ' HG ' HG12 ' A' ' 41' ' ' ILE . 2.3 tt -114.81 121.84 44.53 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.768 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -106.28 125.3 50.83 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.641 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.1 mt -129.26 121.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -171.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.695 HG21 HG22 ' A' ' 58' ' ' VAL . 23.9 m -104.01 129.07 51.59 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 40.0 t80 -116.45 106.47 13.64 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.42 -99.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.546 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 t -94.37 -28.72 15.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 110.846 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -107.71 125.37 51.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.841 -166.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 53' ' ' THR . 21.2 t -99.51 125.19 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.693 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -124.82 114.33 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 122.635 1.207 . . . . 0.0 109.093 177.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.483 ' CB ' ' HA ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -109.72 149.56 29.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.334 -172.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.64 108.38 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.59 125.65 51.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.065 0.46 . . . . 0.0 110.403 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CD1' HG21 ' A' ' 83' ' ' VAL . 3.5 p90 -151.38 152.73 33.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.618 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 15.6 m -111.6 134.71 52.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.78 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.836 ' HG ' ' HB3' ' A' ' 46' ' ' LYS . 4.0 pp -49.43 143.81 6.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.17 0.51 . . . . 0.0 111.617 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.15 19.15 69.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.763 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 64' ' ' THR . 76.1 mm-40 -129.24 146.94 51.05 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.692 0.246 . . . . 0.0 110.86 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.509 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 41.8 tt0 -79.86 118.41 21.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.9 m -134.21 150.48 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.101 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.79 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 3.3 pt-20 -95.01 140.01 30.57 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.19 -173.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.623 HD13 ' HB1' ' A' ' 81' ' ' ALA . 18.5 mt -109.54 134.35 52.01 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.202 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HG3' ' HD2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -87.57 138.26 31.63 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 121.948 0.88 . . . . 0.0 108.927 169.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.9 p -95.16 167.81 11.13 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.769 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.3 tpp -65.67 -18.17 65.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -83.74 -39.93 19.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.901 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.693 ' HA2' ' CD1' ' A' ' 59' ' ' ILE . . . 130.1 -5.81 6.04 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.308 -0.948 . . . . 0.0 114.719 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -79.87 144.72 33.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.573 0.686 . . . . 0.0 110.558 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.17 125.73 38.98 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.11 130.94 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 22.8 pttt -97.12 140.48 31.56 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.321 1.058 . . . . 0.0 112.976 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.623 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -146.43 159.99 42.67 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.168 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -94.36 112.85 27.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.348 0.594 . . . . 0.0 110.153 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.715 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 2.0 m -103.78 136.36 37.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.682 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -116.45 156.94 25.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.768 0.318 . . . . 0.0 110.336 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.698 ' HE2' HD21 ' A' ' 65' ' ' LEU . 32.6 ttp -126.34 135.54 51.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.888 0.851 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.05 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 11.1 tp10 -86.12 -14.75 43.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.614 -173.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 114.36 -68.87 0.25 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.993 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.65 44.46 0.21 Allowed 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.342 0.592 . . . . 0.0 110.966 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.866 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 7.6 m-80 65.02 44.98 3.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.8 169.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 1.05 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -106.51 121.37 44.16 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 166.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.467 ' HE2' HG13 ' A' ' 48' ' ' VAL . 2.0 mpt? -119.58 114.39 22.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.492 HG13 HG23 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -124.43 119.22 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.715 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -126.4 139.86 52.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.182 0.515 . . . . 0.0 110.661 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -128.99 139.89 51.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.899 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -138.84 113.4 8.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.971 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.0 -95.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.024 0.53 . . . . 0.0 111.677 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.19 10.15 15.13 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.0 mm -92.19 122.77 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 113' ' ' MET . 38.1 tttm -123.97 116.72 23.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.229 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 93' ' ' THR . 14.6 m -121.65 119.92 33.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.492 HG23 HG13 ' A' ' 92' ' ' VAL . 92.0 t -117.0 119.64 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.779 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 m -117.47 126.1 52.04 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.823 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 39.1 tt0 -127.45 121.98 32.26 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.659 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.866 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 7.4 m-30 -92.98 116.12 28.76 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 167.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -124.24 110.99 15.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.49 -74.32 1.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.637 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -165.91 13.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.106 -0.547 . . . . 0.0 109.591 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.449 HG21 ' HA ' ' A' ' 125' ' ' LYS . 2.8 m -123.44 142.22 51.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.52 0.676 . . . . 0.0 110.425 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 7' ' ' TYR . 15.0 mt -102.77 129.85 53.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.338 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -113.38 117.4 31.67 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 167.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.1 t-20 -113.74 120.38 40.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.946 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.808 HG21 ' HG3' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -121.88 115.97 23.55 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.623 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 9.3 ttp -125.93 144.45 50.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -121.44 121.62 37.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HB2' HG12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -92.95 145.59 24.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.05 25.46 0.15 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -165.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.4 t70 -149.83 -9.04 0.3 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 159.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.695 HG12 ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -116.01 139.62 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.71 -168.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 p -106.56 116.55 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.433 0.635 . . . . 0.0 110.192 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.623 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -115.36 120.97 41.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.105 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.808 ' HG3' HG21 ' A' ' 112' ' ' THR . 23.6 ttpt -125.14 137.34 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.24 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.539 ' HD3' ' HB3' ' A' ' 111' ' ' ASN . 44.4 ttt180 -132.08 127.12 35.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 111.682 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.815 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.3 p -101.88 128.15 54.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 20.9 m -134.63 131.89 38.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.409 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.449 ' HA ' HG21 ' A' ' 108' ' ' THR . 11.4 ptmt -120.96 145.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.609 0.64 . . . . 0.0 111.334 -170.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.707 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 43.3 ttt180 -70.1 151.5 45.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 6' ' ' LYS . 6.0 pt . . . . . 0 N--CA 1.431 -1.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.814 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.665 HD21 ' ND2' ' A' ' 89' ' ' ASN . 1.7 p-10 -89.47 128.44 35.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.624 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 0.7 OUTLIER -173.96 -59.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.359 169.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.698 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 68.6 p -144.54 175.8 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.744 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.97 -174.29 18.26 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.573 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.989 ' HE2' HG12 ' A' ' 127' ' ' ILE . 6.1 mtpt -97.64 120.71 38.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.642 0.734 . . . . 0.0 110.685 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 35.9 m-85 -123.79 124.95 43.82 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.402 ' CG ' HG23 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.57 138.86 31.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -168.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.458 HG22 ' HD3' ' A' ' 122' ' ' ARG . 1.6 t -70.77 127.96 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.398 0.618 . . . . 0.0 109.918 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.784 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.2 mm100 -111.59 -47.24 3.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.518 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.548 ' HB2' HG11 ' A' ' 123' ' ' VAL . 24.3 m -161.61 152.82 18.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.987 -172.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.512 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -145.57 156.5 43.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.257 0.551 . . . . 0.0 111.362 174.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.81 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 51.3 mm-40 -97.51 142.81 28.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.954 174.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 16' ' ' GLU . 1.9 m-80 69.22 26.48 5.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 33' ' ' LYS . 4.7 p90 -63.26 -0.31 0.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.663 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 80.7 mt-10 -116.84 -51.2 0.04 OUTLIER Pre-proline 0 C--O 1.216 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.155 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.642 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 27.1 Cg_exo -55.43 -42.81 64.39 Favored 'Trans proline' 0 CA--C 1.511 -0.656 0 C-N-CA 121.853 1.702 . . . . 0.0 112.732 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.422 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -60.55 -49.6 76.87 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.833 -1.531 . . . . 0.0 109.601 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.043 ' HB2' HD12 ' A' ' 29' ' ' ILE . 25.2 mmt -63.02 -43.7 98.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.447 176.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.642 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 15.5 ptmt -64.71 -36.94 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.925 -171.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -73.37 -36.82 66.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.851 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -82.96 -28.18 29.98 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.6 -39.7 0.36 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.372 -1.394 . . . . 0.0 114.402 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.634 HD22 HG12 ' A' ' 29' ' ' ILE . 13.0 tp -80.65 129.09 69.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 117.689 0.745 . . . . 0.0 110.131 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.586 ' CG ' HD12 ' A' ' 28' ' ' LEU . 93.2 Cg_endo -73.5 146.87 40.09 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.296 1.998 . . . . 0.0 111.196 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.866 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 7.4 tt0 -48.81 -41.22 32.01 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.108 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.724 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 29.3 t70 -64.1 -37.44 87.45 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 119.197 0.908 . . . . 0.0 110.871 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.586 HD12 ' CG ' ' A' ' 25' ' ' PRO . 31.1 mt -69.78 -34.46 73.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 19' ' ' MET . 20.4 mt -64.11 -45.94 95.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.431 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.599 172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.043 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 35.1 mm-40 -51.32 -48.17 62.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.671 0.748 . . . . 0.0 112.078 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.724 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -63.53 -30.05 71.22 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.619 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.62 41.14 1.46 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.438 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 1.043 ' HE2' ' HA ' ' A' ' 30' ' ' GLN . 15.7 ptpt -79.96 -41.45 25.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -165.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 38.7 t70 -109.96 60.37 0.6 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.917 0.865 . . . . 0.0 110.562 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 mm -80.89 130.27 36.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.026 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.85 146.55 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.3 169.05 27.02 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 8' ' ' GLN . 15.2 t -127.85 141.55 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.339 0.569 . . . . 0.0 109.494 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.718 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.5 t -119.02 131.76 56.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -125.01 122.92 38.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.595 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.698 ' O ' ' HB2' ' A' ' 4' ' ' SER . 97.1 mt -117.47 138.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' A' ' 49' ' ' LYS . 96.8 t -109.15 119.87 59.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.615 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.646 ' H ' ' HB3' ' A' ' 4' ' ' SER . 10.6 t-160 -97.77 114.72 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.352 0.596 . . . . 0.0 110.562 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -133.17 141.55 48.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -37.24 114.27 0.24 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 113.642 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 28.0 mtmt 75.47 -43.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.882 1.273 . . . . 0.0 112.539 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -96.28 109.79 22.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.897 0.856 . . . . 0.0 111.822 -171.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.7 128.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.261 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 78.0 mttt -107.94 125.44 51.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.297 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.656 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -120.04 123.64 43.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.718 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.6 m -106.84 124.15 49.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.656 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.2 mt -131.3 122.27 50.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.332 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.658 HG21 HG22 ' A' ' 58' ' ' VAL . 19.8 m -101.45 130.08 47.61 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.063 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.648 ' HD2' ' HE3' ' A' ' 74' ' ' MET . 30.4 t80 -116.64 106.21 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.35 -99.58 0.09 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.04 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t -99.09 -24.4 14.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.418 0.628 . . . . 0.0 110.483 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HE2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.96 123.01 47.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.239 -169.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.658 HG22 HG21 ' A' ' 53' ' ' THR . 24.3 t -98.26 124.8 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-O 121.873 0.844 . . . . 0.0 109.55 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -116.45 114.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.82 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 148.5 26.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.28 -1.782 . . . . 0.0 112.378 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -139.7 87.84 2.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.487 0.661 . . . . 0.0 110.482 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 33.4 mt-10 -107.21 127.16 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.643 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.506 ' HE1' ' HG2' ' A' ' 91' ' ' MET . 9.7 p90 -150.43 152.0 33.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.09 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.3 m -106.54 132.44 52.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.601 ' O ' HD11 ' A' ' 65' ' ' LEU . 3.8 pp -47.17 143.36 3.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 112.394 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 68.42 25.03 74.99 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.569 177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -135.24 145.45 47.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 23.6 tt0 -76.6 118.64 19.46 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.2 m -134.03 158.75 42.75 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.273 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 4.1 mt-10 -97.6 120.64 38.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.5 1.143 . . . . 0.0 111.906 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.766 HD13 ' HB1' ' A' ' 81' ' ' ALA . 32.5 mt -93.69 121.59 35.27 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.732 -2.031 . . . . 0.0 109.872 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.496 ' OE1' HG12 ' A' ' 59' ' ' ILE . 15.8 tt0 -95.22 120.54 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.46 ' O ' HD11 ' A' ' 59' ' ' ILE . 24.2 p -86.72 164.19 16.88 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.648 ' HE3' ' HD2' ' A' ' 54' ' ' TYR . 23.4 ttt -64.61 -14.65 58.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.198 0.523 . . . . 0.0 109.827 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -85.9 -40.7 15.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.798 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.42 -13.32 4.01 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.148 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.54 129.65 35.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.663 -0.316 . . . . 0.0 111.315 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.702 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -105.17 130.52 53.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 176.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -134.64 147.99 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.065 0.46 . . . . 0.0 112.048 -175.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 51.0 mttm -82.7 123.27 29.13 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.766 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -143.64 145.19 32.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.5 t -90.5 112.84 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.488 0.661 . . . . 0.0 109.803 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.714 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -109.14 134.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.363 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.459 ' HD2' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -113.67 153.1 29.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.602 ' HG2' ' HG3' ' A' ' 91' ' ' MET . 9.4 tmm? -129.41 124.88 35.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.257 1.027 . . . . 0.0 110.015 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 6.1 tp10 -56.67 -60.64 3.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.959 -1.928 . . . . 0.0 113.736 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 145.56 -54.38 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.552 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 23.0 t70 -80.67 27.24 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.008 0.909 . . . . 0.0 109.086 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.665 ' ND2' HD21 ' A' ' 2' ' ' ASN . 7.2 m-80 65.37 58.49 0.85 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.685 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.789 ' HE2' ' HG2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -108.14 121.37 44.71 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.161 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.602 ' HG3' ' HG2' ' A' ' 85' ' ' MET . 1.4 mpp? -118.27 114.61 23.26 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.459 ' O ' ' HD2' ' A' ' 84' ' ' LYS . 3.5 t -124.84 122.02 62.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.196 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.714 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.71 144.17 51.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.207 0.527 . . . . 0.0 110.61 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -122.31 126.43 48.09 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -138.58 114.6 10.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt 56.85 -102.45 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.268 0.355 . . . . 0.0 111.128 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.32 14.14 12.19 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.595 HD13 HD22 ' A' ' 115' ' ' LEU . 1.6 mm -94.37 113.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' MET . 18.2 ttpt -110.16 118.17 35.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.943 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -114.85 120.62 40.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.162 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.73 119.91 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.287 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.553 HG22 ' HE1' ' A' ' 104' ' ' PHE . 2.6 m -117.69 120.5 38.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.789 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 5.0 tm-20 -130.29 127.27 39.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.144 -0.347 . . . . 0.0 110.669 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 109' ' ' ILE . 7.1 m-30 -104.74 114.79 29.22 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 126.23 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.413 0.445 . . . . 0.0 110.771 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.56 31.79 71.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.811 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 64.06 19.34 11.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.99 0.516 . . . . 0.0 112.253 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.0 p -116.02 130.57 56.87 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.564 HD12 ' CE1' ' A' ' 104' ' ' PHE . 6.1 mt -110.21 128.59 66.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.834 -170.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -116.88 120.19 37.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.94 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.7 121.78 45.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.695 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 4.4 m -120.36 120.58 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.647 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.527 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 65.9 mtt -119.68 149.72 41.53 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.149 0.499 . . . . 0.0 110.36 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 49.8 m -118.86 119.82 35.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.595 HD22 HD13 ' A' ' 98' ' ' ILE . 3.4 tm? -123.79 113.49 18.63 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.623 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.56 10.78 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.952 0.882 . . . . 0.0 109.357 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -97.74 141.33 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.696 -173.125 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.86 114.95 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.621 0.724 . . . . 0.0 111.267 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.614 ' HD2' ' O ' ' A' ' 13' ' ' GLU . 1.3 t80 -117.01 125.58 51.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.68 -170.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.81 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -124.97 129.83 51.13 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.998 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.458 ' HD3' HG22 ' A' ' 9' ' ' VAL . 30.3 ttm180 -116.96 137.8 51.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.52 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.784 HG13 ' HB2' ' A' ' 10' ' ' GLN . 12.7 p -101.87 117.06 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.88 0.847 . . . . 0.0 109.771 173.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 16.2 m -121.36 127.9 51.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.079 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -121.3 137.54 54.65 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.299 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 24.5 ttt180 -68.1 147.77 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.989 HG12 ' HE2' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 C--O 1.247 0.948 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -170.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.577 0.227 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.704 HD21 ' ND2' ' A' ' 89' ' ' ASN . 2.1 p-10 -99.15 116.88 32.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 0.0 110.42 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.564 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.0 p90 -172.96 45.18 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.486 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.64 ' HB3' ' C ' ' A' ' 41' ' ' ILE . 58.6 m 69.16 174.17 0.29 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.324 -174.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.59 -164.04 28.47 Favored Glycine 0 CA--C 1.499 -0.933 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.888 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.856 ' HE3' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -90.03 117.8 29.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.732 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 59.2 m-85 -132.06 127.67 36.61 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -103.4 140.74 37.05 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.24 -171.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 t -66.19 137.51 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.147 0.975 . . . . 0.0 111.566 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.521 ' HB3' HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -114.2 -59.94 1.95 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.942 -168.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.53 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 11.5 m -158.02 153.9 26.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.435 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.528 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -145.98 155.42 42.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.615 0.722 . . . . 0.0 112.015 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.747 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 16.6 mm-40 -94.2 142.11 27.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.342 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 9.0 m-20 72.61 -82.42 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.472 0 O-C-N 123.559 0.537 . . . . 0.0 111.876 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.61 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.8 p90 39.93 28.03 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.266 1.826 . . . . 0.0 113.236 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.665 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 74.5 mt-10 -147.26 -49.9 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.634 -172.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.777 ' HB2' HG23 ' A' ' 118' ' ' ILE . 59.6 Cg_endo -74.7 -23.98 13.95 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 108.411 -1.419 . . . . 0.0 108.411 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 118' ' ' ILE . 3.5 t80 -60.8 -52.79 63.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.983 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.004 ' HB2' HD12 ' A' ' 29' ' ' ILE . 24.6 mmt -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.526 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.588 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 7.5 ptmm? -66.05 -33.06 74.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.126 0.488 . . . . 0.0 110.069 -174.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.79 86.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.457 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.8 ptm -85.86 -22.16 27.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.88 -39.02 0.69 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.677 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 19' ' ' MET . 14.9 tp -75.54 130.01 80.5 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 117.308 0.554 . . . . 0.0 110.478 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.835 ' HD2' HD13 ' A' ' 28' ' ' LEU . 88.3 Cg_endo -78.1 153.83 28.72 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.799 1.666 . . . . 0.0 111.346 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.842 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 9.6 tt0 -50.09 -44.34 51.88 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.383 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.621 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 7.7 t70 -59.12 -37.26 76.8 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.308 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.835 HD13 ' HD2' ' A' ' 25' ' ' PRO . 59.8 mt -72.32 -37.5 68.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.912 0.387 . . . . 0.0 110.076 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.004 HD12 ' HB2' ' A' ' 19' ' ' MET . 38.9 mt -59.22 -44.2 91.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.904 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.842 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.3 mm-40 -54.03 -34.01 58.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.621 1.169 . . . . 0.0 111.775 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.621 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 2.1 mptp? -68.44 -33.03 73.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.961 0.41 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.55 35.66 2.37 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.835 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.61 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 25.3 pttm -79.1 -32.24 44.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.297 0.57 . . . . 0.0 112.321 -169.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -99.16 24.55 7.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.062 -167.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.523 HD12 HG21 ' A' ' 35' ' ' ILE . 33.0 mt -81.13 115.93 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.372 0.606 . . . . 0.0 112.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -109.8 126.69 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.329 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -115.31 -169.02 15.71 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.963 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 11.1 t -121.57 141.1 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.8 t -117.01 139.22 50.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 1.1 mm-40 -135.23 124.59 24.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.965 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.862 HG12 ' HG ' ' A' ' 50' ' ' LEU . 5.1 mt -127.96 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.1 -171.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -111.16 120.47 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.627 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.567 ' H ' ' HB2' ' A' ' 4' ' ' SER . 11.5 t-160 -92.41 114.52 27.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.805 0.812 . . . . 0.0 110.45 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 142.21 46.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -33.58 111.17 0.06 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.643 0.589 . . . . 0.0 113.998 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.807 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 2.3 mtmt 66.62 -45.47 0.44 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.476 1.51 . . . . 0.0 113.342 -173.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -90.74 107.45 19.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.762 0.791 . . . . 0.0 111.282 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.618 HG21 ' SD ' ' A' ' 85' ' ' MET . 90.6 t -123.09 125.87 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.159 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.682 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -109.24 130.47 55.49 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.248 0.547 . . . . 0.0 109.678 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.862 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -116.42 133.33 56.14 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.88 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.822 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.1 m -114.34 124.88 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.644 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.9 mt -131.84 121.96 48.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.692 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 26.4 m -96.8 127.81 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.627 ' HD1' ' HE2' ' A' ' 74' ' ' MET . 50.0 t80 -120.88 107.34 12.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.91 -98.07 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.565 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -103.95 -24.14 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.854 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.633 ' HE2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.41 128.73 55.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.189 -172.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.649 HG22 HG21 ' A' ' 53' ' ' THR . 26.9 t -96.6 125.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.925 0.869 . . . . 0.0 109.522 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 73' ' ' THR . 1.3 mt -112.51 112.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.524 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.625 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -91.37 141.47 28.72 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.668 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.592 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.4 m120 -125.29 83.73 2.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.747 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 43.1 tt0 -102.24 126.75 49.32 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -147.62 153.08 38.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.955 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 13.5 m -114.05 128.68 56.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.807 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -58.59 143.32 46.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.155 0.502 . . . . 0.0 111.941 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 59.0 23.38 56.99 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.58 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 8.8 tt0 -145.32 133.13 21.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -80.48 119.42 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.285 0.564 . . . . 0.0 110.66 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.8 t -136.3 163.64 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.256 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -95.1 119.57 33.84 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.317 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 61.6 mt -100.72 122.39 43.27 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.728 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HB3' HG23 ' A' ' 59' ' ' ILE . 39.2 tt0 -89.24 128.1 35.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.654 ' O ' HD12 ' A' ' 59' ' ' ILE . 13.2 p -84.78 168.03 15.53 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.833 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.627 ' HE2' ' HD1' ' A' ' 54' ' ' TYR . 11.9 tpt -56.16 -28.22 57.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.437 0.637 . . . . 0.0 109.978 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 -27.73 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.995 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.501 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 123.12 -11.2 8.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.658 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.35 127.03 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.901 0.351 . . . . 0.0 110.466 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.84 127.65 48.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.65 147.07 27.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.362 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -82.01 123.77 29.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.479 0.657 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB1' ' CD1' ' A' ' 71' ' ' LEU . . . -139.07 147.44 42.02 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.49 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -95.26 111.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.649 0.738 . . . . 0.0 109.368 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.7 m -100.73 133.37 44.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.49 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.448 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 3.9 mmtt -106.08 151.37 24.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.734 ' HE1' ' HA ' ' A' ' 89' ' ' ASN . 21.1 ttt -132.89 131.42 40.9 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.317 1.056 . . . . 0.0 112.785 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.104 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 5.4 tp10 -84.95 139.32 31.9 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 112.766 -2.015 . . . . 0.0 108.57 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -60.83 -25.39 63.77 Favored Glycine 0 C--O 1.23 -0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.953 -168.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.722 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 32.5 t70 -83.68 23.09 1.01 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 110.208 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.734 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 10.5 m-80 71.53 57.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.962 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.104 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -113.19 121.84 45.69 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 1.041 ' HG2' ' HB ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -116.78 115.8 26.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.118 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.733 HG11 HG23 ' A' ' 101' ' ' VAL . 5.3 t -125.73 117.7 49.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.568 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -129.86 144.29 51.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.408 0.623 . . . . 0.0 111.765 -177.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 59.3 m -127.26 131.74 50.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.774 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.45 130.04 27.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.825 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 64.05 -75.84 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.78 0.675 . . . . 0.0 110.948 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.63 29.9 0.25 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.47 HD13 HG21 ' A' ' 98' ' ' ILE . 38.9 mm -116.55 131.92 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.58 -0.81 . . . . 0.0 108.851 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 113' ' ' MET . 11.6 ttmm -112.63 128.15 56.3 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.825 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.485 ' HB2' HG23 ' A' ' 93' ' ' THR . 13.3 m -122.18 119.91 32.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.733 HG23 HG11 ' A' ' 92' ' ' VAL . 99.2 t -123.4 117.35 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 110.595 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 1.041 ' HB ' ' HG2' ' A' ' 91' ' ' MET . 32.3 m -118.31 121.38 40.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.885 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 8.2 tm-20 -129.55 128.38 42.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.881 0.372 . . . . 0.0 110.633 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.587 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 5.3 m-30 -96.88 115.37 27.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.074 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.96 102.87 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.754 175.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' A' ' 108' ' ' THR . . . 54.24 75.03 0.25 Allowed Glycine 0 N--CA 1.455 -0.087 0 CA-C-O 119.758 -0.468 . . . . 0.0 113.701 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 6.6 t70 72.23 -26.44 0.18 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.462 ' H ' ' C ' ' A' ' 106' ' ' GLY . 7.7 p -107.21 134.68 49.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.037 0.922 . . . . 0.0 112.315 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.551 HD12 ' CE1' ' A' ' 104' ' ' PHE . 4.4 mt -109.38 127.11 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.079 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -104.54 118.35 36.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 54.3 t30 -109.58 121.25 44.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.613 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.32 114.9 21.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.721 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.617 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 22.1 ttt -127.26 150.36 49.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 93.9 m -126.98 120.29 28.73 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.156 -0.34 . . . . 0.0 110.098 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.597 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -108.62 113.55 26.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.74 -91.84 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.31 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.17 1.64 7.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.934 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.777 HG23 ' HB2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -91.32 141.53 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.815 -172.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.8 116.32 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.896 0.855 . . . . 0.0 110.585 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.617 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 60.8 t80 -103.52 117.98 35.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.88 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.747 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -124.22 124.63 42.86 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 33.9 ttt180 -127.24 132.67 50.34 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.973 -169.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 11.2 p -101.52 118.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.182 171.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 m -127.64 134.19 49.64 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.3 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.609 ' HZ1' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -136.19 150.55 49.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.336 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 ttt180 -69.06 149.35 48.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.849 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.856 HG13 ' HE3' ' A' ' 6' ' ' LYS . 3.0 pt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.104 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 21.4 ptm . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.326 0.107 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 1.3 m120 -112.63 134.89 53.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.557 ' H ' ' CG ' ' A' ' 89' ' ' ASN . 30.6 m-85 79.06 -66.18 0.19 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.067 0.854 . . . . 0.0 110.684 167.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.674 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 30.0 p -134.68 -176.23 4.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.609 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.75 179.73 16.0 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.343 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.706 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -106.99 122.48 46.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.726 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.9 m-85 -127.85 126.01 40.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.646 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -93.83 134.25 36.38 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -172.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.796 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -70.04 134.38 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.677 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.5 mm100 -115.71 -40.87 3.29 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.105 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.697 ' HB2' HG11 ' A' ' 123' ' ' VAL . 58.2 m -156.24 151.47 26.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.819 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.905 0.859 . . . . 0.0 111.109 174.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -103.28 130.09 50.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.902 176.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 3.2 m-20 67.96 21.27 8.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.506 ' O ' ' HG2' ' A' ' 19' ' ' MET . 47.5 p90 -67.35 17.07 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.89 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.4 mt-10 -132.6 -44.58 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 123.175 0.59 . . . . 0.0 111.18 -173.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.914 ' HA ' ' HE2' ' A' ' 20' ' ' LYS . 38.1 Cg_endo -70.07 -28.77 23.35 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 C-N-CA 121.734 1.623 . . . . 0.0 109.637 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -65.57 -52.53 51.61 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.111 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.066 ' HB2' HD12 ' A' ' 29' ' ' ILE . 83.8 mmm -61.22 -37.86 84.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.685 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.914 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 8.4 pttt -69.73 -36.27 75.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.206 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -71.34 -25.99 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.59 172.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.588 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 29.6 tpp -82.61 -43.76 16.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.027 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.44 -42.75 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 HG12 ' A' ' 29' ' ' ILE . 12.8 tp -78.86 128.57 76.32 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.577 ' CG ' HD12 ' A' ' 28' ' ' LEU . 95.0 Cg_endo -73.32 149.95 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.228 1.952 . . . . 0.0 111.498 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.793 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 2.6 tt0 -50.09 -44.43 51.99 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.673 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 36.6 t70 -56.97 -42.96 81.11 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.803 0.729 . . . . 0.0 110.19 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.577 HD12 ' CG ' ' A' ' 25' ' ' PRO . 45.1 mt -68.47 -33.5 74.27 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.466 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.066 HD12 ' HB2' ' A' ' 19' ' ' MET . 28.0 mt -62.87 -47.1 94.44 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.699 170.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.977 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 21.6 mm-40 -53.09 -38.46 62.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.229 1.012 . . . . 0.0 112.474 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.977 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.64 -30.2 68.85 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.739 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.77 28.98 5.07 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.86 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.577 ' HD2' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -78.25 -39.56 39.81 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -166.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -96.29 54.41 1.41 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.645 0.736 . . . . 0.0 110.812 -166.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 35' ' ' ILE . 31.4 mm -99.53 133.16 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.61 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 147.0 33.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.765 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.796 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -144.85 -172.57 15.43 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.981 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG23 ' HG3' ' A' ' 8' ' ' GLN . 60.8 t -123.71 143.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.241 0.521 . . . . 0.0 110.732 -173.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 51' ' ' THR . 14.9 m -122.96 120.99 35.03 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.809 0.338 . . . . 0.0 110.122 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.623 ' HG2' ' CG ' ' A' ' 6' ' ' LYS . 25.5 mt-10 -116.32 124.52 50.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.166 0.508 . . . . 0.0 109.633 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 96.7 mt -123.66 134.58 66.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.915 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.88 114.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.674 ' H ' ' HB3' ' A' ' 4' ' ' SER . 3.3 t-160 -115.07 113.51 24.14 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.042 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 37.3 tt0 -111.07 143.1 42.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.499 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -35.17 108.4 0.05 OUTLIER Glycine 0 C--O 1.225 -0.425 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.59 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.757 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 16.2 mtmt 83.78 -40.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.603 1.561 . . . . 0.0 113.079 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.65 112.15 23.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.104 0.478 . . . . 0.0 110.606 -172.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 t -114.32 123.0 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.69 178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.616 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 18.2 mtpp -113.47 130.87 56.23 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -127.61 130.59 49.25 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -118.04 122.69 43.8 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.67 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.8 mt -124.79 120.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 24.5 m -102.69 127.28 49.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -121.38 107.63 12.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.39 -95.44 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.627 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -107.86 -18.26 13.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 0.0 111.211 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HE3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -113.09 128.54 56.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.17 0.51 . . . . 0.0 111.254 -170.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 31.8 t -97.43 125.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 122.052 0.93 . . . . 0.0 109.592 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.758 HD11 ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -114.52 114.16 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.909 -177.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 144.66 27.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.005 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m120 -129.02 138.85 52.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -145.08 124.73 13.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -151.39 152.29 32.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.03 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.654 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 4.7 m -108.0 132.0 53.98 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 pp -45.55 146.25 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 112.156 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.1 13.0 69.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.439 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.0 mm-40 -124.66 143.48 50.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.703 0.287 . . . . 0.0 110.293 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 80' ' ' LYS . 22.9 tt0 -84.54 116.91 23.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 63.3 m -134.03 158.83 42.55 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.285 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mt-10 -94.83 120.14 34.55 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 122.793 1.282 . . . . 0.0 111.681 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 28.9 mt -100.76 128.52 46.77 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.222 -2.263 . . . . 0.0 110.706 -170.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.744 ' HB3' HG23 ' A' ' 59' ' ' ILE . 16.1 tt0 -85.79 122.01 29.25 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.758 ' O ' HD11 ' A' ' 59' ' ' ILE . 12.6 p -85.85 164.53 17.46 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.255 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.57 -22.7 62.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.25 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.8 -41.27 53.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.761 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' A' ' 59' ' ' ILE . . . 140.27 -21.49 2.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.316 176.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.66 139.44 39.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.618 0.709 . . . . 0.0 111.438 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.01 123.37 41.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.126 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 144.91 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 135.79 34.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.371 0.605 . . . . 0.0 111.966 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.682 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -147.5 152.46 38.08 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.051 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 HG22 ' HG3' ' A' ' 68' ' ' GLU . 70.1 t -95.78 112.43 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.844 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.765 ' CA ' ' HB ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -100.11 133.96 41.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.095 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.1 mmtt -103.28 151.44 22.68 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.483 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . 4.7 ttp -128.91 132.91 47.71 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.682 -1.207 . . . . 0.0 113.041 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.025 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.5 tp10 -100.45 141.13 33.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 112.367 -2.197 . . . . 0.0 108.303 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.87 -36.66 60.48 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.954 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' C ' HD21 ' A' ' 89' ' ' ASN . 19.4 t0 -87.92 53.64 2.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.805 0.812 . . . . 0.0 110.077 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.668 ' HB2' ' CD2' ' A' ' 104' ' ' PHE 0.251 0.0 OUTLIER 49.41 49.88 19.07 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.821 174.519 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.025 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 61.7 mttt -112.39 122.17 46.94 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.318 170.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.628 ' HE1' ' HZ ' ' A' ' 104' ' ' PHE . 5.7 mtm -129.17 117.05 20.15 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.475 HG13 HG23 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -122.16 118.64 56.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.345 -173.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.765 ' HB ' ' CA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -126.61 140.44 52.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.572 0.701 . . . . 0.0 111.451 -177.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -128.07 138.8 52.7 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.752 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.4 124.16 21.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 60.87 -101.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.024 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.32 15.46 6.41 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.485 HD13 ' HG ' ' A' ' 115' ' ' LEU . 37.5 mm -98.75 114.27 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 113' ' ' MET . 59.6 tttt -104.69 118.88 37.65 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.513 -171.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 m -115.67 118.95 34.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG23 HG13 ' A' ' 92' ' ' VAL . 98.1 t -113.41 120.41 63.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.716 HG22 ' HE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -117.34 119.84 36.35 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.268 174.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 90' ' ' LYS . 28.7 tt0 -129.67 119.92 24.32 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.85 ' CD1' HG21 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -113.97 119.2 36.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.697 176.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.03 138.09 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.463 170.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.71 96.63 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.648 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.597 ' HA ' ' HE2' ' A' ' 7' ' ' TYR . 25.8 m-20 70.07 4.98 5.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.72 0.408 . . . . 0.0 112.089 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -110.85 123.35 49.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 111.34 173.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.85 HG21 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mt -102.15 124.75 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.045 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' THR . 19.5 m -115.07 120.9 41.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.718 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.737 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 3.2 t-20 -116.06 121.27 41.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.892 0.377 . . . . 0.0 110.392 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.828 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -120.98 117.81 28.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.96 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 65.9 mtt -111.95 150.91 29.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.339 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 m -127.62 121.84 31.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -121.86 113.84 20.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.45 -93.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.883 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.62 17.06 3.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 110.112 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -85.53 137.44 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.19 114.62 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.675 0.75 . . . . 0.0 111.084 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 112' ' ' THR . 41.9 t80 -102.78 119.08 38.21 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.828 ' HG2' HG21 ' A' ' 112' ' ' THR . 0.8 OUTLIER -128.92 131.03 47.51 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.737 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 7.4 ptt180 -124.33 144.37 50.05 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.631 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 11' ' ' SER . 11.7 p -100.83 117.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.11 0.957 . . . . 0.0 109.488 173.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.506 ' HG ' HG22 ' A' ' 9' ' ' VAL . 73.9 m -123.66 121.52 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.568 -1.197 . . . . 0.0 108.646 175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.467 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.11 149.33 52.13 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.58 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.726 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 15.9 ttp180 -70.17 146.62 50.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.673 -166.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.706 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.74 ' HB3' ' HA ' ' A' ' 89' ' ' ASN . 8.2 p30 -90.18 95.94 10.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.608 0.718 . . . . 0.0 109.446 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -149.1 58.47 1.03 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.677 -0.639 . . . . 0.0 111.98 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.835 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 56.1 p 53.39 -158.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 167.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.01 -172.43 21.59 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.641 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 2.8 mtpp -95.99 130.12 43.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.504 0.669 . . . . 0.0 109.811 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 17.5 m-85 -135.07 133.6 39.47 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -106.21 135.82 47.01 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 37' ' ' GLY . 1.2 p -68.84 141.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.592 0.711 . . . . 0.0 109.782 -177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.811 HE21 ' HA ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -113.69 -49.58 2.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.88 -171.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.486 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 14.7 m -159.69 159.63 33.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.871 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . 2.3 mt-30 -142.09 153.58 44.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.537 0.684 . . . . 0.0 111.93 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.478 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 1.2 mp0 -94.37 137.39 33.58 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.703 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.702 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 8.5 m-20 70.23 -83.35 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 O-C-N 123.892 0.745 . . . . 0.0 110.594 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.95 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.3 p90 37.66 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.75 1.62 . . . . 0.0 112.702 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.702 ' HG3' ' O ' ' A' ' 14' ' ' ASN . 46.7 mt-10 -145.01 -47.97 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.434 -172.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.677 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 44.1 Cg_endo -76.31 -25.25 10.06 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.963 -1.207 . . . . 0.0 108.963 170.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.742 ' HD2' HD11 ' A' ' 118' ' ' ILE . 38.2 t80 -66.47 -52.59 44.58 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.063 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.035 ' HB2' HD12 ' A' ' 29' ' ' ILE . 17.5 mmt -64.04 -37.51 87.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.156 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.9 pttp -67.12 -39.12 86.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.542 ' HB3' ' HG ' ' A' ' 115' ' ' LEU . . . -72.06 -24.14 61.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.516 174.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.566 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 30.0 tpp -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.879 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.53 -38.16 0.3 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.315 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.7 HD22 HG12 ' A' ' 29' ' ' ILE . 15.0 tp -77.55 131.03 72.23 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.671 ' HD2' HD13 ' A' ' 28' ' ' LEU . 90.9 Cg_endo -79.1 151.74 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.502 1.468 . . . . 0.0 111.19 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.855 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 18.1 tt0 -50.59 -40.16 51.71 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.937 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 4.5 p-10 -60.84 -36.36 78.92 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 118.339 0.518 . . . . 0.0 111.511 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD13 ' HD2' ' A' ' 25' ' ' PRO . 21.7 mt -71.92 -36.88 70.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.301 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.035 HD12 ' HB2' ' A' ' 19' ' ' MET . 30.8 mt -62.12 -43.74 98.16 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.369 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.855 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.2 mm-40 -50.23 -49.3 53.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.125 0.965 . . . . 0.0 111.846 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 2.2 mptp? -71.07 -30.32 66.43 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.829 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.99 32.74 3.9 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.931 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.95 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 13.9 ptmm? -78.81 -41.4 30.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.39 0.614 . . . . 0.0 112.589 -168.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.35 52.92 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.66 0.743 . . . . 0.0 110.785 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 35' ' ' ILE . 42.3 mm -92.91 131.18 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.643 177.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.717 ' HZ1' ' HB2' ' A' ' 36' ' ' LYS . 10.4 mtmp? -98.82 98.25 9.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.166 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' N ' HG12 ' A' ' 9' ' ' VAL . . . -91.4 177.43 40.86 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.588 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.1 t -122.37 150.38 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 51' ' ' THR . 9.4 m -132.49 130.01 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 111.538 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.544 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 5.0 mp0 -122.87 140.02 53.4 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.835 ' O ' ' HB2' ' A' ' 4' ' ' SER . 61.2 mt -129.96 141.96 45.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.281 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 99.5 t -108.61 117.98 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 166.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.579 ' N ' ' HB3' ' A' ' 4' ' ' SER . 17.2 t-160 -95.16 115.21 27.13 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.442 0.639 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -137.61 143.11 41.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.535 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.73 107.95 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 O-C-N 123.835 0.709 . . . . 0.0 112.861 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.685 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mtmt 71.64 -38.65 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.843 1.257 . . . . 0.0 113.077 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.33 106.62 18.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.707 0.289 . . . . 0.0 110.878 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.26 122.9 66.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.23 0.538 . . . . 0.0 110.666 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.642 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 6.8 mptt -104.85 132.68 50.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.131 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.5 tt -120.14 132.49 55.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' A' ' 39' ' ' SER . 17.2 m -117.92 124.04 47.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -128.43 121.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 62.1 m -104.01 129.41 51.61 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -118.07 107.26 13.78 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.99 -96.62 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.661 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 t -104.48 -24.1 13.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 0.0 110.645 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.74 128.48 49.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.84 0.829 . . . . 0.0 112.422 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 82.4 t -104.55 124.9 59.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.33 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.32 114.31 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.987 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -101.93 134.72 44.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.307 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.601 HD22 HG13 ' A' ' 59' ' ' ILE . 4.8 m120 -126.14 93.4 3.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -102.39 125.82 49.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.593 0.711 . . . . 0.0 109.915 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -149.57 152.89 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.27 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.573 HG23 ' OE2' ' A' ' 67' ' ' GLU . 3.6 m -109.15 132.4 54.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.345 174.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.685 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -52.09 140.11 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.798 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 65.31 24.11 70.44 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.522 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.573 ' OE2' HG23 ' A' ' 64' ' ' THR . 33.1 mt-10 -138.05 141.26 40.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -76.74 119.07 20.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.631 0.729 . . . . 0.0 109.734 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 m -132.9 152.6 51.85 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.899 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.6 pt-20 -95.57 145.37 25.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.282 1.039 . . . . 0.0 109.192 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.749 HD13 ' HB1' ' A' ' 81' ' ' ALA . 20.2 mt -110.51 133.73 53.02 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -168.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.678 ' OE2' ' HA ' ' A' ' 59' ' ' ILE . 8.1 tt0 -90.72 130.61 36.7 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.7 p -89.45 174.4 7.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.772 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.0 tpp -61.46 -25.93 67.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.6 . . . . 0.0 109.634 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.9 m -80.68 -39.06 27.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.093 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.67 1.13 7.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.523 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.68 138.89 37.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.846 0.323 . . . . 0.0 111.017 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 10.0 mmmm -97.72 131.75 43.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG22 ' O ' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -136.58 133.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.57 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 34.0 mttm -83.05 123.46 29.5 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.507 0.67 . . . . 0.0 111.701 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.749 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -140.94 153.75 45.78 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.474 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -95.53 111.52 26.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.385 0.612 . . . . 0.0 109.944 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.752 ' CA ' ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -102.4 133.89 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.311 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 88.9 mttt -117.45 152.77 34.33 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.594 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.605 ' H ' ' HB2' ' A' ' 65' ' ' LEU . 5.1 ttm -118.45 119.83 35.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.29 1.043 . . . . 0.0 110.486 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.672 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 11.4 tp10 -63.37 -31.88 73.15 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.734 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.511 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 92.11 -32.23 5.54 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.622 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 37.2 t70 -94.69 62.2 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.582 0.705 . . . . 0.0 109.768 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.74 ' HA ' ' HB3' ' A' ' 2' ' ' ASN . 26.7 m-80 70.56 0.94 3.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.253 -1.34 . . . . 0.0 113.549 174.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.672 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 33.0 mttp -109.4 122.91 48.4 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.788 -172.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.472 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 2.8 mpp? -117.7 115.46 25.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.808 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.38 124.2 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.689 -172.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.752 ' HB ' ' CA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -121.49 140.18 52.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.32 0.581 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.2 m -128.17 126.37 40.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.988 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -134.82 113.95 12.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.053 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 60.3 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.891 0.476 . . . . 0.0 111.354 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.85 10.42 3.38 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.545 HD13 HD11 ' A' ' 115' ' ' LEU . 2.0 mm -90.17 113.56 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -115.78 118.37 32.82 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.201 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.9 m -117.81 119.16 34.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.062 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.0 t -118.84 119.01 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.326 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 24.9 m -117.92 122.09 42.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.908 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.666 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 35.9 tt0 -128.74 129.15 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.724 0.297 . . . . 0.0 110.738 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.56 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 22.0 m-30 -95.07 120.51 35.4 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.003 177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 113.07 16.93 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.932 -0.48 . . . . 0.0 110.68 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.05 -102.3 0.83 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.779 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.97 17.23 6.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.138 0.494 . . . . 0.0 109.9 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 p -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.638 0.732 . . . . 0.0 111.723 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 HD12 ' CE1' ' A' ' 104' ' ' PHE . 22.1 mt -111.4 128.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.789 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.7 m -104.67 119.34 38.77 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -118.31 122.72 43.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.226 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.671 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.2 117.5 26.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.444 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.583 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 5.1 ttm -118.63 146.07 44.94 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 m -128.75 121.79 29.19 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.543 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.545 HD11 HD13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -102.73 114.2 28.25 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 169.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -48.21 81.06 0.01 OUTLIER Glycine 0 N--CA 1.468 0.814 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -160.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.2 t70 157.18 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.627 1.571 . . . . 0.0 106.966 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.742 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -115.98 140.72 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.209 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.29 115.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.458 0.647 . . . . 0.0 111.155 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.449 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 3.6 t80 -100.06 118.74 37.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.671 ' HG2' HG21 ' A' ' 112' ' ' THR . 0.7 OUTLIER -123.86 131.83 53.65 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.508 HH12 HD11 ' A' ' 52' ' ' ILE . 45.1 ttt180 -124.39 131.69 53.51 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.061 -169.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 8.4 p -100.91 117.55 46.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.943 0.878 . . . . 0.0 109.431 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -131.67 136.9 48.05 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.928 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.445 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -135.08 150.88 50.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 0.0 111.399 -175.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 76.9 ttt180 -68.73 148.31 50.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.24 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.641 ' CG1' ' HB2' ' A' ' 6' ' ' LYS . 1.1 pp . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.034 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 mtt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.568 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 20.5 p-10 -73.35 123.08 23.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.042 0.449 . . . . 0.0 111.31 -175.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.659 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 10.4 t80 163.62 64.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 80.6 p 57.34 -162.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.754 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.93 -174.72 15.53 Favored Glycine 0 CA--C 1.507 -0.437 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.664 ' HE3' HG12 ' A' ' 127' ' ' ILE . 3.6 mtpp -93.39 118.49 31.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 9.9 m-85 -125.02 124.67 42.47 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -93.0 134.39 35.18 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.536 HG11 ' N ' ' A' ' 10' ' ' GLN . 25.3 t -68.08 137.38 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.925 0.869 . . . . 0.0 111.782 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.536 ' N ' HG11 ' A' ' 9' ' ' VAL . 1.2 mm100 -112.9 -69.12 0.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.699 -168.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.503 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 20.3 m -151.26 143.28 23.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.274 -170.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.795 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 5.5 mm-40 -121.3 157.61 29.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.499 0.666 . . . . 0.0 111.449 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.506 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 66.8 mt-10 -105.9 137.39 43.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.797 168.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.656 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 7.7 m-20 69.76 -80.52 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.87 0 O-C-N 123.524 0.515 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.795 ' CD1' ' HB2' ' A' ' 12' ' ' GLN . 34.0 p90 35.41 35.41 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.691 1.596 . . . . 0.0 113.374 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.664 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.6 mt-10 -152.9 -48.03 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.04 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.664 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 37.4 Cg_endo -75.73 -25.17 11.02 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 N-CA-C 108.657 -1.324 . . . . 0.0 108.657 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.762 ' HD2' HD11 ' A' ' 118' ' ' ILE . 52.6 t80 -65.94 -53.29 41.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.122 173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.104 ' HB2' HD12 ' A' ' 29' ' ' ILE . 16.9 mmt -61.93 -37.15 83.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.478 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 10.7 pttt -66.43 -41.71 88.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.075 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.627 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -72.07 -20.98 61.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.421 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.609 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 25.5 tpp -83.1 -46.21 13.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.871 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.49 -23.92 0.36 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.121 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.741 HD22 HG12 ' A' ' 29' ' ' ILE . 14.4 tp -91.95 132.91 31.51 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.616 ' CG ' HD12 ' A' ' 28' ' ' LEU . 85.0 Cg_endo -76.14 147.94 30.43 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.29 1.993 . . . . 0.0 111.7 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.825 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 4.2 tt0 -49.47 -44.64 46.02 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.56 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 5.1 t70 -61.35 -35.19 76.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.873 0.76 . . . . 0.0 111.445 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.616 HD12 ' CG ' ' A' ' 25' ' ' PRO . 41.1 mt -71.42 -35.71 71.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.874 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.104 HD12 ' HB2' ' A' ' 19' ' ' MET . 23.5 mt -63.73 -46.87 93.37 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.114 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.825 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 26.8 mm-40 -53.13 -38.62 62.84 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 111.376 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 3.8 mptp? -69.71 -46.54 65.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.313 0.578 . . . . 0.0 110.887 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.87 39.87 2.36 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.183 -170.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.492 ' HD2' ' OE2' ' A' ' 16' ' ' GLU . 18.2 pttp -79.77 -43.12 23.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.2 51.27 0.75 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.535 . . . . 0.0 112.0 -171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.667 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 9.3 mm -79.28 118.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.538 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -100.21 118.96 37.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.046 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.715 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -116.89 -160.75 12.01 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.462 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 39.6 t -125.53 137.45 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.728 0.264 . . . . 0.0 110.748 -174.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.5 t -110.22 134.6 52.07 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 30.6 mt-10 -136.89 121.17 18.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.85 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.6 mt -124.22 141.35 44.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 122.319 -0.238 . . . . 0.0 111.583 -169.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.494 HG12 ' HG3' ' A' ' 44' ' ' GLU . 86.1 t -110.56 114.83 48.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 165.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.414 ' H ' ' CB ' ' A' ' 4' ' ' SER . 20.3 t-160 -95.15 112.13 23.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.795 0.807 . . . . 0.0 109.576 176.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' HG3' HG12 ' A' ' 42' ' ' VAL . 37.9 mt-10 -120.82 144.24 48.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.445 174.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -35.85 105.72 0.03 OUTLIER Glycine 0 CA--C 1.52 0.388 0 O-C-N 123.793 0.683 . . . . 0.0 113.183 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.076 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 mtmt 72.85 -40.94 0.49 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.604 1.562 . . . . 0.0 113.631 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.723 ' HZ1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -92.87 107.33 19.13 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.652 0.739 . . . . 0.0 111.544 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.94 124.76 73.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.228 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 44.1 mttp -110.83 123.04 49.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.28 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.85 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.6 tt -112.82 128.22 56.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.636 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' A' ' 39' ' ' SER . 5.6 m -111.33 124.74 52.86 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.682 HG13 ' CD2' ' A' ' 50' ' ' LEU . 2.2 mt -131.12 120.86 47.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.715 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 43.4 m -98.75 127.09 44.57 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.667 ' CE1' ' HB ' ' A' ' 35' ' ' ILE . 48.5 t80 -121.5 108.11 13.24 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.0 -93.77 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.114 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -105.38 -23.46 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.063 0.459 . . . . 0.0 111.15 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.84 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.415 -170.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 71.3 t -98.08 125.33 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.769 0.795 . . . . 0.0 110.438 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.881 HG13 HD22 ' A' ' 61' ' ' ASN . 0.1 OUTLIER -99.85 115.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.245 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -102.49 126.65 49.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.36 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.881 HD22 HG13 ' A' ' 59' ' ' ILE . 3.6 m120 -127.8 97.38 4.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.522 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.13 125.7 50.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.712 ' CZ ' ' HB3' ' A' ' 61' ' ' ASN . 9.9 m-85 -129.06 152.8 48.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.177 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.5 m -112.59 122.7 48.46 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.076 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -46.51 125.67 7.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.181 0.515 . . . . 0.0 111.972 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.569 ' HA2' ' HD3' ' A' ' 84' ' ' LYS . . . 82.49 16.39 71.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.589 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.5 mm-40 -125.9 154.3 42.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 21.5 tt0 -79.87 119.31 22.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.6 m -132.79 156.58 46.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.496 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.541 ' HG3' ' HE2' ' A' ' 78' ' ' LYS . 3.3 pt-20 -96.18 143.93 26.85 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 12.5 mt -106.21 127.26 53.1 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.298 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.437 ' O ' HD12 ' A' ' 59' ' ' ILE . 46.6 tt0 -88.03 129.0 35.4 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 p -88.52 174.9 7.82 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.763 -172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.435 ' HB3' ' HE1' ' A' ' 19' ' ' MET . 20.2 ttt -70.14 -13.18 62.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.287 0.565 . . . . 0.0 109.761 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -90.9 -38.64 12.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.188 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.49 -13.86 4.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.493 -0.86 . . . . 0.0 114.157 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -80.4 147.04 31.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.584 0.692 . . . . 0.0 111.505 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 8.0 mmmm -96.24 136.47 36.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.551 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -138.0 143.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.875 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.525 ' HD2' ' OE1' ' A' ' 68' ' ' GLU . 37.1 mtmt -84.9 126.6 33.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 111.758 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.544 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -146.52 146.85 30.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.05 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.7 113.06 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.003 0.43 . . . . 0.0 109.937 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.734 ' CA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.31 133.24 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.572 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.3 mmtt -104.97 151.87 23.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.08 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.724 ' HB3' HD23 ' A' ' 65' ' ' LEU . 11.7 tpp -128.68 134.79 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.371 1.081 . . . . 0.0 111.622 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.431 ' HB3' ' HG3' ' A' ' 90' ' ' LYS . 13.5 tp10 -82.12 -35.55 28.41 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.326 -176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 121.74 -36.5 3.22 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.178 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -78.82 26.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.858 1.313 . . . . 0.0 108.912 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.874 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 29.8 m-80 72.06 40.58 0.71 Allowed 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.582 168.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.877 ' HE2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -117.73 118.94 33.45 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 113.496 -1.684 . . . . 0.0 107.913 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.624 ' HA ' ' O ' ' A' ' 84' ' ' LYS . 42.4 mtm -116.65 123.03 46.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.848 0.832 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.85 118.7 54.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.663 -175.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.734 ' HB ' ' CA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.58 143.75 47.47 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.445 0.64 . . . . 0.0 111.356 -177.133 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 m -116.9 126.61 53.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.962 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.782 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 35.2 t80 -139.44 161.24 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.28 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.567 ' O ' HG12 ' A' ' 98' ' ' ILE . 22.8 ttmm -27.61 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.691 1.196 . . . . 0.0 114.008 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.34 8.49 19.02 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.58 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.782 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 26.3 mm -110.07 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -114.88 116.65 28.9 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.672 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.4 m -118.08 119.79 35.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 92' ' ' VAL . 84.6 t -115.71 117.52 55.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.1 m -118.89 120.95 38.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.877 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 24.2 tt0 -129.37 123.14 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.947 -0.471 . . . . 0.0 110.128 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.874 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 2.3 m-30 -89.71 114.0 25.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 172.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -125.45 112.13 15.91 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.72 -95.73 0.48 Allowed Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.215 -173.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -145.71 17.08 1.45 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 125' ' ' LYS . 5.2 m -128.07 135.3 49.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.884 0.85 . . . . 0.0 110.402 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.533 HG13 ' CD2' ' A' ' 7' ' ' TYR . 10.6 mt -102.62 131.45 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.593 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.6 m -115.36 119.22 35.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.133 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 19.4 t-20 -108.0 122.81 47.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.759 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.815 HG21 ' HG3' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -119.85 115.81 24.6 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mtt -114.1 150.12 34.55 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 110.262 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 32.1 m -126.61 122.5 35.21 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -116.73 111.16 19.39 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.14 -90.81 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.68 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -125.34 0.19 7.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.514 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -87.11 140.32 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 -177.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.76 116.36 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.471 0.653 . . . . 0.0 111.51 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.55 118.82 37.61 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.815 ' HG3' HG21 ' A' ' 112' ' ' THR . 20.8 ttpt -125.9 129.3 49.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.178 0.513 . . . . 0.0 109.65 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 34.8 ttm180 -120.22 127.17 52.19 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.261 -172.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.512 HG13 ' CB ' ' A' ' 10' ' ' GLN . 14.7 p -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.1 m -135.34 130.09 34.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.913 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.582 ' HB3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -128.98 144.78 51.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.336 0.971 . . . . 0.0 112.552 -171.531 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.7 ttt180 -69.26 149.94 47.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.849 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.712 HD12 ' OXT' ' A' ' 127' ' ' ILE . 1.2 pp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.822 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.013 0.435 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 4' ' ' SER . 2.3 m-20 -109.33 112.6 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.613 ' HE2' HG13 ' A' ' 48' ' ' VAL . 10.7 t80 79.66 -28.97 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.974 0.91 . . . . 0.0 110.357 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.531 ' HB3' ' N ' ' A' ' 43' ' ' HIS . 94.3 p -82.63 149.93 27.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.301 0.572 . . . . 0.0 112.014 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.39 -178.48 17.06 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.14 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.563 ' HB2' HD13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -94.27 117.27 29.87 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 7.3 m-85 -122.39 132.41 54.36 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.773 ' HG3' HG23 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.88 130.74 53.78 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.502 -174.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.72 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.47 139.05 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.854 176.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.785 ' HB2' HG13 ' A' ' 123' ' ' VAL . 4.8 mm-40 -111.05 -49.24 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.584 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.621 ' HB2' HG11 ' A' ' 123' ' ' VAL . 61.1 m -155.52 154.89 32.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.814 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -136.93 157.32 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.5 0.667 . . . . 0.0 111.375 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.614 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 4.3 mm-40 -114.03 130.59 56.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.994 176.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.734 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.9 m-80 63.4 31.16 15.26 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.643 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 23.3 p90 -68.92 16.11 0.05 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.04 0.448 . . . . 0.0 110.87 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.818 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 40.7 mt-10 -129.12 -48.42 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.814 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.818 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.2 Cg_endo -69.91 -28.5 24.45 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.719 1.613 . . . . 0.0 110.297 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.515 ' O ' ' HG3' ' A' ' 22' ' ' MET . 0.1 OUTLIER -63.16 -52.55 61.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.369 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.935 ' HB2' HD12 ' A' ' 29' ' ' ILE . 85.9 mmm -61.78 -37.59 84.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.741 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 18.6 pttt -67.05 -37.31 83.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.229 0.538 . . . . 0.0 109.731 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.608 ' HB3' HD11 ' A' ' 115' ' ' LEU . . . -67.4 -25.36 65.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 18' ' ' PHE . 58.0 mtp -79.34 -53.4 6.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.26 -16.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.305 -0.862 . . . . 0.0 113.501 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD22 HG12 ' A' ' 29' ' ' ILE . 13.2 tp -81.68 130.7 60.23 Favored Pre-proline 0 N--CA 1.441 -0.891 0 CA-C-N 117.358 0.579 . . . . 0.0 109.924 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.58 ' CG ' HD12 ' A' ' 28' ' ' LEU . 91.6 Cg_endo -76.29 146.68 28.47 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.647 2.232 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.752 ' HA ' HD13 ' A' ' 29' ' ' ILE . 32.4 tt0 -50.72 -37.46 41.74 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.131 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.4 t70 -57.74 -47.19 83.17 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.165 0.893 . . . . 0.0 109.977 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.58 HD12 ' CG ' ' A' ' 25' ' ' PRO . 43.8 mt -68.75 -32.97 73.12 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.935 HD12 ' HB2' ' A' ' 19' ' ' MET . 36.0 mt -61.6 -44.82 99.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.027 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 18.5 mm-40 -52.24 -41.89 63.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.535 0.734 . . . . 0.0 111.789 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 1.027 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.81 -30.54 69.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.134 -176.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.36 32.14 3.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.964 -174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 20.5 pttm -79.63 -43.13 23.42 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -165.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.48 47.01 1.19 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.344 0.592 . . . . 0.0 111.922 -167.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.425 HG21 HD12 ' A' ' 35' ' ' ILE . 41.8 mm -81.6 118.36 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.15 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -84.85 145.86 27.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.082 0.468 . . . . 0.0 110.587 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.72 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -145.45 177.81 23.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.773 HG23 ' HG3' ' A' ' 8' ' ' GLN . 3.7 t -122.43 145.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.779 ' HA ' ' O ' ' A' ' 51' ' ' THR . 7.5 p -129.72 120.12 24.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.7 mp0 -110.12 124.07 50.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.876 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.787 HG12 ' HG ' ' A' ' 50' ' ' LEU . 76.3 mt -123.37 140.41 47.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -168.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.09 114.38 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.531 ' N ' ' HB3' ' A' ' 4' ' ' SER . 28.5 t-80 -105.06 114.11 28.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.323 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.29 143.81 49.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 169.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.35 107.85 0.05 OUTLIER Glycine 0 CA--C 1.522 0.491 0 O-C-N 123.517 0.511 . . . . 0.0 112.624 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.872 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.9 mtmm 76.86 -35.58 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.992 1.317 . . . . 0.0 113.069 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -90.53 109.57 20.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.15 0.5 . . . . 0.0 111.182 -172.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.613 HG13 ' HE2' ' A' ' 3' ' ' PHE . 69.1 t -123.0 128.8 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.343 0.592 . . . . 0.0 111.77 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 41.2 mtpt -109.42 126.83 53.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.787 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -118.87 122.59 42.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.779 ' O ' ' HA ' ' A' ' 39' ' ' SER . 3.2 m -108.5 125.15 51.48 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.669 HG13 ' CD2' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -130.75 122.63 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.545 0.688 . . . . 0.0 110.097 -170.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.4 m -103.85 129.78 51.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.196 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.434 ' C ' ' H ' ' A' ' 56' ' ' SER . 46.9 t80 -116.55 105.89 12.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.1 -17.44 0.11 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 54' ' ' TYR . 20.2 t 172.41 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.07 0.938 . . . . 0.0 109.608 -169.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -97.95 133.04 42.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.041 -169.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.6 t -99.63 124.69 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.579 0.704 . . . . 0.0 110.745 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 59' ' ' ILE . 0.3 OUTLIER -126.7 114.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.317 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.656 ' C ' HD21 ' A' ' 61' ' ' ASN . 0.3 OUTLIER -116.53 149.27 39.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -173.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.677 ' N ' HD21 ' A' ' 61' ' ' ASN . 0.5 OUTLIER -124.41 121.38 34.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.058 -171.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -103.69 126.26 50.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.175 0.512 . . . . 0.0 110.237 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -151.26 152.29 33.03 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.304 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 2.0 m -105.83 131.81 52.71 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.872 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 2.5 pp -72.72 168.54 18.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.762 0.791 . . . . 0.0 111.427 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 11.24 41.04 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.397 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 64' ' ' THR . 47.0 mt-10 -135.4 143.58 46.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -174.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.749 ' HB2' HG22 ' A' ' 82' ' ' VAL . 8.0 tt0 -83.26 117.11 22.74 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 67.6 m -132.97 157.39 45.28 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.878 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -94.98 119.57 33.72 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 122.876 1.322 . . . . 0.0 111.217 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.642 HD13 ' HB1' ' A' ' 81' ' ' ALA . 23.0 mt -102.69 145.89 29.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.704 -171.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 21.0 tt0 -109.25 123.86 49.95 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 p -91.43 167.93 11.91 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.253 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.556 ' HE3' HD11 ' A' ' 52' ' ' ILE . 2.0 mpt? -59.73 -29.0 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 110.62 -179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 p -81.18 -30.66 34.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.297 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.98 -5.99 9.55 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.45 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.28 140.74 38.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.346 0.573 . . . . 0.0 110.736 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HZ2' ' HB2' ' A' ' 72' ' ' GLU . 23.7 mmmt -95.67 128.16 42.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.17 137.5 48.34 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.654 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 69' ' ' CYS . 41.8 pttt -101.96 125.31 48.61 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.564 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.642 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -128.93 146.03 51.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.46 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG22 ' HB2' ' A' ' 68' ' ' GLU . 91.8 t -92.79 111.89 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.811 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.05 131.07 53.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.342 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -104.09 152.48 22.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.776 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.72 ' HG3' ' SD ' ' A' ' 91' ' ' MET . 6.7 ttt -127.73 135.32 50.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.18 0.991 . . . . 0.0 111.488 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.078 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 9.2 tp10 -90.98 0.03 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.03 -1.895 . . . . 0.0 109.923 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.676 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 88.56 -65.73 3.29 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.858 173.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.482 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 19.1 m-20 -79.12 57.15 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 0.0 110.947 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.642 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 8.9 m-80 70.59 40.24 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.404 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.078 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -119.65 122.74 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.777 169.161 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.72 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -119.27 115.3 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 171.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 101' ' ' VAL . 2.1 t -125.26 118.86 53.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.811 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -130.04 143.8 50.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.786 0.803 . . . . 0.0 112.283 -178.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 t -126.96 136.99 53.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.806 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -139.86 131.7 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt 55.67 28.56 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.64 2.89 88.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.215 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.5 mm -90.09 137.63 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 113' ' ' MET . 37.4 tttt -112.1 120.73 42.81 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.652 -172.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -121.52 120.78 35.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.999 0.428 . . . . 0.0 110.142 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.459 HG23 HG13 ' A' ' 92' ' ' VAL . 95.4 t -116.4 121.07 66.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.798 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.535 HG21 ' HB2' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -117.19 121.28 40.78 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 177.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -121.36 115.91 23.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.722 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -118.0 119.49 34.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.48 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.15 114.75 17.41 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.514 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.59 46.6 4.85 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.43 11.4 5.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.098 0.475 . . . . 0.0 111.452 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 p -120.92 129.11 53.34 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.978 -0.451 . . . . 0.0 110.403 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.0 mt -109.75 130.24 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.726 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -116.92 119.36 35.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.535 ' HB2' HG21 ' A' ' 102' ' ' THR . 2.9 t-20 -115.38 123.33 48.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.854 0.359 . . . . 0.0 110.504 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 3.3 m -120.02 125.34 48.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.485 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.669 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 30.8 ttm -120.6 149.97 41.63 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.0 m -122.0 121.47 37.11 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.608 HD11 ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -122.86 111.62 16.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 53.31 -101.64 0.09 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.59 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -100.9 -11.94 19.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 0.0 110.733 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -87.59 135.57 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.854 -170.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.404 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.6 p -112.62 115.2 49.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 121.292 0.568 . . . . 0.0 111.231 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.752 ' OH ' ' HD3' ' A' ' 122' ' ' ARG . 15.3 t80 -109.83 119.98 41.04 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 121.536 -0.728 . . . . 0.0 111.125 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.614 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 2.7 ttmt -123.92 124.52 42.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.749 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.752 ' HD3' ' OH ' ' A' ' 120' ' ' TYR . 22.2 ptt85 -119.38 144.14 47.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.371 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.2 p -100.99 118.86 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.483 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.449 ' HG ' HG22 ' A' ' 9' ' ' VAL . 65.4 m -123.55 130.41 52.64 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.421 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HB2' ' HZ2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -134.01 139.01 45.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.038 0.447 . . . . 0.0 110.858 -174.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 2.9 ttt180 -71.85 149.28 45.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 112.055 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.577 ' N ' ' HG2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.71 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.137 0.494 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.634 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 25.2 p-10 -69.67 139.03 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.053 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.953 ' HD2' ' HA ' ' A' ' 89' ' ' ASN . 5.0 t80 92.16 -8.65 0.21 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.176 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.626 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -117.99 160.37 21.6 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.504 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.32 177.18 15.25 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.691 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.974 ' HB2' HD11 ' A' ' 127' ' ' ILE . 44.6 mtpt -96.88 118.22 32.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 31.7 m-85 -120.81 125.08 46.63 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 15.4 tm0? -93.19 134.28 35.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.685 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.24 136.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.072 0.939 . . . . 0.0 109.666 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 123' ' ' VAL . 5.6 mm100 -111.52 -56.89 2.32 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.499 -167.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.63 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 57.3 m -152.97 150.75 29.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.666 HE21 HG23 ' A' ' 9' ' ' VAL . 17.8 mp0 -133.11 147.86 52.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.749 0.785 . . . . 0.0 110.998 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.932 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 9.7 mm-40 -92.55 127.76 38.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.092 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.545 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 45.3 m-20 70.06 -102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.094 0.871 . . . . 0.0 110.123 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CE1' ' HE2' ' A' ' 74' ' ' MET . 5.2 t80 72.82 13.19 5.13 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.249 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.715 ' HB2' ' HD3' ' A' ' 17' ' ' PRO . 33.3 mt-10 -141.2 -45.78 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.652 -171.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.715 ' HD3' ' HB2' ' A' ' 16' ' ' GLU . 31.6 Cg_exo -60.97 -37.53 76.01 Favored 'Trans proline' 0 CA--C 1.494 -1.52 0 C-N-CA 122.439 2.093 . . . . 0.0 108.574 162.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.51 ' HB2' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -57.76 -53.92 52.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.113 -2.767 . . . . 0.0 109.628 175.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.069 ' HB2' HD12 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.13 -36.34 83.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.329 176.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.702 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 16.1 pttt -66.82 -40.15 87.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.08 28.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.1 -44.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -165.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.15 -51.26 0.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.591 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 HD12 ' HB3' ' A' ' 28' ' ' LEU . 15.8 tp -85.08 135.8 39.04 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 116.945 0.372 . . . . 0.0 110.754 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.561 ' CG ' HD12 ' A' ' 28' ' ' LEU . 97.4 Cg_endo -77.69 151.43 28.43 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.968 2.445 . . . . 0.0 111.675 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.731 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 0.9 OUTLIER -49.86 -45.39 50.46 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.891 -178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.664 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 2.4 p-10 -56.61 -42.26 78.46 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 118.664 0.666 . . . . 0.0 110.208 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.561 HD12 ' CG ' ' A' ' 25' ' ' PRO . 40.9 mt -70.55 -33.71 71.43 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.095 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.069 HD12 ' HB2' ' A' ' 19' ' ' MET . 25.6 mt -64.75 -44.39 96.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 172.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.905 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 22.9 mm-40 -52.55 -40.72 62.83 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.079 0.952 . . . . 0.0 111.327 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.905 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -69.56 -31.29 69.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.713 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.63 33.41 2.87 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.902 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' ILE . 20.4 ptmt -78.61 -37.17 42.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.743 0.782 . . . . 0.0 112.784 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.41 51.11 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.96 -165.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 35' ' ' ILE . 27.3 mm -81.1 117.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -102.45 112.6 25.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.685 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -117.09 -163.15 12.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.142 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 23.7 t -129.32 150.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.711 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.2 p -127.96 118.47 23.63 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.972 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.715 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 1.7 mp0 -114.54 123.61 49.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.672 HG12 ' HG ' ' A' ' 50' ' ' LEU . 80.4 mt -122.6 137.83 54.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.078 0.466 . . . . 0.0 111.951 -170.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -109.46 118.58 57.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.626 ' H ' ' HB3' ' A' ' 4' ' ' SER . 15.2 t-160 -96.72 113.16 24.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.926 0.869 . . . . 0.0 110.499 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 8.3 tp10 -116.83 143.35 45.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.42 101.1 0.02 OUTLIER Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.824 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmt 79.1 -31.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.295 1.438 . . . . 0.0 112.353 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -90.44 108.85 20.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 0.0 110.601 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.769 HG13 ' HE1' ' A' ' 3' ' ' PHE . 42.4 t -110.59 124.13 67.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.359 0.599 . . . . 0.0 110.804 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 73.6 mttt -107.16 122.67 46.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.941 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.672 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -117.45 127.63 54.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.711 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.1 m -110.73 123.87 50.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.648 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -126.97 120.49 55.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.676 HG21 HG22 ' A' ' 58' ' ' VAL . 53.7 m -101.32 128.41 47.49 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.955 -171.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.5 t80 -110.35 157.8 19.13 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -43.06 101.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.608 0.567 . . . . 0.0 113.193 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 t 84.42 -21.59 0.25 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.369 1.068 . . . . 0.0 112.707 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 54' ' ' TYR . 4.2 tmmm? -131.49 122.97 27.1 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.783 -0.573 . . . . 0.0 111.733 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.676 HG22 HG21 ' A' ' 53' ' ' THR . 21.4 t -97.99 132.45 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 122.192 0.996 . . . . 0.0 111.407 -177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.668 HD13 ' HA2' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -117.84 114.77 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.506 -176.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.681 ' C ' HD21 ' A' ' 61' ' ' ASN . 10.0 p80 -91.36 146.36 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.118 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.681 HD21 ' C ' ' A' ' 60' ' ' HIS . 0.8 OUTLIER -131.57 105.32 7.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.774 0.429 . . . . 0.0 110.04 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -104.61 127.01 52.24 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.881 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -150.89 151.55 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 1.7 m -110.39 133.59 53.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.526 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.782 HD22 ' HE3' ' A' ' 85' ' ' MET . 4.0 pp -52.66 142.77 17.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.281 0.563 . . . . 0.0 111.129 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 25.08 76.4 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 64' ' ' THR . 70.3 mm-40 -132.75 138.22 47.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.478 0.18 . . . . 0.0 111.069 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.662 ' HB2' HG22 ' A' ' 82' ' ' VAL . 8.3 tt0 -78.53 118.08 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.606 0.717 . . . . 0.0 109.096 168.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.2 m -134.65 162.72 31.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.094 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.757 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 2.2 mt-10 -94.6 119.21 32.9 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.331 1.062 . . . . 0.0 110.585 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD13 ' HB1' ' A' ' 81' ' ' ALA . 25.5 mt -92.88 120.48 33.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.628 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' OE1' HG12 ' A' ' 59' ' ' ILE . 25.2 tt0 -92.79 121.9 34.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.477 ' O ' HD11 ' A' ' 59' ' ' ILE . 19.1 p -87.58 167.42 13.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.159 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.497 ' HE2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -56.01 -27.51 53.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 0.0 110.963 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -91.65 -12.6 33.69 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.668 ' HA2' HD13 ' A' ' 59' ' ' ILE . . . 122.23 -22.7 7.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.973 172.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.62 147.28 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.788 0.794 . . . . 0.0 111.147 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.22 132.03 56.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.791 -176.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.29 142.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.613 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.757 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 76.8 mttt -82.71 123.79 29.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.523 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.758 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -143.95 147.71 34.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.476 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.662 HG22 ' HB2' ' A' ' 68' ' ' GLU . 44.3 t -91.34 113.44 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 109.694 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.744 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -95.62 133.11 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -103.02 140.04 37.8 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.782 ' HE3' HD22 ' A' ' 65' ' ' LEU . 8.0 tmm? -129.2 132.02 47.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.1 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.864 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 4.2 tp10 -80.28 -48.13 13.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.449 -2.16 . . . . 0.0 111.957 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 115.49 -45.21 1.33 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.225 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.08 44.22 0.75 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 122.51 1.148 . . . . 0.0 109.69 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.953 ' HA ' ' HD2' ' A' ' 3' ' ' PHE . 34.5 m-80 69.68 43.43 0.98 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.01 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.864 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 24.5 mttp -131.45 119.97 22.35 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.654 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 ttp -121.92 121.13 36.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.692 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.88 116.69 41.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.744 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -121.37 134.53 55.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.401 0.619 . . . . 0.0 110.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.8 m -128.33 127.36 42.55 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.557 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -122.69 111.46 16.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 46.51 -99.88 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.527 -173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.07 17.94 34.39 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.1 mm -100.88 113.13 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 113' ' ' MET . 42.1 tttp -113.86 118.99 35.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.571 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.588 ' HB3' HG23 ' A' ' 93' ' ' THR . 32.1 t -120.64 119.81 33.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.763 0.316 . . . . 0.0 110.332 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 112' ' ' THR . 1.8 m -112.42 121.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 6.4 m -119.69 120.58 37.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.24 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 42.5 tt0 -130.55 129.19 42.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.101 -0.239 . . . . 0.0 111.029 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.645 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -109.79 118.69 37.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -129.24 102.97 6.69 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.122 171.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.85 62.46 2.81 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.312 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' OD2' ' HD3' ' A' ' 126' ' ' ARG . 7.3 m-20 67.88 -3.84 1.11 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.2 p -117.24 142.02 47.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.752 -0.592 . . . . 0.0 111.834 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.499 HD11 ' CG ' ' A' ' 7' ' ' TYR . 8.9 mt -116.91 135.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.521 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -112.22 119.81 39.63 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 169.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.8 t-20 -114.65 121.49 43.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 110.226 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 101' ' ' VAL . 6.6 m -122.35 117.86 27.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.638 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 33.9 ttm -124.67 149.34 47.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.3 m -123.88 121.85 36.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 118' ' ' ILE . 1.3 tp -117.56 114.58 23.64 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.566 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -82.89 0.19 Allowed Glycine 0 C--N 1.319 -0.366 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.603 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.07 5.64 2.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.862 0.839 . . . . 0.0 109.338 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.601 HG21 ' O ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -91.86 139.07 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.361 -173.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.404 ' H ' HG11 ' A' ' 119' ' ' VAL . 3.4 p -104.67 117.11 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.61 0.719 . . . . 0.0 110.757 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 27.2 t80 -107.16 120.41 42.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.735 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.932 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 3.6 mtmt -123.73 128.31 49.41 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.304 0.573 . . . . 0.0 109.673 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 14.7 ttt180 -119.75 132.34 55.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.067 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.63 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 7.7 p -100.5 117.42 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.537 ' HG ' ' HA ' ' A' ' 9' ' ' VAL . 3.5 m -124.85 133.72 52.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.805 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.47 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.13 149.22 52.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 0.0 111.339 -176.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 ttp180 -69.6 150.47 47.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.053 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.8 pt . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.161 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptp . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.485 ' HB3' ' H ' ' A' ' 106' ' ' GLY . 21.0 p-10 -100.94 110.7 22.77 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.646 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -154.83 -64.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.026 0.917 . . . . 0.0 109.297 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 17.8 p -141.72 -163.64 1.62 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.94 -176.53 16.11 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.819 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.734 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.79 116.93 30.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 50.9 m-85 -121.01 124.51 45.02 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.865 ' HG3' HG23 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.5 137.03 33.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.857 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -68.93 135.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.641 ' HB2' HG13 ' A' ' 123' ' ' VAL . 12.6 mm100 -110.76 -48.4 3.14 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.441 -168.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.576 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 31.3 m -158.12 156.75 31.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.542 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.22 158.18 45.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -119.7 125.79 49.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.663 -177.144 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.628 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 8.9 m-80 64.58 29.06 13.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 123.219 0.325 . . . . 0.0 111.704 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 1.019 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 29.6 p90 -67.58 6.12 0.69 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.078 0.466 . . . . 0.0 110.92 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.809 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 27.8 mt-10 -120.76 -46.23 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.142 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.873 ' HB2' HG23 ' A' ' 118' ' ' ILE . 32.9 Cg_endo -67.48 -29.71 37.0 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.4 1.4 . . . . 0.0 109.978 173.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.666 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 1.1 t80 -65.31 -52.18 55.72 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.48 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.972 ' HB2' HD12 ' A' ' 29' ' ' ILE . 87.1 mmm -61.04 -41.39 96.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.439 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.555 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 14.3 ptmt -68.78 -33.95 74.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.273 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -71.31 -22.71 61.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.15 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 18' ' ' PHE . 86.7 mmm -85.74 -72.15 0.5 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.38 0.609 . . . . 0.0 110.749 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.42 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.641 -172.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.754 HD22 HG12 ' A' ' 29' ' ' ILE . 12.0 tp -86.23 125.03 69.26 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 117.952 0.876 . . . . 0.0 109.718 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.589 ' CG ' HD12 ' A' ' 28' ' ' LEU . 88.4 Cg_endo -72.21 148.18 49.33 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.496 2.131 . . . . 0.0 111.261 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.869 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 8.4 tt0 -48.84 -41.8 34.19 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.663 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.645 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 16.9 t70 -61.85 -37.86 86.08 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 118.944 0.793 . . . . 0.0 111.168 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.589 HD12 ' CG ' ' A' ' 25' ' ' PRO . 35.1 mt -70.37 -35.01 73.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.491 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 19' ' ' MET . 21.5 mt -63.92 -44.61 98.03 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.822 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.869 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.0 mm-40 -50.52 -47.73 57.36 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.974 0.892 . . . . 0.0 112.067 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.645 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -68.62 -30.84 69.65 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.641 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.04 31.65 4.43 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.088 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 1.019 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 14.0 ptmm? -79.23 -39.65 32.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -165.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.07 46.68 0.93 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.536 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 35' ' ' ILE . 7.8 mt -86.41 129.52 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 176.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 147.61 23.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 0.0 109.816 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.857 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -142.69 171.34 24.83 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.865 HG23 ' HG3' ' A' ' 8' ' ' GLN . 11.5 t -121.93 132.93 69.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 117.538 0.669 . . . . 0.0 110.588 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.707 ' HB3' HD23 ' A' ' 50' ' ' LEU . 5.7 m -113.42 120.64 41.75 Favored 'General case' 0 C--O 1.21 -0.997 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.17 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.734 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 46.9 mt-10 -119.66 123.0 42.75 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.117 0.484 . . . . 0.0 110.034 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 4' ' ' SER . 96.4 mt -119.31 138.28 50.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -168.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.83 115.07 48.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.229 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.552 ' N ' ' HB3' ' A' ' 4' ' ' SER . 27.3 t-80 -96.37 122.17 38.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 111.707 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.83 143.09 50.63 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.566 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -42.35 136.09 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.733 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.843 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 66.42 -50.97 0.43 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.198 0.999 . . . . 0.0 112.586 -174.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -99.13 109.26 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.457 0.646 . . . . 0.0 112.37 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG21 ' HE1' ' A' ' 91' ' ' MET . 80.7 t -122.72 129.14 75.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.96 -174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.608 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 39.0 mttp -109.77 135.21 51.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.707 HD23 ' HB3' ' A' ' 39' ' ' SER . 1.6 tt -125.11 125.84 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.4 m -110.9 121.14 44.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.702 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.4 mt -123.96 121.1 61.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.436 0.636 . . . . 0.0 109.394 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.6 m -101.21 128.9 47.12 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.17 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t -121.31 -35.45 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.239 . . . . 0.0 111.559 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HZ2' HD13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -98.8 138.49 35.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.298 0.57 . . . . 0.0 112.127 -170.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.5 t -99.74 126.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.804 0.811 . . . . 0.0 110.769 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.759 HD13 ' HA2' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -118.94 114.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.002 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.584 ' C ' HD21 ' A' ' 61' ' ' ASN . 0.5 OUTLIER -87.15 146.5 26.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.342 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.707 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -127.78 106.91 9.45 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -108.01 126.18 52.41 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.695 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.21 152.28 34.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.309 0.576 . . . . 0.0 111.83 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 7.5 m -121.34 133.31 55.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.9 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.85 ' HB3' ' HB3' ' A' ' 85' ' ' MET . 3.5 pp -46.39 141.95 3.28 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.449 0.642 . . . . 0.0 112.465 176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 66.06 21.9 70.18 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.91 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.5 mm-40 -132.44 140.94 48.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.712 0.256 . . . . 0.0 110.8 -174.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.672 ' HB2' HG22 ' A' ' 82' ' ' VAL . 9.5 tt0 -79.74 117.59 20.77 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.895 0.855 . . . . 0.0 109.311 171.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 m -128.4 159.27 35.88 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.522 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.662 ' HG2' ' HG2' ' A' ' 80' ' ' LYS . 38.9 mt-10 -94.57 119.18 32.84 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.89 1.329 . . . . 0.0 110.588 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.711 HD13 ' HB1' ' A' ' 81' ' ' ALA . 36.3 mt -94.72 121.5 36.37 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.772 -2.467 . . . . 0.0 109.602 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' HB3' HG23 ' A' ' 59' ' ' ILE . 26.8 tt0 -94.59 124.3 38.54 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.57 ' O ' HD11 ' A' ' 59' ' ' ILE . 19.1 p -86.1 164.78 17.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.894 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -62.27 -19.36 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.3 0.571 . . . . 0.0 109.564 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 m -73.78 -48.0 34.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.507 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.759 ' HA2' HD13 ' A' ' 59' ' ' ILE . . . 143.11 -31.18 1.98 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.019 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -77.0 138.71 39.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.929 0.365 . . . . 0.0 110.923 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.94 136.83 41.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.47 143.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 111.114 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.662 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 56.2 mttp -81.69 123.32 28.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.607 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.711 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -145.71 148.54 33.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.858 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 68' ' ' GLU . 38.8 t -91.74 114.27 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.956 0.408 . . . . 0.0 110.059 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -106.71 134.95 46.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.291 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.49 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.5 mmtt -105.11 155.51 18.94 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.85 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 2.1 tmt? -129.16 136.36 50.08 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.105 0.955 . . . . 0.0 112.077 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 8.9 tp10 -110.26 148.53 31.71 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.273 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -58.16 -25.54 57.24 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -168.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.646 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 4.9 m-20 -80.21 28.82 0.29 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.085 0.945 . . . . 0.0 109.738 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.612 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 61.52 47.24 6.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.177 -1.828 . . . . 0.0 109.385 172.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.716 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 7.0 mtpt -107.61 123.9 49.16 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.55 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.572 ' HE1' HG21 ' A' ' 48' ' ' VAL . 16.2 mmt -113.88 112.64 23.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.433 HG12 ' HE3' ' A' ' 99' ' ' LYS . 2.4 t -123.39 116.34 48.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.251 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.722 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -132.13 145.17 51.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.447 0.641 . . . . 0.0 110.667 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.5 m -125.49 124.91 42.39 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.497 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.66 ' CZ ' ' HE3' ' A' ' 96' ' ' LYS . 62.1 t80 -139.74 112.45 7.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.66 ' HE3' ' CZ ' ' A' ' 95' ' ' PHE . 8.6 mtmp? 42.52 57.87 3.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.21 -9.42 60.98 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.152 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 98' ' ' ILE . 2.0 mm -90.31 113.3 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -104.35 130.66 52.19 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.086 0.47 . . . . 0.0 110.577 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.473 ' HB3' HG23 ' A' ' 93' ' ' THR . 19.0 t -125.34 124.92 42.61 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.893 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.9 t -123.32 118.59 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.441 . . . . 0.0 109.877 173.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 2.8 m -118.62 122.58 42.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.716 ' HG3' ' HE3' ' A' ' 90' ' ' LYS . 12.2 tt0 -129.28 124.95 35.7 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.005 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.721 ' CD1' HD12 ' A' ' 109' ' ' ILE . 1.3 m-30 -101.42 115.47 30.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.51 117.46 21.35 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.515 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.485 ' H ' ' HB3' ' A' ' 2' ' ' ASN . . . 69.06 -95.02 0.39 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.088 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.0 12.93 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.36 . . . . 0.0 110.439 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p -131.38 146.4 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.581 0.705 . . . . 0.0 111.784 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.745 ' HB ' ' OG ' ' A' ' 124' ' ' SER . 21.1 mt -129.09 135.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.341 -173.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 m -115.89 120.52 39.47 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.676 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 14.1 t-20 -107.88 124.79 50.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.004 0.431 . . . . 0.0 110.16 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -119.48 122.45 41.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.806 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.6 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.7 mtt -122.09 150.71 41.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' HD12 ' A' ' 98' ' ' ILE . 7.0 m -122.43 120.14 33.06 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.595 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 3.4 tm? -124.63 115.1 20.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.06 -107.0 1.59 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.919 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -115.41 6.69 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.071 0.462 . . . . 0.0 109.959 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.873 HG23 ' HB2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER -93.03 139.61 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.317 -173.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.0 p -108.65 114.99 48.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-O 121.413 0.625 . . . . 0.0 110.841 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.6 ' HD2' ' HB2' ' A' ' 113' ' ' MET . 7.2 t80 -112.03 121.34 44.72 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.367 0.604 . . . . 0.0 111.941 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 6.4 mtmm -121.28 139.42 53.42 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.391 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.676 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 11.4 ptt180 -123.43 142.39 51.04 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.641 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -99.86 118.56 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.745 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 93.5 p -129.57 133.23 47.08 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.358 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -129.32 147.28 51.14 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.718 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 10.6 ttp180 -70.85 148.83 47.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.0 110.172 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.63 HG13 ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.674 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.69 95.84 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.942 0.877 . . . . 0.0 110.746 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -148.87 70.94 1.12 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.025 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 88.0 p 58.19 -157.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 124.073 0.858 . . . . 0.0 111.961 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 -173.37 17.72 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.321 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.917 ' HB2' HD11 ' A' ' 127' ' ' ILE . 42.9 mtpt -94.33 118.12 31.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.133 0.492 . . . . 0.0 110.086 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 30.7 m-85 -120.13 123.53 43.56 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.426 ' HG2' HG23 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -97.08 130.52 44.36 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -173.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 0.5 OUTLIER -69.94 140.75 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.581 0.705 . . . . 0.0 110.794 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.532 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.3 mm100 -109.06 -39.58 5.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.75 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.508 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 13.3 m -159.15 159.99 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.134 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.506 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -139.43 157.5 45.75 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.499 0.666 . . . . 0.0 111.376 177.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.683 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 6.2 tp10 -114.49 126.88 55.45 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.964 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.744 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 89.8 m-20 57.04 35.38 26.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.238 0.542 . . . . 0.0 111.867 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.838 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 32.7 p90 -69.16 21.73 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.402 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.806 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.1 mt-10 -135.36 -48.26 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -172.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.806 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 42.3 Cg_endo -71.0 -26.4 21.81 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.212 1.275 . . . . 0.0 109.432 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.802 ' HD1' HD11 ' A' ' 118' ' ' ILE . 44.6 t80 -65.11 -52.18 56.91 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.031 175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.919 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 23.3 mmt -61.51 -41.86 97.93 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.297 174.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.772 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 9.0 pttt -68.4 -33.92 75.1 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.553 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.23 66.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.639 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.0 ttm -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.86 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.8 -34.24 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.952 HD13 ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -74.56 126.99 88.14 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.952 ' HD2' HD13 ' A' ' 24' ' ' LEU . 98.9 Cg_endo -79.27 141.68 16.32 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.896 1.73 . . . . 0.0 111.227 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.773 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 2.1 tt0 -49.67 -42.22 44.9 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.695 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.7 t70 -55.76 -44.14 77.36 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 118.544 0.611 . . . . 0.0 109.854 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.636 HD12 ' CG ' ' A' ' 25' ' ' PRO . 19.6 mt -68.4 -33.41 74.2 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.777 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.912 HD12 ' HB2' ' A' ' 19' ' ' MET . 27.3 mt -64.66 -44.14 96.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.5 169.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 1.045 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 23.0 mm-40 -53.04 -41.0 64.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 1.045 ' HE2' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -71.23 -31.55 67.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.358 178.053 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.6 44.66 1.18 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.865 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.838 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -79.67 -39.79 30.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -167.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.434 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 7.6 t70 -98.88 61.0 1.27 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.032 0.92 . . . . 0.0 110.236 -167.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.481 HD12 HG21 ' A' ' 35' ' ' ILE . 3.9 mm -90.3 115.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.814 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -98.31 100.88 12.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.001 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.08 -175.57 34.77 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.2 t -122.05 155.51 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 51' ' ' THR . 16.0 m -133.95 119.68 19.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.145 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 3.1 mp0 -116.75 123.85 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 4' ' ' SER . 38.7 mt -116.84 143.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 92.6 t -109.02 114.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 167.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.5 ' N ' ' HB3' ' A' ' 4' ' ' SER . 15.9 t-160 -96.37 112.79 24.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 110.387 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -127.88 145.54 50.91 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -36.67 114.48 0.22 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.433 174.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 1.046 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 58.68 -25.31 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -172.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 21.8 mmtp -91.26 107.09 18.97 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.283 0.492 . . . . 0.0 111.036 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 46.3 t -124.53 124.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.0 110.491 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 1.2 tttm -115.22 139.06 50.26 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.652 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.3 tt -121.93 124.95 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.158 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.725 ' O ' ' HA ' ' A' ' 39' ' ' SER . 58.2 m -110.2 124.38 51.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.652 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -129.33 121.06 52.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.2 m -99.53 130.63 45.79 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.658 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -109.18 108.15 18.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.93 -89.68 0.13 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.919 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.8 t -124.82 -3.65 7.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.749 0.309 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -121.91 136.2 54.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.749 0.309 . . . . 0.0 110.181 -170.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 93.8 t -98.33 134.19 37.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.012 0.91 . . . . 0.0 112.223 -172.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -118.64 114.75 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.603 176.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.592 ' C ' HD21 ' A' ' 61' ' ' ASN . 0.0 OUTLIER -87.35 145.43 26.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.962 -172.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.606 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -135.07 98.6 4.04 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 49' ' ' LYS . 3.5 mp0 -102.55 132.08 48.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.992 -0.443 . . . . 0.0 110.618 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -150.02 151.81 33.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.663 0.744 . . . . 0.0 112.091 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.581 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 22.9 m -107.78 134.03 51.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.112 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.046 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.7 mt -48.08 131.13 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.869 0.366 . . . . 0.0 111.05 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.77 60.8 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.013 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.581 ' HB2' ' O ' ' A' ' 64' ' ' THR . 50.4 mm-40 -132.98 139.03 47.07 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.468 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 28.3 tt0 -80.56 116.98 20.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.9 t -135.75 160.74 37.6 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.272 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.668 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.5 pt-20 -95.95 145.15 25.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.221 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 19.4 mt -105.88 128.42 53.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.509 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.453 ' HB3' HG23 ' A' ' 59' ' ' ILE . 14.5 tt0 -91.63 120.29 32.27 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.609 ' O ' HD12 ' A' ' 59' ' ' ILE . 11.2 p -90.51 166.42 13.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.997 -173.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.27 -20.24 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.858 0.361 . . . . 0.0 110.64 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 p -82.61 -38.67 23.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.449 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 133.04 -14.89 4.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.56 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -77.38 138.39 39.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.824 0.312 . . . . 0.0 111.534 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 9.9 mmmm -96.85 135.83 38.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.804 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.48 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -137.13 131.45 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.346 177.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 41.0 pttt -83.68 124.24 30.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.478 0.656 . . . . 0.0 111.031 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -140.99 149.38 41.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.428 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 93' ' ' THR . 71.2 t -93.95 113.08 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.763 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -104.76 132.33 51.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -117.66 156.17 28.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.492 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.794 ' HB3' HD13 ' A' ' 65' ' ' LEU . 8.7 tpp -126.32 122.23 34.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.098 0.951 . . . . 0.0 110.147 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.621 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 12.2 tp10 -46.43 -43.9 16.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.752 -2.022 . . . . 0.0 110.527 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.568 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . 137.94 -59.65 0.61 Allowed Glycine 0 CA--C 1.5 -0.901 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.857 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.816 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -63.4 -72.0 0.15 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.16 0.505 . . . . 0.0 110.954 176.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.816 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 1.5 p30 -150.43 13.16 0.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.621 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -109.81 119.87 40.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.004 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.485 ' HG2' ' HB2' ' A' ' 85' ' ' MET . 50.9 mtm -121.98 115.96 23.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.783 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.504 HG13 HG23 ' A' ' 101' ' ' VAL . 1.4 t -124.06 122.15 63.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.905 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.763 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -113.07 143.53 44.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.8 m -125.62 129.78 50.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 58.5 t80 -138.59 157.56 45.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.649 175.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 98' ' ' ILE . 48.1 mtmt -41.71 104.58 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.932 0.493 . . . . 0.0 112.007 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.51 -30.7 1.01 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.229 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.693 HD13 HD11 ' A' ' 115' ' ' LEU . 2.1 mm -90.04 111.72 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.634 ' O ' ' HA ' ' A' ' 113' ' ' MET . 46.3 tttt -113.29 125.46 54.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.025 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -114.2 119.11 35.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.504 HG23 HG13 ' A' ' 92' ' ' VAL . 74.9 t -118.74 119.22 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -117.42 120.46 38.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.626 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.86 120.48 24.99 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.969 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.29 112.48 25.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.031 171.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -127.34 107.57 10.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.454 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.44 45.47 37.42 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.237 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 6.5 m-20 68.48 4.83 4.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.955 0.502 . . . . 0.0 111.84 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 p -117.95 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 104' ' ' PHE . 4.9 mt -109.91 132.57 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -107.33 119.76 40.28 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.822 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.763 ' HB2' ' HG2' ' A' ' 122' ' ' ARG . 18.8 m120 -106.61 121.65 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.518 HG21 ' HG2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -121.75 118.78 29.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.103 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.634 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 77.1 mtm -124.8 149.83 46.98 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.487 ' O ' HD12 ' A' ' 98' ' ' ILE . 56.7 m -127.85 122.59 33.0 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 122.126 -0.359 . . . . 0.0 110.722 -173.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.693 HD11 HD13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -111.84 112.41 24.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.18 -98.74 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.703 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -104.97 -12.87 15.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.502 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.802 HD11 ' HD1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.4 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.397 -172.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.59 115.05 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.487 0.66 . . . . 0.0 110.822 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.515 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 t80 -100.37 119.06 37.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.683 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 4.4 tmmm? -128.11 124.58 37.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.469 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.763 ' HG2' ' HB2' ' A' ' 111' ' ' ASN . 14.5 ptt180 -120.02 148.65 43.3 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.549 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 10' ' ' GLN . 6.7 p -101.61 118.26 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.596 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.734 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 84.3 p -125.42 132.54 52.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.8 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -132.0 146.65 52.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.63 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -70.08 149.6 47.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.933 -176.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.6 pt . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.471 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HE2' ' HE2' ' A' ' 3' ' ' PHE . 96.9 mmm . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -83.52 97.11 8.84 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.004 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.496 ' HE2' ' HE2' ' A' ' 1' ' ' MET . 43.7 m-85 -157.14 77.86 0.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 82.1 p 62.26 -168.07 0.2 Allowed 'General case' 0 C--N 1.318 -0.796 0 O-C-N 124.266 0.979 . . . . 0.0 112.783 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -170.7 13.45 Favored Glycine 0 CA--C 1.5 -0.888 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.915 ' HB2' HD11 ' A' ' 127' ' ' ILE . 17.0 mtpp -96.82 118.24 32.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.681 0.753 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.707 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 6.0 m-85 -120.7 134.91 55.25 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.0 140.13 36.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.563 HG11 ' N ' ' A' ' 10' ' ' GLN . 27.9 t -64.64 139.07 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 122.004 0.907 . . . . 0.0 110.984 -177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.815 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.5 mm-40 -114.12 -58.17 2.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.954 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.697 ' HB2' HG11 ' A' ' 123' ' ' VAL . 29.0 m -157.18 152.36 26.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.681 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HG2' ' HE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.67 151.35 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.54 0.686 . . . . 0.0 110.792 174.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.699 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 13.7 mm-40 -94.45 130.22 40.9 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.525 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.769 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 16.9 m-20 70.52 -82.31 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 O-C-N 123.715 0.634 . . . . 0.0 110.927 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.514 ' HA ' ' HD2' ' A' ' 18' ' ' PHE . 51.0 p90 39.57 36.46 0.24 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.651 1.58 . . . . 0.0 112.304 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.875 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.9 mt-10 -144.47 -46.5 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.157 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.875 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 61.1 Cg_endo -68.22 -34.72 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.968 1.779 . . . . 0.0 109.718 169.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.615 ' HD1' HD21 ' A' ' 115' ' ' LEU . 0.9 OUTLIER -62.3 -50.03 73.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.947 -1.933 . . . . 0.0 111.198 174.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 1.058 ' HB2' HD12 ' A' ' 29' ' ' ILE . 61.0 mmm -62.96 -41.07 99.42 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.881 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 16.1 ptmt -69.03 -32.73 72.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.25 0.547 . . . . 0.0 110.319 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.55 71.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.954 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.0 mtt -83.42 -59.46 2.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.25 -44.3 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.678 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.6 tp -75.56 126.44 87.44 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 117.564 0.682 . . . . 0.0 110.037 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.557 ' CG ' HD12 ' A' ' 28' ' ' LEU . 86.3 Cg_endo -73.85 153.39 47.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.709 2.273 . . . . 0.0 111.424 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.777 ' O ' ' HG2' ' A' ' 30' ' ' GLN . 1.3 tt0 -50.56 -43.71 56.39 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.243 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.703 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 p-10 -57.18 -41.72 79.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 118.4 0.545 . . . . 0.0 110.704 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD12 ' CG ' ' A' ' 25' ' ' PRO . 46.8 mt -71.08 -34.32 71.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.883 -0.51 . . . . 0.0 109.714 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 1.058 HD12 ' HB2' ' A' ' 19' ' ' MET . 45.4 mt -61.73 -46.9 95.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.692 170.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.777 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.6 mm-40 -52.36 -44.36 65.19 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.547 1.139 . . . . 0.0 112.05 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.703 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -69.71 -31.35 69.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.415 0.626 . . . . 0.0 110.343 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -122.09 29.16 5.63 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.585 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 29' ' ' ILE . 23.5 pttm -79.41 -28.34 41.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 111.523 -171.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.73 44.99 1.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.23 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 35' ' ' ILE . 27.7 mm -93.9 123.96 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -108.54 99.45 8.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.438 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.62 -179.96 44.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.936 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.5 t -123.26 148.24 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.768 ' HA ' ' O ' ' A' ' 51' ' ' THR . 19.2 m -128.77 123.53 33.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.974 0.416 . . . . 0.0 112.086 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 15.5 mp0 -117.0 123.46 46.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.775 HG12 ' HG ' ' A' ' 50' ' ' LEU . 25.0 mt -120.72 141.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.933 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG12 ' HG2' ' A' ' 44' ' ' GLU . 96.1 t -109.13 119.52 58.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.787 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.436 ' N ' ' HB3' ' A' ' 4' ' ' SER . 23.3 t-80 -93.07 112.55 24.55 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.854 0.835 . . . . 0.0 109.814 173.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.694 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 43.4 mm-40 -123.33 144.01 49.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 47' ' ' LYS . . . -41.6 107.09 0.09 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.363 176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.836 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmm 71.79 -24.01 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.121 1.369 . . . . 0.0 112.869 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.694 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 70.0 mmtt -96.0 109.77 22.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG13 ' HE2' ' A' ' 91' ' ' MET . 55.9 t -121.72 123.56 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 111.5 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.0 mttm -112.37 123.06 49.45 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.715 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.775 ' HG ' HG12 ' A' ' 41' ' ' ILE . 2.3 tt -114.81 121.84 44.53 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.768 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -106.28 125.3 50.83 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.641 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.1 mt -129.26 121.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -171.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.695 HG21 HG22 ' A' ' 58' ' ' VAL . 23.9 m -104.01 129.07 51.59 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.416 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 40.0 t80 -116.45 106.47 13.64 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.42 -99.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.546 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 t -94.37 -28.72 15.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 110.846 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -107.71 125.37 51.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.841 -166.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.695 HG22 HG21 ' A' ' 53' ' ' THR . 21.2 t -99.51 125.19 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.693 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -124.82 114.33 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 122.635 1.207 . . . . 0.0 109.093 177.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.483 ' CB ' ' HA ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -109.72 149.56 29.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.334 -172.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.64 108.38 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.59 125.65 51.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.065 0.46 . . . . 0.0 110.403 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CD1' HG21 ' A' ' 83' ' ' VAL . 3.5 p90 -151.38 152.73 33.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.618 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 15.6 m -111.6 134.71 52.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.78 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.836 ' HG ' ' HB3' ' A' ' 46' ' ' LYS . 4.0 pp -49.43 143.81 6.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.17 0.51 . . . . 0.0 111.617 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 67.15 19.15 69.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.763 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 64' ' ' THR . 76.1 mm-40 -129.24 146.94 51.05 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.692 0.246 . . . . 0.0 110.86 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.509 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 41.8 tt0 -79.86 118.41 21.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.9 m -134.21 150.48 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.101 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.79 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 3.3 pt-20 -95.01 140.01 30.57 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.19 -173.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.623 HD13 ' HB1' ' A' ' 81' ' ' ALA . 18.5 mt -109.54 134.35 52.01 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.202 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HG3' ' HD2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -87.57 138.26 31.63 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 121.948 0.88 . . . . 0.0 108.927 169.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.9 p -95.16 167.81 11.13 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.769 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.3 tpp -65.67 -18.17 65.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -83.74 -39.93 19.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.901 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.693 ' HA2' ' CD1' ' A' ' 59' ' ' ILE . . . 130.1 -5.81 6.04 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.308 -0.948 . . . . 0.0 114.719 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -79.87 144.72 33.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.573 0.686 . . . . 0.0 110.558 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.17 125.73 38.98 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.11 130.94 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 22.8 pttt -97.12 140.48 31.56 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.321 1.058 . . . . 0.0 112.976 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.623 ' HB1' HD13 ' A' ' 71' ' ' LEU . . . -146.43 159.99 42.67 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.168 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -94.36 112.85 27.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.348 0.594 . . . . 0.0 110.153 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.715 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 2.0 m -103.78 136.36 37.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.682 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -116.45 156.94 25.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.768 0.318 . . . . 0.0 110.336 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.698 ' HE2' HD21 ' A' ' 65' ' ' LEU . 32.6 ttp -126.34 135.54 51.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.888 0.851 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.05 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 11.1 tp10 -86.12 -14.75 43.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.614 -173.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 114.36 -68.87 0.25 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.993 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -74.65 44.46 0.21 Allowed 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.342 0.592 . . . . 0.0 110.966 174.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.866 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 7.6 m-80 65.02 44.98 3.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.8 169.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 1.05 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -106.51 121.37 44.16 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 166.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.467 ' HE2' HG13 ' A' ' 48' ' ' VAL . 2.0 mpt? -119.58 114.39 22.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.492 HG13 HG23 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -124.43 119.22 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.715 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -126.4 139.86 52.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.182 0.515 . . . . 0.0 110.661 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -128.99 139.89 51.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.899 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -138.84 113.4 8.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.971 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.0 -95.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.024 0.53 . . . . 0.0 111.677 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.19 10.15 15.13 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 98' ' ' ILE . 3.0 mm -92.19 122.77 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 113' ' ' MET . 38.1 tttm -123.97 116.72 23.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.229 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.402 ' HB2' HG23 ' A' ' 93' ' ' THR . 14.6 m -121.65 119.92 33.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.492 HG23 HG13 ' A' ' 92' ' ' VAL . 92.0 t -117.0 119.64 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.779 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 m -117.47 126.1 52.04 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.823 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 39.1 tt0 -127.45 121.98 32.26 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.659 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.866 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 7.4 m-30 -92.98 116.12 28.76 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 167.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -124.24 110.99 15.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.49 -74.32 1.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.637 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -165.91 13.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.106 -0.547 . . . . 0.0 109.591 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.449 HG21 ' HA ' ' A' ' 125' ' ' LYS . 2.8 m -123.44 142.22 51.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.52 0.676 . . . . 0.0 110.425 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 7' ' ' TYR . 15.0 mt -102.77 129.85 53.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.338 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -113.38 117.4 31.67 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 167.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.539 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.1 t-20 -113.74 120.38 40.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.946 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.808 HG21 ' HG3' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -121.88 115.97 23.55 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.623 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 9.3 ttp -125.93 144.45 50.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -121.44 121.62 37.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.695 ' HB2' HG12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -92.95 145.59 24.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.05 25.46 0.15 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -165.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.4 t70 -149.83 -9.04 0.3 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 159.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.695 HG12 ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -116.01 139.62 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.71 -168.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 p -106.56 116.55 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.433 0.635 . . . . 0.0 110.192 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.623 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -115.36 120.97 41.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.105 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.808 ' HG3' HG21 ' A' ' 112' ' ' THR . 23.6 ttpt -125.14 137.34 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.24 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.539 ' HD3' ' HB3' ' A' ' 111' ' ' ASN . 44.4 ttt180 -132.08 127.12 35.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 111.682 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.815 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.3 p -101.88 128.15 54.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 20.9 m -134.63 131.89 38.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.409 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.449 ' HA ' HG21 ' A' ' 108' ' ' THR . 11.4 ptmt -120.96 145.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.609 0.64 . . . . 0.0 111.334 -170.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.707 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 43.3 ttt180 -70.1 151.5 45.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.915 HD11 ' HB2' ' A' ' 6' ' ' LYS . 6.0 pt . . . . . 0 N--CA 1.431 -1.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.814 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 68.6 p . . . . . 0 N--CA 1.441 -0.884 0 CA-C-O 120.637 0.256 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.97 -174.29 18.26 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.573 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.992 ' HE2' HG12 ' A' ' 127' ' ' ILE . 6.1 mtpt -97.64 120.71 38.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.642 0.734 . . . . 0.0 110.685 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 35.9 m-85 -123.79 124.95 43.82 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.57 138.86 31.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -168.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.485 HG22 ' HD3' ' A' ' 122' ' ' ARG . 1.6 t -70.77 127.96 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.398 0.618 . . . . 0.0 109.918 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.859 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.2 mm100 -111.59 -47.24 3.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.518 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 123' ' ' VAL . 24.3 m -161.61 152.82 18.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.987 -172.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -145.57 156.5 43.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.257 0.551 . . . . 0.0 111.362 174.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.843 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 51.3 mm-40 -97.51 142.81 28.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.954 174.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.9 m-80 69.22 26.48 5.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' CD2' ' HB2' ' A' ' 33' ' ' LYS . 4.7 p90 -63.26 -0.31 0.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.863 ' HA ' HD13 ' A' ' 29' ' ' ILE . 80.7 mt-10 -116.84 -51.2 0.04 OUTLIER Pre-proline 0 C--O 1.216 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.155 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 27.1 Cg_exo -55.43 -42.81 64.39 Favored 'Trans proline' 0 CA--C 1.511 -0.656 0 C-N-CA 121.853 1.702 . . . . 0.0 112.732 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -60.55 -49.6 76.87 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.833 -1.531 . . . . 0.0 109.601 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.637 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 25.2 mmt -63.02 -43.7 98.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.447 176.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 15.5 ptmt -64.71 -36.94 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.925 -171.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -73.37 -36.82 66.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.851 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -82.96 -28.18 29.98 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.6 -39.7 0.36 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.372 -1.394 . . . . 0.0 114.402 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.663 HD23 HG12 ' A' ' 29' ' ' ILE . 13.0 tp -80.65 129.09 69.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 117.689 0.745 . . . . 0.0 110.131 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.659 ' CD ' HD12 ' A' ' 28' ' ' LEU . 93.2 Cg_endo -73.5 146.87 40.09 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.296 1.998 . . . . 0.0 111.196 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 7.4 tt0 -48.81 -41.22 32.01 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.108 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.749 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 29.3 t70 -64.1 -37.44 87.45 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 119.197 0.908 . . . . 0.0 110.871 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.659 HD12 ' CD ' ' A' ' 25' ' ' PRO . 31.1 mt -69.78 -34.46 73.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 20.4 mt -64.11 -45.94 95.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.431 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.599 172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.073 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 35.1 mm-40 -51.32 -48.17 62.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.671 0.748 . . . . 0.0 112.078 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.749 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -63.53 -30.05 71.22 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.619 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.62 41.14 1.46 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.438 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.073 ' HE2' ' HA ' ' A' ' 30' ' ' GLN . 15.7 ptpt -79.96 -41.45 25.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -165.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 38.7 t70 -109.96 60.37 0.6 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.917 0.865 . . . . 0.0 110.562 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 mm -80.89 130.27 36.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.026 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.85 146.55 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.3 169.05 27.02 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 8' ' ' GLN . 15.2 t -127.85 141.55 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.339 0.569 . . . . 0.0 109.494 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.5 t -119.02 131.76 56.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -125.01 122.92 38.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.595 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 4' ' ' SER . 97.1 mt -117.47 138.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 49' ' ' LYS . 96.8 t -109.15 119.87 59.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.615 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.682 ' H ' ' HB3' ' A' ' 4' ' ' SER . 10.6 t-160 -97.77 114.72 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.352 0.596 . . . . 0.0 110.562 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -133.17 141.55 48.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -37.24 114.27 0.24 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 113.642 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 28.0 mtmt 75.47 -43.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.882 1.273 . . . . 0.0 112.539 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -96.28 109.79 22.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.897 0.856 . . . . 0.0 111.822 -171.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.7 128.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.261 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 78.0 mttt -107.94 125.44 51.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.297 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -120.04 123.64 43.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.73 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.6 m -106.84 124.15 49.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.2 mt -131.3 122.27 50.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.332 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 HG22 ' A' ' 58' ' ' VAL . 19.8 m -101.45 130.08 47.61 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.063 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -116.64 106.21 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.35 -99.58 0.09 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.04 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t -99.09 -24.4 14.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.418 0.628 . . . . 0.0 110.483 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HE2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.96 123.01 47.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.239 -169.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 53' ' ' THR . 24.3 t -98.26 124.8 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-O 121.873 0.844 . . . . 0.0 109.55 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.516 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -116.45 114.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.82 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 148.5 26.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.28 -1.782 . . . . 0.0 112.378 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -139.7 87.84 2.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.487 0.661 . . . . 0.0 110.482 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 33.4 mt-10 -107.21 127.16 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.643 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' HE1' ' HG2' ' A' ' 91' ' ' MET . 9.7 p90 -150.43 152.0 33.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.09 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.3 m -106.54 132.44 52.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 65' ' ' LEU . 3.8 pp -47.17 143.36 3.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 112.394 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 68.42 25.03 74.99 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.569 177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -135.24 145.45 47.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 23.6 tt0 -76.6 118.64 19.46 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.2 m -134.03 158.75 42.75 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.273 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 4.1 mt-10 -97.6 120.64 38.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.5 1.143 . . . . 0.0 111.906 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 32.5 mt -93.69 121.59 35.27 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.732 -2.031 . . . . 0.0 109.872 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.516 ' OE1' HG12 ' A' ' 59' ' ' ILE . 15.8 tt0 -95.22 120.54 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 59' ' ' ILE . 24.2 p -86.72 164.19 16.88 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 ttt -64.61 -14.65 58.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.198 0.523 . . . . 0.0 109.827 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -85.9 -40.7 15.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.798 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.42 -13.32 4.01 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.148 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.54 129.65 35.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.663 -0.316 . . . . 0.0 111.315 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -105.17 130.52 53.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 176.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -134.64 147.99 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.065 0.46 . . . . 0.0 112.048 -175.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 51.0 mttm -82.7 123.27 29.13 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.64 145.19 32.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.5 t -90.5 112.84 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.488 0.661 . . . . 0.0 109.803 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.728 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -109.14 134.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.363 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -113.67 153.1 29.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.63 ' HG2' ' HG3' ' A' ' 91' ' ' MET . 9.4 tmm? -129.41 124.88 35.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.257 1.027 . . . . 0.0 110.015 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 6.1 tp10 -56.67 -60.64 3.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.959 -1.928 . . . . 0.0 113.736 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 145.56 -54.38 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 23.0 t70 -80.67 27.24 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.008 0.909 . . . . 0.0 109.086 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 87' ' ' GLY . 5.6 m120 65.37 58.49 0.85 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.685 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.779 ' HE2' ' HG2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -108.14 121.37 44.71 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.161 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.63 ' HG3' ' HG2' ' A' ' 85' ' ' MET . 1.4 mpp? -118.27 114.61 23.26 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 3.5 t -124.84 122.02 62.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.196 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.728 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.71 144.17 51.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.207 0.527 . . . . 0.0 110.61 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -122.31 126.43 48.09 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -138.58 114.6 10.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt 56.85 -102.45 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.268 0.355 . . . . 0.0 111.128 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.32 14.14 12.19 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 115' ' ' LEU . 1.6 mm -94.37 113.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' MET . 18.2 ttpt -110.16 118.17 35.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.943 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -114.85 120.62 40.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.162 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 85.5 t -119.73 119.91 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.287 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.56 HG22 ' HE1' ' A' ' 104' ' ' PHE . 2.6 m -117.69 120.5 38.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 5.0 tm-20 -130.29 127.27 39.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.144 -0.347 . . . . 0.0 110.669 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 109' ' ' ILE . 7.1 m-30 -104.74 114.79 29.22 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 126.23 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.413 0.445 . . . . 0.0 110.771 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.56 31.79 71.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.811 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 64.06 19.34 11.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.99 0.516 . . . . 0.0 112.253 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.0 p -116.02 130.57 56.87 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 104' ' ' PHE . 6.1 mt -110.21 128.59 66.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.834 -170.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -116.88 120.19 37.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.94 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.7 121.78 45.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.695 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 4.4 m -120.36 120.58 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.647 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.522 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 65.9 mtt -119.68 149.72 41.53 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.149 0.499 . . . . 0.0 110.36 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 49.8 m -118.86 119.82 35.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.751 ' HA ' HD12 ' A' ' 98' ' ' ILE . 3.4 tm? -123.79 113.49 18.63 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.623 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.56 10.78 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.952 0.882 . . . . 0.0 109.357 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -97.74 141.33 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.696 -173.125 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 119' ' ' VAL . 7.6 p -110.86 114.95 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.621 0.724 . . . . 0.0 111.267 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HD2' ' O ' ' A' ' 13' ' ' GLU . 1.3 t80 -117.01 125.58 51.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.68 -170.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.843 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -124.97 129.83 51.13 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.998 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.485 ' HD3' HG22 ' A' ' 9' ' ' VAL . 30.3 ttm180 -116.96 137.8 51.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.52 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 10' ' ' GLN . 12.7 p -101.87 117.06 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.88 0.847 . . . . 0.0 109.771 173.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 16.2 m -121.36 127.9 51.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.079 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -121.3 137.54 54.65 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.299 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 24.5 ttt180 -68.1 147.77 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.992 HG12 ' HE2' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 C--O 1.247 0.948 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -170.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.654 ' HB3' ' C ' ' A' ' 41' ' ' ILE . 58.6 m . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 120.872 0.368 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.59 -164.04 28.47 Favored Glycine 0 CA--C 1.499 -0.933 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.888 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.869 ' HE3' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -90.03 117.8 29.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 59.2 m-85 -132.06 127.67 36.61 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 10.1 tm0? -103.4 140.74 37.05 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.24 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 t -66.19 137.51 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.147 0.975 . . . . 0.0 111.566 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.676 ' HB3' HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -114.2 -59.94 1.95 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.942 -168.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.533 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 11.5 m -158.02 153.9 26.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.435 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 4.1 pm0 -145.98 155.42 42.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.615 0.722 . . . . 0.0 112.015 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.767 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 16.6 mm-40 -94.2 142.11 27.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.342 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 1.1 m-80 72.61 -82.42 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.472 0 O-C-N 123.559 0.537 . . . . 0.0 111.876 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.8 p90 39.93 28.03 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.266 1.826 . . . . 0.0 113.236 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.917 ' HA ' HD13 ' A' ' 29' ' ' ILE . 74.5 mt-10 -147.26 -49.9 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.634 -172.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.739 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 59.6 Cg_endo -74.7 -23.98 13.95 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 108.411 -1.419 . . . . 0.0 108.411 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 118' ' ' ILE . 3.5 t80 -60.8 -52.79 63.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.983 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.649 ' HB2' HD11 ' A' ' 29' ' ' ILE . 24.6 mmt -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.526 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 7.5 ptmm? -66.05 -33.06 74.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.126 0.488 . . . . 0.0 110.069 -174.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.79 86.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.457 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.8 ptm -85.86 -22.16 27.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.88 -39.02 0.69 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.677 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 19' ' ' MET . 14.9 tp -75.54 130.01 80.5 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 117.308 0.554 . . . . 0.0 110.478 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' HD12 ' A' ' 28' ' ' LEU . 88.3 Cg_endo -78.1 153.83 28.72 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.799 1.666 . . . . 0.0 111.346 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.087 ' HA ' HD12 ' A' ' 29' ' ' ILE . 9.6 tt0 -50.09 -44.34 51.88 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.383 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.622 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 7.7 t70 -59.12 -37.26 76.8 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.308 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.887 HD12 ' HD2' ' A' ' 25' ' ' PRO . 59.8 mt -72.32 -37.5 68.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.912 0.387 . . . . 0.0 110.076 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.087 HD12 ' HA ' ' A' ' 26' ' ' GLU . 38.9 mt -59.22 -44.2 91.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.904 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.836 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.3 mm-40 -54.03 -34.01 58.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.621 1.169 . . . . 0.0 111.775 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 2.1 mptp? -68.44 -33.03 73.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.961 0.41 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.55 35.66 2.37 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.835 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 25.3 pttm -79.1 -32.24 44.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.297 0.57 . . . . 0.0 112.321 -169.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -99.16 24.55 7.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.062 -167.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.0 mt -81.13 115.93 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.372 0.606 . . . . 0.0 112.39 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -109.8 126.69 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.329 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -115.31 -169.02 15.71 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.963 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 11.1 t -121.57 141.1 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.838 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.8 t -117.01 139.22 50.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 1.1 mm-40 -135.23 124.59 24.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.965 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 5.1 mt -127.96 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.1 -171.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -111.16 120.47 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.627 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 4' ' ' SER . 11.5 t-160 -92.41 114.52 27.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.805 0.812 . . . . 0.0 110.45 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 142.21 46.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -33.58 111.17 0.06 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.643 0.589 . . . . 0.0 113.998 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 2.3 mtmt 66.62 -45.47 0.44 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.476 1.51 . . . . 0.0 113.342 -173.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 47' ' ' LYS . 2.2 ptpp? -90.74 107.45 19.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.762 0.791 . . . . 0.0 111.282 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.64 HG21 ' SD ' ' A' ' 85' ' ' MET . 90.6 t -123.09 125.87 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.159 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -109.24 130.47 55.49 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.248 0.547 . . . . 0.0 109.678 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -116.42 133.33 56.14 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.88 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.838 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.1 m -114.34 124.88 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.9 mt -131.84 121.96 48.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.022 HG23 HG22 ' A' ' 58' ' ' VAL . 26.4 m -96.8 127.81 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -120.88 107.34 12.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.91 -98.07 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.565 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -103.95 -24.14 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.854 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.673 ' HE2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.41 128.73 55.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.189 -172.139 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 53' ' ' THR . 26.9 t -96.6 125.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.925 0.869 . . . . 0.0 109.522 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.673 HG13 ' HE2' ' A' ' 57' ' ' LYS . 1.3 mt -112.51 112.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.524 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.625 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -91.37 141.47 28.72 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.668 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.605 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.4 m120 -125.29 83.73 2.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.747 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 43.1 tt0 -102.24 126.75 49.32 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -147.62 153.08 38.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.955 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 13.5 m -114.05 128.68 56.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.794 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -58.59 143.32 46.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.155 0.502 . . . . 0.0 111.941 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 59.0 23.38 56.99 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.58 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 8.8 tt0 -145.32 133.13 21.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -80.48 119.42 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.285 0.564 . . . . 0.0 110.66 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.8 t -136.3 163.64 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.256 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -95.1 119.57 33.84 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.317 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 61.6 mt -100.72 122.39 43.27 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.728 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 59' ' ' ILE . 39.2 tt0 -89.24 128.1 35.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.654 ' O ' HD13 ' A' ' 59' ' ' ILE . 13.2 p -84.78 168.03 15.53 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.833 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.9 tpt -56.16 -28.22 57.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.437 0.637 . . . . 0.0 109.978 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 -27.73 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.995 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 123.12 -11.2 8.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.658 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.35 127.03 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.901 0.351 . . . . 0.0 110.466 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.84 127.65 48.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.65 147.07 27.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.362 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -82.01 123.77 29.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.479 0.657 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . . . -139.07 147.44 42.02 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.49 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -95.26 111.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.649 0.738 . . . . 0.0 109.368 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.756 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.7 m -100.73 133.37 44.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.49 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 3.9 mmtt -106.08 151.37 24.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HG21 ' A' ' 48' ' ' VAL . 21.1 ttt -132.89 131.42 40.9 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.317 1.056 . . . . 0.0 112.785 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.092 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 5.4 tp10 -84.95 139.32 31.9 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 112.766 -2.015 . . . . 0.0 108.57 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -60.83 -25.39 63.77 Favored Glycine 0 C--O 1.23 -0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.953 -168.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.724 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 32.5 t70 -83.68 23.09 1.01 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 110.208 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.605 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 8.9 m120 71.53 57.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.962 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 1.092 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -113.19 121.84 45.69 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.159 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 1.058 ' HG2' ' HB ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -116.78 115.8 26.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.118 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 101' ' ' VAL . 5.3 t -125.73 117.7 49.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.568 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -129.86 144.29 51.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.408 0.623 . . . . 0.0 111.765 -177.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 59.3 m -127.26 131.74 50.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.774 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.45 130.04 27.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.825 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 64.05 -75.84 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.78 0.675 . . . . 0.0 110.948 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.63 29.9 0.25 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' THR . 38.9 mm -116.55 131.92 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.58 -0.81 . . . . 0.0 108.851 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' MET . 11.6 ttmm -112.63 128.15 56.3 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.825 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.543 ' HB2' HG23 ' A' ' 93' ' ' THR . 13.3 m -122.18 119.91 32.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.915 HG22 HG13 ' A' ' 92' ' ' VAL . 99.2 t -123.4 117.35 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 110.595 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 1.058 ' HB ' ' HG2' ' A' ' 91' ' ' MET . 32.3 m -118.31 121.38 40.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.888 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 8.2 tm-20 -129.55 128.38 42.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.881 0.372 . . . . 0.0 110.633 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.605 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 5.3 m-30 -96.88 115.37 27.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.074 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.96 102.87 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.754 175.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 107' ' ' ASP . . . 54.24 75.03 0.25 Allowed Glycine 0 N--CA 1.455 -0.087 0 CA-C-O 119.758 -0.468 . . . . 0.0 113.701 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 6.6 t70 72.23 -26.44 0.18 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 125' ' ' LYS . 7.7 p -107.21 134.68 49.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.037 0.922 . . . . 0.0 112.315 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.556 HD13 ' CE1' ' A' ' 104' ' ' PHE . 4.4 mt -109.38 127.11 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.079 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -104.54 118.35 36.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.9 t-20 -109.58 121.25 44.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.32 114.9 21.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.721 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 22.1 ttt -127.26 150.36 49.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' ILE . 93.9 m -126.98 120.29 28.73 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.156 -0.34 . . . . 0.0 110.098 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.662 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -108.62 113.55 26.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.74 -91.84 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.31 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.17 1.64 7.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.934 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.662 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -91.32 141.53 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.815 -172.485 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.8 116.32 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.896 0.855 . . . . 0.0 110.585 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.644 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 60.8 t80 -103.52 117.98 35.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.88 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.767 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -124.22 124.63 42.86 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.504 HH22 HD11 ' A' ' 52' ' ' ILE . 33.9 ttt180 -127.24 132.67 50.34 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.973 -169.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.676 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.2 p -101.52 118.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.182 171.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 m -127.64 134.19 49.64 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.3 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -136.19 150.55 49.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.336 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 ttt180 -69.06 149.35 48.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.849 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.869 HG13 ' HE3' ' A' ' 6' ' ' LYS . 3.0 pt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.104 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 30.0 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.75 179.73 16.0 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.343 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.689 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -106.99 122.48 46.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.9 m-85 -127.85 126.01 40.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.697 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.83 134.25 36.38 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -172.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.944 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -70.04 134.38 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.779 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.5 mm100 -115.71 -40.87 3.29 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.105 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.637 ' HB2' HG12 ' A' ' 123' ' ' VAL . 58.2 m -156.24 151.47 26.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.819 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 18.0 mp0 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.905 0.859 . . . . 0.0 111.109 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -103.28 130.09 50.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.902 176.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.592 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 67.96 21.27 8.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 168.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.527 ' O ' ' HG2' ' A' ' 19' ' ' MET . 47.5 p90 -67.35 17.07 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.96 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.4 mt-10 -132.6 -44.58 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 123.175 0.59 . . . . 0.0 111.18 -173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.96 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.1 Cg_endo -70.07 -28.77 23.35 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 C-N-CA 121.734 1.623 . . . . 0.0 109.637 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' HB2' HD13 ' A' ' 118' ' ' ILE . 5.8 t80 -65.57 -52.53 51.61 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.111 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.704 ' HB2' HD11 ' A' ' 29' ' ' ILE . 83.8 mmm -61.22 -37.86 84.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.685 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.883 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 8.4 pttt -69.73 -36.27 75.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.206 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -71.34 -25.99 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.59 172.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.564 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 29.6 tpp -82.61 -43.76 16.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.027 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.44 -42.75 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.659 HD23 HG12 ' A' ' 29' ' ' ILE . 12.8 tp -78.86 128.57 76.32 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.69 ' CD ' HD12 ' A' ' 28' ' ' LEU . 95.0 Cg_endo -73.32 149.95 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.228 1.952 . . . . 0.0 111.498 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.052 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.6 tt0 -50.09 -44.43 51.99 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 36.6 t70 -56.97 -42.96 81.11 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.803 0.729 . . . . 0.0 110.19 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.69 HD12 ' CD ' ' A' ' 25' ' ' PRO . 45.1 mt -68.47 -33.5 74.27 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.466 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.052 HD12 ' HA ' ' A' ' 26' ' ' GLU . 28.0 mt -62.87 -47.1 94.44 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.699 170.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.007 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 21.6 mm-40 -53.09 -38.46 62.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.229 1.012 . . . . 0.0 112.474 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.007 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.64 -30.2 68.85 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.739 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.77 28.98 5.07 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.86 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -78.25 -39.56 39.81 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -166.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -96.29 54.41 1.41 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.645 0.736 . . . . 0.0 110.812 -166.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -99.53 133.16 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.61 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 147.0 33.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.765 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.944 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -144.85 -172.57 15.43 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.981 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 8' ' ' GLN . 60.8 t -123.71 143.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.241 0.521 . . . . 0.0 110.732 -173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 51' ' ' THR . 14.9 m -122.96 120.99 35.03 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.809 0.338 . . . . 0.0 110.122 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HG2' ' CG ' ' A' ' 6' ' ' LYS . 25.5 mt-10 -116.32 124.52 50.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.166 0.508 . . . . 0.0 109.633 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.651 HG12 ' HG ' ' A' ' 50' ' ' LEU . 96.7 mt -123.66 134.58 66.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.915 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.88 114.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.741 ' H ' ' HB3' ' A' ' 4' ' ' SER . 3.3 t-160 -115.07 113.51 24.14 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.042 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 37.3 tt0 -111.07 143.1 42.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -35.17 108.4 0.05 OUTLIER Glycine 0 C--O 1.225 -0.425 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.59 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.752 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 16.2 mtmt 83.78 -40.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.603 1.561 . . . . 0.0 113.079 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.65 112.15 23.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.104 0.478 . . . . 0.0 110.606 -172.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG11 ' SD ' ' A' ' 91' ' ' MET . 4.9 t -114.32 123.0 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.69 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 18.2 mtpp -113.47 130.87 56.23 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.668 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -127.61 130.59 49.25 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -118.04 122.69 43.8 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.8 mt -124.79 120.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.807 HG23 HG22 ' A' ' 58' ' ' VAL . 24.5 m -102.69 127.28 49.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -121.38 107.63 12.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.39 -95.44 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.627 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -107.86 -18.26 13.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 0.0 111.211 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HE3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -113.09 128.54 56.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.17 0.51 . . . . 0.0 111.254 -170.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 53' ' ' THR . 31.8 t -97.43 125.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 122.052 0.93 . . . . 0.0 109.592 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -114.52 114.16 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.909 -177.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 144.66 27.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.005 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m120 -129.02 138.85 52.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -145.08 124.73 13.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -151.39 152.29 32.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.03 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.653 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 4.7 m -108.0 132.0 53.98 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.752 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 pp -45.55 146.25 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 112.156 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.1 13.0 69.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.439 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.0 mm-40 -124.66 143.48 50.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.703 0.287 . . . . 0.0 110.293 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 80' ' ' LYS . 22.9 tt0 -84.54 116.91 23.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 63.3 m -134.03 158.83 42.55 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.285 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mt-10 -94.83 120.14 34.55 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 122.793 1.282 . . . . 0.0 111.681 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 28.9 mt -100.76 128.52 46.77 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.222 -2.263 . . . . 0.0 110.706 -170.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 59' ' ' ILE . 16.1 tt0 -85.79 122.01 29.25 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 59' ' ' ILE . 12.6 p -85.85 164.53 17.46 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.255 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.57 -22.7 62.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.25 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.8 -41.27 53.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.761 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 140.27 -21.49 2.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.316 176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.66 139.44 39.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.618 0.709 . . . . 0.0 111.438 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.01 123.37 41.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.126 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 144.91 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 135.79 34.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.371 0.605 . . . . 0.0 111.966 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -147.5 152.46 38.08 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.051 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.1 t -95.78 112.43 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.844 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.785 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -100.11 133.96 41.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.095 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.1 mmtt -103.28 151.44 22.68 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.496 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . 4.7 ttp -128.91 132.91 47.71 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.682 -1.207 . . . . 0.0 113.041 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.043 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.5 tp10 -100.45 141.13 33.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 112.367 -2.197 . . . . 0.0 108.303 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.87 -36.66 60.48 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.954 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -87.92 53.64 2.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.805 0.812 . . . . 0.0 110.077 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.775 HD21 ' HB2' ' A' ' 104' ' ' PHE 0.251 0.0 OUTLIER 49.41 49.88 19.07 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.821 174.519 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 1.043 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 61.7 mttt -112.39 122.17 46.94 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.318 170.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.638 ' SD ' HG11 ' A' ' 48' ' ' VAL . 5.7 mtm -129.17 117.05 20.15 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -122.16 118.64 56.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.345 -173.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -126.61 140.44 52.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.572 0.701 . . . . 0.0 111.451 -177.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -128.07 138.8 52.7 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.752 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.4 124.16 21.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 60.87 -101.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.024 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.32 15.46 6.41 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.75 114.27 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 113' ' ' MET . 59.6 tttt -104.69 118.88 37.65 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.513 -171.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 m -115.67 118.95 34.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.511 HG22 HG13 ' A' ' 92' ' ' VAL . 98.1 t -113.41 120.41 63.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -117.34 119.84 36.35 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.268 174.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 90' ' ' LYS . 28.7 tt0 -129.67 119.92 24.32 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -113.97 119.2 36.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.697 176.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.03 138.09 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.463 170.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.71 96.63 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.648 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.588 ' HA ' ' HE2' ' A' ' 7' ' ' TYR . 25.8 m-20 70.07 4.98 5.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.72 0.408 . . . . 0.0 112.089 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -110.85 123.35 49.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 111.34 173.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mt -102.15 124.75 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.045 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' THR . 19.5 m -115.07 120.9 41.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.718 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.75 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 3.2 t-20 -116.06 121.27 41.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.892 0.377 . . . . 0.0 110.392 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.792 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -120.98 117.81 28.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.96 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 65.9 mtt -111.95 150.91 29.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.339 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 m -127.62 121.84 31.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -121.86 113.84 20.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.45 -93.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.883 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.62 17.06 3.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 110.112 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -85.53 137.44 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.19 114.62 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.675 0.75 . . . . 0.0 111.084 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 41.9 t80 -102.78 119.08 38.21 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.792 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.8 OUTLIER -128.92 131.03 47.51 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.75 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 7.4 ptt180 -124.33 144.37 50.05 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.631 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.779 HG13 ' HB2' ' A' ' 10' ' ' GLN . 11.7 p -100.83 117.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.11 0.957 . . . . 0.0 109.488 173.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m -123.66 121.52 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.568 -1.197 . . . . 0.0 108.646 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.11 149.33 52.13 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.58 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 15.9 ttp180 -70.17 146.62 50.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.673 -166.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.689 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 56.1 p . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.01 -172.43 21.59 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 2.8 mtpp -95.99 130.12 43.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.504 0.669 . . . . 0.0 109.811 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 17.5 m-85 -135.07 133.6 39.47 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 7.3 tm0? -106.21 135.82 47.01 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.84 141.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.592 0.711 . . . . 0.0 109.782 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.469 HE21 ' HD2' ' A' ' 125' ' ' LYS . 13.6 mm-40 -113.69 -49.58 2.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.88 -171.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 14.7 m -159.69 159.63 33.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.871 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . 2.3 mt-30 -142.09 153.58 44.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.537 0.684 . . . . 0.0 111.93 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 1.2 mp0 -94.37 137.39 33.58 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.703 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.668 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 1.1 m-80 70.23 -83.35 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 O-C-N 123.892 0.745 . . . . 0.0 110.594 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.965 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.3 p90 37.66 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.75 1.62 . . . . 0.0 112.702 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.976 ' HA ' HD13 ' A' ' 29' ' ' ILE . 46.7 mt-10 -145.01 -47.97 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.434 -172.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 44.1 Cg_endo -76.31 -25.25 10.06 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.963 -1.207 . . . . 0.0 108.963 170.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.766 ' HD2' HD11 ' A' ' 118' ' ' ILE . 38.2 t80 -66.47 -52.59 44.58 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.063 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.702 ' HB2' HD11 ' A' ' 29' ' ' ILE . 17.5 mmt -64.04 -37.51 87.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.156 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.9 pttp -67.12 -39.12 86.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.14 61.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.516 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.557 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 30.0 tpp -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.879 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.53 -38.16 0.3 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.315 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD23 HG12 ' A' ' 29' ' ' ILE . 15.0 tp -77.55 131.03 72.23 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.708 ' HD2' HD12 ' A' ' 28' ' ' LEU . 90.9 Cg_endo -79.1 151.74 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.502 1.468 . . . . 0.0 111.19 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.034 ' HA ' HD12 ' A' ' 29' ' ' ILE . 18.1 tt0 -50.59 -40.16 51.71 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.937 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 4.5 p-10 -60.84 -36.36 78.92 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 118.339 0.518 . . . . 0.0 111.511 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 25' ' ' PRO . 21.7 mt -71.92 -36.88 70.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.301 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' A' ' 26' ' ' GLU . 30.8 mt -62.12 -43.74 98.16 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.369 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.0 mm100 -50.23 -49.3 53.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.125 0.965 . . . . 0.0 111.846 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 2.2 mptp? -71.07 -30.32 66.43 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.829 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.99 32.74 3.9 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.931 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.965 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 13.9 ptmm? -78.81 -41.4 30.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.39 0.614 . . . . 0.0 112.589 -168.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.35 52.92 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.66 0.743 . . . . 0.0 110.785 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.3 mm -92.91 131.18 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.643 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' HE22 ' A' ' 8' ' ' GLN . 10.4 mtmp? -98.82 98.25 9.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.166 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -91.4 177.43 40.86 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.588 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.1 t -122.37 150.38 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.738 ' HA ' ' O ' ' A' ' 51' ' ' THR . 9.4 m -132.49 130.01 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 111.538 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 5.0 mp0 -122.87 140.02 53.4 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.85 ' O ' ' HB2' ' A' ' 4' ' ' SER . 61.2 mt -129.96 141.96 45.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.281 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.675 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 99.5 t -108.61 117.98 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 166.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' N ' ' HB3' ' A' ' 4' ' ' SER . 17.2 t-160 -95.16 115.21 27.13 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.442 0.639 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -137.61 143.11 41.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.535 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.73 107.95 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 O-C-N 123.835 0.709 . . . . 0.0 112.861 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mtmt 71.64 -38.65 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.843 1.257 . . . . 0.0 113.077 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.33 106.62 18.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.707 0.289 . . . . 0.0 110.878 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.26 122.9 66.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.23 0.538 . . . . 0.0 110.666 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 6.8 mptt -104.85 132.68 50.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.131 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -120.14 132.49 55.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 39' ' ' SER . 17.2 m -117.92 124.04 47.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -128.43 121.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 58' ' ' VAL . 62.1 m -104.01 129.41 51.61 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -118.07 107.26 13.78 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.99 -96.62 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.661 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 t -104.48 -24.1 13.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 0.0 110.645 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.74 128.48 49.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.84 0.829 . . . . 0.0 112.422 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 53' ' ' THR . 82.4 t -104.55 124.9 59.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.33 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.32 114.31 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.987 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -101.93 134.72 44.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.307 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -126.14 93.4 3.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -102.39 125.82 49.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.593 0.711 . . . . 0.0 109.915 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -149.57 152.89 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.27 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.6 m -109.15 132.4 54.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.345 174.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -52.09 140.11 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.798 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 65.31 24.11 70.44 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.522 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 33.1 mt-10 -138.05 141.26 40.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -76.74 119.07 20.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.631 0.729 . . . . 0.0 109.734 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 m -132.9 152.6 51.85 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.899 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.6 pt-20 -95.57 145.37 25.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.282 1.039 . . . . 0.0 109.192 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.2 mt -110.51 133.73 53.02 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -168.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 59' ' ' ILE . 8.1 tt0 -90.72 130.61 36.7 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.422 HG21 ' SD ' ' A' ' 22' ' ' MET . 18.7 p -89.45 174.4 7.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.772 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.0 tpp -61.46 -25.93 67.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.6 . . . . 0.0 109.634 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.9 m -80.68 -39.06 27.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.093 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.67 1.13 7.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.523 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.68 138.89 37.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.846 0.323 . . . . 0.0 111.017 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 10.0 mmmm -97.72 131.75 43.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -136.58 133.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 34.0 mttm -83.05 123.46 29.5 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.507 0.67 . . . . 0.0 111.701 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.94 153.75 45.78 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.474 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -95.53 111.52 26.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.385 0.612 . . . . 0.0 109.944 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.794 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -102.4 133.89 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.311 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 88.9 mttt -117.45 152.77 34.33 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.594 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.66 ' H ' ' HB2' ' A' ' 65' ' ' LEU . 5.1 ttm -118.45 119.83 35.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.29 1.043 . . . . 0.0 110.486 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.684 ' HG2' ' HD2' ' A' ' 90' ' ' LYS . 11.4 tp10 -63.37 -31.88 73.15 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.734 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 92.11 -32.23 5.54 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.647 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 37.2 t70 -94.69 62.2 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.582 0.705 . . . . 0.0 109.768 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 26.7 m-80 70.56 0.94 3.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.253 -1.34 . . . . 0.0 113.549 174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.687 ' HE3' ' OE1' ' A' ' 103' ' ' GLU . 33.0 mttp -109.4 122.91 48.4 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.788 -172.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.489 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 2.8 mpp? -117.7 115.46 25.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.808 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -130.38 124.2 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.689 -172.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.794 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -121.49 140.18 52.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.32 0.581 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.2 m -128.17 126.37 40.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.988 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -134.82 113.95 12.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.053 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 60.3 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.891 0.476 . . . . 0.0 111.354 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.85 10.42 3.38 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 98' ' ' ILE . 2.0 mm -90.17 113.56 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' MET . 23.3 tttm -115.78 118.37 32.82 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.201 -172.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.9 m -117.81 119.16 34.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.062 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 92' ' ' VAL . 85.0 t -118.84 119.01 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.326 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 24.9 m -117.92 122.09 42.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.908 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.687 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 35.9 tt0 -128.74 129.15 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.724 0.297 . . . . 0.0 110.738 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 22.0 m-30 -95.07 120.51 35.4 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.003 177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 113.07 16.93 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.932 -0.48 . . . . 0.0 110.68 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.05 -102.3 0.83 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.779 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.97 17.23 6.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.138 0.494 . . . . 0.0 109.9 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 125' ' ' LYS . 25.6 p -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.638 0.732 . . . . 0.0 111.723 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 104' ' ' PHE . 22.1 mt -111.4 128.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.789 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.7 m -104.67 119.34 38.77 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -118.31 122.72 43.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.226 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.2 117.5 26.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.444 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.583 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 5.1 ttm -118.63 146.07 44.94 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 m -128.75 121.79 29.19 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.543 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -102.73 114.2 28.25 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 169.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -48.21 81.06 0.01 OUTLIER Glycine 0 N--CA 1.468 0.814 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -160.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 27.2 t70 157.18 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.627 1.571 . . . . 0.0 106.966 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.766 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -115.98 140.72 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.209 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.29 115.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.458 0.647 . . . . 0.0 111.155 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 3.6 t80 -100.06 118.74 37.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.701 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.7 OUTLIER -123.86 131.83 53.65 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -124.39 131.69 53.51 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.061 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 8.4 p -100.91 117.55 46.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.943 0.878 . . . . 0.0 109.431 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -131.67 136.9 48.05 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.928 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.469 ' HD2' HE21 ' A' ' 10' ' ' GLN . 0.0 OUTLIER -135.08 150.88 50.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 0.0 111.399 -175.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.503 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 76.9 ttt180 -68.73 148.31 50.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.24 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.644 ' CG1' ' HB2' ' A' ' 6' ' ' LYS . 1.1 pp . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.034 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 80.6 p . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.93 -174.72 15.53 Favored Glycine 0 CA--C 1.507 -0.437 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.671 ' HE3' HG12 ' A' ' 127' ' ' ILE . 3.6 mtpp -93.39 118.49 31.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 9.9 m-85 -125.02 124.67 42.47 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -93.0 134.39 35.18 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -68.08 137.38 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.925 0.869 . . . . 0.0 111.782 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.574 ' HB3' HG13 ' A' ' 123' ' ' VAL . 4.9 mm-40 -112.9 -69.12 0.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.699 -168.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.513 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 20.3 m -151.26 143.28 23.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.274 -170.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.811 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 5.5 mm-40 -121.3 157.61 29.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.499 0.666 . . . . 0.0 111.449 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 66.8 mt-10 -105.9 137.39 43.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.797 168.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.9 OUTLIER 69.76 -80.52 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.87 0 O-C-N 123.524 0.515 . . . . 0.0 111.062 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 12' ' ' GLN . 34.0 p90 35.41 35.41 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.691 1.596 . . . . 0.0 113.374 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.854 ' HA ' HD13 ' A' ' 29' ' ' ILE . 73.6 mt-10 -152.9 -48.03 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.04 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 37.4 Cg_endo -75.73 -25.17 11.02 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 N-CA-C 108.657 -1.324 . . . . 0.0 108.657 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 118' ' ' ILE . 52.6 t80 -65.94 -53.29 41.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.122 173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.7 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 16.9 mmt -61.93 -37.15 83.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.478 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 17' ' ' PRO . 10.7 pttt -66.43 -41.71 88.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.075 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -72.07 -20.98 61.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.421 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.592 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 25.5 tpp -83.1 -46.21 13.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.871 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.49 -23.92 0.36 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.121 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.781 HD23 HG12 ' A' ' 29' ' ' ILE . 14.4 tp -91.95 132.91 31.51 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.65 ' CD ' HD12 ' A' ' 28' ' ' LEU . 85.0 Cg_endo -76.14 147.94 30.43 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.29 1.993 . . . . 0.0 111.7 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.098 ' HA ' HD12 ' A' ' 29' ' ' ILE . 4.2 tt0 -49.47 -44.64 46.02 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.56 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 5.1 t70 -61.35 -35.19 76.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.873 0.76 . . . . 0.0 111.445 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.65 HD12 ' CD ' ' A' ' 25' ' ' PRO . 41.1 mt -71.42 -35.71 71.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.874 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.098 HD12 ' HA ' ' A' ' 26' ' ' GLU . 23.5 mt -63.73 -46.87 93.37 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.114 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.82 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 13.0 mm100 -53.13 -38.62 62.84 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 111.376 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 3.8 mptp? -69.71 -46.54 65.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.313 0.578 . . . . 0.0 110.887 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.87 39.87 2.36 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.183 -170.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD2' ' OE2' ' A' ' 16' ' ' GLU . 18.2 pttp -79.77 -43.12 23.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.2 51.27 0.75 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.535 . . . . 0.0 112.0 -171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 9.3 mm -79.28 118.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.538 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -100.21 118.96 37.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.046 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -116.89 -160.75 12.01 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.462 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 39.6 t -125.53 137.45 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.728 0.264 . . . . 0.0 110.748 -174.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.5 t -110.22 134.6 52.07 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 30.6 mt-10 -136.89 121.17 18.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.6 mt -124.22 141.35 44.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 122.319 -0.238 . . . . 0.0 111.583 -169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 44' ' ' GLU . 86.1 t -110.56 114.83 48.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 165.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -95.15 112.13 23.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.795 0.807 . . . . 0.0 109.576 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HG3' HG12 ' A' ' 42' ' ' VAL . 37.9 mt-10 -120.82 144.24 48.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.445 174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -35.85 105.72 0.03 OUTLIER Glycine 0 CA--C 1.52 0.388 0 O-C-N 123.793 0.683 . . . . 0.0 113.183 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.037 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 mtmt 72.85 -40.94 0.49 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.604 1.562 . . . . 0.0 113.631 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -92.87 107.33 19.13 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.652 0.739 . . . . 0.0 111.544 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.94 124.76 73.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.228 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 44.1 mttp -110.83 123.04 49.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.28 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.6 tt -112.82 128.22 56.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.636 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 39' ' ' SER . 5.6 m -111.33 124.74 52.86 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -131.12 120.86 47.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.729 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 43.4 m -98.75 127.09 44.57 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CE1' ' HB ' ' A' ' 35' ' ' ILE . 48.5 t80 -121.5 108.11 13.24 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.0 -93.77 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.114 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -105.38 -23.46 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.063 0.459 . . . . 0.0 111.15 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.84 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.415 -170.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 71.3 t -98.08 125.33 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.769 0.795 . . . . 0.0 110.438 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.699 HG23 HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -99.85 115.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.245 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -102.49 126.65 49.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.36 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 11.1 m-20 -127.8 97.38 4.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.522 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.13 125.7 50.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 61' ' ' ASN . 9.9 m-85 -129.06 152.8 48.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.177 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.5 m -112.59 122.7 48.46 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.037 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -46.51 125.67 7.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.181 0.515 . . . . 0.0 111.972 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 84' ' ' LYS . . . 82.49 16.39 71.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.589 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.5 mm-40 -125.9 154.3 42.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 21.5 tt0 -79.87 119.31 22.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.6 m -132.79 156.58 46.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.496 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' HE2' ' A' ' 78' ' ' LYS . 3.3 pt-20 -96.18 143.93 26.85 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 12.5 mt -106.21 127.26 53.1 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.298 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' CD ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 tt0 -88.03 129.0 35.4 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 p -88.52 174.9 7.82 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.763 -172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.2 ttt -70.14 -13.18 62.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.287 0.565 . . . . 0.0 109.761 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -90.9 -38.64 12.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.188 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.49 -13.86 4.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.493 -0.86 . . . . 0.0 114.157 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -80.4 147.04 31.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.584 0.692 . . . . 0.0 111.505 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 8.0 mmmm -96.24 136.47 36.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.551 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -138.0 143.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.875 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.542 ' HD2' ' OE1' ' A' ' 68' ' ' GLU . 37.1 mtmt -84.9 126.6 33.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 111.758 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.52 146.85 30.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.05 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.7 113.06 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.003 0.43 . . . . 0.0 109.937 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.752 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.31 133.24 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.572 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.3 mmtt -104.97 151.87 23.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.08 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.865 ' HB3' HD22 ' A' ' 65' ' ' LEU . 11.7 tpp -128.68 134.79 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.371 1.081 . . . . 0.0 111.622 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 90' ' ' LYS . 13.5 tp10 -82.12 -35.55 28.41 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.326 -176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 121.74 -36.5 3.22 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.178 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -78.82 26.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.858 1.313 . . . . 0.0 108.912 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.89 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 29.8 m-80 72.06 40.58 0.71 Allowed 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.582 168.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.925 ' HE2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -117.73 118.94 33.45 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 113.496 -1.684 . . . . 0.0 107.913 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 84' ' ' LYS . 42.4 mtm -116.65 123.03 46.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.848 0.832 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.85 118.7 54.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.663 -175.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.58 143.75 47.47 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.445 0.64 . . . . 0.0 111.356 -177.133 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 m -116.9 126.61 53.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.962 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.789 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 35.2 t80 -139.44 161.24 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.28 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 98' ' ' ILE . 22.8 ttmm -27.61 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.691 1.196 . . . . 0.0 114.008 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.34 8.49 19.02 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.58 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 26.3 mm -110.07 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -114.88 116.65 28.9 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.747 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.4 m -118.08 119.79 35.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 92' ' ' VAL . 84.6 t -115.71 117.52 55.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 12.1 m -118.89 120.95 38.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.925 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 24.2 tt0 -129.37 123.14 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.947 -0.471 . . . . 0.0 110.128 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.89 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 2.3 m-30 -89.71 114.0 25.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 172.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -125.45 112.13 15.91 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.72 -95.73 0.48 Allowed Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.215 -173.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -145.71 17.08 1.45 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 125' ' ' LYS . 5.2 m -128.07 135.3 49.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.884 0.85 . . . . 0.0 110.402 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 7' ' ' TYR . 10.6 mt -102.62 131.45 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.593 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.6 m -115.36 119.22 35.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.133 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 19.4 t-20 -108.0 122.81 47.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.759 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.748 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -119.85 115.81 24.6 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mtt -114.1 150.12 34.55 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 110.262 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 32.1 m -126.61 122.5 35.21 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.554 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -116.73 111.16 19.39 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.14 -90.81 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.68 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -125.34 0.19 7.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.514 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -87.11 140.32 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 -177.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.76 116.36 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.471 0.653 . . . . 0.0 111.51 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.401 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -109.55 118.82 37.61 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 112' ' ' THR . 20.8 ttpt -125.9 129.3 49.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.178 0.513 . . . . 0.0 109.65 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 34.8 ttm180 -120.22 127.17 52.19 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.261 -172.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 10' ' ' GLN . 14.7 p -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.1 m -135.34 130.09 34.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.913 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -128.98 144.78 51.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.336 0.971 . . . . 0.0 112.552 -171.531 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.7 ttt180 -69.26 149.94 47.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.849 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.671 HG12 ' HE3' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.822 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.56 ' HB3' ' N ' ' A' ' 43' ' ' HIS . 94.3 p . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.301 0.572 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.39 -178.48 17.06 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.14 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -94.27 117.27 29.87 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 7.3 m-85 -122.39 132.41 54.36 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.814 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.88 130.74 53.78 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.502 -174.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.834 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.47 139.05 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.854 176.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.862 ' HB2' HG13 ' A' ' 123' ' ' VAL . 4.3 mm100 -111.05 -49.24 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.584 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.55 ' HB2' HG12 ' A' ' 123' ' ' VAL . 61.1 m -155.52 154.89 32.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.814 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -136.93 157.32 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.5 0.667 . . . . 0.0 111.375 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.725 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 4.3 mm-40 -114.03 130.59 56.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.994 176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.774 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.9 m-80 63.4 31.16 15.26 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.643 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 23.3 p90 -68.92 16.11 0.05 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.04 0.448 . . . . 0.0 110.87 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.883 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 40.7 mt-10 -129.12 -48.42 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.814 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.2 Cg_endo -69.91 -28.5 24.45 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.719 1.613 . . . . 0.0 110.297 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.57 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -63.16 -52.55 61.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.369 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.597 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 85.9 mmm -61.78 -37.59 84.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.741 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 18.6 pttt -67.05 -37.31 83.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.229 0.538 . . . . 0.0 109.731 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -67.4 -25.36 65.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 18' ' ' PHE . 58.0 mtp -79.34 -53.4 6.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.26 -16.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.305 -0.862 . . . . 0.0 113.501 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 29' ' ' ILE . 13.2 tp -81.68 130.7 60.23 Favored Pre-proline 0 N--CA 1.441 -0.891 0 CA-C-N 117.358 0.579 . . . . 0.0 109.924 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.648 ' CD ' HD12 ' A' ' 28' ' ' LEU . 91.6 Cg_endo -76.29 146.68 28.47 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.647 2.232 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.08 ' HA ' HD12 ' A' ' 29' ' ' ILE . 32.4 tt0 -50.72 -37.46 41.74 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.131 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.619 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.4 t70 -57.74 -47.19 83.17 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.165 0.893 . . . . 0.0 109.977 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.648 HD12 ' CD ' ' A' ' 25' ' ' PRO . 43.8 mt -68.75 -32.97 73.12 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.08 HD12 ' HA ' ' A' ' 26' ' ' GLU . 36.0 mt -61.6 -44.82 99.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.053 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 18.5 mm-40 -52.24 -41.89 63.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.535 0.734 . . . . 0.0 111.789 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.053 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.81 -30.54 69.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.134 -176.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.36 32.14 3.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.964 -174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 20.5 pttm -79.63 -43.13 23.42 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -165.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.48 47.01 1.19 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.344 0.592 . . . . 0.0 111.922 -167.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.6 118.36 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.15 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -84.85 145.86 27.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.082 0.468 . . . . 0.0 110.587 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.834 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -145.45 177.81 23.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 8' ' ' GLN . 3.7 t -122.43 145.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.799 ' HA ' ' O ' ' A' ' 51' ' ' THR . 7.5 p -129.72 120.12 24.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.7 mp0 -110.12 124.07 50.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.876 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.813 HG12 ' HG ' ' A' ' 50' ' ' LEU . 76.3 mt -123.37 140.41 47.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -168.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.09 114.38 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.56 ' N ' ' HB3' ' A' ' 4' ' ' SER . 28.5 t-80 -105.06 114.11 28.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.323 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -123.29 143.81 49.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 169.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.35 107.85 0.05 OUTLIER Glycine 0 CA--C 1.522 0.491 0 O-C-N 123.517 0.511 . . . . 0.0 112.624 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.879 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.9 mtmm 76.86 -35.58 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.992 1.317 . . . . 0.0 113.069 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 19.7 mttt -90.53 109.57 20.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.15 0.5 . . . . 0.0 111.182 -172.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.1 t -123.0 128.8 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.343 0.592 . . . . 0.0 111.77 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 41.2 mtpt -109.42 126.83 53.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.813 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -118.87 122.59 42.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.799 ' O ' ' HA ' ' A' ' 39' ' ' SER . 3.2 m -108.5 125.15 51.48 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.673 HG13 HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -130.75 122.63 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.545 0.688 . . . . 0.0 110.097 -170.025 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.4 m -103.85 129.78 51.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.196 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -116.55 105.89 12.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.1 -17.44 0.11 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t 172.41 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.07 0.938 . . . . 0.0 109.608 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -97.95 133.04 42.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.041 -169.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.6 t -99.63 124.69 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.579 0.704 . . . . 0.0 110.745 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -126.7 114.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.317 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 51' ' ' THR . 0.3 OUTLIER -116.53 149.27 39.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -173.171 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.531 HD21 ' HB3' ' A' ' 71' ' ' LEU . 1.6 m-20 -124.41 121.38 34.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.058 -171.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -103.69 126.26 50.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.175 0.512 . . . . 0.0 110.237 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -151.26 152.29 33.03 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.304 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 2.0 m -105.83 131.81 52.71 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.884 HD22 ' HB2' ' A' ' 85' ' ' MET . 2.5 pp -72.72 168.54 18.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.762 0.791 . . . . 0.0 111.427 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 11.24 41.04 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.397 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 64' ' ' THR . 47.0 mt-10 -135.4 143.58 46.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -174.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.654 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.0 tt0 -83.26 117.11 22.74 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 67.6 m -132.97 157.39 45.28 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.878 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -94.98 119.57 33.72 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 122.876 1.322 . . . . 0.0 111.217 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.531 ' HB3' HD21 ' A' ' 61' ' ' ASN . 23.0 mt -102.69 145.89 29.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.704 -171.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE1' HG12 ' A' ' 59' ' ' ILE . 21.0 tt0 -109.25 123.86 49.95 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 p -91.43 167.93 11.91 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.253 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -59.73 -29.0 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 110.62 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 p -81.18 -30.66 34.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.297 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.98 -5.99 9.55 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.45 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.28 140.74 38.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.346 0.573 . . . . 0.0 110.736 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 23.7 mmmt -95.67 128.16 42.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.17 137.5 48.34 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.654 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 69' ' ' CYS . 41.8 pttt -101.96 125.31 48.61 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.564 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . -128.93 146.03 51.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.46 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 91.8 t -92.79 111.89 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.852 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.05 131.07 53.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.342 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -104.09 152.48 22.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.776 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.884 ' HB2' HD22 ' A' ' 65' ' ' LEU . 6.7 ttt -127.73 135.32 50.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.18 0.991 . . . . 0.0 111.488 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.039 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 9.2 tp10 -90.98 0.03 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.03 -1.895 . . . . 0.0 109.923 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.743 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 88.56 -65.73 3.29 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.858 173.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.487 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 19.1 m-20 -79.12 57.15 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 0.0 110.947 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.634 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 7.8 m120 70.59 40.24 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.404 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 1.039 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -119.65 122.74 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.777 169.161 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -119.27 115.3 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 171.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 101' ' ' VAL . 2.1 t -125.26 118.86 53.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -130.04 143.8 50.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.786 0.803 . . . . 0.0 112.283 -178.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 t -126.96 136.99 53.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.806 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -139.86 131.7 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt 55.67 28.56 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.64 2.89 88.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.215 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 98' ' ' ILE . 3.5 mm -90.09 137.63 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 113' ' ' MET . 37.4 tttt -112.1 120.73 42.81 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.652 -172.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -121.52 120.78 35.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.999 0.428 . . . . 0.0 110.142 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 92' ' ' VAL . 95.4 t -116.4 121.07 66.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.798 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -117.19 121.28 40.78 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 177.78 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -121.36 115.91 23.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.734 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -118.0 119.49 34.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.48 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.15 114.75 17.41 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.514 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.59 46.6 4.85 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.43 11.4 5.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.098 0.475 . . . . 0.0 111.452 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 p -120.92 129.11 53.34 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.978 -0.451 . . . . 0.0 110.403 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.0 mt -109.75 130.24 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.726 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -116.92 119.36 35.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' HG23 ' A' ' 102' ' ' THR . 2.9 t-20 -115.38 123.33 48.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.854 0.359 . . . . 0.0 110.504 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 3.3 m -120.02 125.34 48.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.485 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.704 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 30.8 ttm -120.6 149.97 41.63 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.0 m -122.0 121.47 37.11 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.526 ' HB3' HG12 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -122.86 111.62 16.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 53.31 -101.64 0.09 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.59 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -100.9 -11.94 19.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 0.0 110.733 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.59 135.57 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.854 -170.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.404 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.6 p -112.62 115.2 49.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 121.292 0.568 . . . . 0.0 111.231 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.758 ' OH ' ' HD3' ' A' ' 122' ' ' ARG . 15.3 t80 -109.83 119.98 41.04 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 121.536 -0.728 . . . . 0.0 111.125 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.725 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 2.7 ttmt -123.92 124.52 42.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.749 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.758 ' HD3' ' OH ' ' A' ' 120' ' ' TYR . 22.2 ptt85 -119.38 144.14 47.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.371 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.862 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.2 p -100.99 118.86 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.483 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 65.4 m -123.55 130.41 52.64 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.421 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -134.01 139.01 45.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.038 0.447 . . . . 0.0 110.858 -174.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.768 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 2.9 ttt180 -71.85 149.28 45.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 112.055 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.575 ' N ' ' HG2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.71 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.648 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.32 177.18 15.25 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.691 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.763 ' HE3' ' HG2' ' A' ' 40' ' ' GLU . 44.6 mtpt -96.88 118.22 32.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 31.7 m-85 -120.81 125.08 46.63 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 15.4 tm0? -93.19 134.28 35.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG22 HE21 ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.24 136.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.072 0.939 . . . . 0.0 109.666 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 123' ' ' VAL . 5.6 mm100 -111.52 -56.89 2.32 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.499 -167.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.625 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 57.3 m -152.97 150.75 29.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.561 HE21 HG22 ' A' ' 9' ' ' VAL . 17.8 mp0 -133.11 147.86 52.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.749 0.785 . . . . 0.0 110.998 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.997 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 9.7 mm-40 -92.55 127.76 38.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.092 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 45.3 m-20 70.06 -102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.094 0.871 . . . . 0.0 110.123 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HZ ' ' HG3' ' A' ' 74' ' ' MET . 5.2 t80 72.82 13.19 5.13 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.249 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD13 ' A' ' 29' ' ' ILE . 33.3 mt-10 -141.2 -45.78 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.652 -171.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.746 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 31.6 Cg_exo -60.97 -37.53 76.01 Favored 'Trans proline' 0 CA--C 1.494 -1.52 0 C-N-CA 122.439 2.093 . . . . 0.0 108.574 162.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -57.76 -53.92 52.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.113 -2.767 . . . . 0.0 109.628 175.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.672 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.13 -36.34 83.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.329 176.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 16.1 pttt -66.82 -40.15 87.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.08 28.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.1 -44.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -165.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.15 -51.26 0.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.591 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 29' ' ' ILE . 15.8 tp -85.08 135.8 39.04 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 116.945 0.372 . . . . 0.0 110.754 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.613 ' CG ' HD12 ' A' ' 28' ' ' LEU . 97.4 Cg_endo -77.69 151.43 28.43 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.968 2.445 . . . . 0.0 111.675 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.964 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -49.86 -45.39 50.46 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.891 -178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 2.4 p-10 -56.61 -42.26 78.46 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 118.664 0.666 . . . . 0.0 110.208 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.613 HD12 ' CG ' ' A' ' 25' ' ' PRO . 40.9 mt -70.55 -33.71 71.43 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.095 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.964 HD12 ' HA ' ' A' ' 26' ' ' GLU . 25.6 mt -64.75 -44.39 96.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.929 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 22.9 mm-40 -52.55 -40.72 62.83 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.079 0.952 . . . . 0.0 111.327 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.929 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -69.56 -31.29 69.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.713 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.63 33.41 2.87 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.902 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' ILE . 20.4 ptmt -78.61 -37.17 42.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.743 0.782 . . . . 0.0 112.784 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.41 51.11 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.96 -165.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.1 117.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -102.45 112.6 25.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -117.09 -163.15 12.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.142 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 23.7 t -129.32 150.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.2 p -127.96 118.47 23.63 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.972 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.763 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 1.7 mp0 -114.54 123.61 49.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' A' ' 50' ' ' LEU . 80.4 mt -122.6 137.83 54.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.078 0.466 . . . . 0.0 111.951 -170.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -109.46 118.58 57.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.648 ' H ' ' HB3' ' A' ' 4' ' ' SER . 15.2 t-160 -96.72 113.16 24.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.926 0.869 . . . . 0.0 110.499 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.705 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 8.3 tp10 -116.83 143.35 45.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.42 101.1 0.02 OUTLIER Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.824 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmt 79.1 -31.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.295 1.438 . . . . 0.0 112.353 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -90.44 108.85 20.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 0.0 110.601 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.59 124.13 67.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.359 0.599 . . . . 0.0 110.804 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 73.6 mttt -107.16 122.67 46.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.941 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -117.45 127.63 54.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.1 m -110.73 123.87 50.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -126.97 120.49 55.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.025 HG23 HG22 ' A' ' 58' ' ' VAL . 53.7 m -101.32 128.41 47.49 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.955 -171.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.5 t80 -110.35 157.8 19.13 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -43.06 101.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.608 0.567 . . . . 0.0 113.193 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 t 84.42 -21.59 0.25 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.369 1.068 . . . . 0.0 112.707 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 54' ' ' TYR . 4.2 tmmm? -131.49 122.97 27.1 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.783 -0.573 . . . . 0.0 111.733 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 53' ' ' THR . 21.4 t -97.99 132.45 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 122.192 0.996 . . . . 0.0 111.407 -177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.695 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -117.84 114.77 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.506 -176.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -91.36 146.36 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.118 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 4.3 m-20 -131.57 105.32 7.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.774 0.429 . . . . 0.0 110.04 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -104.61 127.01 52.24 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.881 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -150.89 151.55 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 1.7 m -110.39 133.59 53.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.526 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.6 ' O ' HD12 ' A' ' 65' ' ' LEU . 4.0 pp -52.66 142.77 17.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.281 0.563 . . . . 0.0 111.129 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 25.08 76.4 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' THR . 70.3 mm-40 -132.75 138.22 47.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.478 0.18 . . . . 0.0 111.069 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.3 tt0 -78.53 118.08 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.606 0.717 . . . . 0.0 109.096 168.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.2 m -134.65 162.72 31.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.094 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.813 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 2.2 mt-10 -94.6 119.21 32.9 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.331 1.062 . . . . 0.0 110.585 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 25.5 mt -92.88 120.48 33.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.628 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' OE1' HG12 ' A' ' 59' ' ' ILE . 25.2 tt0 -92.79 121.9 34.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.493 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -87.58 167.42 13.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.159 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.486 ' HG3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -56.01 -27.51 53.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 0.0 110.963 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -91.65 -12.6 33.69 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.695 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 122.23 -22.7 7.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.973 172.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.62 147.28 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.788 0.794 . . . . 0.0 111.147 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.22 132.03 56.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.791 -176.305 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.29 142.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.613 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 76.8 mttt -82.71 123.79 29.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.523 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.95 147.71 34.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.476 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 44.3 t -91.34 113.44 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 109.694 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.781 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -95.62 133.11 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -103.02 140.04 37.8 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -129.2 132.02 47.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.1 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 4.2 tp10 -80.28 -48.13 13.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.449 -2.16 . . . . 0.0 111.957 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 115.49 -45.21 1.33 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.225 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.08 44.22 0.75 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 122.51 1.148 . . . . 0.0 109.69 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 34.5 m-80 69.68 43.43 0.98 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.01 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.884 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 24.5 mttp -131.45 119.97 22.35 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.654 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 ttp -121.92 121.13 36.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.692 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -128.88 116.69 41.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.781 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -121.37 134.53 55.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.401 0.619 . . . . 0.0 110.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.8 m -128.33 127.36 42.55 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.557 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -122.69 111.46 16.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 46.51 -99.88 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.527 -173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.07 17.94 34.39 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -100.88 113.13 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 113' ' ' MET . 42.1 tttp -113.86 118.99 35.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.571 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.665 ' HB3' HG23 ' A' ' 93' ' ' THR . 32.1 t -120.64 119.81 33.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.763 0.316 . . . . 0.0 110.332 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 92' ' ' VAL . 1.8 m -112.42 121.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 6.4 m -119.69 120.58 37.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.24 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 42.5 tt0 -130.55 129.19 42.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.101 -0.239 . . . . 0.0 111.029 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -109.79 118.69 37.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -129.24 102.97 6.69 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.122 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.85 62.46 2.81 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.312 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 126' ' ' ARG . 7.3 m-20 67.88 -3.84 1.11 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.2 p -117.24 142.02 47.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.752 -0.592 . . . . 0.0 111.834 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.511 HD11 ' CG ' ' A' ' 7' ' ' TYR . 8.9 mt -116.91 135.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.521 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -112.22 119.81 39.63 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 169.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.8 t-20 -114.65 121.49 43.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 110.226 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 6.6 m -122.35 117.86 27.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.668 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 33.9 ttm -124.67 149.34 47.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.3 m -123.88 121.85 36.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.585 ' H ' HG13 ' A' ' 118' ' ' ILE . 1.3 tp -117.56 114.58 23.64 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.566 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -82.89 0.19 Allowed Glycine 0 C--N 1.319 -0.366 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.603 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.07 5.64 2.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.862 0.839 . . . . 0.0 109.338 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -91.86 139.07 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.361 -173.247 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p -104.67 117.11 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.61 0.719 . . . . 0.0 110.757 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.668 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 27.2 t80 -107.16 120.41 42.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.735 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.997 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 3.6 mtmt -123.73 128.31 49.41 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.304 0.573 . . . . 0.0 109.673 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 14.7 ttt180 -119.75 132.34 55.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.067 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 7.7 p -100.5 117.42 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -124.85 133.72 52.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.805 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.13 149.22 52.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 0.0 111.339 -176.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 ttp180 -69.6 150.47 47.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.053 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.8 pt . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.161 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.726 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 17.8 p . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.94 -176.53 16.11 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.819 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.732 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.79 116.93 30.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 50.9 m-85 -121.01 124.51 45.02 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.911 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.5 137.03 33.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -68.93 135.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.739 ' HB2' HG13 ' A' ' 123' ' ' VAL . 12.6 mm100 -110.76 -48.4 3.14 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.441 -168.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.58 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 31.3 m -158.12 156.75 31.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.542 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.22 158.18 45.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -119.7 125.79 49.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.663 -177.144 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.658 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 8.9 m-80 64.58 29.06 13.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 123.219 0.325 . . . . 0.0 111.704 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 1.03 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 29.6 p90 -67.58 6.12 0.69 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.078 0.466 . . . . 0.0 110.92 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.875 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 27.8 mt-10 -120.76 -46.23 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.142 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.875 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 32.9 Cg_endo -67.48 -29.71 37.0 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.4 1.4 . . . . 0.0 109.978 173.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 1.1 t80 -65.31 -52.18 55.72 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.48 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.589 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 87.1 mmm -61.04 -41.39 96.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.439 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 14.3 ptmt -68.78 -33.95 74.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.273 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -71.31 -22.71 61.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.15 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 18' ' ' PHE . 86.7 mmm -85.74 -72.15 0.5 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.38 0.609 . . . . 0.0 110.749 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.42 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.641 -172.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.74 HD23 HG12 ' A' ' 29' ' ' ILE . 12.0 tp -86.23 125.03 69.26 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 117.952 0.876 . . . . 0.0 109.718 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.686 ' CD ' HD12 ' A' ' 28' ' ' LEU . 88.4 Cg_endo -72.21 148.18 49.33 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.496 2.131 . . . . 0.0 111.261 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 8.4 tt0 -48.84 -41.8 34.19 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.663 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 16.9 t70 -61.85 -37.86 86.08 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 118.944 0.793 . . . . 0.0 111.168 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.686 HD12 ' CD ' ' A' ' 25' ' ' PRO . 35.1 mt -70.37 -35.01 73.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.491 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 21.5 mt -63.92 -44.61 98.03 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.822 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.876 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.0 mm-40 -50.52 -47.73 57.36 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.974 0.892 . . . . 0.0 112.067 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -68.62 -30.84 69.65 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.641 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.04 31.65 4.43 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.088 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.03 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 14.0 ptmm? -79.23 -39.65 32.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -165.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.07 46.68 0.93 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.536 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.41 129.52 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 147.61 23.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 0.0 109.816 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.982 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -142.69 171.34 24.83 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.911 HG22 ' HG3' ' A' ' 8' ' ' GLN . 11.5 t -121.93 132.93 69.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 117.538 0.669 . . . . 0.0 110.588 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.835 ' HB3' HD21 ' A' ' 50' ' ' LEU . 5.7 m -113.42 120.64 41.75 Favored 'General case' 0 C--O 1.21 -0.997 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.17 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.732 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 46.9 mt-10 -119.66 123.0 42.75 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.117 0.484 . . . . 0.0 110.034 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.726 ' O ' ' HB2' ' A' ' 4' ' ' SER . 96.4 mt -119.31 138.28 50.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -168.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.83 115.07 48.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.229 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.57 ' N ' ' HB3' ' A' ' 4' ' ' SER . 27.3 t-80 -96.37 122.17 38.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 111.707 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.83 143.09 50.63 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -42.35 136.09 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.733 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 66.42 -50.97 0.43 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.198 0.999 . . . . 0.0 112.586 -174.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -99.13 109.26 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.457 0.646 . . . . 0.0 112.37 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 91' ' ' MET . 80.7 t -122.72 129.14 75.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.96 -174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 39.0 mttp -109.77 135.21 51.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 39' ' ' SER . 1.6 tt -125.11 125.84 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.4 m -110.9 121.14 44.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.4 mt -123.96 121.1 61.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.436 0.636 . . . . 0.0 109.394 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.6 m -101.21 128.9 47.12 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.17 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t -121.31 -35.45 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.239 . . . . 0.0 111.559 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 138.49 35.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.298 0.57 . . . . 0.0 112.127 -170.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.5 t -99.74 126.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.804 0.811 . . . . 0.0 110.769 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.794 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -118.94 114.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.002 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.15 146.5 26.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.342 -177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m-20 -127.78 106.91 9.45 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -108.01 126.18 52.41 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.695 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.21 152.28 34.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.309 0.576 . . . . 0.0 111.83 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 7.5 m -121.34 133.31 55.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.9 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 85' ' ' MET . 3.5 pp -46.39 141.95 3.28 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.449 0.642 . . . . 0.0 112.465 176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 66.06 21.9 70.18 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.91 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.5 mm-40 -132.44 140.94 48.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.712 0.256 . . . . 0.0 110.8 -174.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB2' HG23 ' A' ' 82' ' ' VAL . 9.5 tt0 -79.74 117.59 20.77 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.895 0.855 . . . . 0.0 109.311 171.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 m -128.4 159.27 35.88 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.522 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.723 ' HG2' ' HG2' ' A' ' 80' ' ' LYS . 38.9 mt-10 -94.57 119.18 32.84 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.89 1.329 . . . . 0.0 110.588 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 36.3 mt -94.72 121.5 36.37 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.772 -2.467 . . . . 0.0 109.602 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HB3' HG23 ' A' ' 59' ' ' ILE . 26.8 tt0 -94.59 124.3 38.54 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -86.1 164.78 17.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.894 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -62.27 -19.36 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.3 0.571 . . . . 0.0 109.564 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 m -73.78 -48.0 34.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.507 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.794 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 143.11 -31.18 1.98 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.019 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -77.0 138.71 39.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.929 0.365 . . . . 0.0 110.923 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.94 136.83 41.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.47 143.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 111.114 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.723 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 56.2 mttp -81.69 123.32 28.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.607 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -145.71 148.54 33.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.858 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 68' ' ' GLU . 38.8 t -91.74 114.27 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.956 0.408 . . . . 0.0 110.059 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.758 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -106.71 134.95 46.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.291 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.5 mmtt -105.11 155.51 18.94 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.9 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 2.1 tmt? -129.16 136.36 50.08 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.105 0.955 . . . . 0.0 112.077 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 8.9 tp10 -110.26 148.53 31.71 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.273 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -58.16 -25.54 57.24 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -168.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.634 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 4.9 m-20 -80.21 28.82 0.29 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.085 0.945 . . . . 0.0 109.738 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 61.52 47.24 6.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.177 -1.828 . . . . 0.0 109.385 172.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.77 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 7.0 mtpt -107.61 123.9 49.16 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.55 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.526 ' HE3' HG11 ' A' ' 48' ' ' VAL . 16.2 mmt -113.88 112.64 23.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.436 HG12 ' HE3' ' A' ' 99' ' ' LYS . 2.4 t -123.39 116.34 48.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.251 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.758 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -132.13 145.17 51.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.447 0.641 . . . . 0.0 110.667 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.5 m -125.49 124.91 42.39 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.497 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 96' ' ' LYS . 62.1 t80 -139.74 112.45 7.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 95' ' ' PHE . 8.6 mtmp? 42.52 57.87 3.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.21 -9.42 60.98 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.152 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 115' ' ' LEU . 2.0 mm -90.31 113.3 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -104.35 130.66 52.19 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.086 0.47 . . . . 0.0 110.577 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 93' ' ' THR . 19.0 t -125.34 124.92 42.61 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.893 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 92' ' ' VAL . 71.9 t -123.32 118.59 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.441 . . . . 0.0 109.877 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 2.8 m -118.62 122.58 42.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.77 ' HG3' ' HE3' ' A' ' 90' ' ' LYS . 12.2 tt0 -129.28 124.95 35.7 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.005 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 109' ' ' ILE . 1.3 m-30 -101.42 115.47 30.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.51 117.46 21.35 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.515 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.06 -95.02 0.39 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.088 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.0 12.93 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.36 . . . . 0.0 110.439 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p -131.38 146.4 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.581 0.705 . . . . 0.0 111.784 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.748 ' HB ' ' OG ' ' A' ' 124' ' ' SER . 21.1 mt -129.09 135.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.341 -173.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 m -115.89 120.52 39.47 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.685 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 14.1 t-20 -107.88 124.79 50.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.004 0.431 . . . . 0.0 110.16 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -119.48 122.45 41.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.806 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.622 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.7 mtt -122.09 150.71 41.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -122.43 120.14 33.06 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.613 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 3.4 tm? -124.63 115.1 20.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.06 -107.0 1.59 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.919 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -115.41 6.69 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.071 0.462 . . . . 0.0 109.959 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.672 ' CD1' ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -93.03 139.61 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.317 -173.269 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.0 p -108.65 114.99 48.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-O 121.413 0.625 . . . . 0.0 110.841 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' HD2' ' HB2' ' A' ' 113' ' ' MET . 7.2 t80 -112.03 121.34 44.72 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.367 0.604 . . . . 0.0 111.941 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 6.4 mtmm -121.28 139.42 53.42 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.391 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.685 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 11.4 ptt180 -123.43 142.39 51.04 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -99.86 118.56 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.748 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 93.5 p -129.57 133.23 47.08 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.358 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -129.32 147.28 51.14 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.718 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 10.6 ttp180 -70.85 148.83 47.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.0 110.172 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.674 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 88.0 p . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 -173.37 17.72 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.321 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.713 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 42.9 mtpt -94.33 118.12 31.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.133 0.492 . . . . 0.0 110.086 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 30.7 m-85 -120.13 123.53 43.56 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -97.08 130.52 44.36 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -173.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 0.5 OUTLIER -69.94 140.75 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.581 0.705 . . . . 0.0 110.794 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.669 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.3 mm100 -109.06 -39.58 5.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.75 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 13.3 m -159.15 159.99 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.134 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 10.3 mp0 -139.43 157.5 45.75 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.499 0.666 . . . . 0.0 111.376 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.766 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 6.2 tp10 -114.49 126.88 55.45 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.964 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.787 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 89.8 m-20 57.04 35.38 26.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.238 0.542 . . . . 0.0 111.867 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.841 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 32.7 p90 -69.16 21.73 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.402 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.945 ' HG2' HG21 ' A' ' 29' ' ' ILE . 41.1 mt-10 -135.36 -48.26 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -172.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.901 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 42.3 Cg_endo -71.0 -26.4 21.81 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.212 1.275 . . . . 0.0 109.432 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.811 ' HD1' HD11 ' A' ' 118' ' ' ILE . 44.6 t80 -65.11 -52.18 56.91 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.031 175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.957 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 23.3 mmt -61.51 -41.86 97.93 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.297 174.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.75 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 9.0 pttt -68.4 -33.92 75.1 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.553 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.23 66.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.639 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.0 ttm -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.86 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.8 -34.24 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.073 HD12 HG13 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -74.56 126.99 88.14 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.918 ' HD2' HD13 ' A' ' 24' ' ' LEU . 98.9 Cg_endo -79.27 141.68 16.32 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.896 1.73 . . . . 0.0 111.227 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.937 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.1 tt0 -49.67 -42.22 44.9 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.705 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.7 t70 -55.76 -44.14 77.36 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 118.544 0.611 . . . . 0.0 109.854 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' CG ' ' A' ' 25' ' ' PRO . 19.6 mt -68.4 -33.41 74.2 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.777 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.073 HG13 HD12 ' A' ' 24' ' ' LEU . 27.3 mt -64.66 -44.14 96.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.5 169.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 1.066 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 23.0 mm-40 -53.04 -41.0 64.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 1.066 ' HE2' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -71.23 -31.55 67.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.358 178.053 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.6 44.66 1.18 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.865 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.841 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -79.67 -39.79 30.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -167.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 7.6 t70 -98.88 61.0 1.27 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.032 0.92 . . . . 0.0 110.236 -167.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.3 115.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.814 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -98.31 100.88 12.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.001 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.08 -175.57 34.77 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.2 t -122.05 155.51 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 51' ' ' THR . 16.0 m -133.95 119.68 19.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.145 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 3.1 mp0 -116.75 123.85 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 4' ' ' SER . 38.7 mt -116.84 143.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 92.6 t -109.02 114.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 167.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 4' ' ' SER . 5.5 t60 -96.37 112.79 24.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 110.387 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -127.88 145.54 50.91 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -36.67 114.48 0.22 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.433 174.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 1.073 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 58.68 -25.31 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -172.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 21.8 mmtp -91.26 107.09 18.97 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.283 0.492 . . . . 0.0 111.036 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 46.3 t -124.53 124.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.0 110.491 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 1.2 tttm -115.22 139.06 50.26 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.3 tt -121.93 124.95 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.158 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 39' ' ' SER . 58.2 m -110.2 124.38 51.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -129.33 121.06 52.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.2 m -99.53 130.63 45.79 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.658 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -109.18 108.15 18.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.93 -89.68 0.13 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.919 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.8 t -124.82 -3.65 7.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.749 0.309 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -121.91 136.2 54.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.749 0.309 . . . . 0.0 110.181 -170.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 93.8 t -98.33 134.19 37.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.012 0.91 . . . . 0.0 112.223 -172.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -118.64 114.75 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.603 176.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 145.43 26.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.962 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 2.4 m120 -135.07 98.6 4.04 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 49' ' ' LYS . 3.5 mp0 -102.55 132.08 48.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.992 -0.443 . . . . 0.0 110.618 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -150.02 151.81 33.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.663 0.744 . . . . 0.0 112.091 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 22.9 m -107.78 134.03 51.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.112 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.073 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.7 mt -48.08 131.13 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.869 0.366 . . . . 0.0 111.05 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.77 60.8 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.013 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 64' ' ' THR . 50.4 mm-40 -132.98 139.03 47.07 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 28.3 tt0 -80.56 116.98 20.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.9 t -135.75 160.74 37.6 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.272 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.5 pt-20 -95.95 145.15 25.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.221 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 19.4 mt -105.88 128.42 53.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.509 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 59' ' ' ILE . 14.5 tt0 -91.63 120.29 32.27 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.2 p -90.51 166.42 13.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.997 -173.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.27 -20.24 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.858 0.361 . . . . 0.0 110.64 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 p -82.61 -38.67 23.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 133.04 -14.89 4.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.56 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -77.38 138.39 39.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.824 0.312 . . . . 0.0 111.534 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 9.9 mmmm -96.85 135.83 38.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.804 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -137.13 131.45 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.346 177.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 41.0 pttt -83.68 124.24 30.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.478 0.656 . . . . 0.0 111.031 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.99 149.38 41.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.428 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' THR . 71.2 t -93.95 113.08 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -104.76 132.33 51.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -117.66 156.17 28.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.492 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.789 ' HB3' HD13 ' A' ' 65' ' ' LEU . 8.7 tpp -126.32 122.23 34.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.098 0.951 . . . . 0.0 110.147 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.634 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 12.2 tp10 -46.43 -43.9 16.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.752 -2.022 . . . . 0.0 110.527 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.572 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . 137.94 -59.65 0.61 Allowed Glycine 0 CA--C 1.5 -0.901 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.857 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -63.4 -72.0 0.15 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.16 0.505 . . . . 0.0 110.954 176.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.811 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 1.5 p30 -150.43 13.16 0.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.634 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -109.81 119.87 40.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.004 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.496 ' HG2' ' HB2' ' A' ' 85' ' ' MET . 50.9 mtm -121.98 115.96 23.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.783 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 101' ' ' VAL . 1.4 t -124.06 122.15 63.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.905 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.834 HG22 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -113.07 143.53 44.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.8 m -125.62 129.78 50.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 58.5 t80 -138.59 157.56 45.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.649 175.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 98' ' ' ILE . 48.1 mtmt -41.71 104.58 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.932 0.493 . . . . 0.0 112.007 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.51 -30.7 1.01 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.229 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 2.1 mm -90.04 111.72 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 113' ' ' MET . 46.3 tttt -113.29 125.46 54.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.025 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -114.2 119.11 35.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 92' ' ' VAL . 74.9 t -118.74 119.22 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -117.42 120.46 38.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.626 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.86 120.48 24.99 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.977 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.29 112.48 25.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.031 171.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -127.34 107.57 10.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.454 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.44 45.47 37.42 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.237 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 6.5 m-20 68.48 4.83 4.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.955 0.502 . . . . 0.0 111.84 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 p -117.95 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 104' ' ' PHE . 4.9 mt -109.91 132.57 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -107.33 119.76 40.28 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.822 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.786 ' HB2' ' HG2' ' A' ' 122' ' ' ARG . 18.8 m120 -106.61 121.65 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -121.75 118.78 29.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.103 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 77.1 mtm -124.8 149.83 46.98 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -127.85 122.59 33.0 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 122.126 -0.359 . . . . 0.0 110.722 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -111.84 112.41 24.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.18 -98.74 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.703 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -104.97 -12.87 15.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.502 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.811 HD11 ' HD1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.4 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.397 -172.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.59 115.05 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.487 0.66 . . . . 0.0 110.822 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 t80 -100.37 119.06 37.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 4.4 tmmm? -128.11 124.58 37.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.469 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.786 ' HG2' ' HB2' ' A' ' 111' ' ' ASN . 14.5 ptt180 -120.02 148.65 43.3 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.549 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 10' ' ' GLN . 6.7 p -101.61 118.26 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.596 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.737 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 84.3 p -125.42 132.54 52.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.8 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -132.0 146.65 52.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -70.08 149.6 47.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.933 -176.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.713 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 5.6 pt . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.471 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.687 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 82.1 p . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -170.7 13.45 Favored Glycine 0 CA--C 1.5 -0.888 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 17.0 mtpp -96.82 118.24 32.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.681 0.753 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.74 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 6.0 m-85 -120.7 134.91 55.25 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -102.0 140.13 36.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -175.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.9 t -64.64 139.07 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 122.004 0.907 . . . . 0.0 110.984 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.896 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.5 mm-40 -114.12 -58.17 2.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.954 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.681 ' HB2' HG12 ' A' ' 123' ' ' VAL . 29.0 m -157.18 152.36 26.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.681 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.67 151.35 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.54 0.686 . . . . 0.0 110.792 174.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 13.7 mm-40 -94.45 130.22 40.9 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.525 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.723 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 16.9 m-20 70.52 -82.31 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 O-C-N 123.715 0.634 . . . . 0.0 110.927 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' PHE . 51.0 p90 39.57 36.46 0.24 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.651 1.58 . . . . 0.0 112.304 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.913 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.9 mt-10 -144.47 -46.5 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.157 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.913 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 61.1 Cg_endo -68.22 -34.72 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.968 1.779 . . . . 0.0 109.718 169.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -62.3 -50.03 73.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.947 -1.933 . . . . 0.0 111.198 174.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.614 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 61.0 mmm -62.96 -41.07 99.42 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.881 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 16.1 ptmt -69.03 -32.73 72.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.25 0.547 . . . . 0.0 110.319 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.55 71.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.954 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.0 mtt -83.42 -59.46 2.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.25 -44.3 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.678 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.6 tp -75.56 126.44 87.44 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 117.564 0.682 . . . . 0.0 110.037 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.667 ' CD ' HD12 ' A' ' 28' ' ' LEU . 86.3 Cg_endo -73.85 153.39 47.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.709 2.273 . . . . 0.0 111.424 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.992 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 tt0 -50.56 -43.71 56.39 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.243 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.724 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 p-10 -57.18 -41.72 79.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 118.4 0.545 . . . . 0.0 110.704 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CD ' ' A' ' 25' ' ' PRO . 46.8 mt -71.08 -34.32 71.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.883 -0.51 . . . . 0.0 109.714 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.992 HD12 ' HA ' ' A' ' 26' ' ' GLU . 45.4 mt -61.73 -46.9 95.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.692 170.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.785 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 11.5 mm100 -52.36 -44.36 65.19 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.547 1.139 . . . . 0.0 112.05 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.724 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -69.71 -31.35 69.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.415 0.626 . . . . 0.0 110.343 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -122.09 29.16 5.63 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.585 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 29' ' ' ILE . 23.5 pttm -79.41 -28.34 41.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 111.523 -171.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.73 44.99 1.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.23 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 32' ' ' GLY . 27.7 mm -93.9 123.96 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -108.54 99.45 8.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.438 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -89.62 -179.96 44.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.936 -174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 3.5 t -123.26 148.24 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 51' ' ' THR . 19.2 m -128.77 123.53 33.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.974 0.416 . . . . 0.0 112.086 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 15.5 mp0 -117.0 123.46 46.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.805 HG12 ' HG ' ' A' ' 50' ' ' LEU . 25.0 mt -120.72 141.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.933 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 44' ' ' GLU . 96.1 t -109.13 119.52 58.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.787 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.443 ' N ' ' HB3' ' A' ' 4' ' ' SER . 23.3 t-80 -93.07 112.55 24.55 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.854 0.835 . . . . 0.0 109.814 173.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 43.4 mm-40 -123.33 144.01 49.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.09 0.09 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.363 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.801 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmm 71.79 -24.01 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.121 1.369 . . . . 0.0 112.869 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 70.0 mmtt -96.0 109.77 22.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG21 ' CE ' ' A' ' 91' ' ' MET . 55.9 t -121.72 123.56 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 111.5 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.0 mttm -112.37 123.06 49.45 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.715 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.805 ' HG ' HG12 ' A' ' 41' ' ' ILE . 2.3 tt -114.81 121.84 44.53 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -106.28 125.3 50.83 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.678 HG13 HD22 ' A' ' 50' ' ' LEU . 1.1 mt -129.26 121.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -171.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.969 HG23 HG22 ' A' ' 58' ' ' VAL . 23.9 m -104.01 129.07 51.59 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 40.0 t80 -116.45 106.47 13.64 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.42 -99.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.546 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 t -94.37 -28.72 15.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 110.846 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -107.71 125.37 51.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.841 -166.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.969 HG22 HG23 ' A' ' 53' ' ' THR . 21.2 t -99.51 125.19 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.709 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -124.82 114.33 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 122.635 1.207 . . . . 0.0 109.093 177.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.505 ' HB3' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -109.72 149.56 29.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.334 -172.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -117.64 108.38 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.59 125.65 51.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.065 0.46 . . . . 0.0 110.403 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 83' ' ' VAL . 3.5 p90 -151.38 152.73 33.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.618 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 15.6 m -111.6 134.71 52.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.78 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.801 ' HG ' ' HB3' ' A' ' 46' ' ' LYS . 4.0 pp -49.43 143.81 6.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.17 0.51 . . . . 0.0 111.617 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 67.15 19.15 69.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.763 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' THR . 76.1 mm-40 -129.24 146.94 51.05 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.692 0.246 . . . . 0.0 110.86 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 41.8 tt0 -79.86 118.41 21.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.9 m -134.21 150.48 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.101 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 3.3 pt-20 -95.01 140.01 30.57 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.19 -173.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 81' ' ' ALA . 18.5 mt -109.54 134.35 52.01 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.202 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HG3' ' HD2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -87.57 138.26 31.63 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 121.948 0.88 . . . . 0.0 108.927 169.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.9 p -95.16 167.81 11.13 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.769 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.3 tpp -65.67 -18.17 65.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -83.74 -39.93 19.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.901 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.709 ' HA2' ' CD1' ' A' ' 59' ' ' ILE . . . 130.1 -5.81 6.04 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.308 -0.948 . . . . 0.0 114.719 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -79.87 144.72 33.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.573 0.686 . . . . 0.0 110.558 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.17 125.73 38.98 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.11 130.94 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 22.8 pttt -97.12 140.48 31.56 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.321 1.058 . . . . 0.0 112.976 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.43 159.99 42.67 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.168 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -94.36 112.85 27.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.348 0.594 . . . . 0.0 110.153 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.738 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 2.0 m -103.78 136.36 37.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.682 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.1 mttt -116.45 156.94 25.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.768 0.318 . . . . 0.0 110.336 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' HD23 ' A' ' 65' ' ' LEU . 32.6 ttp -126.34 135.54 51.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.888 0.851 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.081 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 11.1 tp10 -86.12 -14.75 43.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.614 -173.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 114.36 -68.87 0.25 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.993 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 90' ' ' LYS . 2.4 p-10 -74.65 44.46 0.21 Allowed 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.342 0.592 . . . . 0.0 110.966 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.868 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 9.6 m120 65.02 44.98 3.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.8 169.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 1.081 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -106.51 121.37 44.16 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 166.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.441 ' CE ' HG21 ' A' ' 48' ' ' VAL . 2.0 mpt? -119.58 114.39 22.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -124.43 119.22 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -126.4 139.86 52.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.182 0.515 . . . . 0.0 110.661 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -128.99 139.89 51.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.899 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -138.84 113.4 8.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.971 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.0 -95.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.024 0.53 . . . . 0.0 111.677 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.19 10.15 15.13 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mm -92.19 122.77 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 113' ' ' MET . 38.1 tttm -123.97 116.72 23.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.229 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 93' ' ' THR . 14.6 m -121.65 119.92 33.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 92.0 t -117.0 119.64 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.779 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 m -117.47 126.1 52.04 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.823 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 39.1 tt0 -127.45 121.98 32.26 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.659 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.868 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 7.4 m-30 -92.98 116.12 28.76 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 167.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -124.24 110.99 15.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.49 -74.32 1.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.637 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -165.91 13.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.106 -0.547 . . . . 0.0 109.591 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 125' ' ' LYS . 2.8 m -123.44 142.22 51.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.52 0.676 . . . . 0.0 110.425 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 7' ' ' TYR . 15.0 mt -102.77 129.85 53.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.338 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -113.38 117.4 31.67 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 167.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.1 t-20 -113.74 120.38 40.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.946 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.729 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -121.88 115.97 23.55 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.64 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 9.3 ttp -125.93 144.45 50.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -121.44 121.62 37.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.771 ' HB2' HG12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -92.95 145.59 24.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.05 25.46 0.15 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -165.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.4 t70 -149.83 -9.04 0.3 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 159.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -116.01 139.62 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.71 -168.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 p -106.56 116.55 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.433 0.635 . . . . 0.0 110.192 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.64 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -115.36 120.97 41.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.105 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 23.6 ttpt -125.14 137.34 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.24 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 111' ' ' ASN . 44.4 ttt180 -132.08 127.12 35.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 111.682 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.896 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.3 p -101.88 128.15 54.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 20.9 m -134.63 131.89 38.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.409 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HA ' HG23 ' A' ' 108' ' ' THR . 11.4 ptmt -120.96 145.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.609 0.64 . . . . 0.0 111.334 -170.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 43.3 ttt180 -70.1 151.5 45.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.624 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 6.0 pt . . . . . 0 N--CA 1.431 -1.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.814 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -89.47 128.44 35.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.782 ' HA ' ' ND2' ' A' ' 89' ' ' ASN . 0.7 OUTLIER -173.96 -59.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.359 169.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 68.6 p -144.54 175.8 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.744 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.97 -174.29 18.26 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.573 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.992 ' HE2' HG12 ' A' ' 127' ' ' ILE . 6.1 mtpt -97.64 120.71 38.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.642 0.734 . . . . 0.0 110.685 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 35.9 m-85 -123.79 124.95 43.82 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.57 138.86 31.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -168.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.485 HG22 ' HD3' ' A' ' 122' ' ' ARG . 1.6 t -70.77 127.96 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.398 0.618 . . . . 0.0 109.918 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.859 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.2 mm100 -111.59 -47.24 3.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.518 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 123' ' ' VAL . 24.3 m -161.61 152.82 18.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.987 -172.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -145.57 156.5 43.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.257 0.551 . . . . 0.0 111.362 174.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.843 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 51.3 mm-40 -97.51 142.81 28.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.954 174.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.9 m-80 69.22 26.48 5.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' CD2' ' HB2' ' A' ' 33' ' ' LYS . 4.7 p90 -63.26 -0.31 0.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.863 ' HA ' HD13 ' A' ' 29' ' ' ILE . 80.7 mt-10 -116.84 -51.2 0.04 OUTLIER Pre-proline 0 C--O 1.216 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.155 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 27.1 Cg_exo -55.43 -42.81 64.39 Favored 'Trans proline' 0 CA--C 1.511 -0.656 0 C-N-CA 121.853 1.702 . . . . 0.0 112.732 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -60.55 -49.6 76.87 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.833 -1.531 . . . . 0.0 109.601 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.637 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 25.2 mmt -63.02 -43.7 98.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.447 176.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 15.5 ptmt -64.71 -36.94 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.925 -171.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -73.37 -36.82 66.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.851 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -82.96 -28.18 29.98 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.6 -39.7 0.36 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.372 -1.394 . . . . 0.0 114.402 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.663 HD23 HG12 ' A' ' 29' ' ' ILE . 13.0 tp -80.65 129.09 69.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 117.689 0.745 . . . . 0.0 110.131 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.659 ' CD ' HD12 ' A' ' 28' ' ' LEU . 93.2 Cg_endo -73.5 146.87 40.09 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.296 1.998 . . . . 0.0 111.196 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 7.4 tt0 -48.81 -41.22 32.01 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.108 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.749 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 29.3 t70 -64.1 -37.44 87.45 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 119.197 0.908 . . . . 0.0 110.871 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.659 HD12 ' CD ' ' A' ' 25' ' ' PRO . 31.1 mt -69.78 -34.46 73.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 20.4 mt -64.11 -45.94 95.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.431 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.599 172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.073 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 35.1 mm-40 -51.32 -48.17 62.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.671 0.748 . . . . 0.0 112.078 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.749 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -63.53 -30.05 71.22 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.619 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.62 41.14 1.46 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.438 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.073 ' HE2' ' HA ' ' A' ' 30' ' ' GLN . 15.7 ptpt -79.96 -41.45 25.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -165.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 38.7 t70 -109.96 60.37 0.6 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.917 0.865 . . . . 0.0 110.562 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 mm -80.89 130.27 36.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.026 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.85 146.55 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.3 169.05 27.02 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 8' ' ' GLN . 15.2 t -127.85 141.55 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.339 0.569 . . . . 0.0 109.494 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.5 t -119.02 131.76 56.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -125.01 122.92 38.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.595 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 4' ' ' SER . 97.1 mt -117.47 138.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 49' ' ' LYS . 96.8 t -109.15 119.87 59.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.615 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.682 ' H ' ' HB3' ' A' ' 4' ' ' SER . 10.6 t-160 -97.77 114.72 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.352 0.596 . . . . 0.0 110.562 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -133.17 141.55 48.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -37.24 114.27 0.24 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 113.642 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 28.0 mtmt 75.47 -43.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.882 1.273 . . . . 0.0 112.539 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -96.28 109.79 22.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.897 0.856 . . . . 0.0 111.822 -171.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.7 128.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.261 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 78.0 mttt -107.94 125.44 51.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.297 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -120.04 123.64 43.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.73 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.6 m -106.84 124.15 49.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.2 mt -131.3 122.27 50.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.332 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 HG22 ' A' ' 58' ' ' VAL . 19.8 m -101.45 130.08 47.61 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.063 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -116.64 106.21 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.35 -99.58 0.09 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.04 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t -99.09 -24.4 14.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.418 0.628 . . . . 0.0 110.483 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HE2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.96 123.01 47.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.239 -169.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 53' ' ' THR . 24.3 t -98.26 124.8 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-O 121.873 0.844 . . . . 0.0 109.55 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.516 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -116.45 114.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.82 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 148.5 26.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.28 -1.782 . . . . 0.0 112.378 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -139.7 87.84 2.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.487 0.661 . . . . 0.0 110.482 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 33.4 mt-10 -107.21 127.16 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.643 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' HE1' ' HG2' ' A' ' 91' ' ' MET . 9.7 p90 -150.43 152.0 33.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.09 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.3 m -106.54 132.44 52.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 65' ' ' LEU . 3.8 pp -47.17 143.36 3.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 112.394 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 68.42 25.03 74.99 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.569 177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -135.24 145.45 47.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 23.6 tt0 -76.6 118.64 19.46 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.2 m -134.03 158.75 42.75 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.273 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 4.1 mt-10 -97.6 120.64 38.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.5 1.143 . . . . 0.0 111.906 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 32.5 mt -93.69 121.59 35.27 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.732 -2.031 . . . . 0.0 109.872 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.516 ' OE1' HG12 ' A' ' 59' ' ' ILE . 15.8 tt0 -95.22 120.54 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 59' ' ' ILE . 24.2 p -86.72 164.19 16.88 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 ttt -64.61 -14.65 58.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.198 0.523 . . . . 0.0 109.827 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -85.9 -40.7 15.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.798 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.42 -13.32 4.01 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.148 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.54 129.65 35.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.663 -0.316 . . . . 0.0 111.315 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -105.17 130.52 53.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 176.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -134.64 147.99 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.065 0.46 . . . . 0.0 112.048 -175.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 51.0 mttm -82.7 123.27 29.13 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.64 145.19 32.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.5 t -90.5 112.84 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.488 0.661 . . . . 0.0 109.803 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.728 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -109.14 134.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.363 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -113.67 153.1 29.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.63 ' HG2' ' HG3' ' A' ' 91' ' ' MET . 9.4 tmm? -129.41 124.88 35.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.257 1.027 . . . . 0.0 110.015 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 6.1 tp10 -56.67 -60.64 3.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.959 -1.928 . . . . 0.0 113.736 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 145.56 -54.38 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 23.0 t70 -80.67 27.24 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.008 0.909 . . . . 0.0 109.086 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.782 ' ND2' ' HA ' ' A' ' 3' ' ' PHE . 5.6 m120 65.37 58.49 0.85 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.685 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.779 ' HE2' ' HG2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -108.14 121.37 44.71 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.161 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.63 ' HG3' ' HG2' ' A' ' 85' ' ' MET . 1.4 mpp? -118.27 114.61 23.26 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 3.5 t -124.84 122.02 62.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.196 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.728 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.71 144.17 51.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.207 0.527 . . . . 0.0 110.61 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -122.31 126.43 48.09 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -138.58 114.6 10.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt 56.85 -102.45 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.268 0.355 . . . . 0.0 111.128 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.32 14.14 12.19 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 115' ' ' LEU . 1.6 mm -94.37 113.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' MET . 18.2 ttpt -110.16 118.17 35.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.943 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -114.85 120.62 40.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.162 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 85.5 t -119.73 119.91 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.287 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.56 HG22 ' HE1' ' A' ' 104' ' ' PHE . 2.6 m -117.69 120.5 38.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 5.0 tm-20 -130.29 127.27 39.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.144 -0.347 . . . . 0.0 110.669 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 109' ' ' ILE . 7.1 m-30 -104.74 114.79 29.22 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 126.23 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.413 0.445 . . . . 0.0 110.771 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.56 31.79 71.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.811 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 64.06 19.34 11.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.99 0.516 . . . . 0.0 112.253 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.0 p -116.02 130.57 56.87 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 104' ' ' PHE . 6.1 mt -110.21 128.59 66.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.834 -170.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -116.88 120.19 37.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.94 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.7 121.78 45.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.695 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 4.4 m -120.36 120.58 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.647 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.522 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 65.9 mtt -119.68 149.72 41.53 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.149 0.499 . . . . 0.0 110.36 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 49.8 m -118.86 119.82 35.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.751 ' HA ' HD12 ' A' ' 98' ' ' ILE . 3.4 tm? -123.79 113.49 18.63 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.623 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.56 10.78 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.952 0.882 . . . . 0.0 109.357 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -97.74 141.33 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.696 -173.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 119' ' ' VAL . 7.6 p -110.86 114.95 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.621 0.724 . . . . 0.0 111.267 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HD2' ' O ' ' A' ' 13' ' ' GLU . 1.3 t80 -117.01 125.58 51.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.68 -170.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.843 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -124.97 129.83 51.13 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.998 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.485 ' HD3' HG22 ' A' ' 9' ' ' VAL . 30.3 ttm180 -116.96 137.8 51.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.52 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 10' ' ' GLN . 12.7 p -101.87 117.06 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.88 0.847 . . . . 0.0 109.771 173.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 16.2 m -121.36 127.9 51.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.079 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -121.3 137.54 54.65 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.299 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 24.5 ttt180 -68.1 147.77 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.992 HG12 ' HE2' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 C--O 1.247 0.948 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -170.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.577 0.227 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -99.15 116.88 32.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 0.0 110.42 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.678 ' HA ' HD22 ' A' ' 89' ' ' ASN . 2.0 p90 -172.96 45.18 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.486 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.654 ' HB3' ' C ' ' A' ' 41' ' ' ILE . 58.6 m 69.16 174.17 0.29 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.324 -174.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.59 -164.04 28.47 Favored Glycine 0 CA--C 1.499 -0.933 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.888 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.869 ' HE3' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -90.03 117.8 29.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 59.2 m-85 -132.06 127.67 36.61 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 10.1 tm0? -103.4 140.74 37.05 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.24 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 t -66.19 137.51 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.147 0.975 . . . . 0.0 111.566 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.676 ' HB3' HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -114.2 -59.94 1.95 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.942 -168.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.533 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 11.5 m -158.02 153.9 26.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.435 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 4.1 pm0 -145.98 155.42 42.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.615 0.722 . . . . 0.0 112.015 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.767 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 16.6 mm-40 -94.2 142.11 27.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.342 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 1.1 m-80 72.61 -82.42 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.472 0 O-C-N 123.559 0.537 . . . . 0.0 111.876 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.8 p90 39.93 28.03 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.266 1.826 . . . . 0.0 113.236 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.917 ' HA ' HD13 ' A' ' 29' ' ' ILE . 74.5 mt-10 -147.26 -49.9 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.634 -172.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.739 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 59.6 Cg_endo -74.7 -23.98 13.95 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 108.411 -1.419 . . . . 0.0 108.411 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 118' ' ' ILE . 3.5 t80 -60.8 -52.79 63.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.983 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.649 ' HB2' HD11 ' A' ' 29' ' ' ILE . 24.6 mmt -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.526 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 7.5 ptmm? -66.05 -33.06 74.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.126 0.488 . . . . 0.0 110.069 -174.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.79 86.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.457 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.8 ptm -85.86 -22.16 27.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.88 -39.02 0.69 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.677 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 19' ' ' MET . 14.9 tp -75.54 130.01 80.5 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 117.308 0.554 . . . . 0.0 110.478 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' HD12 ' A' ' 28' ' ' LEU . 88.3 Cg_endo -78.1 153.83 28.72 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.799 1.666 . . . . 0.0 111.346 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.087 ' HA ' HD12 ' A' ' 29' ' ' ILE . 9.6 tt0 -50.09 -44.34 51.88 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.383 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.622 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 7.7 t70 -59.12 -37.26 76.8 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.308 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.887 HD12 ' HD2' ' A' ' 25' ' ' PRO . 59.8 mt -72.32 -37.5 68.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.912 0.387 . . . . 0.0 110.076 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.087 HD12 ' HA ' ' A' ' 26' ' ' GLU . 38.9 mt -59.22 -44.2 91.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.904 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.836 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.3 mm-40 -54.03 -34.01 58.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.621 1.169 . . . . 0.0 111.775 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 2.1 mptp? -68.44 -33.03 73.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.961 0.41 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.55 35.66 2.37 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.835 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 25.3 pttm -79.1 -32.24 44.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.297 0.57 . . . . 0.0 112.321 -169.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -99.16 24.55 7.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.062 -167.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.0 mt -81.13 115.93 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.372 0.606 . . . . 0.0 112.39 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -109.8 126.69 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.329 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -115.31 -169.02 15.71 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.963 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 11.1 t -121.57 141.1 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.838 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.8 t -117.01 139.22 50.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 1.1 mm-40 -135.23 124.59 24.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.965 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 5.1 mt -127.96 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.1 -171.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -111.16 120.47 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.627 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 4' ' ' SER . 11.5 t-160 -92.41 114.52 27.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.805 0.812 . . . . 0.0 110.45 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 142.21 46.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -33.58 111.17 0.06 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.643 0.589 . . . . 0.0 113.998 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 2.3 mtmt 66.62 -45.47 0.44 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.476 1.51 . . . . 0.0 113.342 -173.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 47' ' ' LYS . 2.2 ptpp? -90.74 107.45 19.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.762 0.791 . . . . 0.0 111.282 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.64 HG21 ' SD ' ' A' ' 85' ' ' MET . 90.6 t -123.09 125.87 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.159 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -109.24 130.47 55.49 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.248 0.547 . . . . 0.0 109.678 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -116.42 133.33 56.14 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.88 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.838 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.1 m -114.34 124.88 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.9 mt -131.84 121.96 48.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.022 HG23 HG22 ' A' ' 58' ' ' VAL . 26.4 m -96.8 127.81 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -120.88 107.34 12.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.91 -98.07 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.565 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -103.95 -24.14 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.854 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.673 ' HE2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.41 128.73 55.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.189 -172.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 53' ' ' THR . 26.9 t -96.6 125.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.925 0.869 . . . . 0.0 109.522 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.673 HG13 ' HE2' ' A' ' 57' ' ' LYS . 1.3 mt -112.51 112.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.524 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.625 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -91.37 141.47 28.72 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.668 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.605 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.4 m120 -125.29 83.73 2.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.747 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 43.1 tt0 -102.24 126.75 49.32 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -147.62 153.08 38.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.955 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 13.5 m -114.05 128.68 56.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.794 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -58.59 143.32 46.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.155 0.502 . . . . 0.0 111.941 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 59.0 23.38 56.99 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.58 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 8.8 tt0 -145.32 133.13 21.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -80.48 119.42 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.285 0.564 . . . . 0.0 110.66 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.8 t -136.3 163.64 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.256 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -95.1 119.57 33.84 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.317 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 61.6 mt -100.72 122.39 43.27 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.728 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 59' ' ' ILE . 39.2 tt0 -89.24 128.1 35.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.654 ' O ' HD13 ' A' ' 59' ' ' ILE . 13.2 p -84.78 168.03 15.53 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.833 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.9 tpt -56.16 -28.22 57.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.437 0.637 . . . . 0.0 109.978 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 -27.73 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.995 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 123.12 -11.2 8.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.658 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.35 127.03 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.901 0.351 . . . . 0.0 110.466 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.84 127.65 48.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.65 147.07 27.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.362 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -82.01 123.77 29.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.479 0.657 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . . . -139.07 147.44 42.02 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.49 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -95.26 111.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.649 0.738 . . . . 0.0 109.368 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.756 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.7 m -100.73 133.37 44.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.49 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 3.9 mmtt -106.08 151.37 24.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HG21 ' A' ' 48' ' ' VAL . 21.1 ttt -132.89 131.42 40.9 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.317 1.056 . . . . 0.0 112.785 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.092 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 5.4 tp10 -84.95 139.32 31.9 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 112.766 -2.015 . . . . 0.0 108.57 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -60.83 -25.39 63.77 Favored Glycine 0 C--O 1.23 -0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.953 -168.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.724 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 32.5 t70 -83.68 23.09 1.01 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 110.208 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.678 HD22 ' HA ' ' A' ' 3' ' ' PHE . 8.9 m120 71.53 57.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.962 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.092 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -113.19 121.84 45.69 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 1.058 ' HG2' ' HB ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -116.78 115.8 26.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.118 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 101' ' ' VAL . 5.3 t -125.73 117.7 49.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.568 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -129.86 144.29 51.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.408 0.623 . . . . 0.0 111.765 -177.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 59.3 m -127.26 131.74 50.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.774 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.45 130.04 27.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.825 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 64.05 -75.84 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.78 0.675 . . . . 0.0 110.948 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.63 29.9 0.25 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' THR . 38.9 mm -116.55 131.92 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.58 -0.81 . . . . 0.0 108.851 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' MET . 11.6 ttmm -112.63 128.15 56.3 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.825 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.543 ' HB2' HG23 ' A' ' 93' ' ' THR . 13.3 m -122.18 119.91 32.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.915 HG22 HG13 ' A' ' 92' ' ' VAL . 99.2 t -123.4 117.35 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 110.595 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 1.058 ' HB ' ' HG2' ' A' ' 91' ' ' MET . 32.3 m -118.31 121.38 40.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.888 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 8.2 tm-20 -129.55 128.38 42.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.881 0.372 . . . . 0.0 110.633 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.605 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 5.3 m-30 -96.88 115.37 27.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.074 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.96 102.87 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.754 175.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 107' ' ' ASP . . . 54.24 75.03 0.25 Allowed Glycine 0 N--CA 1.455 -0.087 0 CA-C-O 119.758 -0.468 . . . . 0.0 113.701 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 6.6 t70 72.23 -26.44 0.18 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 125' ' ' LYS . 7.7 p -107.21 134.68 49.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.037 0.922 . . . . 0.0 112.315 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.556 HD13 ' CE1' ' A' ' 104' ' ' PHE . 4.4 mt -109.38 127.11 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.079 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -104.54 118.35 36.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.9 t-20 -109.58 121.25 44.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.32 114.9 21.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.721 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 22.1 ttt -127.26 150.36 49.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' ILE . 93.9 m -126.98 120.29 28.73 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.156 -0.34 . . . . 0.0 110.098 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.662 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -108.62 113.55 26.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.74 -91.84 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.31 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.17 1.64 7.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.934 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.662 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -91.32 141.53 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.815 -172.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.8 116.32 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.896 0.855 . . . . 0.0 110.585 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.644 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 60.8 t80 -103.52 117.98 35.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.88 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.767 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -124.22 124.63 42.86 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.504 HH22 HD11 ' A' ' 52' ' ' ILE . 33.9 ttt180 -127.24 132.67 50.34 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.973 -169.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.676 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.2 p -101.52 118.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.182 171.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 m -127.64 134.19 49.64 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.3 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -136.19 150.55 49.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.336 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 ttt180 -69.06 149.35 48.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.849 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.869 HG13 ' HE3' ' A' ' 6' ' ' LYS . 3.0 pt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.104 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 21.4 ptm . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.326 0.107 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 1.4 m-80 -112.63 134.89 53.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.616 ' H ' ' CG ' ' A' ' 89' ' ' ASN . 30.6 m-85 79.06 -66.18 0.19 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.067 0.854 . . . . 0.0 110.684 167.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 30.0 p -134.68 -176.23 4.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.609 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.75 179.73 16.0 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.343 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.689 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -106.99 122.48 46.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.9 m-85 -127.85 126.01 40.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.697 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.83 134.25 36.38 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -172.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.944 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -70.04 134.38 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.779 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.5 mm100 -115.71 -40.87 3.29 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.105 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.637 ' HB2' HG12 ' A' ' 123' ' ' VAL . 58.2 m -156.24 151.47 26.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.819 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 18.0 mp0 -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.905 0.859 . . . . 0.0 111.109 174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -103.28 130.09 50.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.902 176.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.592 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 0.8 OUTLIER 67.96 21.27 8.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 168.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.527 ' O ' ' HG2' ' A' ' 19' ' ' MET . 47.5 p90 -67.35 17.07 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.96 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.4 mt-10 -132.6 -44.58 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 123.175 0.59 . . . . 0.0 111.18 -173.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.96 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.1 Cg_endo -70.07 -28.77 23.35 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 C-N-CA 121.734 1.623 . . . . 0.0 109.637 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' HB2' HD13 ' A' ' 118' ' ' ILE . 5.8 t80 -65.57 -52.53 51.61 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.111 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.704 ' HB2' HD11 ' A' ' 29' ' ' ILE . 83.8 mmm -61.22 -37.86 84.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.685 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.883 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 8.4 pttt -69.73 -36.27 75.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.206 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -71.34 -25.99 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.59 172.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.564 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 29.6 tpp -82.61 -43.76 16.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.027 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.44 -42.75 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.659 HD23 HG12 ' A' ' 29' ' ' ILE . 12.8 tp -78.86 128.57 76.32 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.69 ' CD ' HD12 ' A' ' 28' ' ' LEU . 95.0 Cg_endo -73.32 149.95 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.228 1.952 . . . . 0.0 111.498 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.052 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.6 tt0 -50.09 -44.43 51.99 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 36.6 t70 -56.97 -42.96 81.11 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.803 0.729 . . . . 0.0 110.19 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.69 HD12 ' CD ' ' A' ' 25' ' ' PRO . 45.1 mt -68.47 -33.5 74.27 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.466 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.052 HD12 ' HA ' ' A' ' 26' ' ' GLU . 28.0 mt -62.87 -47.1 94.44 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.699 170.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.007 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 21.6 mm-40 -53.09 -38.46 62.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.229 1.012 . . . . 0.0 112.474 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.007 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.64 -30.2 68.85 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.739 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.77 28.98 5.07 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.86 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -78.25 -39.56 39.81 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -166.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -96.29 54.41 1.41 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.645 0.736 . . . . 0.0 110.812 -166.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -99.53 133.16 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.61 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 147.0 33.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.765 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.944 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -144.85 -172.57 15.43 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.981 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 8' ' ' GLN . 60.8 t -123.71 143.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.241 0.521 . . . . 0.0 110.732 -173.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 51' ' ' THR . 14.9 m -122.96 120.99 35.03 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.809 0.338 . . . . 0.0 110.122 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HG2' ' CG ' ' A' ' 6' ' ' LYS . 25.5 mt-10 -116.32 124.52 50.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.166 0.508 . . . . 0.0 109.633 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.651 HG12 ' HG ' ' A' ' 50' ' ' LEU . 96.7 mt -123.66 134.58 66.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.915 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.88 114.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.741 ' H ' ' HB3' ' A' ' 4' ' ' SER . 3.3 t-160 -115.07 113.51 24.14 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.042 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 37.3 tt0 -111.07 143.1 42.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -35.17 108.4 0.05 OUTLIER Glycine 0 C--O 1.225 -0.425 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.59 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.752 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 16.2 mtmt 83.78 -40.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.603 1.561 . . . . 0.0 113.079 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' H ' ' HD2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.65 112.15 23.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.104 0.478 . . . . 0.0 110.606 -172.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG11 ' SD ' ' A' ' 91' ' ' MET . 4.9 t -114.32 123.0 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.69 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 18.2 mtpp -113.47 130.87 56.23 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.668 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -127.61 130.59 49.25 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -118.04 122.69 43.8 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.8 mt -124.79 120.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.807 HG23 HG22 ' A' ' 58' ' ' VAL . 24.5 m -102.69 127.28 49.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -121.38 107.63 12.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.39 -95.44 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.627 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -107.86 -18.26 13.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 0.0 111.211 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HE3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -113.09 128.54 56.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.17 0.51 . . . . 0.0 111.254 -170.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 53' ' ' THR . 31.8 t -97.43 125.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 122.052 0.93 . . . . 0.0 109.592 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -114.52 114.16 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.909 -177.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 144.66 27.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.005 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m120 -129.02 138.85 52.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -145.08 124.73 13.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -151.39 152.29 32.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.03 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.653 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 4.7 m -108.0 132.0 53.98 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.752 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 pp -45.55 146.25 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 112.156 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.1 13.0 69.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.439 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.0 mm-40 -124.66 143.48 50.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.703 0.287 . . . . 0.0 110.293 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 80' ' ' LYS . 22.9 tt0 -84.54 116.91 23.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 63.3 m -134.03 158.83 42.55 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.285 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mt-10 -94.83 120.14 34.55 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 122.793 1.282 . . . . 0.0 111.681 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 28.9 mt -100.76 128.52 46.77 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.222 -2.263 . . . . 0.0 110.706 -170.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 59' ' ' ILE . 16.1 tt0 -85.79 122.01 29.25 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 59' ' ' ILE . 12.6 p -85.85 164.53 17.46 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.255 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.57 -22.7 62.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.25 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.8 -41.27 53.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.761 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 140.27 -21.49 2.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.316 176.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.66 139.44 39.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.618 0.709 . . . . 0.0 111.438 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.01 123.37 41.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.126 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 144.91 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.602 ' O ' ' HD2' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 135.79 34.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.371 0.605 . . . . 0.0 111.966 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -147.5 152.46 38.08 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.051 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.1 t -95.78 112.43 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.844 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.785 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -100.11 133.96 41.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.095 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.1 mmtt -103.28 151.44 22.68 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.496 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . 4.7 ttp -128.91 132.91 47.71 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.682 -1.207 . . . . 0.0 113.041 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.043 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.5 tp10 -100.45 141.13 33.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 112.367 -2.197 . . . . 0.0 108.303 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.87 -36.66 60.48 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.954 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' C ' HD22 ' A' ' 89' ' ' ASN . 19.4 t0 -87.92 53.64 2.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.805 0.812 . . . . 0.0 110.077 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HB2' ' CD2' ' A' ' 104' ' ' PHE 0.251 0.0 OUTLIER 49.41 49.88 19.07 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.821 174.519 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.043 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 61.7 mttt -112.39 122.17 46.94 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.318 170.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.638 ' SD ' HG11 ' A' ' 48' ' ' VAL . 5.7 mtm -129.17 117.05 20.15 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -122.16 118.64 56.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.345 -173.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -126.61 140.44 52.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.572 0.701 . . . . 0.0 111.451 -177.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -128.07 138.8 52.7 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.752 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.4 124.16 21.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 60.87 -101.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.024 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.32 15.46 6.41 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.75 114.27 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 113' ' ' MET . 59.6 tttt -104.69 118.88 37.65 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.513 -171.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 m -115.67 118.95 34.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.511 HG22 HG13 ' A' ' 92' ' ' VAL . 98.1 t -113.41 120.41 63.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -117.34 119.84 36.35 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.268 174.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 90' ' ' LYS . 28.7 tt0 -129.67 119.92 24.32 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -113.97 119.2 36.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.697 176.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.03 138.09 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.463 170.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.71 96.63 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.648 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.588 ' HA ' ' HE2' ' A' ' 7' ' ' TYR . 25.8 m-20 70.07 4.98 5.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.72 0.408 . . . . 0.0 112.089 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -110.85 123.35 49.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 111.34 173.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mt -102.15 124.75 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.045 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' THR . 19.5 m -115.07 120.9 41.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.718 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.75 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 3.2 t-20 -116.06 121.27 41.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.892 0.377 . . . . 0.0 110.392 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.792 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -120.98 117.81 28.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.96 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 65.9 mtt -111.95 150.91 29.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.339 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 m -127.62 121.84 31.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -121.86 113.84 20.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.45 -93.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.883 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.62 17.06 3.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 110.112 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -85.53 137.44 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.19 114.62 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.675 0.75 . . . . 0.0 111.084 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 41.9 t80 -102.78 119.08 38.21 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.792 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.8 OUTLIER -128.92 131.03 47.51 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.75 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 7.4 ptt180 -124.33 144.37 50.05 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.631 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.779 HG13 ' HB2' ' A' ' 10' ' ' GLN . 11.7 p -100.83 117.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.11 0.957 . . . . 0.0 109.488 173.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m -123.66 121.52 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.568 -1.197 . . . . 0.0 108.646 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.11 149.33 52.13 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.58 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 15.9 ttp180 -70.17 146.62 50.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.673 -166.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.689 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.745 ' HB3' ' HA ' ' A' ' 89' ' ' ASN . 8.2 p30 -90.18 95.94 10.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.608 0.718 . . . . 0.0 109.446 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -149.1 58.47 1.03 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.677 -0.639 . . . . 0.0 111.98 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 56.1 p 53.39 -158.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 167.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.01 -172.43 21.59 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 2.8 mtpp -95.99 130.12 43.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.504 0.669 . . . . 0.0 109.811 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 17.5 m-85 -135.07 133.6 39.47 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 7.3 tm0? -106.21 135.82 47.01 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.84 141.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.592 0.711 . . . . 0.0 109.782 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.469 HE21 ' HD2' ' A' ' 125' ' ' LYS . 13.6 mm-40 -113.69 -49.58 2.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.88 -171.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 14.7 m -159.69 159.63 33.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.871 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . 2.3 mt-30 -142.09 153.58 44.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.537 0.684 . . . . 0.0 111.93 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 1.2 mp0 -94.37 137.39 33.58 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.703 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.668 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 1.1 m-80 70.23 -83.35 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 O-C-N 123.892 0.745 . . . . 0.0 110.594 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.965 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.3 p90 37.66 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.75 1.62 . . . . 0.0 112.702 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.976 ' HA ' HD13 ' A' ' 29' ' ' ILE . 46.7 mt-10 -145.01 -47.97 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.434 -172.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 44.1 Cg_endo -76.31 -25.25 10.06 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.963 -1.207 . . . . 0.0 108.963 170.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.766 ' HD2' HD11 ' A' ' 118' ' ' ILE . 38.2 t80 -66.47 -52.59 44.58 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.063 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.702 ' HB2' HD11 ' A' ' 29' ' ' ILE . 17.5 mmt -64.04 -37.51 87.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.156 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.9 pttp -67.12 -39.12 86.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.14 61.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.516 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.557 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 30.0 tpp -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.879 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.53 -38.16 0.3 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.315 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD23 HG12 ' A' ' 29' ' ' ILE . 15.0 tp -77.55 131.03 72.23 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.708 ' HD2' HD12 ' A' ' 28' ' ' LEU . 90.9 Cg_endo -79.1 151.74 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.502 1.468 . . . . 0.0 111.19 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.034 ' HA ' HD12 ' A' ' 29' ' ' ILE . 18.1 tt0 -50.59 -40.16 51.71 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.937 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 4.5 p-10 -60.84 -36.36 78.92 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 118.339 0.518 . . . . 0.0 111.511 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 25' ' ' PRO . 21.7 mt -71.92 -36.88 70.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.301 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' A' ' 26' ' ' GLU . 30.8 mt -62.12 -43.74 98.16 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.369 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.0 mm100 -50.23 -49.3 53.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.125 0.965 . . . . 0.0 111.846 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 2.2 mptp? -71.07 -30.32 66.43 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.829 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.99 32.74 3.9 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.931 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.965 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 13.9 ptmm? -78.81 -41.4 30.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.39 0.614 . . . . 0.0 112.589 -168.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.35 52.92 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.66 0.743 . . . . 0.0 110.785 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.3 mm -92.91 131.18 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.643 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' HE22 ' A' ' 8' ' ' GLN . 10.4 mtmp? -98.82 98.25 9.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.166 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -91.4 177.43 40.86 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.588 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.1 t -122.37 150.38 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.738 ' HA ' ' O ' ' A' ' 51' ' ' THR . 9.4 m -132.49 130.01 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 111.538 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 5.0 mp0 -122.87 140.02 53.4 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.85 ' O ' ' HB2' ' A' ' 4' ' ' SER . 61.2 mt -129.96 141.96 45.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.281 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.675 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 99.5 t -108.61 117.98 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 166.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' N ' ' HB3' ' A' ' 4' ' ' SER . 17.2 t-160 -95.16 115.21 27.13 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.442 0.639 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -137.61 143.11 41.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.535 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.73 107.95 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 O-C-N 123.835 0.709 . . . . 0.0 112.861 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mtmt 71.64 -38.65 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.843 1.257 . . . . 0.0 113.077 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.33 106.62 18.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.707 0.289 . . . . 0.0 110.878 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.26 122.9 66.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.23 0.538 . . . . 0.0 110.666 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 6.8 mptt -104.85 132.68 50.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.131 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -120.14 132.49 55.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 39' ' ' SER . 17.2 m -117.92 124.04 47.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -128.43 121.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 58' ' ' VAL . 62.1 m -104.01 129.41 51.61 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -118.07 107.26 13.78 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.99 -96.62 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.661 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 t -104.48 -24.1 13.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 0.0 110.645 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.74 128.48 49.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.84 0.829 . . . . 0.0 112.422 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 53' ' ' THR . 82.4 t -104.55 124.9 59.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.33 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.32 114.31 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.987 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -101.93 134.72 44.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.307 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -126.14 93.4 3.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -102.39 125.82 49.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.593 0.711 . . . . 0.0 109.915 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -149.57 152.89 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.27 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.6 m -109.15 132.4 54.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.345 174.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -52.09 140.11 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.798 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 65.31 24.11 70.44 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.522 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 33.1 mt-10 -138.05 141.26 40.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -76.74 119.07 20.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.631 0.729 . . . . 0.0 109.734 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 m -132.9 152.6 51.85 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.899 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.6 pt-20 -95.57 145.37 25.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.282 1.039 . . . . 0.0 109.192 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.2 mt -110.51 133.73 53.02 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -168.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 59' ' ' ILE . 8.1 tt0 -90.72 130.61 36.7 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.422 HG21 ' SD ' ' A' ' 22' ' ' MET . 18.7 p -89.45 174.4 7.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.772 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.0 tpp -61.46 -25.93 67.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.6 . . . . 0.0 109.634 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.9 m -80.68 -39.06 27.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.093 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.67 1.13 7.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.523 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.68 138.89 37.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.846 0.323 . . . . 0.0 111.017 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 10.0 mmmm -97.72 131.75 43.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -136.58 133.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 34.0 mttm -83.05 123.46 29.5 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.507 0.67 . . . . 0.0 111.701 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.94 153.75 45.78 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.474 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -95.53 111.52 26.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.385 0.612 . . . . 0.0 109.944 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.794 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -102.4 133.89 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.311 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 88.9 mttt -117.45 152.77 34.33 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.594 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.66 ' H ' ' HB2' ' A' ' 65' ' ' LEU . 5.1 ttm -118.45 119.83 35.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.29 1.043 . . . . 0.0 110.486 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.684 ' HG2' ' HD2' ' A' ' 90' ' ' LYS . 11.4 tp10 -63.37 -31.88 73.15 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.734 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 92.11 -32.23 5.54 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.647 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 37.2 t70 -94.69 62.2 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.582 0.705 . . . . 0.0 109.768 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 2' ' ' ASN . 26.7 m-80 70.56 0.94 3.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.253 -1.34 . . . . 0.0 113.549 174.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.687 ' HE3' ' OE1' ' A' ' 103' ' ' GLU . 33.0 mttp -109.4 122.91 48.4 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.788 -172.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.489 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 2.8 mpp? -117.7 115.46 25.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.808 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -130.38 124.2 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.689 -172.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.794 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -121.49 140.18 52.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.32 0.581 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.2 m -128.17 126.37 40.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.988 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -134.82 113.95 12.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.053 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 60.3 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.891 0.476 . . . . 0.0 111.354 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.85 10.42 3.38 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 98' ' ' ILE . 2.0 mm -90.17 113.56 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' MET . 23.3 tttm -115.78 118.37 32.82 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.201 -172.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.9 m -117.81 119.16 34.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.062 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 92' ' ' VAL . 85.0 t -118.84 119.01 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.326 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 24.9 m -117.92 122.09 42.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.908 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.687 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 35.9 tt0 -128.74 129.15 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.724 0.297 . . . . 0.0 110.738 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 22.0 m-30 -95.07 120.51 35.4 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.003 177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 113.07 16.93 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.932 -0.48 . . . . 0.0 110.68 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.05 -102.3 0.83 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.779 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.97 17.23 6.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.138 0.494 . . . . 0.0 109.9 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 125' ' ' LYS . 25.6 p -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.638 0.732 . . . . 0.0 111.723 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 104' ' ' PHE . 22.1 mt -111.4 128.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.789 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.7 m -104.67 119.34 38.77 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -118.31 122.72 43.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.226 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.2 117.5 26.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.444 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.583 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 5.1 ttm -118.63 146.07 44.94 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 m -128.75 121.79 29.19 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.543 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -102.73 114.2 28.25 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 169.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -48.21 81.06 0.01 OUTLIER Glycine 0 N--CA 1.468 0.814 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -160.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 27.2 t70 157.18 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.627 1.571 . . . . 0.0 106.966 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.766 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -115.98 140.72 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.209 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.29 115.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.458 0.647 . . . . 0.0 111.155 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 3.6 t80 -100.06 118.74 37.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.701 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.7 OUTLIER -123.86 131.83 53.65 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -124.39 131.69 53.51 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.061 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 8.4 p -100.91 117.55 46.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.943 0.878 . . . . 0.0 109.431 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -131.67 136.9 48.05 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.928 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.469 ' HD2' HE21 ' A' ' 10' ' ' GLN . 0.0 OUTLIER -135.08 150.88 50.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 0.0 111.399 -175.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.503 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 76.9 ttt180 -68.73 148.31 50.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.24 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.644 ' CG1' ' HB2' ' A' ' 6' ' ' LYS . 1.1 pp . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.034 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 mtt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 20.5 p-10 -73.35 123.08 23.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.042 0.449 . . . . 0.0 111.31 -175.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.655 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 10.4 t80 163.62 64.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 80.6 p 57.34 -162.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.754 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.93 -174.72 15.53 Favored Glycine 0 CA--C 1.507 -0.437 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.671 ' HE3' HG12 ' A' ' 127' ' ' ILE . 3.6 mtpp -93.39 118.49 31.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 9.9 m-85 -125.02 124.67 42.47 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -93.0 134.39 35.18 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -68.08 137.38 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.925 0.869 . . . . 0.0 111.782 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.574 ' HB3' HG13 ' A' ' 123' ' ' VAL . 4.9 mm-40 -112.9 -69.12 0.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.699 -168.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.513 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 20.3 m -151.26 143.28 23.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.274 -170.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.811 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 5.5 mm-40 -121.3 157.61 29.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.499 0.666 . . . . 0.0 111.449 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 66.8 mt-10 -105.9 137.39 43.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.797 168.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 0.9 OUTLIER 69.76 -80.52 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.87 0 O-C-N 123.524 0.515 . . . . 0.0 111.062 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 12' ' ' GLN . 34.0 p90 35.41 35.41 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.691 1.596 . . . . 0.0 113.374 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.854 ' HA ' HD13 ' A' ' 29' ' ' ILE . 73.6 mt-10 -152.9 -48.03 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.04 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 37.4 Cg_endo -75.73 -25.17 11.02 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 N-CA-C 108.657 -1.324 . . . . 0.0 108.657 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 118' ' ' ILE . 52.6 t80 -65.94 -53.29 41.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.122 173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.7 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 16.9 mmt -61.93 -37.15 83.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.478 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 17' ' ' PRO . 10.7 pttt -66.43 -41.71 88.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.075 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -72.07 -20.98 61.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.421 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.592 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 25.5 tpp -83.1 -46.21 13.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.871 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.49 -23.92 0.36 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.121 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.781 HD23 HG12 ' A' ' 29' ' ' ILE . 14.4 tp -91.95 132.91 31.51 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.65 ' CD ' HD12 ' A' ' 28' ' ' LEU . 85.0 Cg_endo -76.14 147.94 30.43 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.29 1.993 . . . . 0.0 111.7 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.098 ' HA ' HD12 ' A' ' 29' ' ' ILE . 4.2 tt0 -49.47 -44.64 46.02 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.56 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 5.1 t70 -61.35 -35.19 76.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.873 0.76 . . . . 0.0 111.445 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.65 HD12 ' CD ' ' A' ' 25' ' ' PRO . 41.1 mt -71.42 -35.71 71.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.874 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.098 HD12 ' HA ' ' A' ' 26' ' ' GLU . 23.5 mt -63.73 -46.87 93.37 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.114 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.82 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 13.0 mm100 -53.13 -38.62 62.84 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 111.376 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 3.8 mptp? -69.71 -46.54 65.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.313 0.578 . . . . 0.0 110.887 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.87 39.87 2.36 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.183 -170.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD2' ' OE2' ' A' ' 16' ' ' GLU . 18.2 pttp -79.77 -43.12 23.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.2 51.27 0.75 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.535 . . . . 0.0 112.0 -171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 9.3 mm -79.28 118.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.538 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -100.21 118.96 37.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.046 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -116.89 -160.75 12.01 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.462 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 39.6 t -125.53 137.45 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.728 0.264 . . . . 0.0 110.748 -174.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.5 t -110.22 134.6 52.07 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 30.6 mt-10 -136.89 121.17 18.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.6 mt -124.22 141.35 44.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 122.319 -0.238 . . . . 0.0 111.583 -169.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 44' ' ' GLU . 86.1 t -110.56 114.83 48.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 165.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -95.15 112.13 23.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.795 0.807 . . . . 0.0 109.576 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HG3' HG12 ' A' ' 42' ' ' VAL . 37.9 mt-10 -120.82 144.24 48.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.445 174.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -35.85 105.72 0.03 OUTLIER Glycine 0 CA--C 1.52 0.388 0 O-C-N 123.793 0.683 . . . . 0.0 113.183 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.037 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 mtmt 72.85 -40.94 0.49 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.604 1.562 . . . . 0.0 113.631 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' H ' ' HG2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -92.87 107.33 19.13 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.652 0.739 . . . . 0.0 111.544 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.94 124.76 73.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.228 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 44.1 mttp -110.83 123.04 49.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.28 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.6 tt -112.82 128.22 56.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.636 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 39' ' ' SER . 5.6 m -111.33 124.74 52.86 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -131.12 120.86 47.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.729 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 43.4 m -98.75 127.09 44.57 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CE1' ' HB ' ' A' ' 35' ' ' ILE . 48.5 t80 -121.5 108.11 13.24 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.0 -93.77 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.114 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -105.38 -23.46 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.063 0.459 . . . . 0.0 111.15 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.84 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.415 -170.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 71.3 t -98.08 125.33 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.769 0.795 . . . . 0.0 110.438 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.699 HG23 HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -99.85 115.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.245 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -102.49 126.65 49.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.36 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 63' ' ' PHE . 11.1 m-20 -127.8 97.38 4.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.522 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.13 125.7 50.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 61' ' ' ASN . 9.9 m-85 -129.06 152.8 48.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.177 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.5 m -112.59 122.7 48.46 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.037 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -46.51 125.67 7.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.181 0.515 . . . . 0.0 111.972 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 84' ' ' LYS . . . 82.49 16.39 71.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.589 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.5 mm-40 -125.9 154.3 42.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 21.5 tt0 -79.87 119.31 22.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.6 m -132.79 156.58 46.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.496 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' HE2' ' A' ' 78' ' ' LYS . 3.3 pt-20 -96.18 143.93 26.85 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 12.5 mt -106.21 127.26 53.1 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.298 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' CD ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 tt0 -88.03 129.0 35.4 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 p -88.52 174.9 7.82 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.763 -172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.2 ttt -70.14 -13.18 62.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.287 0.565 . . . . 0.0 109.761 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -90.9 -38.64 12.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.188 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.49 -13.86 4.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.493 -0.86 . . . . 0.0 114.157 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -80.4 147.04 31.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.584 0.692 . . . . 0.0 111.505 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 8.0 mmmm -96.24 136.47 36.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.551 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -138.0 143.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.875 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.542 ' HD2' ' OE1' ' A' ' 68' ' ' GLU . 37.1 mtmt -84.9 126.6 33.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 111.758 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.52 146.85 30.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.05 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.7 113.06 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.003 0.43 . . . . 0.0 109.937 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.752 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.31 133.24 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.572 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.3 mmtt -104.97 151.87 23.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.08 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.865 ' HB3' HD22 ' A' ' 65' ' ' LEU . 11.7 tpp -128.68 134.79 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.371 1.081 . . . . 0.0 111.622 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 90' ' ' LYS . 13.5 tp10 -82.12 -35.55 28.41 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.326 -176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 121.74 -36.5 3.22 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.178 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -78.82 26.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.858 1.313 . . . . 0.0 108.912 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.89 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 29.8 m-80 72.06 40.58 0.71 Allowed 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.582 168.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.925 ' HE2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -117.73 118.94 33.45 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 113.496 -1.684 . . . . 0.0 107.913 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 84' ' ' LYS . 42.4 mtm -116.65 123.03 46.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.848 0.832 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.85 118.7 54.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.663 -175.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.58 143.75 47.47 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.445 0.64 . . . . 0.0 111.356 -177.133 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 m -116.9 126.61 53.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.962 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.789 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 35.2 t80 -139.44 161.24 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.28 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 98' ' ' ILE . 22.8 ttmm -27.61 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.691 1.196 . . . . 0.0 114.008 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.34 8.49 19.02 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.58 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 26.3 mm -110.07 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -114.88 116.65 28.9 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.747 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.4 m -118.08 119.79 35.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 92' ' ' VAL . 84.6 t -115.71 117.52 55.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 12.1 m -118.89 120.95 38.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.925 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 24.2 tt0 -129.37 123.14 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.947 -0.471 . . . . 0.0 110.128 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.89 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 2.3 m-30 -89.71 114.0 25.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 172.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -125.45 112.13 15.91 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.72 -95.73 0.48 Allowed Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.215 -173.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -145.71 17.08 1.45 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 125' ' ' LYS . 5.2 m -128.07 135.3 49.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.884 0.85 . . . . 0.0 110.402 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 7' ' ' TYR . 10.6 mt -102.62 131.45 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.593 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.6 m -115.36 119.22 35.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.133 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 19.4 t-20 -108.0 122.81 47.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.759 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.748 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -119.85 115.81 24.6 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mtt -114.1 150.12 34.55 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 110.262 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 32.1 m -126.61 122.5 35.21 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.554 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -116.73 111.16 19.39 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.14 -90.81 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.68 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -125.34 0.19 7.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.514 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -87.11 140.32 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 -177.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.76 116.36 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.471 0.653 . . . . 0.0 111.51 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.401 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -109.55 118.82 37.61 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 112' ' ' THR . 20.8 ttpt -125.9 129.3 49.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.178 0.513 . . . . 0.0 109.65 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 34.8 ttm180 -120.22 127.17 52.19 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.261 -172.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 10' ' ' GLN . 14.7 p -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.1 m -135.34 130.09 34.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.913 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -128.98 144.78 51.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.336 0.971 . . . . 0.0 112.552 -171.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.7 ttt180 -69.26 149.94 47.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.849 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.671 HG12 ' HE3' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.822 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.013 0.435 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -109.33 112.6 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.641 ' HE2' HG11 ' A' ' 48' ' ' VAL . 10.7 t80 79.66 -28.97 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.974 0.91 . . . . 0.0 110.357 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.56 ' HB3' ' N ' ' A' ' 43' ' ' HIS . 94.3 p -82.63 149.93 27.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.301 0.572 . . . . 0.0 112.014 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.39 -178.48 17.06 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.14 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -94.27 117.27 29.87 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 7.3 m-85 -122.39 132.41 54.36 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.814 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.88 130.74 53.78 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.502 -174.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.834 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.47 139.05 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.854 176.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.862 ' HB2' HG13 ' A' ' 123' ' ' VAL . 4.3 mm100 -111.05 -49.24 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.584 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.55 ' HB2' HG12 ' A' ' 123' ' ' VAL . 61.1 m -155.52 154.89 32.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.814 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -136.93 157.32 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.5 0.667 . . . . 0.0 111.375 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.725 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 4.3 mm-40 -114.03 130.59 56.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.994 176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.774 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.9 m-80 63.4 31.16 15.26 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.643 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 23.3 p90 -68.92 16.11 0.05 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.04 0.448 . . . . 0.0 110.87 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.883 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 40.7 mt-10 -129.12 -48.42 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.814 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.2 Cg_endo -69.91 -28.5 24.45 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.719 1.613 . . . . 0.0 110.297 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.57 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -63.16 -52.55 61.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.369 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.597 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 85.9 mmm -61.78 -37.59 84.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.741 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 18.6 pttt -67.05 -37.31 83.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.229 0.538 . . . . 0.0 109.731 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -67.4 -25.36 65.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 18' ' ' PHE . 58.0 mtp -79.34 -53.4 6.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.26 -16.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.305 -0.862 . . . . 0.0 113.501 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 29' ' ' ILE . 13.2 tp -81.68 130.7 60.23 Favored Pre-proline 0 N--CA 1.441 -0.891 0 CA-C-N 117.358 0.579 . . . . 0.0 109.924 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.648 ' CD ' HD12 ' A' ' 28' ' ' LEU . 91.6 Cg_endo -76.29 146.68 28.47 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.647 2.232 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.08 ' HA ' HD12 ' A' ' 29' ' ' ILE . 32.4 tt0 -50.72 -37.46 41.74 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.131 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.619 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.4 t70 -57.74 -47.19 83.17 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.165 0.893 . . . . 0.0 109.977 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.648 HD12 ' CD ' ' A' ' 25' ' ' PRO . 43.8 mt -68.75 -32.97 73.12 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.08 HD12 ' HA ' ' A' ' 26' ' ' GLU . 36.0 mt -61.6 -44.82 99.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.053 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 18.5 mm-40 -52.24 -41.89 63.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.535 0.734 . . . . 0.0 111.789 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.053 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.81 -30.54 69.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.134 -176.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.36 32.14 3.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.964 -174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 20.5 pttm -79.63 -43.13 23.42 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -165.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.48 47.01 1.19 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.344 0.592 . . . . 0.0 111.922 -167.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.6 118.36 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.15 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -84.85 145.86 27.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.082 0.468 . . . . 0.0 110.587 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.834 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -145.45 177.81 23.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 8' ' ' GLN . 3.7 t -122.43 145.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.799 ' HA ' ' O ' ' A' ' 51' ' ' THR . 7.5 p -129.72 120.12 24.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.7 mp0 -110.12 124.07 50.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.876 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.813 HG12 ' HG ' ' A' ' 50' ' ' LEU . 76.3 mt -123.37 140.41 47.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -168.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.09 114.38 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.56 ' N ' ' HB3' ' A' ' 4' ' ' SER . 28.5 t-80 -105.06 114.11 28.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.323 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -123.29 143.81 49.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 169.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.35 107.85 0.05 OUTLIER Glycine 0 CA--C 1.522 0.491 0 O-C-N 123.517 0.511 . . . . 0.0 112.624 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.879 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.9 mtmm 76.86 -35.58 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.992 1.317 . . . . 0.0 113.069 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 19.7 mttt -90.53 109.57 20.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.15 0.5 . . . . 0.0 111.182 -172.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 ' HE2' ' A' ' 3' ' ' PHE . 69.1 t -123.0 128.8 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.343 0.592 . . . . 0.0 111.77 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 41.2 mtpt -109.42 126.83 53.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.813 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -118.87 122.59 42.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.799 ' O ' ' HA ' ' A' ' 39' ' ' SER . 3.2 m -108.5 125.15 51.48 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.673 HG13 HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -130.75 122.63 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.545 0.688 . . . . 0.0 110.097 -170.025 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.4 m -103.85 129.78 51.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.196 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -116.55 105.89 12.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.1 -17.44 0.11 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t 172.41 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.07 0.938 . . . . 0.0 109.608 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -97.95 133.04 42.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.041 -169.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.6 t -99.63 124.69 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.579 0.704 . . . . 0.0 110.745 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -126.7 114.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.317 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 51' ' ' THR . 0.3 OUTLIER -116.53 149.27 39.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -173.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.531 HD21 ' HB3' ' A' ' 71' ' ' LEU . 1.6 m-20 -124.41 121.38 34.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.058 -171.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -103.69 126.26 50.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.175 0.512 . . . . 0.0 110.237 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -151.26 152.29 33.03 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.304 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 2.0 m -105.83 131.81 52.71 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.884 HD22 ' HB2' ' A' ' 85' ' ' MET . 2.5 pp -72.72 168.54 18.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.762 0.791 . . . . 0.0 111.427 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 11.24 41.04 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.397 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 64' ' ' THR . 47.0 mt-10 -135.4 143.58 46.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -174.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.654 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.0 tt0 -83.26 117.11 22.74 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 67.6 m -132.97 157.39 45.28 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.878 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -94.98 119.57 33.72 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 122.876 1.322 . . . . 0.0 111.217 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.531 ' HB3' HD21 ' A' ' 61' ' ' ASN . 23.0 mt -102.69 145.89 29.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.704 -171.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE1' HG12 ' A' ' 59' ' ' ILE . 21.0 tt0 -109.25 123.86 49.95 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 p -91.43 167.93 11.91 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.253 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -59.73 -29.0 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 110.62 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 p -81.18 -30.66 34.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.297 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.98 -5.99 9.55 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.45 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.28 140.74 38.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.346 0.573 . . . . 0.0 110.736 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 23.7 mmmt -95.67 128.16 42.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.17 137.5 48.34 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.654 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 69' ' ' CYS . 41.8 pttt -101.96 125.31 48.61 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.564 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . -128.93 146.03 51.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.46 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 91.8 t -92.79 111.89 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.852 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.05 131.07 53.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.342 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -104.09 152.48 22.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.776 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.884 ' HB2' HD22 ' A' ' 65' ' ' LEU . 6.7 ttt -127.73 135.32 50.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.18 0.991 . . . . 0.0 111.488 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.039 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 9.2 tp10 -90.98 0.03 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.03 -1.895 . . . . 0.0 109.923 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.743 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 88.56 -65.73 3.29 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.858 173.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.487 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 19.1 m-20 -79.12 57.15 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 0.0 110.947 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.634 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 8.9 m-80 70.59 40.24 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.404 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.039 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -119.65 122.74 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.777 169.161 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -119.27 115.3 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 171.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 101' ' ' VAL . 2.1 t -125.26 118.86 53.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -130.04 143.8 50.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.786 0.803 . . . . 0.0 112.283 -178.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 t -126.96 136.99 53.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.806 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -139.86 131.7 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt 55.67 28.56 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.64 2.89 88.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.215 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 98' ' ' ILE . 3.5 mm -90.09 137.63 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 113' ' ' MET . 37.4 tttt -112.1 120.73 42.81 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.652 -172.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -121.52 120.78 35.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.999 0.428 . . . . 0.0 110.142 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 92' ' ' VAL . 95.4 t -116.4 121.07 66.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.798 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -117.19 121.28 40.78 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 177.78 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -121.36 115.91 23.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.734 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -118.0 119.49 34.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.48 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.15 114.75 17.41 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.514 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.59 46.6 4.85 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.43 11.4 5.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.098 0.475 . . . . 0.0 111.452 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 p -120.92 129.11 53.34 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.978 -0.451 . . . . 0.0 110.403 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.0 mt -109.75 130.24 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.726 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -116.92 119.36 35.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' HG23 ' A' ' 102' ' ' THR . 2.9 t-20 -115.38 123.33 48.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.854 0.359 . . . . 0.0 110.504 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 3.3 m -120.02 125.34 48.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.485 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.704 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 30.8 ttm -120.6 149.97 41.63 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.0 m -122.0 121.47 37.11 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.526 ' HB3' HG12 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -122.86 111.62 16.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 53.31 -101.64 0.09 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.59 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -100.9 -11.94 19.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 0.0 110.733 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.59 135.57 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.854 -170.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.404 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.6 p -112.62 115.2 49.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 121.292 0.568 . . . . 0.0 111.231 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.758 ' OH ' ' HD3' ' A' ' 122' ' ' ARG . 15.3 t80 -109.83 119.98 41.04 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 121.536 -0.728 . . . . 0.0 111.125 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.725 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 2.7 ttmt -123.92 124.52 42.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.749 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.758 ' HD3' ' OH ' ' A' ' 120' ' ' TYR . 22.2 ptt85 -119.38 144.14 47.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.371 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.862 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.2 p -100.99 118.86 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.483 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 65.4 m -123.55 130.41 52.64 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.421 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -134.01 139.01 45.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.038 0.447 . . . . 0.0 110.858 -174.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.768 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 2.9 ttt180 -71.85 149.28 45.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 112.055 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.575 ' N ' ' HG2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.71 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.137 0.494 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.621 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 25.2 p-10 -69.67 139.03 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.053 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.959 ' HD2' ' HA ' ' A' ' 89' ' ' ASN . 5.0 t80 92.16 -8.65 0.21 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.176 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.648 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -117.99 160.37 21.6 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.504 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.32 177.18 15.25 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.691 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.763 ' HE3' ' HG2' ' A' ' 40' ' ' GLU . 44.6 mtpt -96.88 118.22 32.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 31.7 m-85 -120.81 125.08 46.63 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 15.4 tm0? -93.19 134.28 35.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG22 HE21 ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.24 136.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.072 0.939 . . . . 0.0 109.666 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 123' ' ' VAL . 5.6 mm100 -111.52 -56.89 2.32 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.499 -167.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.625 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 57.3 m -152.97 150.75 29.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.561 HE21 HG22 ' A' ' 9' ' ' VAL . 17.8 mp0 -133.11 147.86 52.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.749 0.785 . . . . 0.0 110.998 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.997 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 9.7 mm-40 -92.55 127.76 38.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.092 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 45.3 m-20 70.06 -102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.094 0.871 . . . . 0.0 110.123 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HZ ' ' HG3' ' A' ' 74' ' ' MET . 5.2 t80 72.82 13.19 5.13 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.249 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD13 ' A' ' 29' ' ' ILE . 33.3 mt-10 -141.2 -45.78 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.652 -171.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.746 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 31.6 Cg_exo -60.97 -37.53 76.01 Favored 'Trans proline' 0 CA--C 1.494 -1.52 0 C-N-CA 122.439 2.093 . . . . 0.0 108.574 162.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -57.76 -53.92 52.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.113 -2.767 . . . . 0.0 109.628 175.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.672 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.13 -36.34 83.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.329 176.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 16.1 pttt -66.82 -40.15 87.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.08 28.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.1 -44.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -165.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.15 -51.26 0.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.591 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 29' ' ' ILE . 15.8 tp -85.08 135.8 39.04 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 116.945 0.372 . . . . 0.0 110.754 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.613 ' CG ' HD12 ' A' ' 28' ' ' LEU . 97.4 Cg_endo -77.69 151.43 28.43 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.968 2.445 . . . . 0.0 111.675 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.964 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -49.86 -45.39 50.46 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.891 -178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 2.4 p-10 -56.61 -42.26 78.46 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 118.664 0.666 . . . . 0.0 110.208 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.613 HD12 ' CG ' ' A' ' 25' ' ' PRO . 40.9 mt -70.55 -33.71 71.43 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.095 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.964 HD12 ' HA ' ' A' ' 26' ' ' GLU . 25.6 mt -64.75 -44.39 96.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.929 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 22.9 mm-40 -52.55 -40.72 62.83 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.079 0.952 . . . . 0.0 111.327 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.929 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -69.56 -31.29 69.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.713 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.63 33.41 2.87 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.902 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' ILE . 20.4 ptmt -78.61 -37.17 42.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.743 0.782 . . . . 0.0 112.784 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.41 51.11 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.96 -165.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.1 117.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -102.45 112.6 25.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -117.09 -163.15 12.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.142 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 23.7 t -129.32 150.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.2 p -127.96 118.47 23.63 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.972 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.763 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 1.7 mp0 -114.54 123.61 49.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' A' ' 50' ' ' LEU . 80.4 mt -122.6 137.83 54.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.078 0.466 . . . . 0.0 111.951 -170.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -109.46 118.58 57.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.648 ' H ' ' HB3' ' A' ' 4' ' ' SER . 15.2 t-160 -96.72 113.16 24.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.926 0.869 . . . . 0.0 110.499 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.705 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 8.3 tp10 -116.83 143.35 45.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.548 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.42 101.1 0.02 OUTLIER Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.824 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmt 79.1 -31.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.295 1.438 . . . . 0.0 112.353 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -90.44 108.85 20.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 0.0 110.601 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG11 ' HE1' ' A' ' 3' ' ' PHE . 42.4 t -110.59 124.13 67.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.359 0.599 . . . . 0.0 110.804 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 73.6 mttt -107.16 122.67 46.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.941 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -117.45 127.63 54.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.1 m -110.73 123.87 50.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -126.97 120.49 55.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.025 HG23 HG22 ' A' ' 58' ' ' VAL . 53.7 m -101.32 128.41 47.49 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.955 -171.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.5 t80 -110.35 157.8 19.13 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -43.06 101.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.608 0.567 . . . . 0.0 113.193 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 t 84.42 -21.59 0.25 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.369 1.068 . . . . 0.0 112.707 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 54' ' ' TYR . 4.2 tmmm? -131.49 122.97 27.1 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.783 -0.573 . . . . 0.0 111.733 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 53' ' ' THR . 21.4 t -97.99 132.45 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 122.192 0.996 . . . . 0.0 111.407 -177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.695 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -117.84 114.77 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.506 -176.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -91.36 146.36 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.118 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 4.3 m-20 -131.57 105.32 7.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.774 0.429 . . . . 0.0 110.04 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -104.61 127.01 52.24 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.881 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -150.89 151.55 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 1.7 m -110.39 133.59 53.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.526 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.6 ' O ' HD12 ' A' ' 65' ' ' LEU . 4.0 pp -52.66 142.77 17.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.281 0.563 . . . . 0.0 111.129 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 25.08 76.4 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' THR . 70.3 mm-40 -132.75 138.22 47.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.478 0.18 . . . . 0.0 111.069 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.3 tt0 -78.53 118.08 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.606 0.717 . . . . 0.0 109.096 168.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.2 m -134.65 162.72 31.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.094 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.813 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 2.2 mt-10 -94.6 119.21 32.9 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.331 1.062 . . . . 0.0 110.585 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 25.5 mt -92.88 120.48 33.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.628 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' OE1' HG12 ' A' ' 59' ' ' ILE . 25.2 tt0 -92.79 121.9 34.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.493 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -87.58 167.42 13.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.159 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.486 ' HG3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -56.01 -27.51 53.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 0.0 110.963 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -91.65 -12.6 33.69 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.695 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 122.23 -22.7 7.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.973 172.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.62 147.28 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.788 0.794 . . . . 0.0 111.147 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.22 132.03 56.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.791 -176.305 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.29 142.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.613 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 76.8 mttt -82.71 123.79 29.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.523 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.95 147.71 34.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.476 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 44.3 t -91.34 113.44 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 109.694 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.781 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -95.62 133.11 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -103.02 140.04 37.8 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -129.2 132.02 47.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.1 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 4.2 tp10 -80.28 -48.13 13.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.449 -2.16 . . . . 0.0 111.957 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 115.49 -45.21 1.33 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.225 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.08 44.22 0.75 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 122.51 1.148 . . . . 0.0 109.69 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.959 ' HA ' ' HD2' ' A' ' 3' ' ' PHE . 34.5 m-80 69.68 43.43 0.98 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.01 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.884 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 24.5 mttp -131.45 119.97 22.35 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.654 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 ttp -121.92 121.13 36.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.692 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -128.88 116.69 41.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.781 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -121.37 134.53 55.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.401 0.619 . . . . 0.0 110.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.8 m -128.33 127.36 42.55 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.557 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -122.69 111.46 16.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 46.51 -99.88 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.527 -173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.07 17.94 34.39 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -100.88 113.13 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 113' ' ' MET . 42.1 tttp -113.86 118.99 35.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.571 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.665 ' HB3' HG23 ' A' ' 93' ' ' THR . 32.1 t -120.64 119.81 33.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.763 0.316 . . . . 0.0 110.332 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 92' ' ' VAL . 1.8 m -112.42 121.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 6.4 m -119.69 120.58 37.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.24 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 42.5 tt0 -130.55 129.19 42.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.101 -0.239 . . . . 0.0 111.029 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -109.79 118.69 37.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -129.24 102.97 6.69 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.122 171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.85 62.46 2.81 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.312 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 126' ' ' ARG . 7.3 m-20 67.88 -3.84 1.11 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.2 p -117.24 142.02 47.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.752 -0.592 . . . . 0.0 111.834 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.511 HD11 ' CG ' ' A' ' 7' ' ' TYR . 8.9 mt -116.91 135.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.521 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -112.22 119.81 39.63 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 169.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.8 t-20 -114.65 121.49 43.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 110.226 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 6.6 m -122.35 117.86 27.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.668 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 33.9 ttm -124.67 149.34 47.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.3 m -123.88 121.85 36.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.585 ' H ' HG13 ' A' ' 118' ' ' ILE . 1.3 tp -117.56 114.58 23.64 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.566 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -82.89 0.19 Allowed Glycine 0 C--N 1.319 -0.366 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.603 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.07 5.64 2.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.862 0.839 . . . . 0.0 109.338 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -91.86 139.07 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.361 -173.247 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p -104.67 117.11 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.61 0.719 . . . . 0.0 110.757 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.668 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 27.2 t80 -107.16 120.41 42.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.735 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.997 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 3.6 mtmt -123.73 128.31 49.41 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.304 0.573 . . . . 0.0 109.673 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 14.7 ttt180 -119.75 132.34 55.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.067 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 7.7 p -100.5 117.42 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -124.85 133.72 52.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.805 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.13 149.22 52.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 0.0 111.339 -176.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 ttp180 -69.6 150.47 47.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.053 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.8 pt . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.161 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptp . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.541 ' HB3' ' H ' ' A' ' 106' ' ' GLY . 21.0 p-10 -100.94 110.7 22.77 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.646 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -154.83 -64.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.026 0.917 . . . . 0.0 109.297 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.726 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 17.8 p -141.72 -163.64 1.62 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.94 -176.53 16.11 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.819 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.732 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.79 116.93 30.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 50.9 m-85 -121.01 124.51 45.02 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.911 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.5 137.03 33.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -68.93 135.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.739 ' HB2' HG13 ' A' ' 123' ' ' VAL . 12.6 mm100 -110.76 -48.4 3.14 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.441 -168.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.58 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 31.3 m -158.12 156.75 31.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.542 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.22 158.18 45.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -119.7 125.79 49.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.663 -177.144 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.658 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 8.9 m-80 64.58 29.06 13.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 123.219 0.325 . . . . 0.0 111.704 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 1.03 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 29.6 p90 -67.58 6.12 0.69 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.078 0.466 . . . . 0.0 110.92 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.875 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 27.8 mt-10 -120.76 -46.23 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.142 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.875 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 32.9 Cg_endo -67.48 -29.71 37.0 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.4 1.4 . . . . 0.0 109.978 173.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 1.1 t80 -65.31 -52.18 55.72 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.48 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.589 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 87.1 mmm -61.04 -41.39 96.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.439 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 14.3 ptmt -68.78 -33.95 74.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.273 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -71.31 -22.71 61.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.15 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 18' ' ' PHE . 86.7 mmm -85.74 -72.15 0.5 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.38 0.609 . . . . 0.0 110.749 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.42 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.641 -172.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.74 HD23 HG12 ' A' ' 29' ' ' ILE . 12.0 tp -86.23 125.03 69.26 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 117.952 0.876 . . . . 0.0 109.718 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.686 ' CD ' HD12 ' A' ' 28' ' ' LEU . 88.4 Cg_endo -72.21 148.18 49.33 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.496 2.131 . . . . 0.0 111.261 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 8.4 tt0 -48.84 -41.8 34.19 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.663 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 16.9 t70 -61.85 -37.86 86.08 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 118.944 0.793 . . . . 0.0 111.168 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.686 HD12 ' CD ' ' A' ' 25' ' ' PRO . 35.1 mt -70.37 -35.01 73.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.491 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 21.5 mt -63.92 -44.61 98.03 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.822 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.876 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.0 mm-40 -50.52 -47.73 57.36 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.974 0.892 . . . . 0.0 112.067 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -68.62 -30.84 69.65 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.641 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.04 31.65 4.43 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.088 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.03 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 14.0 ptmm? -79.23 -39.65 32.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -165.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.07 46.68 0.93 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.536 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.41 129.52 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 147.61 23.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 0.0 109.816 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.982 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -142.69 171.34 24.83 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.911 HG22 ' HG3' ' A' ' 8' ' ' GLN . 11.5 t -121.93 132.93 69.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 117.538 0.669 . . . . 0.0 110.588 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.835 ' HB3' HD21 ' A' ' 50' ' ' LEU . 5.7 m -113.42 120.64 41.75 Favored 'General case' 0 C--O 1.21 -0.997 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.17 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.732 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 46.9 mt-10 -119.66 123.0 42.75 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.117 0.484 . . . . 0.0 110.034 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.726 ' O ' ' HB2' ' A' ' 4' ' ' SER . 96.4 mt -119.31 138.28 50.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -168.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.83 115.07 48.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.229 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.57 ' N ' ' HB3' ' A' ' 4' ' ' SER . 27.3 t-80 -96.37 122.17 38.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 111.707 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.83 143.09 50.63 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -42.35 136.09 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.733 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 66.42 -50.97 0.43 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.198 0.999 . . . . 0.0 112.586 -174.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -99.13 109.26 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.457 0.646 . . . . 0.0 112.37 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 91' ' ' MET . 80.7 t -122.72 129.14 75.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.96 -174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 39.0 mttp -109.77 135.21 51.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 39' ' ' SER . 1.6 tt -125.11 125.84 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.4 m -110.9 121.14 44.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.4 mt -123.96 121.1 61.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.436 0.636 . . . . 0.0 109.394 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.6 m -101.21 128.9 47.12 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.17 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t -121.31 -35.45 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.239 . . . . 0.0 111.559 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 138.49 35.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.298 0.57 . . . . 0.0 112.127 -170.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.5 t -99.74 126.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.804 0.811 . . . . 0.0 110.769 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.794 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -118.94 114.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.002 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -87.15 146.5 26.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.342 -177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m-20 -127.78 106.91 9.45 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -108.01 126.18 52.41 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.695 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.21 152.28 34.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.309 0.576 . . . . 0.0 111.83 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 7.5 m -121.34 133.31 55.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.9 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 85' ' ' MET . 3.5 pp -46.39 141.95 3.28 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.449 0.642 . . . . 0.0 112.465 176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 66.06 21.9 70.18 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.91 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.5 mm-40 -132.44 140.94 48.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.712 0.256 . . . . 0.0 110.8 -174.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB2' HG23 ' A' ' 82' ' ' VAL . 9.5 tt0 -79.74 117.59 20.77 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.895 0.855 . . . . 0.0 109.311 171.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 m -128.4 159.27 35.88 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.522 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.723 ' HG2' ' HG2' ' A' ' 80' ' ' LYS . 38.9 mt-10 -94.57 119.18 32.84 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.89 1.329 . . . . 0.0 110.588 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 36.3 mt -94.72 121.5 36.37 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.772 -2.467 . . . . 0.0 109.602 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HB3' HG23 ' A' ' 59' ' ' ILE . 26.8 tt0 -94.59 124.3 38.54 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -86.1 164.78 17.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.894 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -62.27 -19.36 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.3 0.571 . . . . 0.0 109.564 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 m -73.78 -48.0 34.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.507 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.794 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 143.11 -31.18 1.98 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.019 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -77.0 138.71 39.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.929 0.365 . . . . 0.0 110.923 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.94 136.83 41.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.47 143.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 111.114 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.723 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 56.2 mttp -81.69 123.32 28.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.607 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -145.71 148.54 33.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.858 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 68' ' ' GLU . 38.8 t -91.74 114.27 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.956 0.408 . . . . 0.0 110.059 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.758 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -106.71 134.95 46.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.291 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.5 mmtt -105.11 155.51 18.94 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.9 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 2.1 tmt? -129.16 136.36 50.08 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.105 0.955 . . . . 0.0 112.077 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 8.9 tp10 -110.26 148.53 31.71 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.273 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -58.16 -25.54 57.24 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -168.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.634 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 4.9 m-20 -80.21 28.82 0.29 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.085 0.945 . . . . 0.0 109.738 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 61.52 47.24 6.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.177 -1.828 . . . . 0.0 109.385 172.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.77 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 7.0 mtpt -107.61 123.9 49.16 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.55 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.526 ' HE3' HG11 ' A' ' 48' ' ' VAL . 16.2 mmt -113.88 112.64 23.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.436 HG12 ' HE3' ' A' ' 99' ' ' LYS . 2.4 t -123.39 116.34 48.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.251 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.758 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -132.13 145.17 51.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.447 0.641 . . . . 0.0 110.667 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.5 m -125.49 124.91 42.39 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.497 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 96' ' ' LYS . 62.1 t80 -139.74 112.45 7.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 95' ' ' PHE . 8.6 mtmp? 42.52 57.87 3.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.21 -9.42 60.98 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.152 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 115' ' ' LEU . 2.0 mm -90.31 113.3 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -104.35 130.66 52.19 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.086 0.47 . . . . 0.0 110.577 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 93' ' ' THR . 19.0 t -125.34 124.92 42.61 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.893 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 92' ' ' VAL . 71.9 t -123.32 118.59 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.441 . . . . 0.0 109.877 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 2.8 m -118.62 122.58 42.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.77 ' HG3' ' HE3' ' A' ' 90' ' ' LYS . 12.2 tt0 -129.28 124.95 35.7 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.005 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 109' ' ' ILE . 1.3 m-30 -101.42 115.47 30.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.51 117.46 21.35 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.515 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' A' ' 2' ' ' ASN . . . 69.06 -95.02 0.39 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.088 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.0 12.93 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.36 . . . . 0.0 110.439 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p -131.38 146.4 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.581 0.705 . . . . 0.0 111.784 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.748 ' HB ' ' OG ' ' A' ' 124' ' ' SER . 21.1 mt -129.09 135.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.341 -173.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 m -115.89 120.52 39.47 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.685 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 14.1 t-20 -107.88 124.79 50.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.004 0.431 . . . . 0.0 110.16 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -119.48 122.45 41.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.806 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.622 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.7 mtt -122.09 150.71 41.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -122.43 120.14 33.06 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.613 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 3.4 tm? -124.63 115.1 20.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.06 -107.0 1.59 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.919 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -115.41 6.69 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.071 0.462 . . . . 0.0 109.959 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.672 ' CD1' ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -93.03 139.61 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.317 -173.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.0 p -108.65 114.99 48.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-O 121.413 0.625 . . . . 0.0 110.841 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' HD2' ' HB2' ' A' ' 113' ' ' MET . 7.2 t80 -112.03 121.34 44.72 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.367 0.604 . . . . 0.0 111.941 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 6.4 mtmm -121.28 139.42 53.42 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.391 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.685 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 11.4 ptt180 -123.43 142.39 51.04 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -99.86 118.56 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.748 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 93.5 p -129.57 133.23 47.08 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.358 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -129.32 147.28 51.14 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.718 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 10.6 ttp180 -70.85 148.83 47.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.0 110.172 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.674 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.69 95.84 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.942 0.877 . . . . 0.0 110.746 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -148.87 70.94 1.12 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.025 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 88.0 p 58.19 -157.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 124.073 0.858 . . . . 0.0 111.961 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 -173.37 17.72 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.321 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.713 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 42.9 mtpt -94.33 118.12 31.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.133 0.492 . . . . 0.0 110.086 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 30.7 m-85 -120.13 123.53 43.56 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -97.08 130.52 44.36 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -173.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 0.5 OUTLIER -69.94 140.75 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.581 0.705 . . . . 0.0 110.794 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.669 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.3 mm100 -109.06 -39.58 5.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.75 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 13.3 m -159.15 159.99 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.134 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 10.3 mp0 -139.43 157.5 45.75 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.499 0.666 . . . . 0.0 111.376 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.766 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 6.2 tp10 -114.49 126.88 55.45 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.964 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.787 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 89.8 m-20 57.04 35.38 26.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.238 0.542 . . . . 0.0 111.867 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.841 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 32.7 p90 -69.16 21.73 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.402 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.945 ' HG2' HG21 ' A' ' 29' ' ' ILE . 41.1 mt-10 -135.36 -48.26 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -172.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.901 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 42.3 Cg_endo -71.0 -26.4 21.81 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.212 1.275 . . . . 0.0 109.432 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.811 ' HD1' HD11 ' A' ' 118' ' ' ILE . 44.6 t80 -65.11 -52.18 56.91 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.031 175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.957 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 23.3 mmt -61.51 -41.86 97.93 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.297 174.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.75 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 9.0 pttt -68.4 -33.92 75.1 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.553 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.23 66.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.639 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.0 ttm -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.86 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.8 -34.24 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.073 HD12 HG13 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -74.56 126.99 88.14 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.918 ' HD2' HD13 ' A' ' 24' ' ' LEU . 98.9 Cg_endo -79.27 141.68 16.32 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.896 1.73 . . . . 0.0 111.227 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.937 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.1 tt0 -49.67 -42.22 44.9 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.705 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.7 t70 -55.76 -44.14 77.36 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 118.544 0.611 . . . . 0.0 109.854 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' CG ' ' A' ' 25' ' ' PRO . 19.6 mt -68.4 -33.41 74.2 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.777 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.073 HG13 HD12 ' A' ' 24' ' ' LEU . 27.3 mt -64.66 -44.14 96.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.5 169.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 1.066 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 23.0 mm-40 -53.04 -41.0 64.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 1.066 ' HE2' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -71.23 -31.55 67.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.358 178.053 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.6 44.66 1.18 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.865 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.841 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -79.67 -39.79 30.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -167.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 7.6 t70 -98.88 61.0 1.27 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.032 0.92 . . . . 0.0 110.236 -167.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.3 115.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.814 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -98.31 100.88 12.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.001 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.08 -175.57 34.77 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.2 t -122.05 155.51 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 51' ' ' THR . 16.0 m -133.95 119.68 19.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.145 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 3.1 mp0 -116.75 123.85 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 4' ' ' SER . 38.7 mt -116.84 143.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 92.6 t -109.02 114.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 167.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 4' ' ' SER . 15.9 t-160 -96.37 112.79 24.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 110.387 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -127.88 145.54 50.91 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -36.67 114.48 0.22 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.433 174.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 1.073 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 58.68 -25.31 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -172.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 21.8 mmtp -91.26 107.09 18.97 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.283 0.492 . . . . 0.0 111.036 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 46.3 t -124.53 124.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.0 110.491 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 1.2 tttm -115.22 139.06 50.26 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.3 tt -121.93 124.95 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.158 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 39' ' ' SER . 58.2 m -110.2 124.38 51.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -129.33 121.06 52.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.2 m -99.53 130.63 45.79 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.658 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -109.18 108.15 18.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.93 -89.68 0.13 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.919 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.8 t -124.82 -3.65 7.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.749 0.309 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -121.91 136.2 54.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.749 0.309 . . . . 0.0 110.181 -170.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 93.8 t -98.33 134.19 37.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.012 0.91 . . . . 0.0 112.223 -172.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -118.64 114.75 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.603 176.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -87.35 145.43 26.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.962 -172.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 2.4 m120 -135.07 98.6 4.04 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 49' ' ' LYS . 3.5 mp0 -102.55 132.08 48.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.992 -0.443 . . . . 0.0 110.618 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -150.02 151.81 33.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.663 0.744 . . . . 0.0 112.091 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 22.9 m -107.78 134.03 51.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.112 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.073 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.7 mt -48.08 131.13 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.869 0.366 . . . . 0.0 111.05 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.77 60.8 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.013 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 64' ' ' THR . 50.4 mm-40 -132.98 139.03 47.07 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 28.3 tt0 -80.56 116.98 20.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.9 t -135.75 160.74 37.6 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.272 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.5 pt-20 -95.95 145.15 25.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.221 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 19.4 mt -105.88 128.42 53.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.509 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 59' ' ' ILE . 14.5 tt0 -91.63 120.29 32.27 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.2 p -90.51 166.42 13.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.997 -173.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.27 -20.24 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.858 0.361 . . . . 0.0 110.64 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 p -82.61 -38.67 23.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 133.04 -14.89 4.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.56 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -77.38 138.39 39.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.824 0.312 . . . . 0.0 111.534 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 9.9 mmmm -96.85 135.83 38.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.804 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -137.13 131.45 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.346 177.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 41.0 pttt -83.68 124.24 30.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.478 0.656 . . . . 0.0 111.031 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.99 149.38 41.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.428 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' THR . 71.2 t -93.95 113.08 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -104.76 132.33 51.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -117.66 156.17 28.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.492 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.789 ' HB3' HD13 ' A' ' 65' ' ' LEU . 8.7 tpp -126.32 122.23 34.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.098 0.951 . . . . 0.0 110.147 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.634 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 12.2 tp10 -46.43 -43.9 16.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.752 -2.022 . . . . 0.0 110.527 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.572 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . 137.94 -59.65 0.61 Allowed Glycine 0 CA--C 1.5 -0.901 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.857 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.664 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -63.4 -72.0 0.15 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.16 0.505 . . . . 0.0 110.954 176.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.664 ' OD1' ' HB3' ' A' ' 88' ' ' ASP . 2.0 p-10 -150.43 13.16 0.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.634 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -109.81 119.87 40.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.004 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.496 ' HG2' ' HB2' ' A' ' 85' ' ' MET . 50.9 mtm -121.98 115.96 23.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.783 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 101' ' ' VAL . 1.4 t -124.06 122.15 63.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.905 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.834 HG22 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -113.07 143.53 44.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.8 m -125.62 129.78 50.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 58.5 t80 -138.59 157.56 45.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.649 175.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 98' ' ' ILE . 48.1 mtmt -41.71 104.58 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.932 0.493 . . . . 0.0 112.007 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.51 -30.7 1.01 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.229 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 2.1 mm -90.04 111.72 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 113' ' ' MET . 46.3 tttt -113.29 125.46 54.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.025 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -114.2 119.11 35.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 92' ' ' VAL . 74.9 t -118.74 119.22 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -117.42 120.46 38.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.626 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.86 120.48 24.99 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.977 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.29 112.48 25.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.031 171.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -127.34 107.57 10.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.454 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.44 45.47 37.42 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.237 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 6.5 m-20 68.48 4.83 4.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.955 0.502 . . . . 0.0 111.84 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 p -117.95 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 104' ' ' PHE . 4.9 mt -109.91 132.57 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -107.33 119.76 40.28 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.822 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.786 ' HB2' ' HG2' ' A' ' 122' ' ' ARG . 18.8 m120 -106.61 121.65 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -121.75 118.78 29.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.103 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 77.1 mtm -124.8 149.83 46.98 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -127.85 122.59 33.0 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 122.126 -0.359 . . . . 0.0 110.722 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -111.84 112.41 24.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.18 -98.74 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.703 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -104.97 -12.87 15.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.502 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.811 HD11 ' HD1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.4 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.397 -172.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.59 115.05 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.487 0.66 . . . . 0.0 110.822 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 t80 -100.37 119.06 37.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 4.4 tmmm? -128.11 124.58 37.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.469 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.786 ' HG2' ' HB2' ' A' ' 111' ' ' ASN . 14.5 ptt180 -120.02 148.65 43.3 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.549 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 10' ' ' GLN . 6.7 p -101.61 118.26 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.596 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.737 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 84.3 p -125.42 132.54 52.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.8 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -132.0 146.65 52.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -70.08 149.6 47.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.933 -176.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.713 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 5.6 pt . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.471 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -83.52 97.11 8.84 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.004 -178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' HA ' HD22 ' A' ' 89' ' ' ASN . 43.7 m-85 -157.14 77.86 0.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.687 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 82.1 p 62.26 -168.07 0.2 Allowed 'General case' 0 C--N 1.318 -0.796 0 O-C-N 124.266 0.979 . . . . 0.0 112.783 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -170.7 13.45 Favored Glycine 0 CA--C 1.5 -0.888 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 17.0 mtpp -96.82 118.24 32.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.681 0.753 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.74 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 6.0 m-85 -120.7 134.91 55.25 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -102.0 140.13 36.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -175.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.9 t -64.64 139.07 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 122.004 0.907 . . . . 0.0 110.984 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.896 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.5 mm-40 -114.12 -58.17 2.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.954 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.681 ' HB2' HG12 ' A' ' 123' ' ' VAL . 29.0 m -157.18 152.36 26.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.681 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.67 151.35 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.54 0.686 . . . . 0.0 110.792 174.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 13.7 mm-40 -94.45 130.22 40.9 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.525 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.723 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 16.9 m-20 70.52 -82.31 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 O-C-N 123.715 0.634 . . . . 0.0 110.927 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' PHE . 51.0 p90 39.57 36.46 0.24 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.651 1.58 . . . . 0.0 112.304 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.913 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.9 mt-10 -144.47 -46.5 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.157 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.913 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 61.1 Cg_endo -68.22 -34.72 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.968 1.779 . . . . 0.0 109.718 169.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -62.3 -50.03 73.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.947 -1.933 . . . . 0.0 111.198 174.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.614 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 61.0 mmm -62.96 -41.07 99.42 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.881 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 16.1 ptmt -69.03 -32.73 72.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.25 0.547 . . . . 0.0 110.319 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.55 71.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.954 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.0 mtt -83.42 -59.46 2.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.25 -44.3 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.678 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.6 tp -75.56 126.44 87.44 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 117.564 0.682 . . . . 0.0 110.037 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.667 ' CD ' HD12 ' A' ' 28' ' ' LEU . 86.3 Cg_endo -73.85 153.39 47.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.709 2.273 . . . . 0.0 111.424 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.992 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 tt0 -50.56 -43.71 56.39 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.243 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.724 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 p-10 -57.18 -41.72 79.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 118.4 0.545 . . . . 0.0 110.704 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CD ' ' A' ' 25' ' ' PRO . 46.8 mt -71.08 -34.32 71.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.883 -0.51 . . . . 0.0 109.714 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.992 HD12 ' HA ' ' A' ' 26' ' ' GLU . 45.4 mt -61.73 -46.9 95.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.692 170.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.785 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 11.5 mm100 -52.36 -44.36 65.19 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.547 1.139 . . . . 0.0 112.05 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.724 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -69.71 -31.35 69.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.415 0.626 . . . . 0.0 110.343 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -122.09 29.16 5.63 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.585 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 29' ' ' ILE . 23.5 pttm -79.41 -28.34 41.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 111.523 -171.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.73 44.99 1.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.23 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 32' ' ' GLY . 27.7 mm -93.9 123.96 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -108.54 99.45 8.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.438 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -89.62 -179.96 44.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.936 -174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 3.5 t -123.26 148.24 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 51' ' ' THR . 19.2 m -128.77 123.53 33.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.974 0.416 . . . . 0.0 112.086 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 15.5 mp0 -117.0 123.46 46.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.805 HG12 ' HG ' ' A' ' 50' ' ' LEU . 25.0 mt -120.72 141.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.933 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 44' ' ' GLU . 96.1 t -109.13 119.52 58.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.787 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.443 ' N ' ' HB3' ' A' ' 4' ' ' SER . 23.3 t-80 -93.07 112.55 24.55 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.854 0.835 . . . . 0.0 109.814 173.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 43.4 mm-40 -123.33 144.01 49.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.09 0.09 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.363 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.801 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmm 71.79 -24.01 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.121 1.369 . . . . 0.0 112.869 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 70.0 mmtt -96.0 109.77 22.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG21 ' CE ' ' A' ' 91' ' ' MET . 55.9 t -121.72 123.56 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 111.5 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.0 mttm -112.37 123.06 49.45 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.715 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.805 ' HG ' HG12 ' A' ' 41' ' ' ILE . 2.3 tt -114.81 121.84 44.53 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -106.28 125.3 50.83 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.678 HG13 HD22 ' A' ' 50' ' ' LEU . 1.1 mt -129.26 121.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -171.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.969 HG23 HG22 ' A' ' 58' ' ' VAL . 23.9 m -104.01 129.07 51.59 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 40.0 t80 -116.45 106.47 13.64 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.42 -99.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.546 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 t -94.37 -28.72 15.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 110.846 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -107.71 125.37 51.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.841 -166.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.969 HG22 HG23 ' A' ' 53' ' ' THR . 21.2 t -99.51 125.19 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.709 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -124.82 114.33 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 122.635 1.207 . . . . 0.0 109.093 177.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' HB3' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -109.72 149.56 29.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.334 -172.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -117.64 108.38 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.59 125.65 51.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.065 0.46 . . . . 0.0 110.403 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 83' ' ' VAL . 3.5 p90 -151.38 152.73 33.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.618 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 15.6 m -111.6 134.71 52.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.78 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.801 ' HG ' ' HB3' ' A' ' 46' ' ' LYS . 4.0 pp -49.43 143.81 6.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.17 0.51 . . . . 0.0 111.617 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 67.15 19.15 69.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.763 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' THR . 76.1 mm-40 -129.24 146.94 51.05 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.692 0.246 . . . . 0.0 110.86 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 41.8 tt0 -79.86 118.41 21.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.9 m -134.21 150.48 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.101 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 3.3 pt-20 -95.01 140.01 30.57 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.19 -173.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 81' ' ' ALA . 18.5 mt -109.54 134.35 52.01 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.202 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HG3' ' HD2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -87.57 138.26 31.63 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 121.948 0.88 . . . . 0.0 108.927 169.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.9 p -95.16 167.81 11.13 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.769 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.3 tpp -65.67 -18.17 65.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -83.74 -39.93 19.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.901 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.709 ' HA2' ' CD1' ' A' ' 59' ' ' ILE . . . 130.1 -5.81 6.04 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.308 -0.948 . . . . 0.0 114.719 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -79.87 144.72 33.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.573 0.686 . . . . 0.0 110.558 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.17 125.73 38.98 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.11 130.94 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 22.8 pttt -97.12 140.48 31.56 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.321 1.058 . . . . 0.0 112.976 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.43 159.99 42.67 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.168 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -94.36 112.85 27.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.348 0.594 . . . . 0.0 110.153 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.738 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 2.0 m -103.78 136.36 37.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.682 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.1 mttt -116.45 156.94 25.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.768 0.318 . . . . 0.0 110.336 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' HD23 ' A' ' 65' ' ' LEU . 32.6 ttp -126.34 135.54 51.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.888 0.851 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.081 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 11.1 tp10 -86.12 -14.75 43.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.614 -173.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 114.36 -68.87 0.25 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.993 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 90' ' ' LYS . 2.4 p-10 -74.65 44.46 0.21 Allowed 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.342 0.592 . . . . 0.0 110.966 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.868 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 9.6 m120 65.02 44.98 3.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.8 169.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 1.081 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -106.51 121.37 44.16 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 166.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.441 ' CE ' HG21 ' A' ' 48' ' ' VAL . 2.0 mpt? -119.58 114.39 22.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -124.43 119.22 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -126.4 139.86 52.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.182 0.515 . . . . 0.0 110.661 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -128.99 139.89 51.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.899 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -138.84 113.4 8.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.971 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.0 -95.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.024 0.53 . . . . 0.0 111.677 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.19 10.15 15.13 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mm -92.19 122.77 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 113' ' ' MET . 38.1 tttm -123.97 116.72 23.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.229 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 93' ' ' THR . 14.6 m -121.65 119.92 33.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 92.0 t -117.0 119.64 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.779 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 m -117.47 126.1 52.04 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.823 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 39.1 tt0 -127.45 121.98 32.26 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.659 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.868 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 7.4 m-30 -92.98 116.12 28.76 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 167.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -124.24 110.99 15.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.49 -74.32 1.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.637 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -165.91 13.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.106 -0.547 . . . . 0.0 109.591 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 125' ' ' LYS . 2.8 m -123.44 142.22 51.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.52 0.676 . . . . 0.0 110.425 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 7' ' ' TYR . 15.0 mt -102.77 129.85 53.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.338 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -113.38 117.4 31.67 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 167.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.1 t-20 -113.74 120.38 40.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.946 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.729 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -121.88 115.97 23.55 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.64 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 9.3 ttp -125.93 144.45 50.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -121.44 121.62 37.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.771 ' HB2' HG12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -92.95 145.59 24.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.05 25.46 0.15 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -165.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.4 t70 -149.83 -9.04 0.3 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 159.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -116.01 139.62 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.71 -168.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 p -106.56 116.55 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.433 0.635 . . . . 0.0 110.192 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.64 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -115.36 120.97 41.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.105 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 23.6 ttpt -125.14 137.34 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.24 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 111' ' ' ASN . 44.4 ttt180 -132.08 127.12 35.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 111.682 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.896 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.3 p -101.88 128.15 54.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 20.9 m -134.63 131.89 38.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.409 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HA ' HG23 ' A' ' 108' ' ' THR . 11.4 ptmt -120.96 145.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.609 0.64 . . . . 0.0 111.334 -170.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 43.3 ttt180 -70.1 151.5 45.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.624 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 6.0 pt . . . . . 0 N--CA 1.431 -1.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.814 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 68.6 p . . . . . 0 N--CA 1.441 -0.884 0 CA-C-O 120.637 0.256 . . . . 0.0 110.744 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.97 -174.29 18.26 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.573 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.992 ' HE2' HG12 ' A' ' 127' ' ' ILE . 6.1 mtpt -97.64 120.71 38.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.642 0.734 . . . . 0.0 110.685 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 35.9 m-85 -123.79 124.95 43.82 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.57 138.86 31.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -168.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.485 HG22 ' HD3' ' A' ' 122' ' ' ARG . 1.6 t -70.77 127.96 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.398 0.618 . . . . 0.0 109.918 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.859 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.2 mm100 -111.59 -47.24 3.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.518 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 123' ' ' VAL . 24.3 m -161.61 152.82 18.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.987 -172.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -145.57 156.5 43.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.257 0.551 . . . . 0.0 111.362 174.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.843 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 51.3 mm-40 -97.51 142.81 28.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.954 174.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.9 m-80 69.22 26.48 5.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' CD2' ' HB2' ' A' ' 33' ' ' LYS . 4.7 p90 -63.26 -0.31 0.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.863 ' HA ' HD13 ' A' ' 29' ' ' ILE . 80.7 mt-10 -116.84 -51.2 0.04 OUTLIER Pre-proline 0 C--O 1.216 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.155 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 27.1 Cg_exo -55.43 -42.81 64.39 Favored 'Trans proline' 0 CA--C 1.511 -0.656 0 C-N-CA 121.853 1.702 . . . . 0.0 112.732 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -60.55 -49.6 76.87 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.833 -1.531 . . . . 0.0 109.601 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.637 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 25.2 mmt -63.02 -43.7 98.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.447 176.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 15.5 ptmt -64.71 -36.94 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.925 -171.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -73.37 -36.82 66.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.851 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -82.96 -28.18 29.98 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.6 -39.7 0.36 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.372 -1.394 . . . . 0.0 114.402 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.663 HD23 HG12 ' A' ' 29' ' ' ILE . 13.0 tp -80.65 129.09 69.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 117.689 0.745 . . . . 0.0 110.131 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.659 ' CD ' HD12 ' A' ' 28' ' ' LEU . 93.2 Cg_endo -73.5 146.87 40.09 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.296 1.998 . . . . 0.0 111.196 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 7.4 tt0 -48.81 -41.22 32.01 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.108 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.749 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 29.3 t70 -64.1 -37.44 87.45 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 119.197 0.908 . . . . 0.0 110.871 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.659 HD12 ' CD ' ' A' ' 25' ' ' PRO . 31.1 mt -69.78 -34.46 73.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 20.4 mt -64.11 -45.94 95.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.431 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.599 172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.073 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 35.1 mm-40 -51.32 -48.17 62.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.671 0.748 . . . . 0.0 112.078 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.749 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -63.53 -30.05 71.22 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.619 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.62 41.14 1.46 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.438 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.073 ' HE2' ' HA ' ' A' ' 30' ' ' GLN . 15.7 ptpt -79.96 -41.45 25.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -165.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 38.7 t70 -109.96 60.37 0.6 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.917 0.865 . . . . 0.0 110.562 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 mm -80.89 130.27 36.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.026 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.85 146.55 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.3 169.05 27.02 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 8' ' ' GLN . 15.2 t -127.85 141.55 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.339 0.569 . . . . 0.0 109.494 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.5 t -119.02 131.76 56.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -125.01 122.92 38.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.595 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 4' ' ' SER . 97.1 mt -117.47 138.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 49' ' ' LYS . 96.8 t -109.15 119.87 59.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.615 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.682 ' H ' ' HB3' ' A' ' 4' ' ' SER . 10.6 t-160 -97.77 114.72 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.352 0.596 . . . . 0.0 110.562 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -133.17 141.55 48.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -37.24 114.27 0.24 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 113.642 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 28.0 mtmt 75.47 -43.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.882 1.273 . . . . 0.0 112.539 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -96.28 109.79 22.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.897 0.856 . . . . 0.0 111.822 -171.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.7 128.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.261 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 78.0 mttt -107.94 125.44 51.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.297 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -120.04 123.64 43.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.73 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.6 m -106.84 124.15 49.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.2 mt -131.3 122.27 50.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.332 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 HG22 ' A' ' 58' ' ' VAL . 19.8 m -101.45 130.08 47.61 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.063 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -116.64 106.21 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.35 -99.58 0.09 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.04 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t -99.09 -24.4 14.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.418 0.628 . . . . 0.0 110.483 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HE2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.96 123.01 47.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.239 -169.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 53' ' ' THR . 24.3 t -98.26 124.8 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-O 121.873 0.844 . . . . 0.0 109.55 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.516 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -116.45 114.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.82 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 148.5 26.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.28 -1.782 . . . . 0.0 112.378 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -139.7 87.84 2.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.487 0.661 . . . . 0.0 110.482 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 33.4 mt-10 -107.21 127.16 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.643 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' HE1' ' HG2' ' A' ' 91' ' ' MET . 9.7 p90 -150.43 152.0 33.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.09 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.3 m -106.54 132.44 52.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 65' ' ' LEU . 3.8 pp -47.17 143.36 3.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 112.394 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 68.42 25.03 74.99 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.569 177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -135.24 145.45 47.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 23.6 tt0 -76.6 118.64 19.46 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.2 m -134.03 158.75 42.75 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.273 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 4.1 mt-10 -97.6 120.64 38.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.5 1.143 . . . . 0.0 111.906 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 32.5 mt -93.69 121.59 35.27 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.732 -2.031 . . . . 0.0 109.872 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.516 ' OE1' HG12 ' A' ' 59' ' ' ILE . 15.8 tt0 -95.22 120.54 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 59' ' ' ILE . 24.2 p -86.72 164.19 16.88 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 ttt -64.61 -14.65 58.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.198 0.523 . . . . 0.0 109.827 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -85.9 -40.7 15.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.798 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.42 -13.32 4.01 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.148 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.54 129.65 35.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.663 -0.316 . . . . 0.0 111.315 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -105.17 130.52 53.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 176.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -134.64 147.99 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.065 0.46 . . . . 0.0 112.048 -175.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 51.0 mttm -82.7 123.27 29.13 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.64 145.19 32.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.5 t -90.5 112.84 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.488 0.661 . . . . 0.0 109.803 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.728 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -109.14 134.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.363 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -113.67 153.1 29.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.63 ' HG2' ' HG3' ' A' ' 91' ' ' MET . 9.4 tmm? -129.41 124.88 35.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.257 1.027 . . . . 0.0 110.015 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 6.1 tp10 -56.67 -60.64 3.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.959 -1.928 . . . . 0.0 113.736 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 145.56 -54.38 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 23.0 t70 -80.67 27.24 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.008 0.909 . . . . 0.0 109.086 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 87' ' ' GLY . 7.2 m-80 65.37 58.49 0.85 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.685 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.779 ' HE2' ' HG2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -108.14 121.37 44.71 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.63 ' HG3' ' HG2' ' A' ' 85' ' ' MET . 1.4 mpp? -118.27 114.61 23.26 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 3.5 t -124.84 122.02 62.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.196 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.728 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.71 144.17 51.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.207 0.527 . . . . 0.0 110.61 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -122.31 126.43 48.09 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -138.58 114.6 10.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt 56.85 -102.45 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.268 0.355 . . . . 0.0 111.128 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.32 14.14 12.19 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 115' ' ' LEU . 1.6 mm -94.37 113.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' MET . 18.2 ttpt -110.16 118.17 35.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.943 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -114.85 120.62 40.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.162 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 85.5 t -119.73 119.91 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.287 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.56 HG22 ' HE1' ' A' ' 104' ' ' PHE . 2.6 m -117.69 120.5 38.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 5.0 tm-20 -130.29 127.27 39.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.144 -0.347 . . . . 0.0 110.669 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 109' ' ' ILE . 7.1 m-30 -104.74 114.79 29.22 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 126.23 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.413 0.445 . . . . 0.0 110.771 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.56 31.79 71.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.811 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 64.06 19.34 11.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.99 0.516 . . . . 0.0 112.253 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.0 p -116.02 130.57 56.87 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 104' ' ' PHE . 6.1 mt -110.21 128.59 66.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.834 -170.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -116.88 120.19 37.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.94 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.7 121.78 45.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.695 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 4.4 m -120.36 120.58 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.647 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.522 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 65.9 mtt -119.68 149.72 41.53 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.149 0.499 . . . . 0.0 110.36 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 49.8 m -118.86 119.82 35.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.751 ' HA ' HD12 ' A' ' 98' ' ' ILE . 3.4 tm? -123.79 113.49 18.63 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.623 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.56 10.78 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.952 0.882 . . . . 0.0 109.357 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -97.74 141.33 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.696 -173.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 119' ' ' VAL . 7.6 p -110.86 114.95 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.621 0.724 . . . . 0.0 111.267 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HD2' ' O ' ' A' ' 13' ' ' GLU . 1.3 t80 -117.01 125.58 51.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.68 -170.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.843 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -124.97 129.83 51.13 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.998 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.485 ' HD3' HG22 ' A' ' 9' ' ' VAL . 30.3 ttm180 -116.96 137.8 51.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.52 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 10' ' ' GLN . 12.7 p -101.87 117.06 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.88 0.847 . . . . 0.0 109.771 173.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 16.2 m -121.36 127.9 51.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.079 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -121.3 137.54 54.65 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.299 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 24.5 ttt180 -68.1 147.77 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.992 HG12 ' HE2' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 C--O 1.247 0.948 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -170.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.654 ' HB3' ' C ' ' A' ' 41' ' ' ILE . 58.6 m . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 120.872 0.368 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.59 -164.04 28.47 Favored Glycine 0 CA--C 1.499 -0.933 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.888 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.869 ' HE3' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -90.03 117.8 29.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 59.2 m-85 -132.06 127.67 36.61 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 10.1 tm0? -103.4 140.74 37.05 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.24 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 t -66.19 137.51 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.147 0.975 . . . . 0.0 111.566 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.676 ' HB3' HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -114.2 -59.94 1.95 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.942 -168.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.533 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 11.5 m -158.02 153.9 26.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.435 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -145.98 155.42 42.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.615 0.722 . . . . 0.0 112.015 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.767 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 16.6 mm-40 -94.2 142.11 27.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.342 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 9.0 m-20 72.61 -82.42 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.472 0 O-C-N 123.559 0.537 . . . . 0.0 111.876 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.8 p90 39.93 28.03 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.266 1.826 . . . . 0.0 113.236 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.917 ' HA ' HD13 ' A' ' 29' ' ' ILE . 74.5 mt-10 -147.26 -49.9 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.634 -172.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.739 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 59.6 Cg_endo -74.7 -23.98 13.95 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 108.411 -1.419 . . . . 0.0 108.411 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 118' ' ' ILE . 3.5 t80 -60.8 -52.79 63.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.983 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.649 ' HB2' HD11 ' A' ' 29' ' ' ILE . 24.6 mmt -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.526 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 7.5 ptmm? -66.05 -33.06 74.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.126 0.488 . . . . 0.0 110.069 -174.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.79 86.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.457 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.8 ptm -85.86 -22.16 27.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.88 -39.02 0.69 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.677 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 19' ' ' MET . 14.9 tp -75.54 130.01 80.5 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 117.308 0.554 . . . . 0.0 110.478 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' HD12 ' A' ' 28' ' ' LEU . 88.3 Cg_endo -78.1 153.83 28.72 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.799 1.666 . . . . 0.0 111.346 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.087 ' HA ' HD12 ' A' ' 29' ' ' ILE . 9.6 tt0 -50.09 -44.34 51.88 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.383 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.622 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 7.7 t70 -59.12 -37.26 76.8 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.308 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.887 HD12 ' HD2' ' A' ' 25' ' ' PRO . 59.8 mt -72.32 -37.5 68.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.912 0.387 . . . . 0.0 110.076 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.087 HD12 ' HA ' ' A' ' 26' ' ' GLU . 38.9 mt -59.22 -44.2 91.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.904 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.836 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.3 mm-40 -54.03 -34.01 58.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.621 1.169 . . . . 0.0 111.775 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 2.1 mptp? -68.44 -33.03 73.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.961 0.41 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.55 35.66 2.37 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.835 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 25.3 pttm -79.1 -32.24 44.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.297 0.57 . . . . 0.0 112.321 -169.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -99.16 24.55 7.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.062 -167.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.0 mt -81.13 115.93 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.372 0.606 . . . . 0.0 112.39 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -109.8 126.69 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.329 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -115.31 -169.02 15.71 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.963 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 11.1 t -121.57 141.1 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.838 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.8 t -117.01 139.22 50.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 1.1 mm-40 -135.23 124.59 24.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.965 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 5.1 mt -127.96 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.1 -171.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -111.16 120.47 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.627 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 4' ' ' SER . 11.5 t-160 -92.41 114.52 27.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.805 0.812 . . . . 0.0 110.45 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 142.21 46.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -33.58 111.17 0.06 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.643 0.589 . . . . 0.0 113.998 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 2.3 mtmt 66.62 -45.47 0.44 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.476 1.51 . . . . 0.0 113.342 -173.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 47' ' ' LYS . 2.2 ptpp? -90.74 107.45 19.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.762 0.791 . . . . 0.0 111.282 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.64 HG21 ' SD ' ' A' ' 85' ' ' MET . 90.6 t -123.09 125.87 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.159 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -109.24 130.47 55.49 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.248 0.547 . . . . 0.0 109.678 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -116.42 133.33 56.14 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.88 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.838 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.1 m -114.34 124.88 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.9 mt -131.84 121.96 48.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.022 HG23 HG22 ' A' ' 58' ' ' VAL . 26.4 m -96.8 127.81 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -120.88 107.34 12.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.91 -98.07 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.565 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -103.95 -24.14 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.854 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.673 ' HE2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.41 128.73 55.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.189 -172.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 53' ' ' THR . 26.9 t -96.6 125.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.925 0.869 . . . . 0.0 109.522 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.673 HG13 ' HE2' ' A' ' 57' ' ' LYS . 1.3 mt -112.51 112.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.524 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.625 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -91.37 141.47 28.72 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.668 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.605 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.4 m120 -125.29 83.73 2.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.747 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 43.1 tt0 -102.24 126.75 49.32 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -147.62 153.08 38.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.955 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 13.5 m -114.05 128.68 56.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.794 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -58.59 143.32 46.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.155 0.502 . . . . 0.0 111.941 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 59.0 23.38 56.99 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.58 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 8.8 tt0 -145.32 133.13 21.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -80.48 119.42 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.285 0.564 . . . . 0.0 110.66 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.8 t -136.3 163.64 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.256 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -95.1 119.57 33.84 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.317 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 61.6 mt -100.72 122.39 43.27 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.728 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 59' ' ' ILE . 39.2 tt0 -89.24 128.1 35.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.654 ' O ' HD13 ' A' ' 59' ' ' ILE . 13.2 p -84.78 168.03 15.53 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.833 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.9 tpt -56.16 -28.22 57.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.437 0.637 . . . . 0.0 109.978 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 -27.73 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.995 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 123.12 -11.2 8.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.658 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.35 127.03 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.901 0.351 . . . . 0.0 110.466 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.84 127.65 48.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.65 147.07 27.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.362 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -82.01 123.77 29.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.479 0.657 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . . . -139.07 147.44 42.02 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.49 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -95.26 111.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.649 0.738 . . . . 0.0 109.368 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.756 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.7 m -100.73 133.37 44.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.49 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 3.9 mmtt -106.08 151.37 24.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HG21 ' A' ' 48' ' ' VAL . 21.1 ttt -132.89 131.42 40.9 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.317 1.056 . . . . 0.0 112.785 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.092 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 5.4 tp10 -84.95 139.32 31.9 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 112.766 -2.015 . . . . 0.0 108.57 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -60.83 -25.39 63.77 Favored Glycine 0 C--O 1.23 -0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.953 -168.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.724 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 32.5 t70 -83.68 23.09 1.01 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 110.208 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.605 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 10.5 m-80 71.53 57.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.962 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 1.092 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -113.19 121.84 45.69 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 1.058 ' HG2' ' HB ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -116.78 115.8 26.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.118 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 101' ' ' VAL . 5.3 t -125.73 117.7 49.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.568 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -129.86 144.29 51.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.408 0.623 . . . . 0.0 111.765 -177.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 59.3 m -127.26 131.74 50.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.774 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.45 130.04 27.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.825 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 64.05 -75.84 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.78 0.675 . . . . 0.0 110.948 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.63 29.9 0.25 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' THR . 38.9 mm -116.55 131.92 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.58 -0.81 . . . . 0.0 108.851 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' MET . 11.6 ttmm -112.63 128.15 56.3 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.825 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.543 ' HB2' HG23 ' A' ' 93' ' ' THR . 13.3 m -122.18 119.91 32.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.915 HG22 HG13 ' A' ' 92' ' ' VAL . 99.2 t -123.4 117.35 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 110.595 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 1.058 ' HB ' ' HG2' ' A' ' 91' ' ' MET . 32.3 m -118.31 121.38 40.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.888 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 8.2 tm-20 -129.55 128.38 42.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.881 0.372 . . . . 0.0 110.633 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.605 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 5.3 m-30 -96.88 115.37 27.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.074 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.96 102.87 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.754 175.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 107' ' ' ASP . . . 54.24 75.03 0.25 Allowed Glycine 0 N--CA 1.455 -0.087 0 CA-C-O 119.758 -0.468 . . . . 0.0 113.701 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 6.6 t70 72.23 -26.44 0.18 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 125' ' ' LYS . 7.7 p -107.21 134.68 49.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.037 0.922 . . . . 0.0 112.315 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.556 HD13 ' CE1' ' A' ' 104' ' ' PHE . 4.4 mt -109.38 127.11 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.079 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -104.54 118.35 36.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 54.3 t30 -109.58 121.25 44.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.32 114.9 21.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.721 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 22.1 ttt -127.26 150.36 49.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' ILE . 93.9 m -126.98 120.29 28.73 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.156 -0.34 . . . . 0.0 110.098 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.662 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -108.62 113.55 26.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.74 -91.84 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.31 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.17 1.64 7.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.934 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.662 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -91.32 141.53 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.815 -172.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.8 116.32 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.896 0.855 . . . . 0.0 110.585 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.644 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 60.8 t80 -103.52 117.98 35.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.88 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.767 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -124.22 124.63 42.86 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.504 HH22 HD11 ' A' ' 52' ' ' ILE . 33.9 ttt180 -127.24 132.67 50.34 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.973 -169.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.676 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.2 p -101.52 118.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.182 171.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 m -127.64 134.19 49.64 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.3 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -136.19 150.55 49.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.336 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 ttt180 -69.06 149.35 48.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.849 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.869 HG13 ' HE3' ' A' ' 6' ' ' LYS . 3.0 pt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.104 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 30.0 p . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.75 179.73 16.0 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.343 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.689 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -106.99 122.48 46.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.9 m-85 -127.85 126.01 40.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.697 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.83 134.25 36.38 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -172.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.944 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -70.04 134.38 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.779 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.5 mm100 -115.71 -40.87 3.29 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.105 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.637 ' HB2' HG12 ' A' ' 123' ' ' VAL . 58.2 m -156.24 151.47 26.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.819 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.905 0.859 . . . . 0.0 111.109 174.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -103.28 130.09 50.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.902 176.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.592 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 3.2 m-20 67.96 21.27 8.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.527 ' O ' ' HG2' ' A' ' 19' ' ' MET . 47.5 p90 -67.35 17.07 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.96 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.4 mt-10 -132.6 -44.58 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 123.175 0.59 . . . . 0.0 111.18 -173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.96 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.1 Cg_endo -70.07 -28.77 23.35 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 C-N-CA 121.734 1.623 . . . . 0.0 109.637 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' HB2' HD13 ' A' ' 118' ' ' ILE . 5.8 t80 -65.57 -52.53 51.61 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.111 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.704 ' HB2' HD11 ' A' ' 29' ' ' ILE . 83.8 mmm -61.22 -37.86 84.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.685 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.883 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 8.4 pttt -69.73 -36.27 75.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.206 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -71.34 -25.99 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.59 172.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.564 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 29.6 tpp -82.61 -43.76 16.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.027 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.44 -42.75 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.659 HD23 HG12 ' A' ' 29' ' ' ILE . 12.8 tp -78.86 128.57 76.32 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.69 ' CD ' HD12 ' A' ' 28' ' ' LEU . 95.0 Cg_endo -73.32 149.95 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.228 1.952 . . . . 0.0 111.498 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.052 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.6 tt0 -50.09 -44.43 51.99 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 36.6 t70 -56.97 -42.96 81.11 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.803 0.729 . . . . 0.0 110.19 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.69 HD12 ' CD ' ' A' ' 25' ' ' PRO . 45.1 mt -68.47 -33.5 74.27 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.466 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.052 HD12 ' HA ' ' A' ' 26' ' ' GLU . 28.0 mt -62.87 -47.1 94.44 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.699 170.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.007 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 21.6 mm-40 -53.09 -38.46 62.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.229 1.012 . . . . 0.0 112.474 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.007 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.64 -30.2 68.85 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.739 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.77 28.98 5.07 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.86 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -78.25 -39.56 39.81 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -166.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -96.29 54.41 1.41 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.645 0.736 . . . . 0.0 110.812 -166.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -99.53 133.16 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.61 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 147.0 33.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.765 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.944 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -144.85 -172.57 15.43 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.981 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 8' ' ' GLN . 60.8 t -123.71 143.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.241 0.521 . . . . 0.0 110.732 -173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 51' ' ' THR . 14.9 m -122.96 120.99 35.03 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.809 0.338 . . . . 0.0 110.122 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HG2' ' CG ' ' A' ' 6' ' ' LYS . 25.5 mt-10 -116.32 124.52 50.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.166 0.508 . . . . 0.0 109.633 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.651 HG12 ' HG ' ' A' ' 50' ' ' LEU . 96.7 mt -123.66 134.58 66.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.915 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.88 114.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.741 ' H ' ' HB3' ' A' ' 4' ' ' SER . 3.3 t-160 -115.07 113.51 24.14 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.042 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 37.3 tt0 -111.07 143.1 42.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -35.17 108.4 0.05 OUTLIER Glycine 0 C--O 1.225 -0.425 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.59 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.752 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 16.2 mtmt 83.78 -40.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.603 1.561 . . . . 0.0 113.079 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HD2' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.65 112.15 23.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.104 0.478 . . . . 0.0 110.606 -172.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.638 HG11 ' SD ' ' A' ' 91' ' ' MET . 4.9 t -114.32 123.0 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.69 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 18.2 mtpp -113.47 130.87 56.23 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.668 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -127.61 130.59 49.25 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -118.04 122.69 43.8 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.8 mt -124.79 120.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.807 HG23 HG22 ' A' ' 58' ' ' VAL . 24.5 m -102.69 127.28 49.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -121.38 107.63 12.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.39 -95.44 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.627 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -107.86 -18.26 13.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 0.0 111.211 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HE3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -113.09 128.54 56.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.17 0.51 . . . . 0.0 111.254 -170.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 53' ' ' THR . 31.8 t -97.43 125.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 122.052 0.93 . . . . 0.0 109.592 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -114.52 114.16 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.909 -177.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 144.66 27.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.005 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m120 -129.02 138.85 52.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -145.08 124.73 13.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -151.39 152.29 32.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.03 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.653 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 4.7 m -108.0 132.0 53.98 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.752 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 pp -45.55 146.25 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 112.156 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.1 13.0 69.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.439 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.0 mm-40 -124.66 143.48 50.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.703 0.287 . . . . 0.0 110.293 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 80' ' ' LYS . 22.9 tt0 -84.54 116.91 23.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 63.3 m -134.03 158.83 42.55 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.285 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mt-10 -94.83 120.14 34.55 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 122.793 1.282 . . . . 0.0 111.681 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 28.9 mt -100.76 128.52 46.77 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.222 -2.263 . . . . 0.0 110.706 -170.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 59' ' ' ILE . 16.1 tt0 -85.79 122.01 29.25 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 59' ' ' ILE . 12.6 p -85.85 164.53 17.46 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.255 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.57 -22.7 62.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.25 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.8 -41.27 53.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.761 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 140.27 -21.49 2.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.316 176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.66 139.44 39.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.618 0.709 . . . . 0.0 111.438 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.01 123.37 41.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.126 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 144.91 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 135.79 34.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.371 0.605 . . . . 0.0 111.966 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -147.5 152.46 38.08 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.051 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.1 t -95.78 112.43 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.844 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.785 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -100.11 133.96 41.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.095 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.1 mmtt -103.28 151.44 22.68 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.496 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . 4.7 ttp -128.91 132.91 47.71 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.682 -1.207 . . . . 0.0 113.041 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.043 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.5 tp10 -100.45 141.13 33.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 112.367 -2.197 . . . . 0.0 108.303 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.87 -36.66 60.48 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.954 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.503 ' C ' HD22 ' A' ' 89' ' ' ASN . 19.4 t0 -87.92 53.64 2.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.805 0.812 . . . . 0.0 110.077 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HB2' ' CD2' ' A' ' 104' ' ' PHE 0.251 0.0 OUTLIER 49.41 49.88 19.07 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.821 174.519 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 1.043 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 61.7 mttt -112.39 122.17 46.94 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.318 170.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.638 ' SD ' HG11 ' A' ' 48' ' ' VAL . 5.7 mtm -129.17 117.05 20.15 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -122.16 118.64 56.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.345 -173.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -126.61 140.44 52.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.572 0.701 . . . . 0.0 111.451 -177.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -128.07 138.8 52.7 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.752 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.4 124.16 21.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 60.87 -101.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.024 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.32 15.46 6.41 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.75 114.27 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 113' ' ' MET . 59.6 tttt -104.69 118.88 37.65 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.513 -171.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 m -115.67 118.95 34.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.511 HG22 HG13 ' A' ' 92' ' ' VAL . 98.1 t -113.41 120.41 63.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -117.34 119.84 36.35 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.268 174.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 90' ' ' LYS . 28.7 tt0 -129.67 119.92 24.32 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -113.97 119.2 36.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.697 176.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.03 138.09 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.463 170.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.71 96.63 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.648 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.588 ' HA ' ' HE2' ' A' ' 7' ' ' TYR . 25.8 m-20 70.07 4.98 5.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.72 0.408 . . . . 0.0 112.089 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -110.85 123.35 49.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 111.34 173.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mt -102.15 124.75 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.045 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' THR . 19.5 m -115.07 120.9 41.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.718 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.75 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 3.2 t-20 -116.06 121.27 41.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.892 0.377 . . . . 0.0 110.392 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.792 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -120.98 117.81 28.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.96 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 65.9 mtt -111.95 150.91 29.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.339 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 m -127.62 121.84 31.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -121.86 113.84 20.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.45 -93.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.883 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.62 17.06 3.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 110.112 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -85.53 137.44 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.19 114.62 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.675 0.75 . . . . 0.0 111.084 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 41.9 t80 -102.78 119.08 38.21 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.792 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.8 OUTLIER -128.92 131.03 47.51 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.75 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 7.4 ptt180 -124.33 144.37 50.05 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.631 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.779 HG13 ' HB2' ' A' ' 10' ' ' GLN . 11.7 p -100.83 117.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.11 0.957 . . . . 0.0 109.488 173.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m -123.66 121.52 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.568 -1.197 . . . . 0.0 108.646 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.11 149.33 52.13 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.58 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 15.9 ttp180 -70.17 146.62 50.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.673 -166.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.689 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 56.1 p . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.01 -172.43 21.59 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 2.8 mtpp -95.99 130.12 43.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.504 0.669 . . . . 0.0 109.811 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 17.5 m-85 -135.07 133.6 39.47 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 7.3 tm0? -106.21 135.82 47.01 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.84 141.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.592 0.711 . . . . 0.0 109.782 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.832 HE21 ' HA ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -113.69 -49.58 2.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.88 -171.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 14.7 m -159.69 159.63 33.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.871 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . 2.3 mt-30 -142.09 153.58 44.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.537 0.684 . . . . 0.0 111.93 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 1.2 mp0 -94.37 137.39 33.58 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.703 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.668 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 8.5 m-20 70.23 -83.35 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 O-C-N 123.892 0.745 . . . . 0.0 110.594 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.965 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.3 p90 37.66 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.75 1.62 . . . . 0.0 112.702 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.976 ' HA ' HD13 ' A' ' 29' ' ' ILE . 46.7 mt-10 -145.01 -47.97 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.434 -172.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 44.1 Cg_endo -76.31 -25.25 10.06 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.963 -1.207 . . . . 0.0 108.963 170.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.766 ' HD2' HD11 ' A' ' 118' ' ' ILE . 38.2 t80 -66.47 -52.59 44.58 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.063 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.702 ' HB2' HD11 ' A' ' 29' ' ' ILE . 17.5 mmt -64.04 -37.51 87.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.156 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.9 pttp -67.12 -39.12 86.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.14 61.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.516 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.557 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 30.0 tpp -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.879 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.53 -38.16 0.3 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.315 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD23 HG12 ' A' ' 29' ' ' ILE . 15.0 tp -77.55 131.03 72.23 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.708 ' HD2' HD12 ' A' ' 28' ' ' LEU . 90.9 Cg_endo -79.1 151.74 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.502 1.468 . . . . 0.0 111.19 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.034 ' HA ' HD12 ' A' ' 29' ' ' ILE . 18.1 tt0 -50.59 -40.16 51.71 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.937 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 4.5 p-10 -60.84 -36.36 78.92 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 118.339 0.518 . . . . 0.0 111.511 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 25' ' ' PRO . 21.7 mt -71.92 -36.88 70.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.301 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' A' ' 26' ' ' GLU . 30.8 mt -62.12 -43.74 98.16 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.369 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.2 mm-40 -50.23 -49.3 53.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.125 0.965 . . . . 0.0 111.846 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 2.2 mptp? -71.07 -30.32 66.43 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.829 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.99 32.74 3.9 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.931 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.965 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 13.9 ptmm? -78.81 -41.4 30.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.39 0.614 . . . . 0.0 112.589 -168.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.35 52.92 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.66 0.743 . . . . 0.0 110.785 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.3 mm -92.91 131.18 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.643 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' HE22 ' A' ' 8' ' ' GLN . 10.4 mtmp? -98.82 98.25 9.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.166 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -91.4 177.43 40.86 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.588 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.1 t -122.37 150.38 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.738 ' HA ' ' O ' ' A' ' 51' ' ' THR . 9.4 m -132.49 130.01 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 111.538 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 5.0 mp0 -122.87 140.02 53.4 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.85 ' O ' ' HB2' ' A' ' 4' ' ' SER . 61.2 mt -129.96 141.96 45.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.281 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.675 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 99.5 t -108.61 117.98 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 166.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' N ' ' HB3' ' A' ' 4' ' ' SER . 17.2 t-160 -95.16 115.21 27.13 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.442 0.639 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -137.61 143.11 41.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.535 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.73 107.95 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 O-C-N 123.835 0.709 . . . . 0.0 112.861 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mtmt 71.64 -38.65 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.843 1.257 . . . . 0.0 113.077 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.33 106.62 18.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.707 0.289 . . . . 0.0 110.878 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.26 122.9 66.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.23 0.538 . . . . 0.0 110.666 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 6.8 mptt -104.85 132.68 50.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.131 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -120.14 132.49 55.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 39' ' ' SER . 17.2 m -117.92 124.04 47.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -128.43 121.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 58' ' ' VAL . 62.1 m -104.01 129.41 51.61 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -118.07 107.26 13.78 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.99 -96.62 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.661 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 t -104.48 -24.1 13.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 0.0 110.645 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.74 128.48 49.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.84 0.829 . . . . 0.0 112.422 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 53' ' ' THR . 82.4 t -104.55 124.9 59.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.33 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.32 114.31 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.987 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -101.93 134.72 44.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.307 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.658 HD21 HG13 ' A' ' 59' ' ' ILE . 4.8 m120 -126.14 93.4 3.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -102.39 125.82 49.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.593 0.711 . . . . 0.0 109.915 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -149.57 152.89 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.27 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.6 m -109.15 132.4 54.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.345 174.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HB2' ' H ' ' A' ' 85' ' ' MET . 4.0 pp -52.09 140.11 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.798 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 65.31 24.11 70.44 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.522 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 33.1 mt-10 -138.05 141.26 40.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -76.74 119.07 20.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.631 0.729 . . . . 0.0 109.734 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 m -132.9 152.6 51.85 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.899 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.6 pt-20 -95.57 145.37 25.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.282 1.039 . . . . 0.0 109.192 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.2 mt -110.51 133.73 53.02 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -168.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 59' ' ' ILE . 8.1 tt0 -90.72 130.61 36.7 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.422 HG21 ' SD ' ' A' ' 22' ' ' MET . 18.7 p -89.45 174.4 7.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.772 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.0 tpp -61.46 -25.93 67.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.6 . . . . 0.0 109.634 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.9 m -80.68 -39.06 27.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.093 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.67 1.13 7.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.523 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.68 138.89 37.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.846 0.323 . . . . 0.0 111.017 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 10.0 mmmm -97.72 131.75 43.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -136.58 133.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 34.0 mttm -83.05 123.46 29.5 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.507 0.67 . . . . 0.0 111.701 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.94 153.75 45.78 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.474 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -95.53 111.52 26.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.385 0.612 . . . . 0.0 109.944 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.794 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -102.4 133.89 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.311 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 88.9 mttt -117.45 152.77 34.33 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.594 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.66 ' H ' ' HB2' ' A' ' 65' ' ' LEU . 5.1 ttm -118.45 119.83 35.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.29 1.043 . . . . 0.0 110.486 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.684 ' HG2' ' HD2' ' A' ' 90' ' ' LYS . 11.4 tp10 -63.37 -31.88 73.15 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.734 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 92.11 -32.23 5.54 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.647 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 37.2 t70 -94.69 62.2 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.582 0.705 . . . . 0.0 109.768 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 26.7 m-80 70.56 0.94 3.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.253 -1.34 . . . . 0.0 113.549 174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.687 ' HE3' ' OE1' ' A' ' 103' ' ' GLU . 33.0 mttp -109.4 122.91 48.4 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.788 -172.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.489 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 2.8 mpp? -117.7 115.46 25.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.808 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -130.38 124.2 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.689 -172.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.794 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -121.49 140.18 52.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.32 0.581 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.2 m -128.17 126.37 40.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.988 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -134.82 113.95 12.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.053 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 60.3 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.891 0.476 . . . . 0.0 111.354 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.85 10.42 3.38 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 98' ' ' ILE . 2.0 mm -90.17 113.56 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' MET . 23.3 tttm -115.78 118.37 32.82 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.201 -172.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.9 m -117.81 119.16 34.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.062 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 92' ' ' VAL . 85.0 t -118.84 119.01 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.326 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 24.9 m -117.92 122.09 42.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.908 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.687 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 35.9 tt0 -128.74 129.15 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.724 0.297 . . . . 0.0 110.738 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 22.0 m-30 -95.07 120.51 35.4 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.003 177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 113.07 16.93 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.932 -0.48 . . . . 0.0 110.68 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.05 -102.3 0.83 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.779 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.97 17.23 6.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.138 0.494 . . . . 0.0 109.9 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 125' ' ' LYS . 25.6 p -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.638 0.732 . . . . 0.0 111.723 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 104' ' ' PHE . 22.1 mt -111.4 128.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.789 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.7 m -104.67 119.34 38.77 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -118.31 122.72 43.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.226 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.2 117.5 26.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.444 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.583 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 5.1 ttm -118.63 146.07 44.94 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 m -128.75 121.79 29.19 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.543 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -102.73 114.2 28.25 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 169.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -48.21 81.06 0.01 OUTLIER Glycine 0 N--CA 1.468 0.814 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -160.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 27.2 t70 157.18 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.627 1.571 . . . . 0.0 106.966 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.766 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -115.98 140.72 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.209 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.29 115.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.458 0.647 . . . . 0.0 111.155 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 3.6 t80 -100.06 118.74 37.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.701 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.7 OUTLIER -123.86 131.83 53.65 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -124.39 131.69 53.51 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.061 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 8.4 p -100.91 117.55 46.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.943 0.878 . . . . 0.0 109.431 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -131.67 136.9 48.05 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.928 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.455 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -135.08 150.88 50.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 0.0 111.399 -175.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.503 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 76.9 ttt180 -68.73 148.31 50.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.24 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.644 ' CG1' ' HB2' ' A' ' 6' ' ' LYS . 1.1 pp . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.034 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 80.6 p . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.93 -174.72 15.53 Favored Glycine 0 CA--C 1.507 -0.437 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.671 ' HE3' HG12 ' A' ' 127' ' ' ILE . 3.6 mtpp -93.39 118.49 31.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 9.9 m-85 -125.02 124.67 42.47 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -93.0 134.39 35.18 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -68.08 137.38 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.925 0.869 . . . . 0.0 111.782 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.574 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.2 mm100 -112.9 -69.12 0.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.699 -168.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.513 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 20.3 m -151.26 143.28 23.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.274 -170.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.811 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 5.5 mm-40 -121.3 157.61 29.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.499 0.666 . . . . 0.0 111.449 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 66.8 mt-10 -105.9 137.39 43.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.797 168.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 7.7 m-20 69.76 -80.52 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.87 0 O-C-N 123.524 0.515 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 12' ' ' GLN . 34.0 p90 35.41 35.41 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.691 1.596 . . . . 0.0 113.374 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.854 ' HA ' HD13 ' A' ' 29' ' ' ILE . 73.6 mt-10 -152.9 -48.03 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.04 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 37.4 Cg_endo -75.73 -25.17 11.02 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 N-CA-C 108.657 -1.324 . . . . 0.0 108.657 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 118' ' ' ILE . 52.6 t80 -65.94 -53.29 41.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.122 173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.7 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 16.9 mmt -61.93 -37.15 83.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.478 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 17' ' ' PRO . 10.7 pttt -66.43 -41.71 88.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.075 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -72.07 -20.98 61.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.421 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.592 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 25.5 tpp -83.1 -46.21 13.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.871 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.49 -23.92 0.36 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.121 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.781 HD23 HG12 ' A' ' 29' ' ' ILE . 14.4 tp -91.95 132.91 31.51 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.65 ' CD ' HD12 ' A' ' 28' ' ' LEU . 85.0 Cg_endo -76.14 147.94 30.43 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.29 1.993 . . . . 0.0 111.7 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.098 ' HA ' HD12 ' A' ' 29' ' ' ILE . 4.2 tt0 -49.47 -44.64 46.02 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.56 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 5.1 t70 -61.35 -35.19 76.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.873 0.76 . . . . 0.0 111.445 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.65 HD12 ' CD ' ' A' ' 25' ' ' PRO . 41.1 mt -71.42 -35.71 71.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.874 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.098 HD12 ' HA ' ' A' ' 26' ' ' GLU . 23.5 mt -63.73 -46.87 93.37 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.114 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.82 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 26.8 mm-40 -53.13 -38.62 62.84 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 111.376 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 3.8 mptp? -69.71 -46.54 65.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.313 0.578 . . . . 0.0 110.887 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.87 39.87 2.36 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.183 -170.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD2' ' OE2' ' A' ' 16' ' ' GLU . 18.2 pttp -79.77 -43.12 23.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.2 51.27 0.75 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.535 . . . . 0.0 112.0 -171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 9.3 mm -79.28 118.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.538 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -100.21 118.96 37.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.046 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -116.89 -160.75 12.01 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.462 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 39.6 t -125.53 137.45 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.728 0.264 . . . . 0.0 110.748 -174.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.5 t -110.22 134.6 52.07 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 30.6 mt-10 -136.89 121.17 18.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.6 mt -124.22 141.35 44.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 122.319 -0.238 . . . . 0.0 111.583 -169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 44' ' ' GLU . 86.1 t -110.56 114.83 48.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 165.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -95.15 112.13 23.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.795 0.807 . . . . 0.0 109.576 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HG3' HG12 ' A' ' 42' ' ' VAL . 37.9 mt-10 -120.82 144.24 48.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.445 174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -35.85 105.72 0.03 OUTLIER Glycine 0 CA--C 1.52 0.388 0 O-C-N 123.793 0.683 . . . . 0.0 113.183 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.037 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 mtmt 72.85 -40.94 0.49 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.604 1.562 . . . . 0.0 113.631 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HG2' ' H ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -92.87 107.33 19.13 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.652 0.739 . . . . 0.0 111.544 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.94 124.76 73.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.228 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 44.1 mttp -110.83 123.04 49.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.28 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.6 tt -112.82 128.22 56.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.636 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 39' ' ' SER . 5.6 m -111.33 124.74 52.86 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -131.12 120.86 47.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.729 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 43.4 m -98.75 127.09 44.57 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CE1' ' HB ' ' A' ' 35' ' ' ILE . 48.5 t80 -121.5 108.11 13.24 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.0 -93.77 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.114 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -105.38 -23.46 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.063 0.459 . . . . 0.0 111.15 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.84 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.415 -170.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 71.3 t -98.08 125.33 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.769 0.795 . . . . 0.0 110.438 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.883 HG13 HD21 ' A' ' 61' ' ' ASN . 0.1 OUTLIER -99.85 115.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.245 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -102.49 126.65 49.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.36 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.883 HD21 HG13 ' A' ' 59' ' ' ILE . 3.6 m120 -127.8 97.38 4.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.522 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.13 125.7 50.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 61' ' ' ASN . 9.9 m-85 -129.06 152.8 48.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.177 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.5 m -112.59 122.7 48.46 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.037 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -46.51 125.67 7.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.181 0.515 . . . . 0.0 111.972 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 84' ' ' LYS . . . 82.49 16.39 71.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.589 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.5 mm-40 -125.9 154.3 42.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 21.5 tt0 -79.87 119.31 22.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.6 m -132.79 156.58 46.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.496 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' HE2' ' A' ' 78' ' ' LYS . 3.3 pt-20 -96.18 143.93 26.85 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 12.5 mt -106.21 127.26 53.1 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.298 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' CD ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 tt0 -88.03 129.0 35.4 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 p -88.52 174.9 7.82 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.763 -172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.2 ttt -70.14 -13.18 62.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.287 0.565 . . . . 0.0 109.761 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -90.9 -38.64 12.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.188 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.49 -13.86 4.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.493 -0.86 . . . . 0.0 114.157 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -80.4 147.04 31.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.584 0.692 . . . . 0.0 111.505 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 8.0 mmmm -96.24 136.47 36.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.551 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -138.0 143.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.875 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.542 ' HD2' ' OE1' ' A' ' 68' ' ' GLU . 37.1 mtmt -84.9 126.6 33.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 111.758 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.52 146.85 30.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.05 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.7 113.06 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.003 0.43 . . . . 0.0 109.937 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.752 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.31 133.24 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.572 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.3 mmtt -104.97 151.87 23.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.08 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.865 ' HB3' HD22 ' A' ' 65' ' ' LEU . 11.7 tpp -128.68 134.79 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.371 1.081 . . . . 0.0 111.622 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 90' ' ' LYS . 13.5 tp10 -82.12 -35.55 28.41 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.326 -176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 121.74 -36.5 3.22 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.178 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -78.82 26.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.858 1.313 . . . . 0.0 108.912 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.89 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 29.8 m-80 72.06 40.58 0.71 Allowed 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.582 168.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.925 ' HE2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -117.73 118.94 33.45 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 113.496 -1.684 . . . . 0.0 107.913 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 84' ' ' LYS . 42.4 mtm -116.65 123.03 46.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.848 0.832 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.85 118.7 54.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.663 -175.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.58 143.75 47.47 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.445 0.64 . . . . 0.0 111.356 -177.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 m -116.9 126.61 53.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.962 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.789 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 35.2 t80 -139.44 161.24 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.28 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 98' ' ' ILE . 22.8 ttmm -27.61 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.691 1.196 . . . . 0.0 114.008 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.34 8.49 19.02 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.58 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 26.3 mm -110.07 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -114.88 116.65 28.9 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.747 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.4 m -118.08 119.79 35.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 92' ' ' VAL . 84.6 t -115.71 117.52 55.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 12.1 m -118.89 120.95 38.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.925 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 24.2 tt0 -129.37 123.14 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.947 -0.471 . . . . 0.0 110.128 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.89 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 2.3 m-30 -89.71 114.0 25.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 172.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -125.45 112.13 15.91 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.72 -95.73 0.48 Allowed Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.215 -173.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -145.71 17.08 1.45 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 125' ' ' LYS . 5.2 m -128.07 135.3 49.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.884 0.85 . . . . 0.0 110.402 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 7' ' ' TYR . 10.6 mt -102.62 131.45 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.593 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.6 m -115.36 119.22 35.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.133 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 19.4 t-20 -108.0 122.81 47.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.759 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.748 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -119.85 115.81 24.6 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mtt -114.1 150.12 34.55 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 110.262 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 32.1 m -126.61 122.5 35.21 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.554 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -116.73 111.16 19.39 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.14 -90.81 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.68 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -125.34 0.19 7.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.514 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -87.11 140.32 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 -177.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.76 116.36 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.471 0.653 . . . . 0.0 111.51 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.401 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -109.55 118.82 37.61 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 112' ' ' THR . 20.8 ttpt -125.9 129.3 49.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.178 0.513 . . . . 0.0 109.65 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 34.8 ttm180 -120.22 127.17 52.19 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.261 -172.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 10' ' ' GLN . 14.7 p -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.1 m -135.34 130.09 34.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.913 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -128.98 144.78 51.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.336 0.971 . . . . 0.0 112.552 -171.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.7 ttt180 -69.26 149.94 47.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.849 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.671 HG12 ' HE3' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.822 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.56 ' HB3' ' N ' ' A' ' 43' ' ' HIS . 94.3 p . . . . . 0 N--CA 1.448 -0.545 0 CA-C-O 121.301 0.572 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.39 -178.48 17.06 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.14 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -94.27 117.27 29.87 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 7.3 m-85 -122.39 132.41 54.36 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.814 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.88 130.74 53.78 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.502 -174.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.834 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.47 139.05 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.854 176.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.862 ' HB2' HG13 ' A' ' 123' ' ' VAL . 4.8 mm-40 -111.05 -49.24 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.584 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.55 ' HB2' HG12 ' A' ' 123' ' ' VAL . 61.1 m -155.52 154.89 32.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.814 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -136.93 157.32 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.5 0.667 . . . . 0.0 111.375 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.725 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 4.3 mm-40 -114.03 130.59 56.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.994 176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.774 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.9 m-80 63.4 31.16 15.26 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.643 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 23.3 p90 -68.92 16.11 0.05 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.04 0.448 . . . . 0.0 110.87 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.883 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 40.7 mt-10 -129.12 -48.42 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.814 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.2 Cg_endo -69.91 -28.5 24.45 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.719 1.613 . . . . 0.0 110.297 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.57 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -63.16 -52.55 61.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.369 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.597 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 85.9 mmm -61.78 -37.59 84.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.741 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 18.6 pttt -67.05 -37.31 83.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.229 0.538 . . . . 0.0 109.731 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -67.4 -25.36 65.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 18' ' ' PHE . 58.0 mtp -79.34 -53.4 6.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.26 -16.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.305 -0.862 . . . . 0.0 113.501 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 29' ' ' ILE . 13.2 tp -81.68 130.7 60.23 Favored Pre-proline 0 N--CA 1.441 -0.891 0 CA-C-N 117.358 0.579 . . . . 0.0 109.924 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.648 ' CD ' HD12 ' A' ' 28' ' ' LEU . 91.6 Cg_endo -76.29 146.68 28.47 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.647 2.232 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.08 ' HA ' HD12 ' A' ' 29' ' ' ILE . 32.4 tt0 -50.72 -37.46 41.74 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.131 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.619 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.4 t70 -57.74 -47.19 83.17 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.165 0.893 . . . . 0.0 109.977 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.648 HD12 ' CD ' ' A' ' 25' ' ' PRO . 43.8 mt -68.75 -32.97 73.12 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.08 HD12 ' HA ' ' A' ' 26' ' ' GLU . 36.0 mt -61.6 -44.82 99.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.053 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 18.5 mm-40 -52.24 -41.89 63.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.535 0.734 . . . . 0.0 111.789 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.053 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.81 -30.54 69.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.134 -176.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.36 32.14 3.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.964 -174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 20.5 pttm -79.63 -43.13 23.42 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -165.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.48 47.01 1.19 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.344 0.592 . . . . 0.0 111.922 -167.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.6 118.36 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.15 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -84.85 145.86 27.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.082 0.468 . . . . 0.0 110.587 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.834 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -145.45 177.81 23.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 8' ' ' GLN . 3.7 t -122.43 145.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.799 ' HA ' ' O ' ' A' ' 51' ' ' THR . 7.5 p -129.72 120.12 24.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.7 mp0 -110.12 124.07 50.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.876 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.813 HG12 ' HG ' ' A' ' 50' ' ' LEU . 76.3 mt -123.37 140.41 47.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -168.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.09 114.38 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.56 ' N ' ' HB3' ' A' ' 4' ' ' SER . 28.5 t-80 -105.06 114.11 28.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.323 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -123.29 143.81 49.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 169.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.35 107.85 0.05 OUTLIER Glycine 0 CA--C 1.522 0.491 0 O-C-N 123.517 0.511 . . . . 0.0 112.624 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.879 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.9 mtmm 76.86 -35.58 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.992 1.317 . . . . 0.0 113.069 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 19.7 mttt -90.53 109.57 20.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.15 0.5 . . . . 0.0 111.182 -172.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 69.1 t -123.0 128.8 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.343 0.592 . . . . 0.0 111.77 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 41.2 mtpt -109.42 126.83 53.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.813 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -118.87 122.59 42.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.799 ' O ' ' HA ' ' A' ' 39' ' ' SER . 3.2 m -108.5 125.15 51.48 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.673 HG13 HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -130.75 122.63 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.545 0.688 . . . . 0.0 110.097 -170.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.4 m -103.85 129.78 51.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.196 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -116.55 105.89 12.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.1 -17.44 0.11 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t 172.41 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.07 0.938 . . . . 0.0 109.608 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -97.95 133.04 42.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.041 -169.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.6 t -99.63 124.69 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.579 0.704 . . . . 0.0 110.745 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -126.7 114.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.317 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.679 ' C ' HD22 ' A' ' 61' ' ' ASN . 0.3 OUTLIER -116.53 149.27 39.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -173.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.679 HD22 ' C ' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -124.41 121.38 34.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.058 -171.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -103.69 126.26 50.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.175 0.512 . . . . 0.0 110.237 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -151.26 152.29 33.03 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.304 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 2.0 m -105.83 131.81 52.71 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.884 HD22 ' HB2' ' A' ' 85' ' ' MET . 2.5 pp -72.72 168.54 18.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.762 0.791 . . . . 0.0 111.427 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 11.24 41.04 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.397 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 64' ' ' THR . 47.0 mt-10 -135.4 143.58 46.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -174.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.654 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.0 tt0 -83.26 117.11 22.74 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 67.6 m -132.97 157.39 45.28 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.878 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -94.98 119.57 33.72 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 122.876 1.322 . . . . 0.0 111.217 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 23.0 mt -102.69 145.89 29.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.704 -171.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE1' HG12 ' A' ' 59' ' ' ILE . 21.0 tt0 -109.25 123.86 49.95 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 p -91.43 167.93 11.91 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.253 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -59.73 -29.0 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 110.62 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 p -81.18 -30.66 34.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.297 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.98 -5.99 9.55 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.45 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.28 140.74 38.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.346 0.573 . . . . 0.0 110.736 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 23.7 mmmt -95.67 128.16 42.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.17 137.5 48.34 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.654 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 69' ' ' CYS . 41.8 pttt -101.96 125.31 48.61 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.564 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . -128.93 146.03 51.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.46 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 91.8 t -92.79 111.89 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.852 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.05 131.07 53.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.342 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -104.09 152.48 22.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.776 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.884 ' HB2' HD22 ' A' ' 65' ' ' LEU . 6.7 ttt -127.73 135.32 50.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.18 0.991 . . . . 0.0 111.488 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.039 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 9.2 tp10 -90.98 0.03 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.03 -1.895 . . . . 0.0 109.923 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.743 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 88.56 -65.73 3.29 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.858 173.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.487 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 19.1 m-20 -79.12 57.15 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 0.0 110.947 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.634 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 8.9 m-80 70.59 40.24 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.404 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 1.039 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -119.65 122.74 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.777 169.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -119.27 115.3 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 171.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 101' ' ' VAL . 2.1 t -125.26 118.86 53.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -130.04 143.8 50.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.786 0.803 . . . . 0.0 112.283 -178.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 t -126.96 136.99 53.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.806 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -139.86 131.7 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt 55.67 28.56 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.64 2.89 88.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.215 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 98' ' ' ILE . 3.5 mm -90.09 137.63 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 113' ' ' MET . 37.4 tttt -112.1 120.73 42.81 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.652 -172.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -121.52 120.78 35.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.999 0.428 . . . . 0.0 110.142 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 92' ' ' VAL . 95.4 t -116.4 121.07 66.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.798 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -117.19 121.28 40.78 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 177.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -121.36 115.91 23.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.734 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -118.0 119.49 34.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.48 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.15 114.75 17.41 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.514 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.59 46.6 4.85 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.43 11.4 5.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.098 0.475 . . . . 0.0 111.452 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 p -120.92 129.11 53.34 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.978 -0.451 . . . . 0.0 110.403 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.0 mt -109.75 130.24 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.726 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -116.92 119.36 35.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' HG23 ' A' ' 102' ' ' THR . 2.9 t-20 -115.38 123.33 48.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.854 0.359 . . . . 0.0 110.504 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 3.3 m -120.02 125.34 48.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.485 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.704 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 30.8 ttm -120.6 149.97 41.63 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.0 m -122.0 121.47 37.11 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -122.86 111.62 16.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 53.31 -101.64 0.09 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.59 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -100.9 -11.94 19.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 0.0 110.733 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.59 135.57 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.854 -170.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.404 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.6 p -112.62 115.2 49.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 121.292 0.568 . . . . 0.0 111.231 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.758 ' OH ' ' HD3' ' A' ' 122' ' ' ARG . 15.3 t80 -109.83 119.98 41.04 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 121.536 -0.728 . . . . 0.0 111.125 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.725 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 2.7 ttmt -123.92 124.52 42.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.749 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.758 ' HD3' ' OH ' ' A' ' 120' ' ' TYR . 22.2 ptt85 -119.38 144.14 47.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.371 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.862 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.2 p -100.99 118.86 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.483 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 65.4 m -123.55 130.41 52.64 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.421 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -134.01 139.01 45.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.038 0.447 . . . . 0.0 110.858 -174.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.768 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 2.9 ttt180 -71.85 149.28 45.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 112.055 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.575 ' N ' ' HG2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.71 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.648 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.32 177.18 15.25 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.691 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.763 ' HE3' ' HG2' ' A' ' 40' ' ' GLU . 44.6 mtpt -96.88 118.22 32.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 31.7 m-85 -120.81 125.08 46.63 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 15.4 tm0? -93.19 134.28 35.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG22 HE21 ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.24 136.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.072 0.939 . . . . 0.0 109.666 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 123' ' ' VAL . 5.6 mm100 -111.52 -56.89 2.32 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.499 -167.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.625 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 57.3 m -152.97 150.75 29.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.561 HE21 HG22 ' A' ' 9' ' ' VAL . 17.8 mp0 -133.11 147.86 52.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.749 0.785 . . . . 0.0 110.998 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.997 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 9.7 mm-40 -92.55 127.76 38.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.092 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.566 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 45.3 m-20 70.06 -102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.094 0.871 . . . . 0.0 110.123 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HZ ' ' HG3' ' A' ' 74' ' ' MET . 5.2 t80 72.82 13.19 5.13 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.249 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD13 ' A' ' 29' ' ' ILE . 33.3 mt-10 -141.2 -45.78 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.652 -171.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.746 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 31.6 Cg_exo -60.97 -37.53 76.01 Favored 'Trans proline' 0 CA--C 1.494 -1.52 0 C-N-CA 122.439 2.093 . . . . 0.0 108.574 162.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -57.76 -53.92 52.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.113 -2.767 . . . . 0.0 109.628 175.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.672 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.13 -36.34 83.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.329 176.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 16.1 pttt -66.82 -40.15 87.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.08 28.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.1 -44.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -165.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.15 -51.26 0.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.591 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 29' ' ' ILE . 15.8 tp -85.08 135.8 39.04 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 116.945 0.372 . . . . 0.0 110.754 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.613 ' CG ' HD12 ' A' ' 28' ' ' LEU . 97.4 Cg_endo -77.69 151.43 28.43 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.968 2.445 . . . . 0.0 111.675 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.964 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -49.86 -45.39 50.46 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.891 -178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 2.4 p-10 -56.61 -42.26 78.46 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 118.664 0.666 . . . . 0.0 110.208 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.613 HD12 ' CG ' ' A' ' 25' ' ' PRO . 40.9 mt -70.55 -33.71 71.43 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.095 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.964 HD12 ' HA ' ' A' ' 26' ' ' GLU . 25.6 mt -64.75 -44.39 96.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.929 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 22.9 mm-40 -52.55 -40.72 62.83 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.079 0.952 . . . . 0.0 111.327 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.929 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -69.56 -31.29 69.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.713 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.63 33.41 2.87 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.902 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' ILE . 20.4 ptmt -78.61 -37.17 42.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.743 0.782 . . . . 0.0 112.784 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.41 51.11 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.96 -165.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.1 117.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -102.45 112.6 25.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -117.09 -163.15 12.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.142 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 23.7 t -129.32 150.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.2 p -127.96 118.47 23.63 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.972 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.763 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 1.7 mp0 -114.54 123.61 49.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' A' ' 50' ' ' LEU . 80.4 mt -122.6 137.83 54.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.078 0.466 . . . . 0.0 111.951 -170.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -109.46 118.58 57.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.648 ' H ' ' HB3' ' A' ' 4' ' ' SER . 15.2 t-160 -96.72 113.16 24.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.926 0.869 . . . . 0.0 110.499 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.705 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 8.3 tp10 -116.83 143.35 45.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.548 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.42 101.1 0.02 OUTLIER Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.824 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmt 79.1 -31.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.295 1.438 . . . . 0.0 112.353 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -90.44 108.85 20.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 0.0 110.601 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.59 124.13 67.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.359 0.599 . . . . 0.0 110.804 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 73.6 mttt -107.16 122.67 46.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.941 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -117.45 127.63 54.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.1 m -110.73 123.87 50.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.646 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -126.97 120.49 55.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.025 HG23 HG22 ' A' ' 58' ' ' VAL . 53.7 m -101.32 128.41 47.49 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.955 -171.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.5 t80 -110.35 157.8 19.13 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -43.06 101.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.608 0.567 . . . . 0.0 113.193 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 t 84.42 -21.59 0.25 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.369 1.068 . . . . 0.0 112.707 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 54' ' ' TYR . 4.2 tmmm? -131.49 122.97 27.1 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.783 -0.573 . . . . 0.0 111.733 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 53' ' ' THR . 21.4 t -97.99 132.45 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 122.192 0.996 . . . . 0.0 111.407 -177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.695 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -117.84 114.77 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.506 -176.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.709 ' C ' HD22 ' A' ' 61' ' ' ASN . 10.0 p80 -91.36 146.36 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.118 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.709 HD22 ' C ' ' A' ' 60' ' ' HIS . 0.8 OUTLIER -131.57 105.32 7.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.774 0.429 . . . . 0.0 110.04 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -104.61 127.01 52.24 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.881 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -150.89 151.55 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 1.7 m -110.39 133.59 53.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.526 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.6 ' O ' HD12 ' A' ' 65' ' ' LEU . 4.0 pp -52.66 142.77 17.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.281 0.563 . . . . 0.0 111.129 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 25.08 76.4 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' THR . 70.3 mm-40 -132.75 138.22 47.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.478 0.18 . . . . 0.0 111.069 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.3 tt0 -78.53 118.08 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.606 0.717 . . . . 0.0 109.096 168.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.2 m -134.65 162.72 31.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.094 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.813 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 2.2 mt-10 -94.6 119.21 32.9 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.331 1.062 . . . . 0.0 110.585 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 25.5 mt -92.88 120.48 33.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.628 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' OE1' HG12 ' A' ' 59' ' ' ILE . 25.2 tt0 -92.79 121.9 34.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.493 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -87.58 167.42 13.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.159 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.486 ' HG3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -56.01 -27.51 53.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 0.0 110.963 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -91.65 -12.6 33.69 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.695 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 122.23 -22.7 7.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.973 172.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.62 147.28 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.788 0.794 . . . . 0.0 111.147 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.22 132.03 56.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.791 -176.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.29 142.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.613 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 76.8 mttt -82.71 123.79 29.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.523 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.95 147.71 34.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.476 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 44.3 t -91.34 113.44 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 109.694 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.781 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -95.62 133.11 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -103.02 140.04 37.8 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -129.2 132.02 47.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.1 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 4.2 tp10 -80.28 -48.13 13.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.449 -2.16 . . . . 0.0 111.957 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 115.49 -45.21 1.33 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.225 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.08 44.22 0.75 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 122.51 1.148 . . . . 0.0 109.69 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 104' ' ' PHE . 34.5 m-80 69.68 43.43 0.98 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.01 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.884 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 24.5 mttp -131.45 119.97 22.35 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.654 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 ttp -121.92 121.13 36.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.692 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -128.88 116.69 41.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.781 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -121.37 134.53 55.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.401 0.619 . . . . 0.0 110.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.8 m -128.33 127.36 42.55 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.557 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -122.69 111.46 16.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 46.51 -99.88 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.527 -173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.07 17.94 34.39 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -100.88 113.13 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 113' ' ' MET . 42.1 tttp -113.86 118.99 35.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.571 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.665 ' HB3' HG23 ' A' ' 93' ' ' THR . 32.1 t -120.64 119.81 33.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.763 0.316 . . . . 0.0 110.332 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 92' ' ' VAL . 1.8 m -112.42 121.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 6.4 m -119.69 120.58 37.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.24 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 42.5 tt0 -130.55 129.19 42.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.101 -0.239 . . . . 0.0 111.029 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -109.79 118.69 37.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.52 HD22 ' HA ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -129.24 102.97 6.69 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.122 171.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.85 62.46 2.81 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.312 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 126' ' ' ARG . 7.3 m-20 67.88 -3.84 1.11 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.2 p -117.24 142.02 47.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.752 -0.592 . . . . 0.0 111.834 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.511 HD11 ' CG ' ' A' ' 7' ' ' TYR . 8.9 mt -116.91 135.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.521 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -112.22 119.81 39.63 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 169.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.8 t-20 -114.65 121.49 43.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 110.226 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 6.6 m -122.35 117.86 27.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.668 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 33.9 ttm -124.67 149.34 47.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.3 m -123.88 121.85 36.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.585 ' H ' HG13 ' A' ' 118' ' ' ILE . 1.3 tp -117.56 114.58 23.64 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.566 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -82.89 0.19 Allowed Glycine 0 C--N 1.319 -0.366 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.603 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.07 5.64 2.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.862 0.839 . . . . 0.0 109.338 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -91.86 139.07 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.361 -173.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p -104.67 117.11 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.61 0.719 . . . . 0.0 110.757 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.668 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 27.2 t80 -107.16 120.41 42.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.735 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.997 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 3.6 mtmt -123.73 128.31 49.41 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.304 0.573 . . . . 0.0 109.673 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 14.7 ttt180 -119.75 132.34 55.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.067 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 7.7 p -100.5 117.42 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -124.85 133.72 52.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.805 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.13 149.22 52.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 0.0 111.339 -176.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 ttp180 -69.6 150.47 47.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.053 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.8 pt . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.161 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.726 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 17.8 p . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.732 0.301 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.94 -176.53 16.11 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.819 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.732 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.79 116.93 30.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 50.9 m-85 -121.01 124.51 45.02 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.911 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.5 137.03 33.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -68.93 135.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.739 ' HB2' HG13 ' A' ' 123' ' ' VAL . 12.6 mm100 -110.76 -48.4 3.14 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.441 -168.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.58 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 31.3 m -158.12 156.75 31.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.542 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.22 158.18 45.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -119.7 125.79 49.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.663 -177.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.658 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 8.9 m-80 64.58 29.06 13.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 123.219 0.325 . . . . 0.0 111.704 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 1.03 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 29.6 p90 -67.58 6.12 0.69 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.078 0.466 . . . . 0.0 110.92 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.875 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 27.8 mt-10 -120.76 -46.23 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.142 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.875 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 32.9 Cg_endo -67.48 -29.71 37.0 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.4 1.4 . . . . 0.0 109.978 173.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 1.1 t80 -65.31 -52.18 55.72 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.48 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.589 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 87.1 mmm -61.04 -41.39 96.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.439 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.573 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 14.3 ptmt -68.78 -33.95 74.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.273 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -71.31 -22.71 61.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.15 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 18' ' ' PHE . 86.7 mmm -85.74 -72.15 0.5 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.38 0.609 . . . . 0.0 110.749 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.42 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.641 -172.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.74 HD23 HG12 ' A' ' 29' ' ' ILE . 12.0 tp -86.23 125.03 69.26 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 117.952 0.876 . . . . 0.0 109.718 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.686 ' CD ' HD12 ' A' ' 28' ' ' LEU . 88.4 Cg_endo -72.21 148.18 49.33 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.496 2.131 . . . . 0.0 111.261 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 8.4 tt0 -48.84 -41.8 34.19 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.663 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 16.9 t70 -61.85 -37.86 86.08 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 118.944 0.793 . . . . 0.0 111.168 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.686 HD12 ' CD ' ' A' ' 25' ' ' PRO . 35.1 mt -70.37 -35.01 73.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.491 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 21.5 mt -63.92 -44.61 98.03 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.822 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.876 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.0 mm-40 -50.52 -47.73 57.36 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.974 0.892 . . . . 0.0 112.067 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -68.62 -30.84 69.65 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.641 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.04 31.65 4.43 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.088 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.03 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 14.0 ptmm? -79.23 -39.65 32.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -165.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.07 46.68 0.93 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.536 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.41 129.52 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 147.61 23.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 0.0 109.816 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.982 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -142.69 171.34 24.83 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.911 HG22 ' HG3' ' A' ' 8' ' ' GLN . 11.5 t -121.93 132.93 69.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 117.538 0.669 . . . . 0.0 110.588 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.835 ' HB3' HD21 ' A' ' 50' ' ' LEU . 5.7 m -113.42 120.64 41.75 Favored 'General case' 0 C--O 1.21 -0.997 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.17 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.732 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 46.9 mt-10 -119.66 123.0 42.75 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.117 0.484 . . . . 0.0 110.034 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.726 ' O ' ' HB2' ' A' ' 4' ' ' SER . 96.4 mt -119.31 138.28 50.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -168.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.83 115.07 48.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.229 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.57 ' N ' ' HB3' ' A' ' 4' ' ' SER . 27.3 t-80 -96.37 122.17 38.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 111.707 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.83 143.09 50.63 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -42.35 136.09 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.733 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 66.42 -50.97 0.43 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.198 0.999 . . . . 0.0 112.586 -174.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -99.13 109.26 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.457 0.646 . . . . 0.0 112.37 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 91' ' ' MET . 80.7 t -122.72 129.14 75.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.96 -174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 39.0 mttp -109.77 135.21 51.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 39' ' ' SER . 1.6 tt -125.11 125.84 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.4 m -110.9 121.14 44.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.4 mt -123.96 121.1 61.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.436 0.636 . . . . 0.0 109.394 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.6 m -101.21 128.9 47.12 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.17 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t -121.31 -35.45 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.239 . . . . 0.0 111.559 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 138.49 35.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.298 0.57 . . . . 0.0 112.127 -170.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.5 t -99.74 126.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.804 0.811 . . . . 0.0 110.769 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.794 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -118.94 114.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.002 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.622 ' C ' HD22 ' A' ' 61' ' ' ASN . 0.5 OUTLIER -87.15 146.5 26.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.342 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -127.78 106.91 9.45 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -108.01 126.18 52.41 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.695 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.21 152.28 34.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.309 0.576 . . . . 0.0 111.83 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 7.5 m -121.34 133.31 55.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.9 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 85' ' ' MET . 3.5 pp -46.39 141.95 3.28 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.449 0.642 . . . . 0.0 112.465 176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 66.06 21.9 70.18 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.91 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.5 mm-40 -132.44 140.94 48.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.712 0.256 . . . . 0.0 110.8 -174.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB2' HG23 ' A' ' 82' ' ' VAL . 9.5 tt0 -79.74 117.59 20.77 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.895 0.855 . . . . 0.0 109.311 171.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 m -128.4 159.27 35.88 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.522 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.723 ' HG2' ' HG2' ' A' ' 80' ' ' LYS . 38.9 mt-10 -94.57 119.18 32.84 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.89 1.329 . . . . 0.0 110.588 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 36.3 mt -94.72 121.5 36.37 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.772 -2.467 . . . . 0.0 109.602 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HB3' HG23 ' A' ' 59' ' ' ILE . 26.8 tt0 -94.59 124.3 38.54 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -86.1 164.78 17.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.894 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -62.27 -19.36 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.3 0.571 . . . . 0.0 109.564 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 m -73.78 -48.0 34.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.507 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.794 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 143.11 -31.18 1.98 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.019 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -77.0 138.71 39.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.929 0.365 . . . . 0.0 110.923 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.94 136.83 41.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.47 143.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 111.114 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.723 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 56.2 mttp -81.69 123.32 28.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.607 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -145.71 148.54 33.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.858 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 68' ' ' GLU . 38.8 t -91.74 114.27 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.956 0.408 . . . . 0.0 110.059 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.758 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -106.71 134.95 46.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.291 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.5 mmtt -105.11 155.51 18.94 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.9 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 2.1 tmt? -129.16 136.36 50.08 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.105 0.955 . . . . 0.0 112.077 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 8.9 tp10 -110.26 148.53 31.71 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.273 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -58.16 -25.54 57.24 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -168.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.634 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 4.9 m-20 -80.21 28.82 0.29 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.085 0.945 . . . . 0.0 109.738 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 61.52 47.24 6.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.177 -1.828 . . . . 0.0 109.385 172.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.77 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 7.0 mtpt -107.61 123.9 49.16 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.55 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.526 ' HE3' HG11 ' A' ' 48' ' ' VAL . 16.2 mmt -113.88 112.64 23.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.436 HG12 ' HE3' ' A' ' 99' ' ' LYS . 2.4 t -123.39 116.34 48.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.251 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.758 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -132.13 145.17 51.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.447 0.641 . . . . 0.0 110.667 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.5 m -125.49 124.91 42.39 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.497 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 96' ' ' LYS . 62.1 t80 -139.74 112.45 7.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 95' ' ' PHE . 8.6 mtmp? 42.52 57.87 3.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.21 -9.42 60.98 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.152 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 115' ' ' LEU . 2.0 mm -90.31 113.3 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -104.35 130.66 52.19 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.086 0.47 . . . . 0.0 110.577 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 93' ' ' THR . 19.0 t -125.34 124.92 42.61 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.893 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 92' ' ' VAL . 71.9 t -123.32 118.59 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.441 . . . . 0.0 109.877 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 2.8 m -118.62 122.58 42.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.77 ' HG3' ' HE3' ' A' ' 90' ' ' LYS . 12.2 tt0 -129.28 124.95 35.7 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.005 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 109' ' ' ILE . 1.3 m-30 -101.42 115.47 30.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.51 117.46 21.35 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.515 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.06 -95.02 0.39 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.088 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.0 12.93 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.36 . . . . 0.0 110.439 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p -131.38 146.4 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.581 0.705 . . . . 0.0 111.784 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.748 ' HB ' ' OG ' ' A' ' 124' ' ' SER . 21.1 mt -129.09 135.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.341 -173.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 m -115.89 120.52 39.47 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.685 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 14.1 t-20 -107.88 124.79 50.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.004 0.431 . . . . 0.0 110.16 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -119.48 122.45 41.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.806 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.622 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.7 mtt -122.09 150.71 41.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -122.43 120.14 33.06 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.613 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 3.4 tm? -124.63 115.1 20.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.06 -107.0 1.59 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.919 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -115.41 6.69 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.071 0.462 . . . . 0.0 109.959 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.672 ' CD1' ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -93.03 139.61 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.317 -173.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.0 p -108.65 114.99 48.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-O 121.413 0.625 . . . . 0.0 110.841 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.622 ' HD2' ' HB2' ' A' ' 113' ' ' MET . 7.2 t80 -112.03 121.34 44.72 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.367 0.604 . . . . 0.0 111.941 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 6.4 mtmm -121.28 139.42 53.42 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.391 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.685 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 11.4 ptt180 -123.43 142.39 51.04 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -99.86 118.56 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.748 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 93.5 p -129.57 133.23 47.08 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.358 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -129.32 147.28 51.14 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.718 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 10.6 ttp180 -70.85 148.83 47.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.0 110.172 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.674 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 88.0 p . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 -173.37 17.72 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.321 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.713 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 42.9 mtpt -94.33 118.12 31.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.133 0.492 . . . . 0.0 110.086 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 30.7 m-85 -120.13 123.53 43.56 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -97.08 130.52 44.36 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -173.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 0.5 OUTLIER -69.94 140.75 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.581 0.705 . . . . 0.0 110.794 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.669 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.3 mm100 -109.06 -39.58 5.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.75 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 13.3 m -159.15 159.99 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.134 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -139.43 157.5 45.75 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.499 0.666 . . . . 0.0 111.376 177.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.766 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 6.2 tp10 -114.49 126.88 55.45 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.964 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.787 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 89.8 m-20 57.04 35.38 26.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.238 0.542 . . . . 0.0 111.867 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.841 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 32.7 p90 -69.16 21.73 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.402 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.945 ' HG2' HG21 ' A' ' 29' ' ' ILE . 41.1 mt-10 -135.36 -48.26 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -172.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.901 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 42.3 Cg_endo -71.0 -26.4 21.81 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.212 1.275 . . . . 0.0 109.432 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.811 ' HD1' HD11 ' A' ' 118' ' ' ILE . 44.6 t80 -65.11 -52.18 56.91 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.031 175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.957 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 23.3 mmt -61.51 -41.86 97.93 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.297 174.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.75 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 9.0 pttt -68.4 -33.92 75.1 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.553 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.23 66.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.639 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.0 ttm -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.86 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.8 -34.24 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.073 HD12 HG13 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -74.56 126.99 88.14 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.918 ' HD2' HD13 ' A' ' 24' ' ' LEU . 98.9 Cg_endo -79.27 141.68 16.32 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.896 1.73 . . . . 0.0 111.227 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.937 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.1 tt0 -49.67 -42.22 44.9 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.705 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.7 t70 -55.76 -44.14 77.36 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 118.544 0.611 . . . . 0.0 109.854 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' CG ' ' A' ' 25' ' ' PRO . 19.6 mt -68.4 -33.41 74.2 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.777 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.073 HG13 HD12 ' A' ' 24' ' ' LEU . 27.3 mt -64.66 -44.14 96.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.5 169.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 1.066 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 23.0 mm-40 -53.04 -41.0 64.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 1.066 ' HE2' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -71.23 -31.55 67.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.358 178.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.6 44.66 1.18 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.865 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.841 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -79.67 -39.79 30.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -167.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 7.6 t70 -98.88 61.0 1.27 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.032 0.92 . . . . 0.0 110.236 -167.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.3 115.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.814 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -98.31 100.88 12.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.001 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.08 -175.57 34.77 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.2 t -122.05 155.51 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 51' ' ' THR . 16.0 m -133.95 119.68 19.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.145 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.57 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 3.1 mp0 -116.75 123.85 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 4' ' ' SER . 38.7 mt -116.84 143.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 92.6 t -109.02 114.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 167.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 4' ' ' SER . 15.9 t-160 -96.37 112.79 24.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 110.387 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -127.88 145.54 50.91 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -36.67 114.48 0.22 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.433 174.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 1.073 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 58.68 -25.31 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -172.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 21.8 mmtp -91.26 107.09 18.97 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.283 0.492 . . . . 0.0 111.036 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 46.3 t -124.53 124.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.0 110.491 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 1.2 tttm -115.22 139.06 50.26 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.3 tt -121.93 124.95 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.158 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 39' ' ' SER . 58.2 m -110.2 124.38 51.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -129.33 121.06 52.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.2 m -99.53 130.63 45.79 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.658 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -109.18 108.15 18.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.93 -89.68 0.13 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.919 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.8 t -124.82 -3.65 7.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.749 0.309 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -121.91 136.2 54.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.749 0.309 . . . . 0.0 110.181 -170.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 93.8 t -98.33 134.19 37.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.012 0.91 . . . . 0.0 112.223 -172.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -118.64 114.75 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.603 176.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.628 ' C ' HD22 ' A' ' 61' ' ' ASN . 0.0 OUTLIER -87.35 145.43 26.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.962 -172.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -135.07 98.6 4.04 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 49' ' ' LYS . 3.5 mp0 -102.55 132.08 48.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.992 -0.443 . . . . 0.0 110.618 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -150.02 151.81 33.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.663 0.744 . . . . 0.0 112.091 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 22.9 m -107.78 134.03 51.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.112 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.073 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.7 mt -48.08 131.13 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.869 0.366 . . . . 0.0 111.05 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.77 60.8 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.013 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 64' ' ' THR . 50.4 mm-40 -132.98 139.03 47.07 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 28.3 tt0 -80.56 116.98 20.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.9 t -135.75 160.74 37.6 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.272 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.5 pt-20 -95.95 145.15 25.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.221 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 19.4 mt -105.88 128.42 53.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.509 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 59' ' ' ILE . 14.5 tt0 -91.63 120.29 32.27 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.2 p -90.51 166.42 13.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.997 -173.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.27 -20.24 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.858 0.361 . . . . 0.0 110.64 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 p -82.61 -38.67 23.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 133.04 -14.89 4.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.56 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -77.38 138.39 39.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.824 0.312 . . . . 0.0 111.534 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 9.9 mmmm -96.85 135.83 38.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.804 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -137.13 131.45 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.346 177.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 41.0 pttt -83.68 124.24 30.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.478 0.656 . . . . 0.0 111.031 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.99 149.38 41.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.428 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' THR . 71.2 t -93.95 113.08 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -104.76 132.33 51.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -117.66 156.17 28.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.492 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.789 ' HB3' HD13 ' A' ' 65' ' ' LEU . 8.7 tpp -126.32 122.23 34.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.098 0.951 . . . . 0.0 110.147 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.634 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 12.2 tp10 -46.43 -43.9 16.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.752 -2.022 . . . . 0.0 110.527 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.572 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . 137.94 -59.65 0.61 Allowed Glycine 0 CA--C 1.5 -0.901 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.857 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -63.4 -72.0 0.15 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.16 0.505 . . . . 0.0 110.954 176.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.811 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 1.5 p30 -150.43 13.16 0.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.634 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -109.81 119.87 40.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.004 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.496 ' HG2' ' HB2' ' A' ' 85' ' ' MET . 50.9 mtm -121.98 115.96 23.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.783 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 101' ' ' VAL . 1.4 t -124.06 122.15 63.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.905 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.834 HG22 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -113.07 143.53 44.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.8 m -125.62 129.78 50.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 58.5 t80 -138.59 157.56 45.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.649 175.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 98' ' ' ILE . 48.1 mtmt -41.71 104.58 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.932 0.493 . . . . 0.0 112.007 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.51 -30.7 1.01 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.229 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 2.1 mm -90.04 111.72 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 113' ' ' MET . 46.3 tttt -113.29 125.46 54.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.025 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -114.2 119.11 35.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 92' ' ' VAL . 74.9 t -118.74 119.22 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -117.42 120.46 38.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.626 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.86 120.48 24.99 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.977 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.29 112.48 25.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.031 171.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -127.34 107.57 10.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.454 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.44 45.47 37.42 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.237 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 6.5 m-20 68.48 4.83 4.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.955 0.502 . . . . 0.0 111.84 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 p -117.95 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 104' ' ' PHE . 4.9 mt -109.91 132.57 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -107.33 119.76 40.28 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.822 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.786 ' HB2' ' HG2' ' A' ' 122' ' ' ARG . 18.8 m120 -106.61 121.65 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -121.75 118.78 29.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.103 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 77.1 mtm -124.8 149.83 46.98 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -127.85 122.59 33.0 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 122.126 -0.359 . . . . 0.0 110.722 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -111.84 112.41 24.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.18 -98.74 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.703 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -104.97 -12.87 15.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.502 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.811 HD11 ' HD1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.4 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.397 -172.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.59 115.05 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.487 0.66 . . . . 0.0 110.822 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 t80 -100.37 119.06 37.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 4.4 tmmm? -128.11 124.58 37.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.469 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.786 ' HG2' ' HB2' ' A' ' 111' ' ' ASN . 14.5 ptt180 -120.02 148.65 43.3 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.549 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 10' ' ' GLN . 6.7 p -101.61 118.26 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.596 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.737 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 84.3 p -125.42 132.54 52.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.8 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -132.0 146.65 52.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -70.08 149.6 47.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.933 -176.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.713 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 5.6 pt . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.471 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.687 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 82.1 p . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -170.7 13.45 Favored Glycine 0 CA--C 1.5 -0.888 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 17.0 mtpp -96.82 118.24 32.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.681 0.753 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.74 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 6.0 m-85 -120.7 134.91 55.25 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -102.0 140.13 36.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -175.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.9 t -64.64 139.07 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 122.004 0.907 . . . . 0.0 110.984 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.896 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.5 mm-40 -114.12 -58.17 2.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.954 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.681 ' HB2' HG12 ' A' ' 123' ' ' VAL . 29.0 m -157.18 152.36 26.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.681 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.67 151.35 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.54 0.686 . . . . 0.0 110.792 174.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 13.7 mm-40 -94.45 130.22 40.9 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.525 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.723 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 16.9 m-20 70.52 -82.31 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 O-C-N 123.715 0.634 . . . . 0.0 110.927 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' PHE . 51.0 p90 39.57 36.46 0.24 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.651 1.58 . . . . 0.0 112.304 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.913 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.9 mt-10 -144.47 -46.5 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.157 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.913 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 61.1 Cg_endo -68.22 -34.72 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.968 1.779 . . . . 0.0 109.718 169.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -62.3 -50.03 73.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.947 -1.933 . . . . 0.0 111.198 174.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.614 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 61.0 mmm -62.96 -41.07 99.42 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.881 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 16.1 ptmt -69.03 -32.73 72.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.25 0.547 . . . . 0.0 110.319 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.55 71.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.954 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.0 mtt -83.42 -59.46 2.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.25 -44.3 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.678 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.6 tp -75.56 126.44 87.44 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 117.564 0.682 . . . . 0.0 110.037 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.667 ' CD ' HD12 ' A' ' 28' ' ' LEU . 86.3 Cg_endo -73.85 153.39 47.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.709 2.273 . . . . 0.0 111.424 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.992 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 tt0 -50.56 -43.71 56.39 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.243 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.724 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 p-10 -57.18 -41.72 79.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 118.4 0.545 . . . . 0.0 110.704 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CD ' ' A' ' 25' ' ' PRO . 46.8 mt -71.08 -34.32 71.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.883 -0.51 . . . . 0.0 109.714 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.992 HD12 ' HA ' ' A' ' 26' ' ' GLU . 45.4 mt -61.73 -46.9 95.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.692 170.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.785 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.6 mm-40 -52.36 -44.36 65.19 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.547 1.139 . . . . 0.0 112.05 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.724 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -69.71 -31.35 69.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.415 0.626 . . . . 0.0 110.343 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -122.09 29.16 5.63 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.585 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 29' ' ' ILE . 23.5 pttm -79.41 -28.34 41.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 111.523 -171.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.73 44.99 1.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.23 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 32' ' ' GLY . 27.7 mm -93.9 123.96 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -108.54 99.45 8.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.438 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -89.62 -179.96 44.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.936 -174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 3.5 t -123.26 148.24 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 51' ' ' THR . 19.2 m -128.77 123.53 33.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.974 0.416 . . . . 0.0 112.086 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 15.5 mp0 -117.0 123.46 46.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.805 HG12 ' HG ' ' A' ' 50' ' ' LEU . 25.0 mt -120.72 141.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.933 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 44' ' ' GLU . 96.1 t -109.13 119.52 58.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.787 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.443 ' N ' ' HB3' ' A' ' 4' ' ' SER . 23.3 t-80 -93.07 112.55 24.55 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.854 0.835 . . . . 0.0 109.814 173.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 43.4 mm-40 -123.33 144.01 49.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.09 0.09 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.363 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.801 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmm 71.79 -24.01 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.121 1.369 . . . . 0.0 112.869 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 70.0 mmtt -96.0 109.77 22.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.441 HG21 ' CE ' ' A' ' 91' ' ' MET . 55.9 t -121.72 123.56 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 111.5 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.0 mttm -112.37 123.06 49.45 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.715 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.805 ' HG ' HG12 ' A' ' 41' ' ' ILE . 2.3 tt -114.81 121.84 44.53 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -106.28 125.3 50.83 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.678 HG13 HD22 ' A' ' 50' ' ' LEU . 1.1 mt -129.26 121.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -171.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.969 HG23 HG22 ' A' ' 58' ' ' VAL . 23.9 m -104.01 129.07 51.59 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 40.0 t80 -116.45 106.47 13.64 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.42 -99.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.546 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 t -94.37 -28.72 15.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 110.846 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -107.71 125.37 51.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.841 -166.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.969 HG22 HG23 ' A' ' 53' ' ' THR . 21.2 t -99.51 125.19 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.709 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -124.82 114.33 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 122.635 1.207 . . . . 0.0 109.093 177.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.505 ' HB3' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -109.72 149.56 29.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.334 -172.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.64 108.38 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.59 125.65 51.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.065 0.46 . . . . 0.0 110.403 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 83' ' ' VAL . 3.5 p90 -151.38 152.73 33.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.618 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 15.6 m -111.6 134.71 52.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.78 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.801 ' HG ' ' HB3' ' A' ' 46' ' ' LYS . 4.0 pp -49.43 143.81 6.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.17 0.51 . . . . 0.0 111.617 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 67.15 19.15 69.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.763 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' THR . 76.1 mm-40 -129.24 146.94 51.05 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.692 0.246 . . . . 0.0 110.86 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 41.8 tt0 -79.86 118.41 21.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.9 m -134.21 150.48 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.101 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 3.3 pt-20 -95.01 140.01 30.57 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.19 -173.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 81' ' ' ALA . 18.5 mt -109.54 134.35 52.01 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.202 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HG3' ' HD2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -87.57 138.26 31.63 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 121.948 0.88 . . . . 0.0 108.927 169.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.9 p -95.16 167.81 11.13 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.769 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.3 tpp -65.67 -18.17 65.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -83.74 -39.93 19.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.901 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.709 ' HA2' ' CD1' ' A' ' 59' ' ' ILE . . . 130.1 -5.81 6.04 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.308 -0.948 . . . . 0.0 114.719 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -79.87 144.72 33.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.573 0.686 . . . . 0.0 110.558 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.17 125.73 38.98 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.11 130.94 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 22.8 pttt -97.12 140.48 31.56 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.321 1.058 . . . . 0.0 112.976 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.43 159.99 42.67 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.168 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -94.36 112.85 27.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.348 0.594 . . . . 0.0 110.153 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.738 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 2.0 m -103.78 136.36 37.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.682 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.1 mttt -116.45 156.94 25.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.768 0.318 . . . . 0.0 110.336 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' HD23 ' A' ' 65' ' ' LEU . 32.6 ttp -126.34 135.54 51.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.888 0.851 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.081 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 11.1 tp10 -86.12 -14.75 43.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.614 -173.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 114.36 -68.87 0.25 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.993 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 90' ' ' LYS . 2.4 p-10 -74.65 44.46 0.21 Allowed 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.342 0.592 . . . . 0.0 110.966 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.868 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 7.6 m-80 65.02 44.98 3.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.8 169.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 1.081 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -106.51 121.37 44.16 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 166.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.441 ' CE ' HG21 ' A' ' 48' ' ' VAL . 2.0 mpt? -119.58 114.39 22.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -124.43 119.22 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -126.4 139.86 52.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.182 0.515 . . . . 0.0 110.661 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -128.99 139.89 51.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.899 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -138.84 113.4 8.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.971 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.0 -95.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.024 0.53 . . . . 0.0 111.677 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.19 10.15 15.13 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mm -92.19 122.77 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 113' ' ' MET . 38.1 tttm -123.97 116.72 23.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.229 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 93' ' ' THR . 14.6 m -121.65 119.92 33.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 92.0 t -117.0 119.64 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.779 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 m -117.47 126.1 52.04 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.823 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 39.1 tt0 -127.45 121.98 32.26 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.659 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.868 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 7.4 m-30 -92.98 116.12 28.76 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 167.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -124.24 110.99 15.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.49 -74.32 1.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.637 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -165.91 13.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.106 -0.547 . . . . 0.0 109.591 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 125' ' ' LYS . 2.8 m -123.44 142.22 51.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.52 0.676 . . . . 0.0 110.425 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 7' ' ' TYR . 15.0 mt -102.77 129.85 53.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.338 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -113.38 117.4 31.67 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 167.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.1 t-20 -113.74 120.38 40.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.946 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.729 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -121.88 115.97 23.55 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.64 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 9.3 ttp -125.93 144.45 50.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -121.44 121.62 37.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.771 ' HB2' HG12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -92.95 145.59 24.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.05 25.46 0.15 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -165.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.4 t70 -149.83 -9.04 0.3 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 159.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -116.01 139.62 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.71 -168.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 p -106.56 116.55 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.433 0.635 . . . . 0.0 110.192 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.64 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -115.36 120.97 41.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.105 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 23.6 ttpt -125.14 137.34 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.24 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 111' ' ' ASN . 44.4 ttt180 -132.08 127.12 35.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 111.682 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.896 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.3 p -101.88 128.15 54.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 20.9 m -134.63 131.89 38.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.409 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HA ' HG23 ' A' ' 108' ' ' THR . 11.4 ptmt -120.96 145.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.609 0.64 . . . . 0.0 111.334 -170.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 43.3 ttt180 -70.1 151.5 45.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.624 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 6.0 pt . . . . . 0 N--CA 1.431 -1.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.814 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.718 HD22 ' ND2' ' A' ' 89' ' ' ASN . 1.7 p-10 -89.47 128.44 35.96 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -174.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.632 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 0.7 OUTLIER -173.96 -59.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.359 169.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 68.6 p -144.54 175.8 9.87 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.744 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.97 -174.29 18.26 Favored Glycine 0 CA--C 1.501 -0.783 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.573 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.992 ' HE2' HG12 ' A' ' 127' ' ' ILE . 6.1 mtpt -97.64 120.71 38.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.642 0.734 . . . . 0.0 110.685 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 35.9 m-85 -123.79 124.95 43.82 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -93.57 138.86 31.41 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -168.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.485 HG22 ' HD3' ' A' ' 122' ' ' ARG . 1.6 t -70.77 127.96 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.398 0.618 . . . . 0.0 109.918 176.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.859 ' HB2' HG13 ' A' ' 123' ' ' VAL . 13.2 mm100 -111.59 -47.24 3.18 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.518 -174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' HG12 ' A' ' 123' ' ' VAL . 24.3 m -161.61 152.82 18.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.987 -172.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -145.57 156.5 43.73 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.257 0.551 . . . . 0.0 111.362 174.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.843 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 51.3 mm-40 -97.51 142.81 28.88 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.954 174.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 118' ' ' ILE . 1.9 m-80 69.22 26.48 5.42 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' CD2' ' HB2' ' A' ' 33' ' ' LYS . 4.7 p90 -63.26 -0.31 0.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 176.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.863 ' HA ' HD13 ' A' ' 29' ' ' ILE . 80.7 mt-10 -116.84 -51.2 0.04 OUTLIER Pre-proline 0 C--O 1.216 -0.665 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.155 -178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.711 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 27.1 Cg_exo -55.43 -42.81 64.39 Favored 'Trans proline' 0 CA--C 1.511 -0.656 0 C-N-CA 121.853 1.702 . . . . 0.0 112.732 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 5.8 t80 -60.55 -49.6 76.87 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.833 -1.531 . . . . 0.0 109.601 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.637 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 25.2 mmt -63.02 -43.7 98.03 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.447 176.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 15.5 ptmt -64.71 -36.94 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.925 -171.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -73.37 -36.82 66.14 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.851 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -82.96 -28.18 29.98 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.6 -39.7 0.36 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 119.372 -1.394 . . . . 0.0 114.402 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.663 HD23 HG12 ' A' ' 29' ' ' ILE . 13.0 tp -80.65 129.09 69.82 Favored Pre-proline 0 N--CA 1.446 -0.673 0 CA-C-N 117.689 0.745 . . . . 0.0 110.131 -176.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.659 ' CD ' HD12 ' A' ' 28' ' ' LEU . 93.2 Cg_endo -73.5 146.87 40.09 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.296 1.998 . . . . 0.0 111.196 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 7.4 tt0 -48.81 -41.22 32.01 Favored 'General case' 0 C--O 1.207 -1.134 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.108 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.749 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 29.3 t70 -64.1 -37.44 87.45 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 119.197 0.908 . . . . 0.0 110.871 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.659 HD12 ' CD ' ' A' ' 25' ' ' PRO . 31.1 mt -69.78 -34.46 73.79 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 20.4 mt -64.11 -45.94 95.08 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.431 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.599 172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.073 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 35.1 mm-40 -51.32 -48.17 62.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.671 0.748 . . . . 0.0 112.078 -173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.749 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -63.53 -30.05 71.22 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.619 -177.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.62 41.14 1.46 Allowed Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.438 -174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.073 ' HE2' ' HA ' ' A' ' 30' ' ' GLN . 15.7 ptpt -79.96 -41.45 25.95 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -165.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 33' ' ' LYS . 38.7 t70 -109.96 60.37 0.6 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.917 0.865 . . . . 0.0 110.562 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.2 mm -80.89 130.27 36.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.026 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.85 146.55 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -145.3 169.05 27.02 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 8' ' ' GLN . 15.2 t -127.85 141.55 46.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 117.339 0.569 . . . . 0.0 109.494 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.5 t -119.02 131.76 56.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.203 0.525 . . . . 0.0 111.238 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -125.01 122.92 38.68 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.595 174.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 4' ' ' SER . 97.1 mt -117.47 138.16 49.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.14 -173.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 49' ' ' LYS . 96.8 t -109.15 119.87 59.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.615 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.682 ' H ' ' HB3' ' A' ' 4' ' ' SER . 10.6 t-160 -97.77 114.72 26.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.352 0.596 . . . . 0.0 110.562 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -133.17 141.55 48.17 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -37.24 114.27 0.24 Allowed Glycine 0 CA--C 1.521 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 113.642 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.556 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 28.0 mtmt 75.47 -43.59 0.5 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.882 1.273 . . . . 0.0 112.539 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 64' ' ' THR . 1.0 OUTLIER -96.28 109.79 22.22 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.897 0.856 . . . . 0.0 111.822 -171.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.6 t -103.7 128.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.261 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 78.0 mttt -107.94 125.44 51.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.297 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.653 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -120.04 123.64 43.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -177.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.73 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.6 m -106.84 124.15 49.2 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.2 mt -131.3 122.27 50.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.332 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.924 HG23 HG22 ' A' ' 58' ' ' VAL . 19.8 m -101.45 130.08 47.61 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.063 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -116.64 106.21 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.35 -99.58 0.09 OUTLIER Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.115 -0.564 . . . . 0.0 113.04 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.3 t -99.09 -24.4 14.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.418 0.628 . . . . 0.0 110.483 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.644 ' HE2' ' N ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -105.96 123.01 47.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.239 -169.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 HG23 ' A' ' 53' ' ' THR . 24.3 t -98.26 124.8 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-O 121.873 0.844 . . . . 0.0 109.55 177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.516 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -116.45 114.99 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 114.105 -1.407 . . . . 0.0 108.82 -173.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 148.5 26.71 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.28 -1.782 . . . . 0.0 112.378 -172.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -139.7 87.84 2.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.487 0.661 . . . . 0.0 110.482 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HG2' ' HA ' ' A' ' 49' ' ' LYS . 33.4 mt-10 -107.21 127.16 53.27 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.643 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' HE1' ' HG2' ' A' ' 91' ' ' MET . 9.7 p90 -150.43 152.0 33.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.09 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 47' ' ' LYS . 4.3 m -106.54 132.44 52.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.63 ' O ' HD12 ' A' ' 65' ' ' LEU . 3.8 pp -47.17 143.36 3.25 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 112.394 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 68.42 25.03 74.99 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.569 177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -135.24 145.45 47.62 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.262 -175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 23.6 tt0 -76.6 118.64 19.46 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 169.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 55.2 m -134.03 158.75 42.75 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.273 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 4.1 mt-10 -97.6 120.64 38.34 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 122.5 1.143 . . . . 0.0 111.906 -175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.713 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 32.5 mt -93.69 121.59 35.27 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 112.732 -2.031 . . . . 0.0 109.872 -174.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.516 ' OE1' HG12 ' A' ' 59' ' ' ILE . 15.8 tt0 -95.22 120.54 35.62 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.471 ' O ' HD13 ' A' ' 59' ' ' ILE . 24.2 p -86.72 164.19 16.88 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.282 -171.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 ttt -64.61 -14.65 58.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.198 0.523 . . . . 0.0 109.827 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -85.9 -40.7 15.65 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.798 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.42 -13.32 4.01 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.148 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -78.54 129.65 35.07 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.663 -0.316 . . . . 0.0 111.315 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.713 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -105.17 130.52 53.32 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.603 176.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -134.64 147.99 29.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.065 0.46 . . . . 0.0 112.048 -175.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 51.0 mttm -82.7 123.27 29.13 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 177.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.64 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.64 145.19 32.28 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 174.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 68.5 t -90.5 112.84 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 121.488 0.661 . . . . 0.0 109.803 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.728 ' HB ' ' CG2' ' A' ' 93' ' ' THR . 0.2 OUTLIER -109.14 134.61 50.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.363 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.505 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -113.67 153.1 29.49 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 172.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.63 ' HG2' ' HG3' ' A' ' 91' ' ' MET . 9.4 tmm? -129.41 124.88 35.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 122.257 1.027 . . . . 0.0 110.015 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 6.1 tp10 -56.67 -60.64 3.26 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 112.959 -1.928 . . . . 0.0 113.736 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.528 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 145.56 -54.38 0.55 Allowed Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -169.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 23.0 t70 -80.67 27.24 0.37 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.008 0.909 . . . . 0.0 109.086 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.718 ' ND2' HD22 ' A' ' 2' ' ' ASN . 7.2 m-80 65.37 58.49 0.85 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 113.909 -1.496 . . . . 0.0 111.685 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.779 ' HE2' ' HG2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -108.14 121.37 44.71 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 166.161 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.63 ' HG3' ' HG2' ' A' ' 85' ' ' MET . 1.4 mpp? -118.27 114.61 23.26 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 3.5 t -124.84 122.02 62.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.196 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.728 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 0.4 OUTLIER -126.71 144.17 51.01 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.207 0.527 . . . . 0.0 110.61 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.1 m -122.31 126.43 48.09 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.992 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -138.58 114.6 10.11 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt 56.85 -102.45 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.268 0.355 . . . . 0.0 111.128 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -118.32 14.14 12.19 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.751 HD12 ' HA ' ' A' ' 115' ' ' LEU . 1.6 mm -94.37 113.37 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' MET . 18.2 ttpt -110.16 118.17 35.65 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.943 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.5 t -114.85 120.62 40.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.162 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 85.5 t -119.73 119.91 61.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.287 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.56 HG22 ' HE1' ' A' ' 104' ' ' PHE . 2.6 m -117.69 120.5 38.17 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.904 174.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.779 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 5.0 tm-20 -130.29 127.27 39.18 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.144 -0.347 . . . . 0.0 110.669 -178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 109' ' ' ILE . 7.1 m-30 -104.74 114.79 29.22 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.039 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.01 126.23 37.24 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.413 0.445 . . . . 0.0 110.771 175.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.56 31.79 71.69 Favored Glycine 0 CA--C 1.517 0.193 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.811 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 64.06 19.34 11.72 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.99 0.516 . . . . 0.0 112.253 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.0 p -116.02 130.57 56.87 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 169.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.574 HD13 ' CE1' ' A' ' 104' ' ' PHE . 6.1 mt -110.21 128.59 66.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.834 -170.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.2 m -116.88 120.19 37.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.94 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -106.7 121.78 45.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.695 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 4.4 m -120.36 120.58 36.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.647 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.522 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 65.9 mtt -119.68 149.72 41.53 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.149 0.499 . . . . 0.0 110.36 177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 49.8 m -118.86 119.82 35.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 169.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.751 ' HA ' HD12 ' A' ' 98' ' ' ILE . 3.4 tm? -123.79 113.49 18.63 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 66.58 -93.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.277 -0.963 . . . . 0.0 111.623 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -133.56 10.78 4.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.952 0.882 . . . . 0.0 109.357 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.539 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -97.74 141.33 16.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.696 -173.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 119' ' ' VAL . 7.6 p -110.86 114.95 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 121.621 0.724 . . . . 0.0 111.267 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HD2' ' O ' ' A' ' 13' ' ' GLU . 1.3 t80 -117.01 125.58 51.58 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.68 -170.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.843 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -124.97 129.83 51.13 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.998 176.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.485 ' HD3' HG22 ' A' ' 9' ' ' VAL . 30.3 ttm180 -116.96 137.8 51.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.52 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.859 HG13 ' HB2' ' A' ' 10' ' ' GLN . 12.7 p -101.87 117.06 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 CA-C-O 121.88 0.847 . . . . 0.0 109.771 173.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 16.2 m -121.36 127.9 51.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.079 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 mtpm? -121.3 137.54 54.65 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.299 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 24.5 ttt180 -68.1 147.77 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.992 HG12 ' HE2' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 C--O 1.247 0.948 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -170.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.577 0.227 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.753 HD22 ' ND2' ' A' ' 89' ' ' ASN . 2.1 p-10 -99.15 116.88 32.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.873 0.368 . . . . 0.0 110.42 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.555 ' O ' ' HB2' ' A' ' 4' ' ' SER . 2.0 p90 -172.96 45.18 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.486 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.654 ' HB3' ' C ' ' A' ' 41' ' ' ILE . 58.6 m 69.16 174.17 0.29 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.324 -174.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.59 -164.04 28.47 Favored Glycine 0 CA--C 1.499 -0.933 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.888 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.869 ' HE3' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -90.03 117.8 29.1 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 59.2 m-85 -132.06 127.67 36.61 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 10.1 tm0? -103.4 140.74 37.05 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.24 -171.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.1 t -66.19 137.51 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 122.147 0.975 . . . . 0.0 111.566 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.676 ' HB3' HG13 ' A' ' 123' ' ' VAL . 0.1 OUTLIER -114.2 -59.94 1.95 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 113.385 -1.734 . . . . 0.0 110.942 -168.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.533 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 11.5 m -158.02 153.9 26.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.435 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -145.98 155.42 42.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.615 0.722 . . . . 0.0 112.015 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.767 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 16.6 mm-40 -94.2 142.11 27.78 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.342 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.558 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 9.0 m-20 72.61 -82.42 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.472 0 O-C-N 123.559 0.537 . . . . 0.0 111.876 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.624 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.8 p90 39.93 28.03 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.266 1.826 . . . . 0.0 113.236 -176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.917 ' HA ' HD13 ' A' ' 29' ' ' ILE . 74.5 mt-10 -147.26 -49.9 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.634 -172.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.739 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 59.6 Cg_endo -74.7 -23.98 13.95 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 108.411 -1.419 . . . . 0.0 108.411 168.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.439 ' HA ' HG12 ' A' ' 118' ' ' ILE . 3.5 t80 -60.8 -52.79 63.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 113.159 -1.837 . . . . 0.0 108.983 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.649 ' HB2' HD11 ' A' ' 29' ' ' ILE . 24.6 mmt -64.98 -38.99 92.78 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.526 177.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.593 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 7.5 ptmm? -66.05 -33.06 74.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.126 0.488 . . . . 0.0 110.069 -174.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.15 -38.79 86.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.457 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 18.8 ptm -85.86 -22.16 27.69 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.88 -39.02 0.69 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.677 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 19' ' ' MET . 14.9 tp -75.54 130.01 80.5 Favored Pre-proline 0 N--CA 1.449 -0.479 0 CA-C-N 117.308 0.554 . . . . 0.0 110.478 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' HD12 ' A' ' 28' ' ' LEU . 88.3 Cg_endo -78.1 153.83 28.72 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.799 1.666 . . . . 0.0 111.346 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.087 ' HA ' HD12 ' A' ' 29' ' ' ILE . 9.6 tt0 -50.09 -44.34 51.88 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.383 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.622 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 7.7 t70 -59.12 -37.26 76.8 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.308 -175.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.887 HD12 ' HD2' ' A' ' 25' ' ' PRO . 59.8 mt -72.32 -37.5 68.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.912 0.387 . . . . 0.0 110.076 175.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.087 HD12 ' HA ' ' A' ' 26' ' ' GLU . 38.9 mt -59.22 -44.2 91.4 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.362 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.904 172.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.836 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.3 mm-40 -54.03 -34.01 58.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 124.621 1.169 . . . . 0.0 111.775 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 2.1 mptp? -68.44 -33.03 73.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.961 0.41 . . . . 0.0 110.669 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -131.55 35.66 2.37 Favored Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.835 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.624 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 25.3 pttm -79.1 -32.24 44.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.297 0.57 . . . . 0.0 112.321 -169.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -99.16 24.55 7.76 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.062 -167.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 33.0 mt -81.13 115.93 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-O 121.372 0.606 . . . . 0.0 112.39 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -109.8 126.69 54.05 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.329 177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.707 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -115.31 -169.02 15.71 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.963 -173.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' HA ' ' HG2' ' A' ' 8' ' ' GLN . 11.1 t -121.57 141.1 43.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.838 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.8 t -117.01 139.22 50.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 -178.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 51' ' ' THR . 1.1 mm-40 -135.23 124.59 24.74 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.965 173.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 5.1 mt -127.96 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.1 -171.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.4 t -111.16 120.47 61.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.627 168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' H ' ' HB2' ' A' ' 4' ' ' SER . 11.5 t-160 -92.41 114.52 27.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.805 0.812 . . . . 0.0 110.45 172.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.62 142.21 46.83 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -33.58 111.17 0.06 OUTLIER Glycine 0 C--N 1.335 0.477 0 O-C-N 123.643 0.589 . . . . 0.0 113.998 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 2.3 mtmt 66.62 -45.47 0.44 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.476 1.51 . . . . 0.0 113.342 -173.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HG2' ' H ' ' A' ' 47' ' ' LYS . 2.2 ptpp? -90.74 107.45 19.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.762 0.791 . . . . 0.0 111.282 -170.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.64 HG21 ' SD ' ' A' ' 85' ' ' MET . 90.6 t -123.09 125.87 72.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.159 -175.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.659 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -109.24 130.47 55.49 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 121.248 0.547 . . . . 0.0 109.678 -176.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -116.42 133.33 56.14 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.937 -1.029 . . . . 0.0 108.88 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.838 ' O ' ' HA ' ' A' ' 39' ' ' SER . 1.1 m -114.34 124.88 53.08 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.9 mt -131.84 121.96 48.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.022 HG23 HG22 ' A' ' 58' ' ' VAL . 26.4 m -96.8 127.81 43.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -175.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -120.88 107.34 12.58 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.91 -98.07 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.565 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.2 t -103.95 -24.14 13.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.107 0.48 . . . . 0.0 110.854 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.673 ' HE2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.41 128.73 55.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.189 -172.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.022 HG22 HG23 ' A' ' 53' ' ' THR . 26.9 t -96.6 125.39 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 121.925 0.869 . . . . 0.0 109.522 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.673 HG13 ' HE2' ' A' ' 57' ' ' LYS . 1.3 mt -112.51 112.42 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.524 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.625 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -91.37 141.47 28.72 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.668 -178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.605 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.4 m120 -125.29 83.73 2.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.747 -178.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 43.1 tt0 -102.24 126.75 49.32 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -147.62 153.08 38.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.955 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' A' ' 67' ' ' GLU . 13.5 m -114.05 128.68 56.49 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.794 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.0 pp -58.59 143.32 46.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.155 0.502 . . . . 0.0 111.941 -178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 59.0 23.38 56.99 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.58 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' HB3' ' HB ' ' A' ' 64' ' ' THR . 8.8 tt0 -145.32 133.13 21.14 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -167.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -80.48 119.42 23.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.285 0.564 . . . . 0.0 110.66 -173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.8 t -136.3 163.64 29.94 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.256 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -95.1 119.57 33.84 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.317 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 61.6 mt -100.72 122.39 43.27 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 112.747 -2.024 . . . . 0.0 110.728 -174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HB3' HG23 ' A' ' 59' ' ' ILE . 39.2 tt0 -89.24 128.1 35.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.654 ' O ' HD13 ' A' ' 59' ' ' ILE . 13.2 p -84.78 168.03 15.53 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.833 -175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.9 tpt -56.16 -28.22 57.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.437 0.637 . . . . 0.0 109.978 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.47 -27.73 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.995 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 123.12 -11.2 8.69 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.658 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.35 127.03 31.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.901 0.351 . . . . 0.0 110.466 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.84 127.65 48.56 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.65 147.07 27.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.362 -176.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.9 pttt -82.01 123.77 29.2 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.479 0.657 . . . . 0.0 109.744 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' HB3' ' CD1' ' A' ' 71' ' ' LEU . . . -139.07 147.44 42.02 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.49 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.7 t -95.26 111.57 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-O 121.649 0.738 . . . . 0.0 109.368 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.756 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.7 m -100.73 133.37 44.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.49 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 3.9 mmtt -106.08 151.37 24.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.64 ' SD ' HG21 ' A' ' 48' ' ' VAL . 21.1 ttt -132.89 131.42 40.9 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.317 1.056 . . . . 0.0 112.785 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.092 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 5.4 tp10 -84.95 139.32 31.9 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 112.766 -2.015 . . . . 0.0 108.57 172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -60.83 -25.39 63.77 Favored Glycine 0 C--O 1.23 -0.151 0 CA-C-N 115.849 -0.614 . . . . 0.0 113.953 -168.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.724 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 32.5 t70 -83.68 23.09 1.01 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.631 0.729 . . . . 0.0 110.208 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.753 ' ND2' HD22 ' A' ' 2' ' ' ASN . 10.5 m-80 71.53 57.12 0.18 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.962 176.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.092 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -113.19 121.84 45.69 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 1.058 ' HG2' ' HB ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -116.78 115.8 26.27 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.475 0.655 . . . . 0.0 110.118 179.131 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.915 HG13 HG22 ' A' ' 101' ' ' VAL . 5.3 t -125.73 117.7 49.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.568 -177.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.756 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -129.86 144.29 51.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.408 0.623 . . . . 0.0 111.765 -177.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 59.3 m -127.26 131.74 50.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.774 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -138.45 130.04 27.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.825 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 64.05 -75.84 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.78 0.675 . . . . 0.0 110.948 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.63 29.9 0.25 Allowed Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 114' ' ' THR . 38.9 mm -116.55 131.92 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 114.58 -0.81 . . . . 0.0 108.851 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' MET . 11.6 ttmm -112.63 128.15 56.3 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.825 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.543 ' HB2' HG23 ' A' ' 93' ' ' THR . 13.3 m -122.18 119.91 32.63 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.915 HG22 HG13 ' A' ' 92' ' ' VAL . 99.2 t -123.4 117.35 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.938 0.399 . . . . 0.0 110.595 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 1.058 ' HB ' ' HG2' ' A' ' 91' ' ' MET . 32.3 m -118.31 121.38 40.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 176.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.888 ' HG2' ' HE2' ' A' ' 90' ' ' LYS . 8.2 tm-20 -129.55 128.38 42.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.881 0.372 . . . . 0.0 110.633 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.605 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 5.3 m-30 -96.88 115.37 27.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.074 -178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.96 102.87 6.47 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.754 175.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 107' ' ' ASP . . . 54.24 75.03 0.25 Allowed Glycine 0 N--CA 1.455 -0.087 0 CA-C-O 119.758 -0.468 . . . . 0.0 113.701 173.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 6.6 t70 72.23 -26.44 0.18 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 125' ' ' LYS . 7.7 p -107.21 134.68 49.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.037 0.922 . . . . 0.0 112.315 -176.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.556 HD13 ' CE1' ' A' ' 104' ' ' PHE . 4.4 mt -109.38 127.11 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.079 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.7 m -104.54 118.35 36.38 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 54.3 t30 -109.58 121.25 44.79 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 174.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.667 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.32 114.9 21.41 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.721 177.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.644 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 22.1 ttt -127.26 150.36 49.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 98' ' ' ILE . 93.9 m -126.98 120.29 28.73 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.156 -0.34 . . . . 0.0 110.098 -177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.662 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -108.62 113.55 26.63 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.74 -91.84 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.31 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -126.17 1.64 7.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.934 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.662 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -91.32 141.53 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.815 -172.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.2 p -105.8 116.32 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 121.896 0.855 . . . . 0.0 110.585 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.644 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 60.8 t80 -103.52 117.98 35.69 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.88 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.767 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -124.22 124.63 42.86 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.073 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.504 HH22 HD11 ' A' ' 52' ' ' ILE . 33.9 ttt180 -127.24 132.67 50.34 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.973 -169.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.676 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.2 p -101.52 118.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.182 171.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 m -127.64 134.19 49.64 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.99 -1.004 . . . . 0.0 109.3 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -136.19 150.55 49.06 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.336 -174.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.77 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 17.3 ttt180 -69.06 149.35 48.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.849 -173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.869 HG13 ' HE3' ' A' ' 6' ' ' LYS . 3.0 pt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.104 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HG3' ' H ' ' A' ' 2' ' ' ASN . 21.4 ptm . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.326 0.107 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.55 ' ND2' HD21 ' A' ' 89' ' ' ASN . 1.3 m120 -112.63 134.89 53.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.616 ' H ' ' CG ' ' A' ' 89' ' ' ASN . 30.6 m-85 79.06 -66.18 0.19 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 124.067 0.854 . . . . 0.0 110.684 167.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 30.0 p -134.68 -176.23 4.16 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.609 -172.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 127.75 179.73 16.0 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.343 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.689 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 0.5 OUTLIER -106.99 122.48 46.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 28.9 m-85 -127.85 126.01 40.81 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.697 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.83 134.25 36.38 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -172.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.944 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -70.04 134.38 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.779 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.5 mm100 -115.71 -40.87 3.29 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.105 -170.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.637 ' HB2' HG12 ' A' ' 123' ' ' VAL . 58.2 m -156.24 151.47 26.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.819 -177.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.554 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -138.04 148.56 45.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.905 0.859 . . . . 0.0 111.109 174.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -103.28 130.09 50.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.902 176.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.592 ' C ' ' HD2' ' A' ' 17' ' ' PRO . 3.2 m-20 67.96 21.27 8.95 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 168.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.527 ' O ' ' HG2' ' A' ' 19' ' ' MET . 47.5 p90 -67.35 17.07 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.96 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 41.4 mt-10 -132.6 -44.58 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 123.175 0.59 . . . . 0.0 111.18 -173.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.96 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.1 Cg_endo -70.07 -28.77 23.35 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 C-N-CA 121.734 1.623 . . . . 0.0 109.637 169.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' HB2' HD13 ' A' ' 118' ' ' ILE . 5.8 t80 -65.57 -52.53 51.61 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.111 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.704 ' HB2' HD11 ' A' ' 29' ' ' ILE . 83.8 mmm -61.22 -37.86 84.52 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.685 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.883 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 8.4 pttt -69.73 -36.27 75.73 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.206 -175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -71.34 -25.99 62.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.59 172.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.564 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 29.6 tpp -82.61 -43.76 16.62 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.027 -176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 161.44 -42.75 0.4 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.639 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.659 HD23 HG12 ' A' ' 29' ' ' ILE . 12.8 tp -78.86 128.57 76.32 Favored Pre-proline 0 N--CA 1.448 -0.573 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.69 ' CD ' HD12 ' A' ' 28' ' ' LEU . 95.0 Cg_endo -73.32 149.95 46.14 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.228 1.952 . . . . 0.0 111.498 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.052 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.6 tt0 -50.09 -44.43 51.99 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-O 118.427 -0.797 . . . . 0.0 111.057 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 36.6 t70 -56.97 -42.96 81.11 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.803 0.729 . . . . 0.0 110.19 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.69 HD12 ' CD ' ' A' ' 25' ' ' PRO . 45.1 mt -68.47 -33.5 74.27 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.01 -0.676 . . . . 0.0 109.466 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.052 HD12 ' HA ' ' A' ' 26' ' ' GLU . 28.0 mt -62.87 -47.1 94.44 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.271 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.699 170.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.007 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 21.6 mm-40 -53.09 -38.46 62.59 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.229 1.012 . . . . 0.0 112.474 -172.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.007 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.64 -30.2 68.85 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.938 -0.573 . . . . 0.0 109.739 -178.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.77 28.98 5.07 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 115.212 -0.904 . . . . 0.0 112.86 -177.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' HD2' ' HA ' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -78.25 -39.56 39.81 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -166.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -96.29 54.41 1.41 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.645 0.736 . . . . 0.0 110.812 -166.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -99.53 133.16 43.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.61 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.75 147.0 33.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.765 172.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.944 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -144.85 -172.57 15.43 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.981 -175.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.697 HG22 ' HG3' ' A' ' 8' ' ' GLN . 60.8 t -123.71 143.76 35.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.241 0.521 . . . . 0.0 110.732 -173.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 51' ' ' THR . 14.9 m -122.96 120.99 35.03 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-O 120.809 0.338 . . . . 0.0 110.122 174.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.66 ' HG2' ' CG ' ' A' ' 6' ' ' LYS . 25.5 mt-10 -116.32 124.52 50.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.166 0.508 . . . . 0.0 109.633 178.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.651 HG12 ' HG ' ' A' ' 50' ' ' LEU . 96.7 mt -123.66 134.58 66.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.915 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -110.88 114.31 46.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 170.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.741 ' H ' ' HB3' ' A' ' 4' ' ' SER . 3.3 t-160 -115.07 113.51 24.14 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.042 -172.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 37.3 tt0 -111.07 143.1 42.31 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 172.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -35.17 108.4 0.05 OUTLIER Glycine 0 C--O 1.225 -0.425 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.59 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.752 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 16.2 mtmt 83.78 -40.44 0.08 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.603 1.561 . . . . 0.0 113.079 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.618 ' HD2' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -89.65 112.15 23.31 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.104 0.478 . . . . 0.0 110.606 -172.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.638 HG11 ' SD ' ' A' ' 91' ' ' MET . 4.9 t -114.32 123.0 69.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.69 178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 18.2 mtpp -113.47 130.87 56.23 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 175.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.668 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.4 tt -127.61 130.59 49.25 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.599 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -118.04 122.69 43.8 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.668 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.8 mt -124.79 120.35 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.807 HG23 HG22 ' A' ' 58' ' ' VAL . 24.5 m -102.69 127.28 49.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -121.38 107.63 12.72 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.39 -95.44 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.627 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -107.86 -18.26 13.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.889 0.376 . . . . 0.0 111.211 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HE3' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -113.09 128.54 56.52 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.17 0.51 . . . . 0.0 111.254 -170.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 53' ' ' THR . 31.8 t -97.43 125.44 50.54 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.747 0 CA-C-O 122.052 0.93 . . . . 0.0 109.592 177.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.767 HD13 ' O ' ' A' ' 73' ' ' THR . 0.8 OUTLIER -114.52 114.16 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.331 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.909 -177.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.53 144.66 27.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.216 -1.356 . . . . 0.0 112.005 -172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 3.2 m120 -129.02 138.85 52.16 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -145.08 124.73 13.26 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -151.39 152.29 32.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.03 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.653 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 4.7 m -108.0 132.0 53.98 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.752 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 3.2 pp -45.55 146.25 1.1 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.225 0.536 . . . . 0.0 112.156 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.1 13.0 69.44 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.439 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.653 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.0 mm-40 -124.66 143.48 50.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.703 0.287 . . . . 0.0 110.293 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 80' ' ' LYS . 22.9 tt0 -84.54 116.91 23.38 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 63.3 m -134.03 158.83 42.55 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.285 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' HG3' ' HB3' ' A' ' 80' ' ' LYS . 3.5 mt-10 -94.83 120.14 34.55 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-O 122.793 1.282 . . . . 0.0 111.681 -173.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.723 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 28.9 mt -100.76 128.52 46.77 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.222 -2.263 . . . . 0.0 110.706 -170.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.745 ' HB3' HG23 ' A' ' 59' ' ' ILE . 16.1 tt0 -85.79 122.01 29.25 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 173.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.767 ' O ' HD13 ' A' ' 59' ' ' ILE . 12.6 p -85.85 164.53 17.46 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.255 -175.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.408 ' SD ' ' N ' ' A' ' 74' ' ' MET . 0.0 OUTLIER -59.57 -22.7 62.1 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.25 179.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.8 -41.27 53.28 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.761 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 140.27 -21.49 2.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.233 -0.984 . . . . 0.0 114.316 176.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.66 139.44 39.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.618 0.709 . . . . 0.0 111.438 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -98.01 123.37 41.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.126 173.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.9 144.91 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.602 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -83.35 135.79 34.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.371 0.605 . . . . 0.0 111.966 -175.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.551 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -147.5 152.46 38.08 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.051 174.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.1 t -95.78 112.43 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.598 -0.441 . . . . 0.0 109.844 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.785 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.4 OUTLIER -100.11 133.96 41.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.095 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.1 mmtt -103.28 151.44 22.68 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.496 ' HB3' ' CD2' ' A' ' 65' ' ' LEU . 4.7 ttp -128.91 132.91 47.71 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.682 -1.207 . . . . 0.0 113.041 178.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.043 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.5 tp10 -100.45 141.13 33.73 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 112.367 -2.197 . . . . 0.0 108.303 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.87 -36.66 60.48 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.954 -167.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.503 ' C ' HD22 ' A' ' 89' ' ' ASN . 19.4 t0 -87.92 53.64 2.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.805 0.812 . . . . 0.0 110.077 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.691 ' HB2' ' CD2' ' A' ' 104' ' ' PHE 0.251 0.0 OUTLIER 49.41 49.88 19.07 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 113.809 -1.541 . . . . 0.0 112.821 174.519 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.043 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 61.7 mttt -112.39 122.17 46.94 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.318 170.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.638 ' SD ' HG11 ' A' ' 48' ' ' VAL . 5.7 mtm -129.17 117.05 20.15 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 101' ' ' VAL . 0.9 OUTLIER -122.16 118.64 56.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.345 -173.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.785 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -126.61 140.44 52.42 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.572 0.701 . . . . 0.0 111.451 -177.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -128.07 138.8 52.7 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.752 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -137.4 124.16 21.18 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 170.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt 60.87 -101.94 0.12 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.024 -175.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -127.32 15.46 6.41 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.5 mm -98.75 114.27 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 113' ' ' MET . 59.6 tttt -104.69 118.88 37.65 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.513 -171.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.8 m -115.67 118.95 34.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.047 0.451 . . . . 0.0 110.308 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.511 HG22 HG13 ' A' ' 92' ' ' VAL . 98.1 t -113.41 120.41 63.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.657 HG22 ' HE1' ' A' ' 104' ' ' PHE . 0.2 OUTLIER -117.34 119.84 36.35 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.268 174.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 90' ' ' LYS . 28.7 tt0 -129.67 119.92 24.32 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.891 ' CD1' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -113.97 119.2 36.42 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.697 176.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.03 138.09 49.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.463 170.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.95 43.71 96.63 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.648 172.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.588 ' HA ' ' HE2' ' A' ' 7' ' ' TYR . 25.8 m-20 70.07 4.98 5.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.72 0.408 . . . . 0.0 112.089 176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 125' ' ' LYS . 1.0 OUTLIER -110.85 123.35 49.93 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.637 0.732 . . . . 0.0 111.34 173.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.891 HG23 ' CD1' ' A' ' 104' ' ' PHE . 1.4 mt -102.15 124.75 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.045 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 102' ' ' THR . 19.5 m -115.07 120.9 41.4 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.718 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.75 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 3.2 t-20 -116.06 121.27 41.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.892 0.377 . . . . 0.0 110.392 173.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.792 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -120.98 117.81 28.26 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.96 178.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 65.9 mtt -111.95 150.91 29.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.339 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.3 m -127.62 121.84 31.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.546 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.9 OUTLIER -121.86 113.84 20.2 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.45 -93.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.883 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -135.62 17.06 3.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.337 0.589 . . . . 0.0 110.112 171.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.566 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -85.53 137.44 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 172.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -110.19 114.62 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.675 0.75 . . . . 0.0 111.084 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 41.9 t80 -102.78 119.08 38.21 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.665 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.792 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.8 OUTLIER -128.92 131.03 47.51 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.75 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 7.4 ptt180 -124.33 144.37 50.05 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.631 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.779 HG13 ' HB2' ' A' ' 10' ' ' GLN . 11.7 p -100.83 117.63 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 122.11 0.957 . . . . 0.0 109.488 173.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.9 m -123.66 121.52 35.75 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.568 -1.197 . . . . 0.0 108.646 175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.481 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.11 149.33 52.13 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.58 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 15.9 ttp180 -70.17 146.62 50.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.673 -166.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.689 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.745 ' HB3' ' HA ' ' A' ' 89' ' ' ASN . 8.2 p30 -90.18 95.94 10.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.608 0.718 . . . . 0.0 109.446 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -149.1 58.47 1.03 Allowed 'General case' 0 C--N 1.316 -0.878 0 O-C-N 121.677 -0.639 . . . . 0.0 111.98 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.85 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 56.1 p 53.39 -158.53 0.15 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 167.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.01 -172.43 21.59 Favored Glycine 0 CA--C 1.502 -0.764 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.128 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.644 ' HB2' ' CG1' ' A' ' 127' ' ' ILE . 2.8 mtpp -95.99 130.12 43.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.504 0.669 . . . . 0.0 109.811 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 17.5 m-85 -135.07 133.6 39.47 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 172.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HG2' ' HA ' ' A' ' 38' ' ' VAL . 7.3 tm0? -106.21 135.82 47.01 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 p -68.84 141.1 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.592 0.711 . . . . 0.0 109.782 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.832 HE21 ' HA ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -113.69 -49.58 2.88 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.88 -171.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.496 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 14.7 m -159.69 159.63 33.17 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.871 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.447 ' HB3' ' HE1' ' A' ' 120' ' ' TYR . 2.3 mt-30 -142.09 153.58 44.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.537 0.684 . . . . 0.0 111.93 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 1.2 mp0 -94.37 137.39 33.58 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.703 173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.668 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 8.5 m-20 70.23 -83.35 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.825 0 O-C-N 123.892 0.745 . . . . 0.0 110.594 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.965 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 52.3 p90 37.66 29.42 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.75 1.62 . . . . 0.0 112.702 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.976 ' HA ' HD13 ' A' ' 29' ' ' ILE . 46.7 mt-10 -145.01 -47.97 0.02 OUTLIER Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.434 -172.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 44.1 Cg_endo -76.31 -25.25 10.06 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 N-CA-C 108.963 -1.207 . . . . 0.0 108.963 170.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.766 ' HD2' HD11 ' A' ' 118' ' ' ILE . 38.2 t80 -66.47 -52.59 44.58 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.063 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.702 ' HB2' HD11 ' A' ' 29' ' ' ILE . 17.5 mmt -64.04 -37.51 87.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.156 176.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 3.9 pttp -67.12 -39.12 86.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.123 0.487 . . . . 0.0 110.134 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.06 -24.14 61.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.516 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.557 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 30.0 tpp -82.71 -48.82 10.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.879 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.53 -38.16 0.3 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.315 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD23 HG12 ' A' ' 29' ' ' ILE . 15.0 tp -77.55 131.03 72.23 Favored Pre-proline 0 N--CA 1.448 -0.568 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.708 ' HD2' HD12 ' A' ' 28' ' ' LEU . 90.9 Cg_endo -79.1 151.74 23.88 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.502 1.468 . . . . 0.0 111.19 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.034 ' HA ' HD12 ' A' ' 29' ' ' ILE . 18.1 tt0 -50.59 -40.16 51.71 Favored 'General case' 0 C--O 1.207 -1.132 0 CA-C-O 118.943 -0.551 . . . . 0.0 110.937 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 4.5 p-10 -60.84 -36.36 78.92 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-N 118.339 0.518 . . . . 0.0 111.511 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.708 HD12 ' HD2' ' A' ' 25' ' ' PRO . 21.7 mt -71.92 -36.88 70.08 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.301 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' A' ' 26' ' ' GLU . 30.8 mt -62.12 -43.74 98.16 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.523 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.369 174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.2 mm-40 -50.23 -49.3 53.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 122.125 0.965 . . . . 0.0 111.846 -175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 2.2 mptp? -71.07 -30.32 66.43 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 113.738 -1.574 . . . . 0.0 110.829 -175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.99 32.74 3.9 Favored Glycine 0 N--CA 1.434 -1.466 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.931 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.965 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 13.9 ptmm? -78.81 -41.4 30.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.39 0.614 . . . . 0.0 112.589 -168.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.35 52.92 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.66 0.743 . . . . 0.0 110.785 -168.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.3 mm -92.91 131.18 40.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.643 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.403 ' HB3' HE22 ' A' ' 8' ' ' GLN . 10.4 mtmp? -98.82 98.25 9.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.196 0.522 . . . . 0.0 110.166 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -91.4 177.43 40.86 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.588 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 6.1 t -122.37 150.38 25.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -175.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.738 ' HA ' ' O ' ' A' ' 51' ' ' THR . 9.4 m -132.49 130.01 39.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.8 0.333 . . . . 0.0 111.538 -177.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.572 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 5.0 mp0 -122.87 140.02 53.4 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-O 120.9 0.381 . . . . 0.0 110.533 174.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.85 ' O ' ' HB2' ' A' ' 4' ' ' SER . 61.2 mt -129.96 141.96 45.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.281 -176.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.675 ' HB ' ' HD3' ' A' ' 49' ' ' LYS . 99.5 t -108.61 117.98 55.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 166.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' N ' ' HB3' ' A' ' 4' ' ' SER . 17.2 t-160 -95.16 115.21 27.13 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.442 0.639 . . . . 0.0 110.495 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -137.61 143.11 41.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.535 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.73 107.95 0.06 OUTLIER Glycine 0 C--N 1.333 0.402 0 O-C-N 123.835 0.709 . . . . 0.0 112.861 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.66 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 1.1 mtmt 71.64 -38.65 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.843 1.257 . . . . 0.0 113.077 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -90.33 106.62 18.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.707 0.289 . . . . 0.0 110.878 -172.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.26 122.9 66.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.23 0.538 . . . . 0.0 110.666 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.675 ' HD3' ' HB ' ' A' ' 42' ' ' VAL . 6.8 mptt -104.85 132.68 50.8 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.131 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.688 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -120.14 132.49 55.42 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.738 ' O ' ' HA ' ' A' ' 39' ' ' SER . 17.2 m -117.92 124.04 47.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.87 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -128.43 121.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -176.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.545 HG23 HG22 ' A' ' 58' ' ' VAL . 62.1 m -104.01 129.41 51.61 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -118.07 107.26 13.78 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.99 -96.62 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.661 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.5 t -104.48 -24.1 13.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.112 0.482 . . . . 0.0 110.645 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.74 128.48 49.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.84 0.829 . . . . 0.0 112.422 -171.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG22 HG23 ' A' ' 53' ' ' THR . 82.4 t -104.55 124.9 59.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.33 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.87 HG23 HG22 ' A' ' 52' ' ' ILE . 0.1 OUTLIER -105.32 114.31 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.987 177.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -101.93 134.72 44.68 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.307 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.658 HD21 HG13 ' A' ' 59' ' ' ILE . 4.8 m120 -126.14 93.4 3.8 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -102.39 125.82 49.22 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.593 0.711 . . . . 0.0 109.915 175.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -149.57 152.89 36.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.246 -1.343 . . . . 0.0 112.27 -174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.6 m -109.15 132.4 54.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.345 174.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.66 ' HB2' ' H ' ' A' ' 85' ' ' MET . 4.0 pp -52.09 140.11 21.51 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.798 175.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 65.31 24.11 70.44 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.522 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.449 ' HB2' ' HB ' ' A' ' 64' ' ' THR . 33.1 mt-10 -138.05 141.26 40.33 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -76.74 119.07 20.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.631 0.729 . . . . 0.0 109.734 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 m -132.9 152.6 51.85 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.453 -1.249 . . . . 0.0 107.899 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.585 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.6 pt-20 -95.57 145.37 25.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 122.282 1.039 . . . . 0.0 109.192 -176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.2 mt -110.51 133.73 53.02 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 113.718 -1.583 . . . . 0.0 109.604 -168.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.692 ' OE2' ' HA ' ' A' ' 59' ' ' ILE . 8.1 tt0 -90.72 130.61 36.7 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.422 HG21 ' SD ' ' A' ' 22' ' ' MET . 18.7 p -89.45 174.4 7.81 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.772 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.0 tpp -61.46 -25.93 67.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.359 0.6 . . . . 0.0 109.634 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.9 m -80.68 -39.06 27.88 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.093 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.67 1.13 7.1 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.523 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.68 138.89 37.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.846 0.323 . . . . 0.0 111.017 178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 10.0 mmmm -97.72 131.75 43.98 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 123.561 0.538 . . . . 0.0 110.816 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -136.58 133.59 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 34.0 mttm -83.05 123.46 29.5 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 121.507 0.67 . . . . 0.0 111.701 -178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.632 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.94 153.75 45.78 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.474 176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 70.9 t -95.53 111.52 26.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 121.385 0.612 . . . . 0.0 109.944 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.794 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.9 OUTLIER -102.4 133.89 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.311 -177.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 88.9 mttt -117.45 152.77 34.33 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.594 178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.66 ' H ' ' HB2' ' A' ' 65' ' ' LEU . 5.1 ttm -118.45 119.83 35.74 Favored 'General case' 0 N--CA 1.432 -1.331 0 CA-C-O 122.29 1.043 . . . . 0.0 110.486 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.684 ' HG2' ' HD2' ' A' ' 90' ' ' LYS . 11.4 tp10 -63.37 -31.88 73.15 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.649 -2.069 . . . . 0.0 110.734 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 92.11 -32.23 5.54 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.647 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 37.2 t70 -94.69 62.2 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.582 0.705 . . . . 0.0 109.768 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.745 ' HA ' ' HB3' ' A' ' 2' ' ' ASN . 26.7 m-80 70.56 0.94 3.46 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 114.253 -1.34 . . . . 0.0 113.549 174.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.687 ' HE3' ' OE1' ' A' ' 103' ' ' GLU . 33.0 mttp -109.4 122.91 48.4 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.788 -172.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.489 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 2.8 mpp? -117.7 115.46 25.09 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.808 169.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -130.38 124.2 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.689 -172.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.794 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -121.49 140.18 52.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.32 0.581 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.2 m -128.17 126.37 40.9 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.988 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -134.82 113.95 12.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.053 176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt 60.3 -83.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.891 0.476 . . . . 0.0 111.354 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.85 10.42 3.38 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.413 HD13 ' N ' ' A' ' 98' ' ' ILE . 2.0 mm -90.17 113.56 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.658 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 113' ' ' MET . 23.3 tttm -115.78 118.37 32.82 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.201 -172.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.519 ' HB2' HG23 ' A' ' 93' ' ' THR . 4.9 m -117.81 119.16 34.04 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.062 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 92' ' ' VAL . 85.0 t -118.84 119.01 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.326 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 24.9 m -117.92 122.09 42.39 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.908 175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.687 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 35.9 tt0 -128.74 129.15 45.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.724 0.297 . . . . 0.0 110.738 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 22.0 m-30 -95.07 120.51 35.4 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.003 177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 113.07 16.93 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.932 -0.48 . . . . 0.0 110.68 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.05 -102.3 0.83 Allowed Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.779 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -127.97 17.23 6.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.138 0.494 . . . . 0.0 109.9 178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 125' ' ' LYS . 25.6 p -129.73 147.13 51.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.638 0.732 . . . . 0.0 111.723 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.44 HD13 ' CE1' ' A' ' 104' ' ' PHE . 22.1 mt -111.4 128.57 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.789 -174.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.7 m -104.67 119.34 38.77 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -118.31 122.72 43.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.226 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.701 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -122.2 117.5 26.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.444 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.583 ' HB3' ' CE2' ' A' ' 18' ' ' PHE . 5.1 ttm -118.63 146.07 44.94 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.1 m -128.75 121.79 29.19 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.543 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.576 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.4 OUTLIER -102.73 114.2 28.25 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 169.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -48.21 81.06 0.01 OUTLIER Glycine 0 N--CA 1.468 0.814 0 N-CA-C 115.978 1.151 . . . . 0.0 115.978 -160.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 27.2 t70 157.18 -29.01 0.0 OUTLIER 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 125.627 1.571 . . . . 0.0 106.966 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.766 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -115.98 140.72 36.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.209 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.29 115.65 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.458 0.647 . . . . 0.0 111.155 172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 3.6 t80 -100.06 118.74 37.05 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.701 ' HG2' HG23 ' A' ' 112' ' ' THR . 0.7 OUTLIER -123.86 131.83 53.65 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -124.39 131.69 53.51 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.061 -169.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.496 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 8.4 p -100.91 117.55 46.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 121.943 0.878 . . . . 0.0 109.431 172.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.0 m -131.67 136.9 48.05 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.928 177.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.455 ' CG ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -135.08 150.88 50.32 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.081 0.467 . . . . 0.0 111.399 -175.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.503 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 76.9 ttt180 -68.73 148.31 50.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.24 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.644 ' CG1' ' HB2' ' A' ' 6' ' ' LYS . 1.1 pp . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.416 -0.802 . . . . 0.0 112.034 -172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.2 mtt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.573 ' O ' ' HB2' ' A' ' 3' ' ' PHE . 20.5 p-10 -73.35 123.08 23.09 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.042 0.449 . . . . 0.0 111.31 -175.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.655 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . 10.4 t80 163.62 64.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.666 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 80.6 p 57.34 -162.36 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.754 -176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.93 -174.72 15.53 Favored Glycine 0 CA--C 1.507 -0.437 0 N-CA-C 112.149 -0.38 . . . . 0.0 112.149 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.671 ' HE3' HG12 ' A' ' 127' ' ' ILE . 3.6 mtpp -93.39 118.49 31.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 9.9 m-85 -125.02 124.67 42.47 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -93.0 134.39 35.18 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -171.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.3 t -68.08 137.38 24.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.925 0.869 . . . . 0.0 111.782 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.574 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.2 mm100 -112.9 -69.12 0.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.699 -168.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.513 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 20.3 m -151.26 143.28 23.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.274 -170.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.811 ' HB2' ' CD1' ' A' ' 15' ' ' PHE . 5.5 mm-40 -121.3 157.61 29.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.499 0.666 . . . . 0.0 111.449 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.584 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 66.8 mt-10 -105.9 137.39 43.89 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.797 168.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 7.7 m-20 69.76 -80.52 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.87 0 O-C-N 123.524 0.515 . . . . 0.0 111.062 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 12' ' ' GLN . 34.0 p90 35.41 35.41 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 125.691 1.596 . . . . 0.0 113.374 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.854 ' HA ' HD13 ' A' ' 29' ' ' ILE . 73.6 mt-10 -152.9 -48.03 0.01 OUTLIER Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.04 -170.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 37.4 Cg_endo -75.73 -25.17 11.02 Favored 'Trans proline' 0 N--CA 1.438 -1.756 0 N-CA-C 108.657 -1.324 . . . . 0.0 108.657 169.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.744 ' HD2' HD11 ' A' ' 118' ' ' ILE . 52.6 t80 -65.94 -53.29 41.11 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.122 173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.7 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 16.9 mmt -61.93 -37.15 83.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.478 176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 17' ' ' PRO . 10.7 pttt -66.43 -41.71 88.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.075 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -72.07 -20.98 61.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.421 175.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.592 ' HB3' ' HA ' ' A' ' 19' ' ' MET . 25.5 tpp -83.1 -46.21 13.06 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.871 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 158.49 -23.92 0.36 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.494 -0.86 . . . . 0.0 113.121 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.781 HD23 HG12 ' A' ' 29' ' ' ILE . 14.4 tp -91.95 132.91 31.51 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.65 ' CD ' HD12 ' A' ' 28' ' ' LEU . 85.0 Cg_endo -76.14 147.94 30.43 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.29 1.993 . . . . 0.0 111.7 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.098 ' HA ' HD12 ' A' ' 29' ' ' ILE . 4.2 tt0 -49.47 -44.64 46.02 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-O 118.458 -0.782 . . . . 0.0 111.56 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' O ' ' HD3' ' A' ' 31' ' ' LYS . 5.1 t70 -61.35 -35.19 76.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.873 0.76 . . . . 0.0 111.445 -177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.65 HD12 ' CD ' ' A' ' 25' ' ' PRO . 41.1 mt -71.42 -35.71 71.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.874 174.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.098 HD12 ' HA ' ' A' ' 26' ' ' GLU . 23.5 mt -63.73 -46.87 93.37 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.383 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.114 173.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.82 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 26.8 mm-40 -53.13 -38.62 62.84 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.063 0.945 . . . . 0.0 111.376 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 3.8 mptp? -69.71 -46.54 65.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.313 0.578 . . . . 0.0 110.887 176.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.87 39.87 2.36 Favored Glycine 0 N--CA 1.441 -1.012 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.183 -170.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD2' ' OE2' ' A' ' 16' ' ' GLU . 18.2 pttp -79.77 -43.12 23.11 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -166.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -107.2 51.27 0.75 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.222 0.535 . . . . 0.0 112.0 -171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.678 ' HB ' ' CE1' ' A' ' 54' ' ' TYR . 9.3 mm -79.28 118.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.538 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -100.21 118.96 37.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.046 -171.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.729 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -116.89 -160.75 12.01 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.462 -177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 39.6 t -125.53 137.45 57.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.728 0.264 . . . . 0.0 110.748 -174.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 51' ' ' THR . 10.5 t -110.22 134.6 52.07 Favored 'General case' 0 C--O 1.214 -0.776 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 175.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 30.6 mt-10 -136.89 121.17 18.01 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.886 HG12 ' HG ' ' A' ' 50' ' ' LEU . 23.6 mt -124.22 141.35 44.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 122.319 -0.238 . . . . 0.0 111.583 -169.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.49 HG12 ' HG3' ' A' ' 44' ' ' GLU . 86.1 t -110.56 114.83 48.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 165.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -95.15 112.13 23.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.795 0.807 . . . . 0.0 109.576 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.49 ' HG3' HG12 ' A' ' 42' ' ' VAL . 37.9 mt-10 -120.82 144.24 48.44 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.064 -1.425 . . . . 0.0 107.445 174.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -35.85 105.72 0.03 OUTLIER Glycine 0 CA--C 1.52 0.388 0 O-C-N 123.793 0.683 . . . . 0.0 113.183 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.037 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 19.3 mtmt 72.85 -40.94 0.49 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.604 1.562 . . . . 0.0 113.631 -175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HG2' ' H ' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -92.87 107.33 19.13 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.652 0.739 . . . . 0.0 111.544 -176.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.0 t -116.94 124.76 73.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.228 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 44.1 mttp -110.83 123.04 49.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.28 -177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.886 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.6 tt -112.82 128.22 56.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.636 -177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 39' ' ' SER . 5.6 m -111.33 124.74 52.86 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 59' ' ' ILE . 2.2 mt -131.12 120.86 47.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.729 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 43.4 m -98.75 127.09 44.57 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.678 ' CE1' ' HB ' ' A' ' 35' ' ' ILE . 48.5 t80 -121.5 108.11 13.24 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.0 -93.77 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 CA-C-N 115.912 -0.586 . . . . 0.0 113.114 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.3 t -105.38 -23.46 12.84 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.063 0.459 . . . . 0.0 111.15 -178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 132.84 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.415 -170.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 71.3 t -98.08 125.33 51.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.769 0.795 . . . . 0.0 110.438 175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.883 HG13 HD21 ' A' ' 61' ' ' ASN . 0.1 OUTLIER -99.85 115.38 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.121 -1.399 . . . . 0.0 108.245 178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -102.49 126.65 49.62 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.36 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.883 HD21 HG13 ' A' ' 59' ' ' ILE . 3.6 m120 -127.8 97.38 4.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.522 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.13 125.7 50.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 61' ' ' ASN . 9.9 m-85 -129.06 152.8 48.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.177 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.666 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 3.5 m -112.59 122.7 48.46 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.037 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -46.51 125.67 7.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.181 0.515 . . . . 0.0 111.972 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.576 ' HA2' ' HD3' ' A' ' 84' ' ' LYS . . . 82.49 16.39 71.25 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.589 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' A' ' 64' ' ' THR . 6.5 mm-40 -125.9 154.3 42.96 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 21.5 tt0 -79.87 119.31 22.57 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 58.6 m -132.79 156.58 46.85 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.496 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.592 ' HG3' ' HE2' ' A' ' 78' ' ' LYS . 3.3 pt-20 -96.18 143.93 26.85 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 12.5 mt -106.21 127.26 53.1 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.298 -174.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' CD ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 tt0 -88.03 129.0 35.4 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 170.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 p -88.52 174.9 7.82 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.763 -172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 20.2 ttt -70.14 -13.18 62.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.287 0.565 . . . . 0.0 109.761 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.4 p -90.9 -38.64 12.78 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.188 172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.49 -13.86 4.53 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.493 -0.86 . . . . 0.0 114.157 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -80.4 147.04 31.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.584 0.692 . . . . 0.0 111.505 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 8.0 mmmm -96.24 136.47 36.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.979 0.512 . . . . 0.0 111.551 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -138.0 143.46 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.875 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.542 ' HD2' ' OE1' ' A' ' 68' ' ' GLU . 37.1 mtmt -84.9 126.6 33.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 111.758 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.52 146.85 30.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.05 172.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.2 t -93.7 113.06 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.003 0.43 . . . . 0.0 109.937 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.752 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.31 133.24 48.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.572 -176.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 91' ' ' MET . 70.3 mmtt -104.97 151.87 23.39 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.08 177.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.865 ' HB3' HD22 ' A' ' 65' ' ' LEU . 11.7 tpp -128.68 134.79 48.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 122.371 1.081 . . . . 0.0 111.622 172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.463 ' HB3' ' HG3' ' A' ' 90' ' ' LYS . 13.5 tp10 -82.12 -35.55 28.41 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 112.989 -1.914 . . . . 0.0 111.326 -176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.582 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 121.74 -36.5 3.22 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.178 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -78.82 26.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.858 1.313 . . . . 0.0 108.912 171.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.89 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 29.8 m-80 72.06 40.58 0.71 Allowed 'General case' 0 CA--C 1.496 -1.11 0 CA-C-N 112.562 -2.108 . . . . 0.0 110.582 168.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.925 ' HE2' ' HG3' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -117.73 118.94 33.45 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-N 113.496 -1.684 . . . . 0.0 107.913 178.09 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.617 ' HA ' ' O ' ' A' ' 84' ' ' LYS . 42.4 mtm -116.65 123.03 46.27 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.848 0.832 . . . . 0.0 109.362 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 101' ' ' VAL . 0.6 OUTLIER -123.85 118.7 54.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 114.291 -1.322 . . . . 0.0 108.663 -175.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.752 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -119.58 143.75 47.47 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.445 0.64 . . . . 0.0 111.356 -177.133 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.3 m -116.9 126.61 53.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.962 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.789 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 35.2 t80 -139.44 161.24 37.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.28 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.576 ' O ' HG12 ' A' ' 98' ' ' ILE . 22.8 ttmm -27.61 90.68 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.691 1.196 . . . . 0.0 114.008 173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.34 8.49 19.02 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.58 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.789 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 26.3 mm -110.07 112.45 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -114.88 116.65 28.9 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.747 ' HB2' HG23 ' A' ' 93' ' ' THR . 5.4 m -118.08 119.79 35.8 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.653 -173.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 92' ' ' VAL . 84.6 t -115.71 117.52 55.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 12.1 m -118.89 120.95 38.83 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 174.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.925 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 24.2 tt0 -129.37 123.14 30.97 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 121.947 -0.471 . . . . 0.0 110.128 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.89 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 2.3 m-30 -89.71 114.0 25.59 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 172.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -125.45 112.13 15.91 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.72 -95.73 0.48 Allowed Glycine 0 N--CA 1.438 -1.168 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.215 -173.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -145.71 17.08 1.45 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.944 0.402 . . . . 0.0 110.571 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' HB3' ' A' ' 125' ' ' LYS . 5.2 m -128.07 135.3 49.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.884 0.85 . . . . 0.0 110.402 172.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.547 HG13 ' CD2' ' A' ' 7' ' ' TYR . 10.6 mt -102.62 131.45 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.593 -175.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.6 m -115.36 119.22 35.54 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.133 171.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 19.4 t-20 -108.0 122.81 47.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.759 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.748 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.2 OUTLIER -119.85 115.81 24.6 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 1.9 mtt -114.1 150.12 34.55 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.01 0.433 . . . . 0.0 110.262 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 98' ' ' ILE . 32.1 m -126.61 122.5 35.21 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.554 ' H ' HG13 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -116.73 111.16 19.39 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.14 -90.81 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.68 -176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -125.34 0.19 7.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.347 -0.427 . . . . 0.0 110.514 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.744 HD11 ' HD2' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -87.11 140.32 15.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.925 -177.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.0 p -110.76 116.36 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.471 0.653 . . . . 0.0 111.51 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.401 ' HE1' ' HB3' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -109.55 118.82 37.61 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.748 ' HG3' HG23 ' A' ' 112' ' ' THR . 20.8 ttpt -125.9 129.3 49.05 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.178 0.513 . . . . 0.0 109.65 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 34.8 ttm180 -120.22 127.17 52.19 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.261 -172.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' A' ' 10' ' ' GLN . 14.7 p -101.02 124.69 54.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 171.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.1 m -135.34 130.09 34.46 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.913 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.594 ' HB3' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -128.98 144.78 51.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.336 0.971 . . . . 0.0 112.552 -171.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 35.7 ttt180 -69.26 149.94 47.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.849 -170.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.671 HG12 ' HE3' ' A' ' 6' ' ' LYS . 1.2 pp . . . . . 0 N--CA 1.438 -1.063 0 CA-C-O 118.315 -0.85 . . . . 0.0 111.822 -173.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 121.013 0.435 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -109.33 112.6 24.83 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.641 ' HE2' HG11 ' A' ' 48' ' ' VAL . 10.7 t80 79.66 -28.97 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.974 0.91 . . . . 0.0 110.357 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.56 ' HB3' ' N ' ' A' ' 43' ' ' HIS . 94.3 p -82.63 149.93 27.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.301 0.572 . . . . 0.0 112.014 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.39 -178.48 17.06 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.14 -177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -94.27 117.27 29.87 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.768 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 7.3 m-85 -122.39 132.41 54.36 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.814 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.88 130.74 53.78 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.502 -174.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.834 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -69.47 139.05 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.854 176.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.862 ' HB2' HG13 ' A' ' 123' ' ' VAL . 4.8 mm-40 -111.05 -49.24 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.584 -174.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.55 ' HB2' HG12 ' A' ' 123' ' ' VAL . 61.1 m -155.52 154.89 32.47 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.814 -169.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -136.93 157.32 47.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.5 0.667 . . . . 0.0 111.375 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.725 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 4.3 mm-40 -114.03 130.59 56.54 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.512 -1.222 . . . . 0.0 109.994 176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.774 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 13.9 m-80 63.4 31.16 15.26 Favored 'General case' 0 CA--C 1.508 -0.654 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.643 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 23.3 p90 -68.92 16.11 0.05 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.04 0.448 . . . . 0.0 110.87 174.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.883 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 40.7 mt-10 -129.12 -48.42 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.814 -175.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.883 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 38.2 Cg_endo -69.91 -28.5 24.45 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 121.719 1.613 . . . . 0.0 110.297 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.57 ' HB2' HD13 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -63.16 -52.55 61.97 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.369 173.373 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.597 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 85.9 mmm -61.78 -37.59 84.91 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.741 177.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 18.6 pttt -67.05 -37.31 83.83 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.229 0.538 . . . . 0.0 109.731 -175.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB3' HD13 ' A' ' 115' ' ' LEU . . . -67.4 -25.36 65.91 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.33 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 18' ' ' PHE . 58.0 mtp -79.34 -53.4 6.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 162.26 -16.07 0.14 Allowed Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.305 -0.862 . . . . 0.0 113.501 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD23 HG12 ' A' ' 29' ' ' ILE . 13.2 tp -81.68 130.7 60.23 Favored Pre-proline 0 N--CA 1.441 -0.891 0 CA-C-N 117.358 0.579 . . . . 0.0 109.924 -177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.648 ' CD ' HD12 ' A' ' 28' ' ' LEU . 91.6 Cg_endo -76.29 146.68 28.47 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.647 2.232 . . . . 0.0 111.051 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.08 ' HA ' HD12 ' A' ' 29' ' ' ILE . 32.4 tt0 -50.72 -37.46 41.74 Favored 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.131 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.619 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.4 t70 -57.74 -47.19 83.17 Favored 'General case' 0 C--O 1.211 -0.955 0 CA-C-N 119.165 0.893 . . . . 0.0 109.977 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.648 HD12 ' CD ' ' A' ' 25' ' ' PRO . 43.8 mt -68.75 -32.97 73.12 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.08 HD12 ' HA ' ' A' ' 26' ' ' GLU . 36.0 mt -61.6 -44.82 99.28 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.053 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 18.5 mm-40 -52.24 -41.89 63.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.535 0.734 . . . . 0.0 111.789 -174.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.053 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -68.81 -30.54 69.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.134 -176.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.36 32.14 3.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.964 -174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.643 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 20.5 pttm -79.63 -43.13 23.42 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -165.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.48 47.01 1.19 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.344 0.592 . . . . 0.0 111.922 -167.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.8 mm -81.6 118.36 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.15 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm -84.85 145.86 27.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.082 0.468 . . . . 0.0 110.587 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.834 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -145.45 177.81 23.62 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.814 HG22 ' HG3' ' A' ' 8' ' ' GLN . 3.7 t -122.43 145.78 28.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.799 ' HA ' ' O ' ' A' ' 51' ' ' THR . 7.5 p -129.72 120.12 24.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.961 0.41 . . . . 0.0 111.797 176.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 3.7 mp0 -110.12 124.07 50.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.876 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.813 HG12 ' HG ' ' A' ' 50' ' ' LEU . 76.3 mt -123.37 140.41 47.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -168.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.1 t -110.09 114.38 46.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.56 ' N ' ' HB3' ' A' ' 4' ' ' SER . 28.5 t-80 -105.06 114.11 28.11 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 119.409 -0.916 . . . . 0.0 111.323 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -123.29 143.81 49.83 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 169.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -36.35 107.85 0.05 OUTLIER Glycine 0 CA--C 1.522 0.491 0 O-C-N 123.517 0.511 . . . . 0.0 112.624 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.879 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 18.9 mtmm 76.86 -35.58 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.992 1.317 . . . . 0.0 113.069 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 19.7 mttt -90.53 109.57 20.71 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.15 0.5 . . . . 0.0 111.182 -172.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.641 HG11 ' HE2' ' A' ' 3' ' ' PHE . 69.1 t -123.0 128.8 75.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.343 0.592 . . . . 0.0 111.77 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 41.2 mtpt -109.42 126.83 53.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.813 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.8 tt -118.87 122.59 42.67 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.799 ' O ' ' HA ' ' A' ' 39' ' ' SER . 3.2 m -108.5 125.15 51.48 Favored 'General case' 0 C--O 1.206 -1.224 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.673 HG13 HD22 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -130.75 122.63 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-O 121.545 0.688 . . . . 0.0 110.097 -170.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.4 m -103.85 129.78 51.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.196 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -116.55 105.89 12.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.1 -17.44 0.11 Allowed Glycine 0 CA--C 1.527 0.837 0 N-CA-C 115.257 0.863 . . . . 0.0 115.257 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t 172.41 -45.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.07 0.938 . . . . 0.0 109.608 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -97.95 133.04 42.98 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.041 -169.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.6 t -99.63 124.69 53.15 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 121.579 0.704 . . . . 0.0 110.745 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG12 ' OE1' ' A' ' 72' ' ' GLU . 0.3 OUTLIER -126.7 114.59 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.317 177.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.679 ' C ' HD22 ' A' ' 61' ' ' ASN . 0.3 OUTLIER -116.53 149.27 39.86 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -173.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.679 HD22 ' C ' ' A' ' 60' ' ' HIS . 0.5 OUTLIER -124.41 121.38 34.76 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.058 -171.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -103.69 126.26 50.72 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.175 0.512 . . . . 0.0 110.237 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -151.26 152.29 33.03 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.304 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.507 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 2.0 m -105.83 131.81 52.71 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 171.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.884 HD22 ' HB2' ' A' ' 85' ' ' MET . 2.5 pp -72.72 168.54 18.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.762 0.791 . . . . 0.0 111.427 178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.59 11.24 41.04 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.397 -166.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 64' ' ' THR . 47.0 mt-10 -135.4 143.58 46.07 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -174.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.654 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.0 tt0 -83.26 117.11 22.74 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 169.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 80' ' ' LYS . 67.6 m -132.97 157.39 45.28 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.878 -175.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -94.98 119.57 33.72 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-O 122.876 1.322 . . . . 0.0 111.217 -165.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 23.0 mt -102.69 145.89 29.02 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 112.299 -2.228 . . . . 0.0 110.704 -171.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' OE1' HG12 ' A' ' 59' ' ' ILE . 21.0 tt0 -109.25 123.86 49.95 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.8 p -91.43 167.93 11.91 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.253 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -59.73 -29.0 67.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.382 . . . . 0.0 110.62 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.9 p -81.18 -30.66 34.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.297 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 122.98 -5.99 9.55 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.45 176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -78.28 140.74 38.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.346 0.573 . . . . 0.0 110.736 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 23.7 mmmt -95.67 128.16 42.31 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.39 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -136.17 137.5 48.34 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.654 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 69' ' ' CYS . 41.8 pttt -101.96 125.31 48.61 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.564 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 68' ' ' GLU . . . -128.93 146.03 51.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.46 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.654 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 91.8 t -92.79 111.89 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.598 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.852 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -104.05 131.07 53.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.342 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -104.09 152.48 22.03 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.776 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.884 ' HB2' HD22 ' A' ' 65' ' ' LEU . 6.7 ttt -127.73 135.32 50.0 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 122.18 0.991 . . . . 0.0 111.488 175.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.039 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 9.2 tp10 -90.98 0.03 57.63 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.03 -1.895 . . . . 0.0 109.923 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.743 ' H ' ' HG2' ' A' ' 85' ' ' MET . . . 88.56 -65.73 3.29 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.858 173.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.487 ' O ' ' HE3' ' A' ' 90' ' ' LYS . 19.1 m-20 -79.12 57.15 2.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.026 0.441 . . . . 0.0 110.947 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.634 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 8.9 m-80 70.59 40.24 1.06 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.999 -1.0 . . . . 0.0 113.404 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.039 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -119.65 122.74 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.777 169.161 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' ' HG3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -119.27 115.3 23.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 171.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 101' ' ' VAL . 2.1 t -125.26 118.86 53.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.852 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -130.04 143.8 50.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.786 0.803 . . . . 0.0 112.283 -178.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.4 t -126.96 136.99 53.03 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.806 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -139.86 131.7 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt 55.67 28.56 12.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.64 2.89 88.62 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.215 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.437 HD13 ' N ' ' A' ' 98' ' ' ILE . 3.5 mm -90.09 137.63 21.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 113' ' ' MET . 37.4 tttt -112.1 120.73 42.81 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.652 -172.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.6 t -121.52 120.78 35.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.999 0.428 . . . . 0.0 110.142 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.506 ' HA ' HG13 ' A' ' 92' ' ' VAL . 95.4 t -116.4 121.07 66.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.798 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.537 HG23 ' HB2' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -117.19 121.28 40.78 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.093 177.78 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -121.36 115.91 23.82 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.734 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -118.0 119.49 34.95 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.48 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.15 114.75 17.41 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.514 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.59 46.6 4.85 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 63.43 11.4 5.52 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.098 0.475 . . . . 0.0 111.452 178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 13.0 p -120.92 129.11 53.34 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.978 -0.451 . . . . 0.0 110.403 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.734 HG12 ' HB3' ' A' ' 104' ' ' PHE . 3.0 mt -109.75 130.24 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.726 -170.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 m -116.92 119.36 35.11 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 172.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.537 ' HB2' HG23 ' A' ' 102' ' ' THR . 2.9 t-20 -115.38 123.33 48.41 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.854 0.359 . . . . 0.0 110.504 178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 3.3 m -120.02 125.34 48.1 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.485 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.704 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 30.8 ttm -120.6 149.97 41.63 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 37.0 m -122.0 121.47 37.11 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 118' ' ' ILE . 0.8 OUTLIER -122.86 111.62 16.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 53.31 -101.64 0.09 OUTLIER Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.59 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -100.9 -11.94 19.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.147 0.499 . . . . 0.0 110.733 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.57 HD13 ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.59 135.57 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.854 -170.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.404 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 3.6 p -112.62 115.2 49.16 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.635 0 CA-C-O 121.292 0.568 . . . . 0.0 111.231 175.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.758 ' OH ' ' HD3' ' A' ' 122' ' ' ARG . 15.3 t80 -109.83 119.98 41.04 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 121.536 -0.728 . . . . 0.0 111.125 -173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.725 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 2.7 ttmt -123.92 124.52 42.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.749 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.758 ' HD3' ' OH ' ' A' ' 120' ' ' TYR . 22.2 ptt85 -119.38 144.14 47.05 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.371 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.862 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.2 p -100.99 118.86 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.483 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.429 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 65.4 m -123.55 130.41 52.64 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.421 177.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.503 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -134.01 139.01 45.76 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.038 0.447 . . . . 0.0 110.858 -174.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.768 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 2.9 ttt180 -71.85 149.28 45.36 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.698 0.761 . . . . 0.0 112.055 -175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.575 ' N ' ' HG2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.313 -0.988 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.71 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 121.137 0.494 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.621 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 25.2 p-10 -69.67 139.03 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.053 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.959 ' HD2' ' HA ' ' A' ' 89' ' ' ASN . 5.0 t80 92.16 -8.65 0.21 Allowed 'General case' 0 CA--C 1.507 -0.69 0 CA-C-N 113.996 -1.456 . . . . 0.0 108.176 176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.648 ' HB3' ' H ' ' A' ' 43' ' ' HIS . 0.0 OUTLIER -117.99 160.37 21.6 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.951 -1.022 . . . . 0.0 112.504 179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 122.32 177.18 15.25 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.691 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.763 ' HE3' ' HG2' ' A' ' 40' ' ' GLU . 44.6 mtpt -96.88 118.22 32.83 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 31.7 m-85 -120.81 125.08 46.63 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 15.4 tm0? -93.19 134.28 35.54 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG22 HE21 ' A' ' 12' ' ' GLN . 0.6 OUTLIER -69.24 136.21 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.072 0.939 . . . . 0.0 109.666 -179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 123' ' ' VAL . 5.6 mm100 -111.52 -56.89 2.32 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.499 -167.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.625 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 57.3 m -152.97 150.75 29.54 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.706 -174.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.561 HE21 HG22 ' A' ' 9' ' ' VAL . 17.8 mp0 -133.11 147.86 52.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.749 0.785 . . . . 0.0 110.998 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.997 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 9.7 mm-40 -92.55 127.76 38.16 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.092 173.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.566 ' CG ' ' HG2' ' A' ' 17' ' ' PRO . 45.3 m-20 70.06 -102.58 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.094 0.871 . . . . 0.0 110.123 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.486 ' HZ ' ' HG3' ' A' ' 74' ' ' MET . 5.2 t80 72.82 13.19 5.13 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 121.842 0.829 . . . . 0.0 110.249 175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.832 ' HA ' HD13 ' A' ' 29' ' ' ILE . 33.3 mt-10 -141.2 -45.78 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.652 -171.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.746 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 31.6 Cg_exo -60.97 -37.53 76.01 Favored 'Trans proline' 0 CA--C 1.494 -1.52 0 C-N-CA 122.439 2.093 . . . . 0.0 108.574 162.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -57.76 -53.92 52.77 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 111.113 -2.767 . . . . 0.0 109.628 175.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.672 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.13 -36.34 83.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.329 176.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 16.1 pttt -66.82 -40.15 87.92 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.08 28.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.837 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.1 tpt -155.1 -44.43 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -165.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 169.15 -51.26 0.21 Allowed Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.591 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.431 HD23 HG12 ' A' ' 29' ' ' ILE . 15.8 tp -85.08 135.8 39.04 Favored Pre-proline 0 N--CA 1.443 -0.797 0 CA-C-N 116.945 0.372 . . . . 0.0 110.754 -173.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.613 ' CG ' HD12 ' A' ' 28' ' ' LEU . 97.4 Cg_endo -77.69 151.43 28.43 Favored 'Trans proline' 0 CA--C 1.518 -0.291 0 C-N-CA 122.968 2.445 . . . . 0.0 111.675 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.964 ' HA ' HD12 ' A' ' 29' ' ' ILE . 0.9 OUTLIER -49.86 -45.39 50.46 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.891 -178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.676 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 2.4 p-10 -56.61 -42.26 78.46 Favored 'General case' 0 C--O 1.207 -1.141 0 CA-C-N 118.664 0.666 . . . . 0.0 110.208 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.613 HD12 ' CG ' ' A' ' 25' ' ' PRO . 40.9 mt -70.55 -33.71 71.43 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.095 178.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.964 HD12 ' HA ' ' A' ' 26' ' ' GLU . 25.6 mt -64.75 -44.39 96.48 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.324 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.015 172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.929 ' HB2' ' HE3' ' A' ' 31' ' ' LYS . 22.9 mm-40 -52.55 -40.72 62.83 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.079 0.952 . . . . 0.0 111.327 -173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.929 ' HE3' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -69.56 -31.29 69.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.713 -178.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.63 33.41 2.87 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.902 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 29' ' ' ILE . 20.4 ptmt -78.61 -37.17 42.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.743 0.782 . . . . 0.0 112.784 -167.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.41 51.11 1.17 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.96 -165.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.1 117.36 26.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.643 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -102.45 112.6 25.4 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -117.09 -163.15 12.94 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.142 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 23.7 t -129.32 150.29 34.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.726 ' HA ' ' O ' ' A' ' 51' ' ' THR . 6.2 p -127.96 118.47 23.63 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.972 171.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.763 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 1.7 mp0 -114.54 123.61 49.8 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.896 -177.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 ' HG ' ' A' ' 50' ' ' LEU . 80.4 mt -122.6 137.83 54.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.078 0.466 . . . . 0.0 111.951 -170.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.1 t -109.46 118.58 57.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.648 ' H ' ' HB3' ' A' ' 4' ' ' SER . 15.2 t-160 -96.72 113.16 24.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.926 0.869 . . . . 0.0 110.499 -177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.705 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 8.3 tp10 -116.83 143.35 45.79 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.548 ' O ' ' HD2' ' A' ' 47' ' ' LYS . . . -43.42 101.1 0.02 OUTLIER Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.824 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmt 79.1 -31.92 0.14 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.295 1.438 . . . . 0.0 112.353 -175.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -90.44 108.85 20.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.057 0.456 . . . . 0.0 110.601 -177.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG11 ' HE1' ' A' ' 3' ' ' PHE . 42.4 t -110.59 124.13 67.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.359 0.599 . . . . 0.0 110.804 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 73.6 mttt -107.16 122.67 46.96 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.941 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.714 ' HG ' HG12 ' A' ' 41' ' ' ILE . 1.5 tt -117.45 127.63 54.21 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -175.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.726 ' O ' ' HA ' ' A' ' 39' ' ' SER . 4.1 m -110.73 123.87 50.88 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.646 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -126.97 120.49 55.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.025 HG23 HG22 ' A' ' 58' ' ' VAL . 53.7 m -101.32 128.41 47.49 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.733 -1.122 . . . . 0.0 108.955 -171.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.5 t80 -110.35 157.8 19.13 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -43.06 101.54 0.02 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 123.608 0.567 . . . . 0.0 113.193 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 t 84.42 -21.59 0.25 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.369 1.068 . . . . 0.0 112.707 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 54' ' ' TYR . 4.2 tmmm? -131.49 122.97 27.1 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.783 -0.573 . . . . 0.0 111.733 -174.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.025 HG22 HG23 ' A' ' 53' ' ' THR . 21.4 t -97.99 132.45 42.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-O 122.192 0.996 . . . . 0.0 111.407 -177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.695 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -117.84 114.77 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.878 0 CA-C-N 113.803 -1.544 . . . . 0.0 109.506 -176.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.709 ' C ' HD22 ' A' ' 61' ' ' ASN . 10.0 p80 -91.36 146.36 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.118 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.709 HD22 ' C ' ' A' ' 60' ' ' HIS . 0.8 OUTLIER -131.57 105.32 7.47 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.774 0.429 . . . . 0.0 110.04 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -104.61 127.01 52.24 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.088 0.47 . . . . 0.0 110.881 176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -150.89 151.55 32.37 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.061 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 1.7 m -110.39 133.59 53.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.074 -0.966 . . . . 0.0 108.526 176.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.6 ' O ' HD12 ' A' ' 65' ' ' LEU . 4.0 pp -52.66 142.77 17.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.281 0.563 . . . . 0.0 111.129 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.87 25.08 76.4 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 64' ' ' THR . 70.3 mm-40 -132.75 138.22 47.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.478 0.18 . . . . 0.0 111.069 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 8.3 tt0 -78.53 118.08 20.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.606 0.717 . . . . 0.0 109.096 168.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 3.2 m -134.65 162.72 31.52 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.094 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.813 ' HG3' ' HG2' ' A' ' 80' ' ' LYS . 2.2 mt-10 -94.6 119.21 32.9 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-O 122.331 1.062 . . . . 0.0 110.585 -175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 25.5 mt -92.88 120.48 33.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 113.061 -1.881 . . . . 0.0 109.628 -175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' OE1' HG12 ' A' ' 59' ' ' ILE . 25.2 tt0 -92.79 121.9 34.64 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.493 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -87.58 167.42 13.94 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.159 -170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.486 ' HG3' ' HZ ' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -56.01 -27.51 53.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.764 0.316 . . . . 0.0 110.963 -177.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -91.65 -12.6 33.69 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.695 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 122.23 -22.7 7.44 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.973 172.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.62 147.28 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.788 0.794 . . . . 0.0 111.147 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.22 132.03 56.34 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.791 -176.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.29 142.12 41.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.613 -178.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.813 ' HG2' ' HG3' ' A' ' 70' ' ' GLU . 76.8 mttt -82.71 123.79 29.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.523 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -143.95 147.71 34.33 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.476 174.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 68' ' ' GLU . 44.3 t -91.34 113.44 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.149 0.5 . . . . 0.0 109.694 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.781 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -95.62 133.11 37.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -103.02 140.04 37.8 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.0 tmm? -129.2 132.02 47.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 118.343 -1.343 . . . . 0.0 112.1 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 4.2 tp10 -80.28 -48.13 13.51 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 112.449 -2.16 . . . . 0.0 111.957 -171.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 115.49 -45.21 1.33 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.225 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -81.08 44.22 0.75 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 122.51 1.148 . . . . 0.0 109.69 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.959 ' HA ' ' HD2' ' A' ' 3' ' ' PHE . 34.5 m-80 69.68 43.43 0.98 Allowed 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 113.204 -1.816 . . . . 0.0 112.01 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.884 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 24.5 mttp -131.45 119.97 22.35 Favored 'General case' 0 N--CA 1.427 -1.603 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.654 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 5.2 ttp -121.92 121.13 36.4 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.455 -1.248 . . . . 0.0 109.692 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 101' ' ' VAL . 0.2 OUTLIER -128.88 116.69 41.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.781 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -121.37 134.53 55.12 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.401 0.619 . . . . 0.0 110.43 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.8 m -128.33 127.36 42.55 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.557 -176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -122.69 111.46 16.76 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 46.51 -99.88 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.527 -173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.07 17.94 34.39 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 mm -100.88 113.13 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 113' ' ' MET . 42.1 tttp -113.86 118.99 35.77 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.571 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.665 ' HB3' HG23 ' A' ' 93' ' ' THR . 32.1 t -120.64 119.81 33.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.763 0.316 . . . . 0.0 110.332 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 92' ' ' VAL . 1.8 m -112.42 121.82 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 6.4 m -119.69 120.58 37.03 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.24 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 42.5 tt0 -130.55 129.19 42.5 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.101 -0.239 . . . . 0.0 111.029 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 89' ' ' ASN . 0.0 OUTLIER -109.79 118.69 37.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.52 HD22 ' HA ' ' A' ' 105' ' ' ASN . 0.4 OUTLIER -129.24 102.97 6.69 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.832 -1.147 . . . . 0.0 111.122 171.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.85 62.46 2.81 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.312 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 126' ' ' ARG . 7.3 m-20 67.88 -3.84 1.11 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.2 p -117.24 142.02 47.57 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.752 -0.592 . . . . 0.0 111.834 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.511 HD11 ' CG ' ' A' ' 7' ' ' TYR . 8.9 mt -116.91 135.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.521 -175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.6 m -112.22 119.81 39.63 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 169.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.435 ' HB3' ' HB3' ' A' ' 122' ' ' ARG . 2.8 t-20 -114.65 121.49 43.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.942 0.401 . . . . 0.0 110.226 176.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 6.6 m -122.35 117.86 27.06 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.161 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.668 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 33.9 ttm -124.67 149.34 47.28 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.3 m -123.88 121.85 36.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.585 ' H ' HG13 ' A' ' 118' ' ' ILE . 1.3 tp -117.56 114.58 23.64 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.566 -178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 68.29 -82.89 0.19 Allowed Glycine 0 C--N 1.319 -0.366 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.603 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -140.07 5.64 2.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.862 0.839 . . . . 0.0 109.338 175.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.585 HG13 ' H ' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -91.86 139.07 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.361 -173.247 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 p -104.67 117.11 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.61 0.719 . . . . 0.0 110.757 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.668 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 27.2 t80 -107.16 120.41 42.05 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.735 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.997 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 3.6 mtmt -123.73 128.31 49.41 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.304 0.573 . . . . 0.0 109.673 175.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 111' ' ' ASN . 14.7 ttt180 -119.75 132.34 55.6 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.067 -174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' A' ' 11' ' ' SER . 7.7 p -100.5 117.42 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 172.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 3.5 m -124.85 133.72 52.98 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.805 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' HG3' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -133.13 149.22 52.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.211 0.529 . . . . 0.0 111.339 -176.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 4.7 ttp180 -69.6 150.47 47.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.053 -174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.709 HD11 ' HB2' ' A' ' 6' ' ' LYS . 5.8 pt . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.161 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptp . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.541 ' HB3' ' H ' ' A' ' 106' ' ' GLY . 21.0 p-10 -100.94 110.7 22.77 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.646 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -154.83 -64.48 0.13 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.026 0.917 . . . . 0.0 109.297 174.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.726 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 17.8 p -141.72 -163.64 1.62 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.428 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.94 -176.53 16.11 Favored Glycine 0 CA--C 1.501 -0.839 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.819 174.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.732 ' HB3' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.79 116.93 30.0 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -176.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 50.9 m-85 -121.01 124.51 45.02 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.911 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -93.5 137.03 33.2 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.982 HG12 ' H ' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -68.93 135.91 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.739 ' HB2' HG13 ' A' ' 123' ' ' VAL . 12.6 mm100 -110.76 -48.4 3.14 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.441 -168.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.58 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 31.3 m -158.12 156.75 31.5 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.542 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.22 158.18 45.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 -178.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -119.7 125.79 49.53 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.663 -177.144 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.658 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 8.9 m-80 64.58 29.06 13.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 O-C-N 123.219 0.325 . . . . 0.0 111.704 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 1.03 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 29.6 p90 -67.58 6.12 0.69 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.078 0.466 . . . . 0.0 110.92 175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.875 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 27.8 mt-10 -120.76 -46.23 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.142 -174.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.875 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 32.9 Cg_endo -67.48 -29.71 37.0 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.4 1.4 . . . . 0.0 109.978 173.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 1.1 t80 -65.31 -52.18 55.72 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.48 176.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.589 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 87.1 mmm -61.04 -41.39 96.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.439 176.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.573 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 14.3 ptmt -68.78 -33.95 74.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.273 -172.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.613 ' HB3' ' CD1' ' A' ' 115' ' ' LEU . . . -71.31 -22.71 61.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.15 177.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 18' ' ' PHE . 86.7 mmm -85.74 -72.15 0.5 Allowed 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.38 0.609 . . . . 0.0 110.749 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.54 -33.42 0.02 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 119.948 -1.12 . . . . 0.0 114.641 -172.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.74 HD23 HG12 ' A' ' 29' ' ' ILE . 12.0 tp -86.23 125.03 69.26 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 117.952 0.876 . . . . 0.0 109.718 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.686 ' CD ' HD12 ' A' ' 28' ' ' LEU . 88.4 Cg_endo -72.21 148.18 49.33 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.496 2.131 . . . . 0.0 111.261 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 1.082 ' HA ' HD12 ' A' ' 29' ' ' ILE . 8.4 tt0 -48.84 -41.8 34.19 Favored 'General case' 0 C--O 1.206 -1.235 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.663 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.666 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 16.9 t70 -61.85 -37.86 86.08 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 118.944 0.793 . . . . 0.0 111.168 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.686 HD12 ' CD ' ' A' ' 25' ' ' PRO . 35.1 mt -70.37 -35.01 73.27 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.491 176.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.082 HD12 ' HA ' ' A' ' 26' ' ' GLU . 21.5 mt -63.92 -44.61 98.03 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.461 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.822 172.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.876 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.0 mm-40 -50.52 -47.73 57.36 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.974 0.892 . . . . 0.0 112.067 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.666 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -68.62 -30.84 69.65 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.641 -177.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.04 31.65 4.43 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.088 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.03 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 14.0 ptmm? -79.23 -39.65 32.63 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -165.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -101.07 46.68 0.93 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.536 -167.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 7.8 mt -86.41 129.52 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.126 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.99 147.61 23.21 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.169 0.509 . . . . 0.0 109.816 177.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.982 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -142.69 171.34 24.83 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.911 HG22 ' HG3' ' A' ' 8' ' ' GLN . 11.5 t -121.93 132.93 69.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 117.538 0.669 . . . . 0.0 110.588 -174.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.835 ' HB3' HD21 ' A' ' 50' ' ' LEU . 5.7 m -113.42 120.64 41.75 Favored 'General case' 0 C--O 1.21 -0.997 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.17 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.732 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 46.9 mt-10 -119.66 123.0 42.75 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.117 0.484 . . . . 0.0 110.034 -177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.726 ' O ' ' HB2' ' A' ' 4' ' ' SER . 96.4 mt -119.31 138.28 50.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -168.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.83 115.07 48.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.229 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.57 ' N ' ' HB3' ' A' ' 4' ' ' SER . 27.3 t-80 -96.37 122.17 38.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.647 0.737 . . . . 0.0 111.707 -176.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -129.83 143.09 50.63 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.57 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -42.35 136.09 3.57 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.733 176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.794 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER 66.42 -50.97 0.43 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.198 0.999 . . . . 0.0 112.586 -174.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -99.13 109.26 21.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.457 0.646 . . . . 0.0 112.37 -167.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.526 HG11 ' HE3' ' A' ' 91' ' ' MET . 80.7 t -122.72 129.14 75.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.96 -174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 39.0 mttp -109.77 135.21 51.04 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 39' ' ' SER . 1.6 tt -125.11 125.84 44.38 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 39' ' ' SER . 9.4 m -110.9 121.14 44.59 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.705 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.4 mt -123.96 121.1 61.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.436 0.636 . . . . 0.0 109.394 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 18.6 m -101.21 128.9 47.12 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -117.47 107.66 14.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.17 -80.09 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.467 -178.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.2 t -121.31 -35.45 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.601 0.239 . . . . 0.0 111.559 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.8 138.49 35.87 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.298 0.57 . . . . 0.0 112.127 -170.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 21.5 t -99.74 126.6 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-O 121.804 0.811 . . . . 0.0 110.769 -177.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.794 HD11 ' HA2' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -118.94 114.89 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.002 -179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.622 ' C ' HD22 ' A' ' 61' ' ' ASN . 0.5 OUTLIER -87.15 146.5 26.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.342 -177.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.729 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -127.78 106.91 9.45 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -108.01 126.18 52.41 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.695 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -150.21 152.28 34.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.309 0.576 . . . . 0.0 111.83 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 7.5 m -121.34 133.31 55.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.9 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.9 ' HB3' ' HB3' ' A' ' 85' ' ' MET . 3.5 pp -46.39 141.95 3.28 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.449 0.642 . . . . 0.0 112.465 176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 66.06 21.9 70.18 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.048 -0.978 . . . . 0.0 112.91 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' THR . 72.5 mm-40 -132.44 140.94 48.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.712 0.256 . . . . 0.0 110.8 -174.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' HB2' HG23 ' A' ' 82' ' ' VAL . 9.5 tt0 -79.74 117.59 20.77 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.895 0.855 . . . . 0.0 109.311 171.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 m -128.4 159.27 35.88 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 114.313 -1.312 . . . . 0.0 108.522 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.723 ' HG2' ' HG2' ' A' ' 80' ' ' LYS . 38.9 mt-10 -94.57 119.18 32.84 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-O 122.89 1.329 . . . . 0.0 110.588 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 36.3 mt -94.72 121.5 36.37 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 111.772 -2.467 . . . . 0.0 109.602 -174.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' HB3' HG23 ' A' ' 59' ' ' ILE . 26.8 tt0 -94.59 124.3 38.54 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 59' ' ' ILE . 19.1 p -86.1 164.78 17.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.894 -172.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -62.27 -19.36 63.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.3 0.571 . . . . 0.0 109.564 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 4.6 m -73.78 -48.0 34.76 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.507 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.794 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 143.11 -31.18 1.98 Allowed Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.433 -0.889 . . . . 0.0 114.019 178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -77.0 138.71 39.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.929 0.365 . . . . 0.0 110.923 -175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -101.94 136.83 41.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.826 -177.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -134.47 143.14 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.901 0.382 . . . . 0.0 111.114 -177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.723 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 56.2 mttp -81.69 123.32 28.63 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.607 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.568 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -145.71 148.54 33.13 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.858 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.512 HG23 ' HB2' ' A' ' 68' ' ' GLU . 38.8 t -91.74 114.27 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.956 0.408 . . . . 0.0 110.059 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.758 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 0.5 OUTLIER -106.71 134.95 46.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.291 177.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.557 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 23.5 mmtt -105.11 155.51 18.94 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.9 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 2.1 tmt? -129.16 136.36 50.08 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.105 0.955 . . . . 0.0 112.077 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 8.9 tp10 -110.26 148.53 31.71 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 113.573 -1.649 . . . . 0.0 109.273 178.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . -58.16 -25.54 57.24 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 115.037 0.775 . . . . 0.0 115.037 -168.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.634 ' HB2' ' HD2' ' A' ' 90' ' ' LYS . 4.9 m-20 -80.21 28.82 0.29 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.085 0.945 . . . . 0.0 109.738 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.596 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 0.1 OUTLIER 61.52 47.24 6.74 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 113.177 -1.828 . . . . 0.0 109.385 172.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.77 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 7.0 mtpt -107.61 123.9 49.16 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-N 114.623 -1.171 . . . . 0.0 108.55 -175.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.526 ' HE3' HG11 ' A' ' 48' ' ' VAL . 16.2 mmt -113.88 112.64 23.68 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -175.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.436 HG12 ' HE3' ' A' ' 99' ' ' LYS . 2.4 t -123.39 116.34 48.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.251 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.758 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -132.13 145.17 51.2 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.447 0.641 . . . . 0.0 110.667 -178.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.5 m -125.49 124.91 42.39 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.497 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.676 ' CZ ' ' HE3' ' A' ' 96' ' ' LYS . 62.1 t80 -139.74 112.45 7.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.974 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.676 ' HE3' ' CZ ' ' A' ' 95' ' ' PHE . 8.6 mtmp? 42.52 57.87 3.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 175.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 83.21 -9.42 60.98 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.646 -0.788 . . . . 0.0 113.152 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 115' ' ' LEU . 2.0 mm -90.31 113.3 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 113' ' ' MET . 0.1 OUTLIER -104.35 130.66 52.19 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.086 0.47 . . . . 0.0 110.577 -179.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' HG23 ' A' ' 93' ' ' THR . 19.0 t -125.34 124.92 42.61 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.893 -176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.435 HG22 HG13 ' A' ' 92' ' ' VAL . 71.9 t -123.32 118.59 55.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.441 . . . . 0.0 109.877 173.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 90' ' ' LYS . 2.8 m -118.62 122.58 42.91 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 175.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.77 ' HG3' ' HE3' ' A' ' 90' ' ' LYS . 12.2 tt0 -129.28 124.95 35.7 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 119.751 -0.78 . . . . 0.0 111.005 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.647 ' CD1' HD13 ' A' ' 109' ' ' ILE . 1.3 m-30 -101.42 115.47 30.59 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -128.51 117.46 21.35 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.515 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.541 ' H ' ' HB3' ' A' ' 2' ' ' ASN . . . 69.06 -95.02 0.39 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.088 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -141.0 12.93 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.857 0.36 . . . . 0.0 110.439 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p -131.38 146.4 52.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.581 0.705 . . . . 0.0 111.784 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.748 ' HB ' ' OG ' ' A' ' 124' ' ' SER . 21.1 mt -129.09 135.31 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.341 -173.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.6 m -115.89 120.52 39.47 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 169.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.685 ' HB3' ' HG2' ' A' ' 122' ' ' ARG . 14.1 t-20 -107.88 124.79 50.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.004 0.431 . . . . 0.0 110.16 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 5.5 m -119.48 122.45 41.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.806 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.622 ' HB2' ' HD2' ' A' ' 120' ' ' TYR . 1.7 mtt -122.09 150.71 41.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 176.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 7.0 m -122.43 120.14 33.06 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.613 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 3.4 tm? -124.63 115.1 20.26 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.06 -107.0 1.59 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.202 -0.999 . . . . 0.0 110.919 -172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -115.41 6.69 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.071 0.462 . . . . 0.0 109.959 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.672 ' CD1' ' HB2' ' A' ' 18' ' ' PHE . 0.8 OUTLIER -93.03 139.61 17.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.317 -173.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 119' ' ' VAL . 5.0 p -108.65 114.99 48.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.489 0 CA-C-O 121.413 0.625 . . . . 0.0 110.841 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.622 ' HD2' ' HB2' ' A' ' 113' ' ' MET . 7.2 t80 -112.03 121.34 44.72 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.367 0.604 . . . . 0.0 111.941 -172.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 6.4 mtmm -121.28 139.42 53.42 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.391 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.685 ' HG2' ' HB3' ' A' ' 111' ' ' ASN . 11.4 ptt180 -123.43 142.39 51.04 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.787 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.739 HG13 ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -99.86 118.56 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 173.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.748 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 93.5 p -129.57 133.23 47.08 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.358 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -129.32 147.28 51.14 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.718 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.63 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 10.6 ttp180 -70.85 148.83 47.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.256 0.55 . . . . 0.0 110.172 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.065 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.674 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.415 ' ND2' HD22 ' A' ' 89' ' ' ASN . 1.1 p-10 -78.69 95.84 5.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.942 0.877 . . . . 0.0 110.746 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -148.87 70.94 1.12 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.025 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.741 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 88.0 p 58.19 -157.25 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 124.073 0.858 . . . . 0.0 111.961 175.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.51 -173.37 17.72 Favored Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 121.197 -0.525 . . . . 0.0 112.321 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.713 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 42.9 mtpt -94.33 118.12 31.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.133 0.492 . . . . 0.0 110.086 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.638 ' CE2' ' HB2' ' A' ' 126' ' ' ARG . 30.7 m-85 -120.13 123.53 43.56 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -97.08 130.52 44.36 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -173.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 124' ' ' SER . 0.5 OUTLIER -69.94 140.75 18.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.581 0.705 . . . . 0.0 110.794 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.669 ' HB2' HG13 ' A' ' 123' ' ' VAL . 8.3 mm100 -109.06 -39.58 5.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.75 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.511 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . 13.3 m -159.15 159.99 35.04 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.134 -174.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.544 ' HG3' ' HB2' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -139.43 157.5 45.75 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.499 0.666 . . . . 0.0 111.376 177.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.766 ' HB3' ' H ' ' A' ' 121' ' ' LYS . 6.2 tp10 -114.49 126.88 55.45 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.964 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.787 ' HB3' ' HG2' ' A' ' 17' ' ' PRO . 89.8 m-20 57.04 35.38 26.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.238 0.542 . . . . 0.0 111.867 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.841 ' HE2' ' HB2' ' A' ' 33' ' ' LYS . 32.7 p90 -69.16 21.73 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.402 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.945 ' HG2' HG21 ' A' ' 29' ' ' ILE . 41.1 mt-10 -135.36 -48.26 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -172.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.901 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 42.3 Cg_endo -71.0 -26.4 21.81 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 121.212 1.275 . . . . 0.0 109.432 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.811 ' HD1' HD11 ' A' ' 118' ' ' ILE . 44.6 t80 -65.11 -52.18 56.91 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 113.967 -1.47 . . . . 0.0 109.031 175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.957 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 23.3 mmt -61.51 -41.86 97.93 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.297 174.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.75 ' HE2' ' HA ' ' A' ' 17' ' ' PRO . 9.0 pttt -68.4 -33.92 75.1 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.288 0.566 . . . . 0.0 110.553 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.65 -30.23 66.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.639 172.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 9.0 ttm -83.19 -48.34 10.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.86 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 164.8 -34.24 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.548 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.073 HD12 HG13 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -74.56 126.99 88.14 Favored Pre-proline 0 N--CA 1.446 -0.66 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.918 ' HD2' HD13 ' A' ' 24' ' ' LEU . 98.9 Cg_endo -79.27 141.68 16.32 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.896 1.73 . . . . 0.0 111.227 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.937 ' HA ' HD12 ' A' ' 29' ' ' ILE . 2.1 tt0 -49.67 -42.22 44.9 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.705 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 9.7 t70 -55.76 -44.14 77.36 Favored 'General case' 0 C--O 1.21 -1.02 0 CA-C-N 118.544 0.611 . . . . 0.0 109.854 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.671 HD12 ' CG ' ' A' ' 25' ' ' PRO . 19.6 mt -68.4 -33.41 74.2 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.777 -178.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.073 HG13 HD12 ' A' ' 24' ' ' LEU . 27.3 mt -64.66 -44.14 96.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.331 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.5 169.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 1.066 ' HB2' ' HE2' ' A' ' 31' ' ' LYS . 23.0 mm-40 -53.04 -41.0 64.36 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.025 0.53 . . . . 0.0 111.255 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 1.066 ' HE2' ' HB2' ' A' ' 30' ' ' GLN . 0.0 OUTLIER -71.23 -31.55 67.71 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.358 178.053 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -132.6 44.66 1.18 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.865 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.841 ' HB2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -79.67 -39.79 30.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -167.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.463 ' H ' ' HE2' ' A' ' 33' ' ' LYS . 7.6 t70 -98.88 61.0 1.27 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 122.032 0.92 . . . . 0.0 110.236 -167.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.3 115.34 29.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.814 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -98.31 100.88 12.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.001 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -97.08 -175.57 34.77 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.598 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 3.2 t -122.05 155.51 26.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 51' ' ' THR . 16.0 m -133.95 119.68 19.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.145 176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.57 ' CG ' ' HG2' ' A' ' 6' ' ' LYS . 3.1 mp0 -116.75 123.85 48.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.192 0.52 . . . . 0.0 110.299 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.741 ' O ' ' HB2' ' A' ' 4' ' ' SER . 38.7 mt -116.84 143.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 -171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 48' ' ' VAL . 92.6 t -109.02 114.73 47.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 167.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 4' ' ' SER . 15.9 t-160 -96.37 112.79 24.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 121.559 0.695 . . . . 0.0 110.387 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -127.88 145.54 50.91 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 171.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' LYS . . . -36.67 114.48 0.22 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.554 -0.831 . . . . 0.0 111.433 174.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 1.073 ' HA ' ' HG ' ' A' ' 65' ' ' LEU . 0.4 OUTLIER 58.68 -25.31 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 -172.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 21.8 mmtp -91.26 107.09 18.97 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 118.283 0.492 . . . . 0.0 111.036 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 46.3 t -124.53 124.4 68.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.015 0.436 . . . . 0.0 110.491 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 1.2 tttm -115.22 139.06 50.26 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.649 ' CD2' HG13 ' A' ' 52' ' ' ILE . 1.3 tt -121.93 124.95 45.28 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.158 -175.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.743 ' O ' ' HA ' ' A' ' 39' ' ' SER . 58.2 m -110.2 124.38 51.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.649 HG13 ' CD2' ' A' ' 50' ' ' LEU . 1.5 mt -129.33 121.06 52.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 10.2 m -99.53 130.63 45.79 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.658 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -109.18 108.15 18.69 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.93 -89.68 0.13 Allowed Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.919 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.8 t -124.82 -3.65 7.68 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.749 0.309 . . . . 0.0 111.145 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -121.91 136.2 54.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.749 0.309 . . . . 0.0 110.181 -170.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 93.8 t -98.33 134.19 37.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.012 0.91 . . . . 0.0 112.223 -172.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD13 ' O ' ' A' ' 73' ' ' THR . 0.2 OUTLIER -118.64 114.75 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.603 176.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.628 ' C ' HD22 ' A' ' 61' ' ' ASN . 0.0 OUTLIER -87.35 145.43 26.32 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.039 -1.437 . . . . 0.0 112.962 -172.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 0.8 OUTLIER -135.07 98.6 4.04 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 49' ' ' LYS . 3.5 mp0 -102.55 132.08 48.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.992 -0.443 . . . . 0.0 110.618 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -150.02 151.81 33.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.663 0.744 . . . . 0.0 112.091 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.585 ' O ' ' HB2' ' A' ' 67' ' ' GLU . 22.9 m -107.78 134.03 51.32 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.112 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.073 ' HG ' ' HA ' ' A' ' 46' ' ' LYS . 4.7 mt -48.08 131.13 15.94 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.869 0.366 . . . . 0.0 111.05 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 72.82 32.77 60.8 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.013 177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 64' ' ' THR . 50.4 mm-40 -132.98 139.03 47.07 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 28.3 tt0 -80.56 116.98 20.88 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 172.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.9 t -135.75 160.74 37.6 Favored 'General case' 0 CA--C 1.481 -1.673 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.272 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.684 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 5.5 pt-20 -95.95 145.15 25.64 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.383 -1.281 . . . . 0.0 108.221 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 19.4 mt -105.88 128.42 53.76 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.509 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 59' ' ' ILE . 14.5 tt0 -91.63 120.29 32.27 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.621 ' O ' HD13 ' A' ' 59' ' ' ILE . 11.2 p -90.51 166.42 13.24 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.997 -173.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -61.27 -20.24 62.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.858 0.361 . . . . 0.0 110.64 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.1 p -82.61 -38.67 23.25 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.11 177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.468 ' HA2' HD11 ' A' ' 59' ' ' ILE . . . 133.04 -14.89 4.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.56 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -77.38 138.39 39.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.824 0.312 . . . . 0.0 111.534 -175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 71' ' ' LEU . 9.9 mmmm -96.85 135.83 38.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.804 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -137.13 131.45 45.82 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.346 177.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.684 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 41.0 pttt -83.68 124.24 30.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.478 0.656 . . . . 0.0 111.031 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.569 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -140.99 149.38 41.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.428 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 93' ' ' THR . 71.2 t -93.95 113.08 27.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.834 ' HB ' HG22 ' A' ' 93' ' ' THR . 0.2 OUTLIER -104.76 132.33 51.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.561 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -117.66 156.17 28.65 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.492 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.789 ' HB3' HD13 ' A' ' 65' ' ' LEU . 8.7 tpp -126.32 122.23 34.86 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 122.098 0.951 . . . . 0.0 110.147 177.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.634 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 12.2 tp10 -46.43 -43.9 16.85 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 112.752 -2.022 . . . . 0.0 110.527 172.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.572 ' N ' ' HG3' ' A' ' 85' ' ' MET . . . 137.94 -59.65 0.61 Allowed Glycine 0 CA--C 1.5 -0.901 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.857 176.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.811 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 0.2 OUTLIER -63.4 -72.0 0.15 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.16 0.505 . . . . 0.0 110.954 176.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.811 ' ND2' ' HB3' ' A' ' 88' ' ' ASP . 1.5 p30 -150.43 13.16 0.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -169.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.634 ' HB2' ' CB ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -109.81 119.87 40.72 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.004 -178.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.496 ' HG2' ' HB2' ' A' ' 85' ' ' MET . 50.9 mtm -121.98 115.96 23.48 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.783 174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.547 HG13 HG22 ' A' ' 101' ' ' VAL . 1.4 t -124.06 122.15 63.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.905 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.834 HG22 ' HB ' ' A' ' 83' ' ' VAL . 0.1 OUTLIER -113.07 143.53 44.17 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.8 m -125.62 129.78 50.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.16 0.505 . . . . 0.0 112.007 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.458 ' HB3' ' HB ' ' A' ' 98' ' ' ILE . 58.5 t80 -138.59 157.56 45.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.649 175.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 98' ' ' ILE . 48.1 mtmt -41.71 104.58 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.932 0.493 . . . . 0.0 112.007 177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.51 -30.7 1.01 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.315 -0.469 . . . . 0.0 113.229 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.458 ' HB ' ' HB3' ' A' ' 95' ' ' PHE . 2.1 mm -90.04 111.72 23.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -176.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.647 ' O ' ' HA ' ' A' ' 113' ' ' MET . 46.3 tttt -113.29 125.46 54.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.025 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -114.2 119.11 35.95 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.547 HG22 HG13 ' A' ' 92' ' ' VAL . 74.9 t -118.74 119.22 60.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.854 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 40.6 m -117.42 120.46 38.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.626 175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.86 120.48 24.99 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.977 ' HB3' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.29 112.48 25.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 118.896 -1.122 . . . . 0.0 109.031 171.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -127.34 107.57 10.09 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.454 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.44 45.47 37.42 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.237 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 126' ' ' ARG . 6.5 m-20 68.48 4.83 4.47 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.955 0.502 . . . . 0.0 111.84 177.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.6 p -117.95 128.09 54.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.877 0.37 . . . . 0.0 110.798 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.977 HG12 ' HB3' ' A' ' 104' ' ' PHE . 4.9 mt -109.91 132.57 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.364 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -107.33 119.76 40.28 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.822 171.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.786 ' HB2' ' HG2' ' A' ' 122' ' ' ARG . 18.8 m120 -106.61 121.65 44.76 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 171.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -121.75 118.78 29.92 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.103 -179.101 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.647 ' HA ' ' O ' ' A' ' 99' ' ' LYS . 77.1 mtm -124.8 149.83 46.98 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 56.7 m -127.85 122.59 33.0 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 122.126 -0.359 . . . . 0.0 110.722 -173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.656 HD23 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -111.84 112.41 24.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 177.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 56.18 -98.74 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.703 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -104.97 -12.87 15.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.502 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.811 HD11 ' HD1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -87.4 137.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.397 -172.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.59 115.05 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-O 121.487 0.66 . . . . 0.0 110.822 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 13' ' ' GLU . 17.3 t80 -100.37 119.06 37.86 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 -178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.766 ' H ' ' HB3' ' A' ' 13' ' ' GLU . 4.4 tmmm? -128.11 124.58 37.3 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.469 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.786 ' HG2' ' HB2' ' A' ' 111' ' ' ASN . 14.5 ptt180 -120.02 148.65 43.3 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.549 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.669 HG13 ' HB2' ' A' ' 10' ' ' GLN . 6.7 p -101.61 118.26 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.596 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.737 ' OG ' ' HB ' ' A' ' 109' ' ' ILE . 84.3 p -125.42 132.54 52.72 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.8 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HG3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -132.0 146.65 52.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.689 0.626 . . . . 0.0 112.689 -171.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -70.08 149.6 47.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.933 -176.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.713 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 5.6 pt . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.471 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.448 HD22 ' ND2' ' A' ' 89' ' ' ASN . 2.5 p-10 -83.52 97.11 8.84 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.004 -178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -157.14 77.86 0.88 Allowed 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 167.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.687 ' HB2' ' O ' ' A' ' 41' ' ' ILE . 82.1 p 62.26 -168.07 0.2 Allowed 'General case' 0 C--N 1.318 -0.796 0 O-C-N 124.266 0.979 . . . . 0.0 112.783 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.28 -170.7 13.45 Favored Glycine 0 CA--C 1.5 -0.888 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.624 ' HB2' ' CD1' ' A' ' 127' ' ' ILE . 17.0 mtpp -96.82 118.24 32.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.681 0.753 . . . . 0.0 110.312 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.74 ' HA ' ' HA ' ' A' ' 126' ' ' ARG . 6.0 m-85 -120.7 134.91 55.25 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -102.0 140.13 36.71 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -175.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.9 t -64.64 139.07 21.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 122.004 0.907 . . . . 0.0 110.984 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.896 ' HB3' HG13 ' A' ' 123' ' ' VAL . 1.5 mm-40 -114.12 -58.17 2.18 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.954 -167.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.681 ' HB2' HG12 ' A' ' 123' ' ' VAL . 29.0 m -157.18 152.36 26.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.681 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.435 ' HG2' ' HE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.67 151.35 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.54 0.686 . . . . 0.0 110.792 174.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.737 ' HB2' ' H ' ' A' ' 121' ' ' LYS . 13.7 mm-40 -94.45 130.22 40.9 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.525 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.723 ' O ' ' HG3' ' A' ' 16' ' ' GLU . 16.9 m-20 70.52 -82.31 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 O-C-N 123.715 0.634 . . . . 0.0 110.927 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.528 ' HA ' ' HD2' ' A' ' 18' ' ' PHE . 51.0 p90 39.57 36.46 0.24 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.651 1.58 . . . . 0.0 112.304 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.913 ' H ' ' HD2' ' A' ' 17' ' ' PRO . 73.9 mt-10 -144.47 -46.5 0.02 OUTLIER Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.157 -175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.913 ' HD2' ' H ' ' A' ' 16' ' ' GLU . 61.1 Cg_endo -68.22 -34.72 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 121.968 1.779 . . . . 0.0 109.718 169.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.608 ' HB2' ' CD1' ' A' ' 118' ' ' ILE . 0.9 OUTLIER -62.3 -50.03 73.28 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.947 -1.933 . . . . 0.0 111.198 174.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.614 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 61.0 mmm -62.96 -41.07 99.42 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.881 174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 17' ' ' PRO . 16.1 ptmt -69.03 -32.73 72.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.25 0.547 . . . . 0.0 110.319 -175.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.06 -32.55 71.03 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.954 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 34.0 mtt -83.42 -59.46 2.44 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.25 -44.3 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 119.393 -1.384 . . . . 0.0 114.678 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 13.6 tp -75.56 126.44 87.44 Favored Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-N 117.564 0.682 . . . . 0.0 110.037 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.667 ' CD ' HD12 ' A' ' 28' ' ' LEU . 86.3 Cg_endo -73.85 153.39 47.86 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.709 2.273 . . . . 0.0 111.424 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.992 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.3 tt0 -50.56 -43.71 56.39 Favored 'General case' 0 C--O 1.207 -1.157 0 CA-C-O 118.655 -0.688 . . . . 0.0 111.243 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.724 ' O ' ' HD2' ' A' ' 31' ' ' LYS . 4.2 p-10 -57.18 -41.72 79.84 Favored 'General case' 0 C--O 1.214 -0.814 0 CA-C-N 118.4 0.545 . . . . 0.0 110.704 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.667 HD12 ' CD ' ' A' ' 25' ' ' PRO . 46.8 mt -71.08 -34.32 71.05 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.883 -0.51 . . . . 0.0 109.714 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.992 HD12 ' HA ' ' A' ' 26' ' ' GLU . 45.4 mt -61.73 -46.9 95.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.476 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.692 170.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.785 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 25.6 mm-40 -52.36 -44.36 65.19 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.547 1.139 . . . . 0.0 112.05 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.724 ' HD2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -69.71 -31.35 69.32 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.415 0.626 . . . . 0.0 110.343 -177.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' HG12 ' A' ' 35' ' ' ILE . . . -122.09 29.16 5.63 Favored Glycine 0 N--CA 1.436 -1.343 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.585 -175.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 29' ' ' ILE . 23.5 pttm -79.41 -28.34 41.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.48 0.657 . . . . 0.0 111.523 -171.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.73 44.99 1.22 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.23 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 32' ' ' GLY . 27.7 mm -93.9 123.96 46.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -108.54 99.45 8.83 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.438 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 53' ' ' THR . . . -89.62 -179.96 44.76 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.936 -174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' GLN . 3.5 t -123.26 148.24 27.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -178.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.789 ' HA ' ' O ' ' A' ' 51' ' ' THR . 19.2 m -128.77 123.53 33.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.974 0.416 . . . . 0.0 112.086 -177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.568 ' HG3' ' HG2' ' A' ' 6' ' ' LYS . 15.5 mp0 -117.0 123.46 46.95 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.413 0.625 . . . . 0.0 110.162 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.805 HG12 ' HG ' ' A' ' 50' ' ' LEU . 25.0 mt -120.72 141.6 40.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.933 -172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.551 HG12 ' HG2' ' A' ' 44' ' ' GLU . 96.1 t -109.13 119.52 58.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.787 166.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.443 ' N ' ' HB3' ' A' ' 4' ' ' SER . 23.3 t-80 -93.07 112.55 24.55 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 121.854 0.835 . . . . 0.0 109.814 173.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 47' ' ' LYS . 43.4 mm-40 -123.33 144.01 49.72 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 174.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -41.6 107.09 0.09 OUTLIER Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.363 176.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.801 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . 11.3 mtmm 71.79 -24.01 0.18 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.121 1.369 . . . . 0.0 112.869 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 70.0 mmtt -96.0 109.77 22.1 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.801 0.334 . . . . 0.0 110.482 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.441 HG21 ' CE ' ' A' ' 91' ' ' MET . 55.9 t -121.72 123.56 69.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.628 0.728 . . . . 0.0 111.5 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 41' ' ' ILE . 25.0 mttm -112.37 123.06 49.45 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.715 176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.805 ' HG ' HG12 ' A' ' 41' ' ' ILE . 2.3 tt -114.81 121.84 44.53 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.789 ' O ' ' HA ' ' A' ' 39' ' ' SER . 2.8 m -106.28 125.3 50.83 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.678 HG13 HD22 ' A' ' 50' ' ' LEU . 1.1 mt -129.26 121.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -171.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.969 HG23 HG22 ' A' ' 58' ' ' VAL . 23.9 m -104.01 129.07 51.59 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 -175.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CZ ' HG13 ' A' ' 35' ' ' ILE . 40.0 t80 -116.45 106.47 13.64 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.42 -99.96 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.122 -0.561 . . . . 0.0 112.546 -177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.6 t -94.37 -28.72 15.38 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.405 0.622 . . . . 0.0 110.846 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -107.71 125.37 51.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.841 -166.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.969 HG22 HG23 ' A' ' 53' ' ' THR . 21.2 t -99.51 125.19 53.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.452 0.644 . . . . 0.0 110.781 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.709 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -124.82 114.33 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 CA-C-O 122.635 1.207 . . . . 0.0 109.093 177.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.505 ' HB3' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -109.72 149.56 29.59 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.352 -1.295 . . . . 0.0 112.334 -172.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -117.64 108.38 15.37 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -174.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.59 125.65 51.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.065 0.46 . . . . 0.0 110.403 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CD1' HG21 ' A' ' 83' ' ' VAL . 3.5 p90 -151.38 152.73 33.51 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.618 -176.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' LYS . 15.6 m -111.6 134.71 52.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.78 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.801 ' HG ' ' HB3' ' A' ' 46' ' ' LYS . 4.0 pp -49.43 143.81 6.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.17 0.51 . . . . 0.0 111.617 175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 84' ' ' LYS . . . 67.15 19.15 69.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.763 177.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 64' ' ' THR . 76.1 mm-40 -129.24 146.94 51.05 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.692 0.246 . . . . 0.0 110.86 -174.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.527 ' OE1' ' HD2' ' A' ' 80' ' ' LYS . 41.8 tt0 -79.86 118.41 21.61 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.9 m -134.21 150.48 51.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.101 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 80' ' ' LYS . 3.3 pt-20 -95.01 140.01 30.57 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.19 -173.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 81' ' ' ALA . 18.5 mt -109.54 134.35 52.01 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.202 -169.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.585 ' HG3' ' HD2' ' A' ' 78' ' ' LYS . 0.9 OUTLIER -87.57 138.26 31.63 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-O 121.948 0.88 . . . . 0.0 108.927 169.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.9 p -95.16 167.81 11.13 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.151 -1.386 . . . . 0.0 109.769 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.3 tpp -65.67 -18.17 65.13 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.1 p -83.74 -39.93 19.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.901 174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.709 ' HA2' ' CD1' ' A' ' 59' ' ' ILE . . . 130.1 -5.81 6.04 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.308 -0.948 . . . . 0.0 114.719 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -79.87 144.72 33.19 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.573 0.686 . . . . 0.0 110.558 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.17 125.73 38.98 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.11 130.94 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 22.8 pttt -97.12 140.48 31.56 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.321 1.058 . . . . 0.0 112.976 -173.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 71' ' ' LEU . . . -146.43 159.99 42.67 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.064 -1.88 . . . . 0.0 108.168 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -94.36 112.85 27.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.348 0.594 . . . . 0.0 110.153 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.738 ' HA ' ' HB ' ' A' ' 93' ' ' THR . 2.0 m -103.78 136.36 37.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.682 -175.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.405 ' HA ' ' H ' ' A' ' 66' ' ' GLY . 10.1 mttt -116.45 156.94 25.94 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.768 0.318 . . . . 0.0 110.336 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.554 ' HB3' HD23 ' A' ' 65' ' ' LEU . 32.6 ttp -126.34 135.54 51.61 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.888 0.851 . . . . 0.0 110.452 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.081 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 11.1 tp10 -86.12 -14.75 43.27 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.614 -173.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' ASN . . . 114.36 -68.87 0.25 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.993 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.406 ' OD1' ' HD3' ' A' ' 90' ' ' LYS . 2.4 p-10 -74.65 44.46 0.21 Allowed 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.342 0.592 . . . . 0.0 110.966 174.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.868 ' HB3' ' CD2' ' A' ' 104' ' ' PHE . 7.6 m-80 65.02 44.98 3.24 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.8 169.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 1.081 ' HB2' ' HB3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -106.51 121.37 44.16 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 166.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.441 ' CE ' HG21 ' A' ' 48' ' ' VAL . 2.0 mpt? -119.58 114.39 22.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 101' ' ' VAL . 0.5 OUTLIER -124.43 119.22 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.738 ' HB ' ' HA ' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -126.4 139.86 52.94 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.182 0.515 . . . . 0.0 110.661 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.0 t -128.99 139.89 51.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.899 -177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -138.84 113.4 8.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.971 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt 53.0 -95.91 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.024 0.53 . . . . 0.0 111.677 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.19 10.15 15.13 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mm -92.19 122.77 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 113' ' ' MET . 38.1 tttm -123.97 116.72 23.32 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.229 -173.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.474 ' HB2' HG23 ' A' ' 93' ' ' THR . 14.6 m -121.65 119.92 33.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 110.679 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 HG13 ' A' ' 92' ' ' VAL . 92.0 t -117.0 119.64 62.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.779 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 m -117.47 126.1 52.04 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.823 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' ' HE2' ' A' ' 90' ' ' LYS . 39.1 tt0 -127.45 121.98 32.26 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.659 175.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.868 ' CD2' ' HB3' ' A' ' 89' ' ' ASN . 7.4 m-30 -92.98 116.12 28.76 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 167.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -124.24 110.99 15.33 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -174.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 75.49 -74.32 1.52 Allowed Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.637 -178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -165.91 13.63 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.106 -0.547 . . . . 0.0 109.591 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 125' ' ' LYS . 2.8 m -123.44 142.22 51.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.52 0.676 . . . . 0.0 110.425 174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.454 HD11 ' CD1' ' A' ' 7' ' ' TYR . 15.0 mt -102.77 129.85 53.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.338 -173.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -113.38 117.4 31.67 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 167.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' A' ' 122' ' ' ARG . 4.1 t-20 -113.74 120.38 40.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.946 176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.729 HG23 ' HG3' ' A' ' 121' ' ' LYS . 0.3 OUTLIER -121.88 115.97 23.55 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 178.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.64 ' HB3' ' HD2' ' A' ' 120' ' ' TYR . 9.3 ttp -125.93 144.45 50.67 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 2.4 m -121.44 121.62 37.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.771 ' HB2' HG12 ' A' ' 118' ' ' ILE . 0.7 OUTLIER -92.95 145.59 24.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 169.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.05 25.46 0.15 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.545 1.378 . . . . 0.0 116.545 -165.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 115' ' ' LEU . 27.4 t70 -149.83 -9.04 0.3 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 159.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 115' ' ' LEU . 0.7 OUTLIER -116.01 139.62 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.71 -168.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 p -106.56 116.55 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 121.433 0.635 . . . . 0.0 110.192 174.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.64 ' HD2' ' HB3' ' A' ' 113' ' ' MET . 14.0 t80 -115.36 120.97 41.36 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.105 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.737 ' H ' ' HB2' ' A' ' 13' ' ' GLU . 23.6 ttpt -125.14 137.34 54.16 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.24 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.544 ' HD3' ' HB3' ' A' ' 111' ' ' ASN . 44.4 ttt180 -132.08 127.12 35.41 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.086 0.47 . . . . 0.0 111.682 -174.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.896 HG13 ' HB3' ' A' ' 10' ' ' GLN . 11.3 p -101.88 128.15 54.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 169.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 109' ' ' ILE . 20.9 m -134.63 131.89 38.34 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.409 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' HA ' HG23 ' A' ' 108' ' ' THR . 11.4 ptmt -120.96 145.27 47.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.609 0.64 . . . . 0.0 111.334 -170.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 7' ' ' TYR . 43.3 ttt180 -70.1 151.5 45.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.624 ' CD1' ' HB2' ' A' ' 6' ' ' LYS . 6.0 pt . . . . . 0 N--CA 1.431 -1.395 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.814 -174.576 . . . . . . . . 1 1 . 1 stop_ save_